Table S7B. Manually Curated List of Genes Predicted by TUSON Explorer to Have OG-like Signatures,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,
Gene,Gene Description,qvalue_LOF/Benign,qvalue_MissDamaging/Benign,qvalue_EntropyMissense,pvalue_Amplification_GISTIC2,qvalue_Amplification_GISTIC2,TUSON_p_value_OG,TUSON_q_value_OG,OG_Probability_LASSO,Manual Confidence,Druggable,Literature Status,"GO FAT Terms (BP, CC, MF)",KEGG Pathways,Implicated in Cancer (PMID),Potential Functional Role in Cancer (PMID)
BRAF,V-raf murine sarcoma viral oncogene homolog B1,1,3.44E-133,1.21E-51,4.90E-06,1.94E-05,6.30E-64,1.18E-59,0.973805795243956,4,YES,known,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0019992~diacylglycerol binding,GO:0030554~adenyl nucleotide binding,GO:0031434~mitogen-activated protein kinase kinase binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0005886~plasma membrane,GO:0000165~MAPKKK cascade,GO:0006461~protein complex assembly,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006916~anti-apoptosis,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007264~small GTPase mediated signal transduction,GO:0010941~regulation of cell death,GO:0016310~phosphorylation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043933~macromolecular complex subunit organization,GO:0051259~protein oligomerization,GO:0051291~protein heterooligomerization,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04150:mTOR signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04510:Focal adhesion,hsa04650:Natural killer cell mediated cytotoxicity,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,",Reviewed (23414474) (23290787) (12068308),Reviewed (22471666) (21577205)
KRAS,V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog,1,4.60E-72,3.20E-36,7.94E-36,8.53E-35,1.28E-49,1.19E-45,0.972689886440149,4,YES,known,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0019002~GMP binding,GO:0019003~GDP binding,GO:0019904~protein domain specific binding,GO:0030275~LRR domain binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0006897~endocytosis,GO:0006915~apoptosis,GO:0007010~cytoskeleton organization,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007568~aging,GO:0007569~cell aging,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007632~visual behavior,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0008542~visual learning,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010324~membrane invagination,GO:0010647~positive regulation of cell communication,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016265~death,GO:0019220~regulation of phosphate metabolic process,GO:0019221~cytokine-mediated signaling pathway,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0031644~regulation of neurological system process,GO:0031960~response to corticosteroid stimulus,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0032768~regulation of monooxygenase activity,GO:0032770~positive regulation of monooxygenase activity,GO:0033674~positive regulation of kinase activity,GO:0035020~regulation of Rac protein signal transduction,GO:0035022~positive regulation of Rac protein signal transduction,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042692~muscle cell differentiation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043388~positive regulation of DNA binding,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0043549~regulation of kinase activity,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0045449~regulation of transcription,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0046579~positive regulation of Ras protein signal transduction,GO:0048167~regulation of synaptic plasticity,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048545~response to steroid hormone stimulus,GO:0050804~regulation of synaptic transmission,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051090~regulation of transcription factor activity,GO:0051091~positive regulation of transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051101~regulation of DNA binding,GO:0051146~striated muscle cell differentiation,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051341~regulation of oxidoreductase activity,GO:0051347~positive regulation of transferase activity,GO:0051353~positive regulation of oxidoreductase activity,GO:0051384~response to glucocorticoid stimulus,GO:0051385~response to mineralocorticoid stimulus,GO:0051969~regulation of transmission of nerve impulse,GO:0060548~negative regulation of cell death,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04320:Dorso-ventral axis formation,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04530:Tight junction,hsa04540:Gap junction,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04916:Melanogenesis,hsa04960:Aldosterone-regulated sodium reabsorption,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,",Reviewed (20108024) (19349489),Reviewed (20563706) (19063751)
PIK3CA,"Phosphoinositide-3-kinase, catalytic, alpha polypeptide",1,9.07E-98,1.75E-32,0,0,4.89E-46,3.04E-42,0.981109040949133,4,NO,known,"GO:0000166~nucleotide binding,GO:0001727~lipid kinase activity,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004428~inositol or phosphatidylinositol kinase activity,GO:0005524~ATP binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035004~phosphoinositide 3-kinase activity,GO:0043560~insulin receptor substrate binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0005829~cytosol,GO:0005942~phosphoinositide 3-kinase complex,GO:0030027~lamellipodium,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0044445~cytosolic part,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006468~protein amino acid phosphorylation,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006916~anti-apoptosis,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0010941~regulation of cell death,GO:0016310~phosphorylation,GO:0019318~hexose metabolic process,GO:0019637~organophosphate metabolic process,GO:0019932~second-messenger-mediated signaling,GO:0030258~lipid modification,GO:0030384~phosphoinositide metabolic process,GO:0040008~regulation of growth,GO:0040014~regulation of multicellular organism growth,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043491~protein kinase B signaling cascade,GO:0046486~glycerolipid metabolic process,GO:0046834~lipid phosphorylation,GO:0046854~phosphoinositide phosphorylation,GO:0048015~phosphoinositide-mediated signaling,GO:0060548~negative regulation of cell death,","hsa00562:Inositol phosphate metabolism,hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04150:mTOR signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04930:Type II diabetes mellitus,hsa04960:Aldosterone-regulated sodium reabsorption,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,",Reviewed (22114931) (22009150),Reviewed (16357568) (21646685) (21649579)
IDH1,"Isocitrate dehydrogenase 1 (NADP+), soluble",1,1,1.72E-49,0.999909065544305,1,2.83E-34,1.32E-30,0.953834548265563,4,NO,known,"GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0004448~isocitrate dehydrogenase activity,GO:0004450~isocitrate dehydrogenase (NADP+) activity,GO:0030145~manganese ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0048037~cofactor binding,GO:0050661~NADP or NADPH binding,GO:0050662~coenzyme binding,GO:0051287~NAD or NADH binding,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005777~peroxisome,GO:0005829~cytosol,GO:0042579~microbody,GO:0003006~reproductive developmental process,GO:0006081~cellular aldehyde metabolic process,GO:0006084~acetyl-CoA metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006097~glyoxylate cycle,GO:0006099~tricarboxylic acid cycle,GO:0006102~isocitrate metabolic process,GO:0006518~peptide metabolic process,GO:0006575~cellular amino acid derivative metabolic process,GO:0006732~coenzyme metabolic process,GO:0006733~oxidoreduction coenzyme metabolic process,GO:0006739~NADP metabolic process,GO:0006749~glutathione metabolic process,GO:0006769~nicotinamide metabolic process,GO:0006790~sulfur metabolic process,GO:0006979~response to oxidative stress,GO:0007548~sex differentiation,GO:0008406~gonad development,GO:0008585~female gonad development,GO:0009060~aerobic respiration,GO:0009109~coenzyme catabolic process,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009820~alkaloid metabolic process,GO:0010033~response to organic substance,GO:0014070~response to organic cyclic substance,GO:0015980~energy derivation by oxidation of organic compounds,GO:0019362~pyridine nucleotide metabolic process,GO:0019748~secondary metabolic process,GO:0043603~cellular amide metabolic process,GO:0045137~development of primary sexual characteristics,GO:0045333~cellular respiration,GO:0046356~acetyl-CoA catabolic process,GO:0046487~glyoxylate metabolic process,GO:0046496~nicotinamide nucleotide metabolic process,GO:0046545~development of primary female sexual characteristics,GO:0046660~female sex differentiation,GO:0048545~response to steroid hormone stimulus,GO:0048608~reproductive structure development,GO:0051186~cofactor metabolic process,GO:0051187~cofactor catabolic process,GO:0055114~oxidation reduction,","hsa00020:Citrate cycle (TCA cycle),hsa00480:Glutathione metabolism,","Mutated in glioblastoma multiforme (18772396); (19228619); mutated in AML (23261068); Alteration in brain, blood and cartilagenous lineages (23232569)",Reviewed (22399191)
CTNNB1,"Catenin (cadherin-associated protein), beta 1, 88kDa",1,1.30E-34,9.17E-16,0.494671069386825,1,2.05E-29,7.67E-26,0.903233550976128,4,YES,known,"GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0010843~promoter binding,GO:0016563~transcription activator activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0030528~transcription regulator activity,GO:0035257~nuclear hormone receptor binding,GO:0035258~steroid hormone receptor binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0045294~alpha-catenin binding,GO:0045296~cadherin binding,GO:0046332~SMAD binding,GO:0050681~androgen receptor binding,GO:0050839~cell adhesion molecule binding,GO:0051427~hormone receptor binding,GO:0070411~I-SMAD binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005916~fascia adherens,GO:0005938~cell cortex,GO:0014704~intercalated disc,GO:0015630~microtubule cytoskeleton,GO:0016323~basolateral plasma membrane,GO:0016327~apicolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0016342~catenin complex,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0030018~Z disc,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030425~dendrite,GO:0030877~beta-catenin destruction complex,GO:0031252~cell leading edge,GO:0031253~cell projection membrane,GO:0031528~microvillus membrane,GO:0031674~I band,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034747~Axin-APC-beta-catenin-GSK3B complex,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043198~dendritic shaft,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0043292~contractile fiber,GO:0043296~apical junction complex,GO:0044430~cytoskeletal part,GO:0044445~cytosolic part,GO:0044449~contractile fiber part,GO:0044451~nucleoplasm part,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045177~apical part of cell,GO:0045202~synapse,GO:0070013~intracellular organelle lumen,GO:0070161~anchoring junction,GO:0070369~beta-catenin-TCF7L2 complex,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000226~microtubule cytoskeleton organization,GO:0000578~embryonic axis specification,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001501~skeletal system development,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001569~patterning of blood vessels,GO:0001654~eye development,GO:0001702~gastrulation with mouth forming second,GO:0001704~formation of primary germ layer,GO:0001706~endoderm formation,GO:0001708~cell fate specification,GO:0001709~cell fate determination,GO:0001711~endodermal cell fate commitment,GO:0001763~morphogenesis of a branching structure,GO:0001775~cell activation,GO:0001837~epithelial to mesenchymal transition,GO:0001889~liver development,GO:0001894~tissue homeostasis,GO:0001944~vasculature development,GO:0002009~morphogenesis of an epithelium,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002762~negative regulation of myeloid leukocyte differentiation,GO:0003002~regionalization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006915~apoptosis,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007098~centrosome cycle,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007242~intracellular signaling cascade,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007369~gastrulation,GO:0007389~pattern specification process,GO:0007398~ectoderm development,GO:0007403~glial cell fate determination,GO:0007423~sensory organ development,GO:0007492~endoderm development,GO:0007494~midgut development,GO:0007507~heart development,GO:0008104~protein localization,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009798~axis specification,GO:0009880~embryonic pattern specification,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009948~anterior/posterior axis specification,GO:0009950~dorsal/ventral axis specification,GO:0009952~anterior/posterior pattern formation,GO:0009953~dorsal/ventral pattern formation,GO:0009954~proximal/distal pattern formation,GO:0009967~positive regulation of signal transduction,GO:0010001~glial cell differentiation,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0010560~positive regulation of glycoprotein biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010908~regulation of heparan sulfate proteoglycan biosynthetic process,GO:0010909~positive regulation of heparan sulfate proteoglycan biosynthetic process,GO:0012501~programmed cell death,GO:0014009~glial cell proliferation,GO:0014010~Schwann cell proliferation,GO:0014031~mesenchymal cell development,GO:0014070~response to organic cyclic substance,GO:0016055~Wnt receptor signaling pathway,GO:0016192~vesicle-mediated transport,GO:0016265~death,GO:0016331~morphogenesis of embryonic epithelium,GO:0016337~cell-cell adhesion,GO:0016481~negative regulation of transcription,GO:0019226~transmission of nerve impulse,GO:0021700~developmental maturation,GO:0021781~glial cell fate commitment,GO:0022402~cell cycle process,GO:0022610~biological adhesion,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030217~T cell differentiation,GO:0030278~regulation of ossification,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0030326~embryonic limb morphogenesis,GO:0030518~steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0030856~regulation of epithelial cell differentiation,GO:0030858~positive regulation of epithelial cell differentiation,GO:0030900~forebrain development,GO:0030997~regulation of centriole-centriole cohesion,GO:0031016~pancreas development,GO:0031023~microtubule organizing center organization,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031589~cell-substrate adhesion,GO:0032330~regulation of chondrocyte differentiation,GO:0032331~negative regulation of chondrocyte differentiation,GO:0032583~regulation of gene-specific transcription,GO:0032886~regulation of microtubule-based process,GO:0032989~cellular component morphogenesis,GO:0033043~regulation of organelle organization,GO:0033077~T cell differentiation in the thymus,GO:0034097~response to cytokine stimulus,GO:0034613~cellular protein localization,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0035117~embryonic arm morphogenesis,GO:0035136~forelimb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0035140~arm morphogenesis,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042063~gliogenesis,GO:0042110~T cell activation,GO:0042127~regulation of cell proliferation,GO:0042475~odontogenesis of dentine-containing tooth,GO:0042476~odontogenesis,GO:0042592~homeostatic process,GO:0042692~muscle cell differentiation,GO:0042733~embryonic digit morphogenesis,GO:0042762~regulation of sulfur metabolic process,GO:0043010~camera-type eye development,GO:0043062~extracellular structure organization,GO:0043193~positive regulation of gene-specific transcription,GO:0043408~regulation of MAPKKK cascade,GO:0043410~positive regulation of MAPKKK cascade,GO:0043627~response to estrogen stimulus,GO:0043933~macromolecular complex subunit organization,GO:0045165~cell fate commitment,GO:0045321~leukocyte activation,GO:0045445~myoblast differentiation,GO:0045449~regulation of transcription,GO:0045453~bone resorption,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045671~negative regulation of osteoclast differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046649~lymphocyte activation,GO:0046686~response to cadmium ion,GO:0046849~bone remodeling,GO:0048469~cell maturation,GO:0048489~synaptic vesicle transport,GO:0048514~blood vessel morphogenesis,GO:0048534~hemopoietic or lymphoid organ development,GO:0048538~thymus development,GO:0048545~response to steroid hormone stimulus,GO:0048565~gut development,GO:0048592~eye morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0048736~appendage development,GO:0048754~branching morphogenesis of a tube,GO:0048762~mesenchymal cell differentiation,GO:0048771~tissue remodeling,GO:0048871~multicellular organismal homeostasis,GO:0050808~synapse organization,GO:0050877~neurological system process,GO:0051094~positive regulation of developmental process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051176~positive regulation of sulfur metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051259~protein oligomerization,GO:0051291~protein heterooligomerization,GO:0051297~centrosome organization,GO:0051493~regulation of cytoskeleton organization,GO:0060070~Wnt receptor signaling pathway through beta-catenin,GO:0060173~limb development,GO:0060249~anatomical structure homeostasis,GO:0060429~epithelium development,GO:0060485~mesenchyme development,GO:0060541~respiratory system development,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070507~regulation of microtubule cytoskeleton organization,GO:0070727~cellular macromolecule localization,","hsa04310:Wnt signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa04916:Melanogenesis,hsa05130:Pathogenic Escherichia coli infection,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),",frequent target of mutation (10493496) (12067995),Role in canonical Wnt signaling pathway reviewed (15372092) (17081971)
AKT1,V-akt murine thymoma viral oncogene homolog 1,1,0.000661931402883,1.92E-20,0.425891394222691,1,5.76E-26,1.35E-22,0.955063164625133,4,YES,known,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0005543~phospholipid binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0008289~lipid binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0030235~nitric-oxide synthase regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035091~phosphoinositide binding,GO:0042802~identical protein binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005654~nucleoplasm,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015630~microtubule cytoskeleton,GO:0030027~lamellipodium,GO:0031252~cell leading edge,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0070013~intracellular organelle lumen,GO:0000060~protein import into nucleus, translocation,GO:0000079~regulation of cyclin-dependent protein kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000271~polysaccharide biosynthetic process,GO:0000278~mitotic cell cycle,GO:0001558~regulation of cell growth,GO:0001568~blood vessel development,GO:0001776~leukocyte homeostasis,GO:0001890~placenta development,GO:0001942~hair follicle development,GO:0001944~vasculature development,GO:0002028~regulation of sodium ion transport,GO:0002260~lymphocyte homeostasis,GO:0003006~reproductive developmental process,GO:0005976~polysaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005978~glycogen biosynthetic process,GO:0005979~regulation of glycogen biosynthetic process,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006073~cellular glucan metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006109~regulation of carbohydrate metabolic process,GO:0006112~energy reserve metabolic process,GO:0006417~regulation of translation,GO:0006468~protein amino acid phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006809~nitric oxide biosynthetic process,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0006924~activation-induced cell death of T cells,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007005~mitochondrion organization,GO:0007049~cell cycle,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007398~ectoderm development,GO:0008104~protein localization,GO:0008219~cell death,GO:0008286~insulin receptor signaling pathway,GO:0008361~regulation of cell size,GO:0008544~epidermis development,GO:0008633~activation of pro-apoptotic gene products,GO:0008637~apoptotic mitochondrial changes,GO:0008643~carbohydrate transport,GO:0008645~hexose transport,GO:0009057~macromolecule catabolic process,GO:0009250~glucan biosynthetic process,GO:0009266~response to temperature stimulus,GO:0009314~response to radiation,GO:0009408~response to heat,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009611~response to wounding,GO:0009628~response to abiotic stimulus,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0009894~regulation of catabolic process,GO:0009895~negative regulation of catabolic process,GO:0009896~positive regulation of catabolic process,GO:0009968~negative regulation of signal transduction,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010565~regulation of cellular ketone metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010627~regulation of protein kinase cascade,GO:0010648~negative regulation of cell communication,GO:0010675~regulation of cellular carbohydrate metabolic process,GO:0010676~positive regulation of cellular carbohydrate metabolic process,GO:0010741~negative regulation of protein kinase cascade,GO:0010746~regulation of plasma membrane long-chain fatty acid transport,GO:0010748~negative regulation of plasma membrane long-chain fatty acid transport,GO:0010765~positive regulation of sodium ion transport,GO:0010827~regulation of glucose transport,GO:0010828~positive regulation of glucose transport,GO:0010906~regulation of glucose metabolic process,GO:0010907~positive regulation of glucose metabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010959~regulation of metal ion transport,GO:0010962~regulation of glucan biosynthetic process,GO:0012501~programmed cell death,GO:0015031~protein transport,GO:0015749~monosaccharide transport,GO:0015758~glucose transport,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016051~carbohydrate biosynthetic process,GO:0016265~death,GO:0016310~phosphorylation,GO:0016567~protein ubiquitination,GO:0017038~protein import,GO:0018105~peptidyl-serine phosphorylation,GO:0018209~peptidyl-serine modification,GO:0019216~regulation of lipid metabolic process,GO:0019217~regulation of fatty acid metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0019318~hexose metabolic process,GO:0019953~sexual reproduction,GO:0021700~developmental maturation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0022404~molting cycle process,GO:0022405~hair cycle process,GO:0030030~cell projection organization,GO:0030162~regulation of proteolysis,GO:0030163~protein catabolic process,GO:0030307~positive regulation of cell growth,GO:0030334~regulation of cell migration,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031329~regulation of cellular catabolic process,GO:0031330~negative regulation of cellular catabolic process,GO:0031331~positive regulation of cellular catabolic process,GO:0031657~regulation of cyclin-dependent protein kinase activity during G1/S,GO:0031659~positive regulation of cyclin-dependent protein kinase activity during G1/S,GO:0031667~response to nutrient levels,GO:0031998~regulation of fatty acid beta-oxidation,GO:0031999~negative regulation of fatty acid beta-oxidation,GO:0032094~response to food,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032368~regulation of lipid transport,GO:0032369~negative regulation of lipid transport,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032446~protein modification by small protein conjugation,GO:0032504~multicellular organism reproduction,GO:0032535~regulation of cellular component size,GO:0032768~regulation of monooxygenase activity,GO:0032770~positive regulation of monooxygenase activity,GO:0032868~response to insulin stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0032880~regulation of protein localization,GO:0032881~regulation of polysaccharide metabolic process,GO:0032885~regulation of polysaccharide biosynthetic process,GO:0032890~regulation of organic acid transport,GO:0032891~negative regulation of organic acid transport,GO:0033365~protein localization in organelle,GO:0033673~negative regulation of kinase activity,GO:0033674~positive regulation of kinase activity,GO:0033692~cellular polysaccharide biosynthetic process,GO:0034405~response to fluid shear stress,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0034637~cellular carbohydrate biosynthetic process,GO:0040007~growth,GO:0040008~regulation of growth,GO:0040012~regulation of locomotion,GO:0040014~regulation of multicellular organism growth,GO:0040018~positive regulation of multicellular organism growth,GO:0042176~regulation of protein catabolic process,GO:0042303~molting cycle,GO:0042325~regulation of phosphorylation,GO:0042592~homeostatic process,GO:0042633~hair cycle,GO:0042640~anagen,GO:0042981~regulation of apoptosis,GO:0043029~T cell homeostasis,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043255~regulation of carbohydrate biosynthetic process,GO:0043269~regulation of ion transport,GO:0043270~positive regulation of ion transport,GO:0043408~regulation of MAPKKK cascade,GO:0043409~negative regulation of MAPKKK cascade,GO:0043434~response to peptide hormone stimulus,GO:0043467~regulation of generation of precursor metabolites and energy,GO:0043491~protein kinase B signaling cascade,GO:0043549~regulation of kinase activity,GO:0044042~glucan metabolic process,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0044264~cellular polysaccharide metabolic process,GO:0044271~nitrogen compound biosynthetic process,GO:0045184~establishment of protein localization,GO:0045428~regulation of nitric oxide biosynthetic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045597~positive regulation of cell differentiation,GO:0045598~regulation of fat cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045725~positive regulation of glycogen biosynthetic process,GO:0045732~positive regulation of protein catabolic process,GO:0045737~positive regulation of cyclin-dependent protein kinase activity,GO:0045787~positive regulation of cell cycle,GO:0045792~negative regulation of cell size,GO:0045793~positive regulation of cell size,GO:0045833~negative regulation of lipid metabolic process,GO:0045834~positive regulation of lipid metabolic process,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045862~positive regulation of proteolysis,GO:0045884~regulation of survival gene product expression,GO:0045913~positive regulation of carbohydrate metabolic process,GO:0045922~negative regulation of fatty acid metabolic process,GO:0045927~positive regulation of growth,GO:0046209~nitric oxide metabolic process,GO:0046320~regulation of fatty acid oxidation,GO:0046322~negative regulation of fatty acid oxidation,GO:0046324~regulation of glucose import,GO:0046326~positive regulation of glucose import,GO:0046328~regulation of JNK cascade,GO:0046329~negative regulation of JNK cascade,GO:0046777~protein amino acid autophosphorylation,GO:0046889~positive regulation of lipid biosynthetic process,GO:0046890~regulation of lipid biosynthetic process,GO:0046907~intracellular transport,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048585~negative regulation of response to stimulus,GO:0048589~developmental growth,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0048820~hair follicle maturation,GO:0048872~homeostasis of number of cells,GO:0050994~regulation of lipid catabolic process,GO:0050995~negative regulation of lipid catabolic process,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0051050~positive regulation of transport,GO:0051051~negative regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051130~positive regulation of cellular component organization,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051247~positive regulation of protein metabolic process,GO:0051270~regulation of cell motion,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051338~regulation of transferase activity,GO:0051341~regulation of oxidoreductase activity,GO:0051347~positive regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0051353~positive regulation of oxidoreductase activity,GO:0051726~regulation of cell cycle,GO:0060548~negative regulation of cell death,GO:0070141~response to UV-A,GO:0070201~regulation of establishment of protein localization,GO:0070227~lymphocyte apoptosis,GO:0070231~T cell apoptosis,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0070303~negative regulation of stress-activated protein kinase signaling pathway,GO:0070647~protein modification by small protein conjugation or removal,GO:0070727~cellular macromolecule localization,GO:0080135~regulation of cellular response to stress,GO:0090003~regulation of establishment of protein localization to plasma membrane,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04150:mTOR signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04530:Tight junction,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04722:Neurotrophin signaling pathway,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04920:Adipocytokine signaling pathway,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,",Reviewed (22471665),Reviewed (22471665) (22443084)
NRAS,Neuroblastoma RAS viral (v-ras) oncogene homolog,1,0.347619906797398,6.11E-22,0.952722598181293,1,7.14E-22,1.21E-18,0.940561011486224,4,YES,known,"GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0044459~plasma membrane part,GO:0006897~endocytosis,GO:0006915~apoptosis,GO:0007010~cytoskeleton organization,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007568~aging,GO:0007569~cell aging,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007632~visual behavior,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0008542~visual learning,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009967~positive regulation of signal transduction,GO:0010324~membrane invagination,GO:0010647~positive regulation of cell communication,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016265~death,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0031644~regulation of neurological system process,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0035020~regulation of Rac protein signal transduction,GO:0035022~positive regulation of Rac protein signal transduction,GO:0042127~regulation of cell proliferation,GO:0042692~muscle cell differentiation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0044057~regulation of system process,GO:0046578~regulation of Ras protein signal transduction,GO:0046579~positive regulation of Ras protein signal transduction,GO:0048167~regulation of synaptic plasticity,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0050804~regulation of synaptic transmission,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051146~striated muscle cell differentiation,GO:0051969~regulation of transmission of nerve impulse,GO:0060548~negative regulation of cell death,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04530:Tight junction,hsa04540:Gap junction,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,",Reviewed (23069660); (22453013),Reviewed (19243303); (9696882); 
RAC1,"Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",1,1.20E-06,8.80E-12,0.281941894895908,0.768367764044451,1.77E-20,2.75E-17,0.95089095945314,4,YES,known,"GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0019899~enzyme binding,GO:0030742~GTP-dependent protein binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0030027~lamellipodium,GO:0031252~cell leading edge,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042470~melanosome,GO:0042995~cell projection,GO:0044459~plasma membrane part,GO:0048770~pigment granule,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001894~tissue homeostasis,GO:0006461~protein complex assembly,GO:0006897~endocytosis,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006928~cell motion,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006970~response to osmotic stress,GO:0006972~hyperosmotic response,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007155~cell adhesion,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008154~actin polymerization or depolymerization,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008624~induction of apoptosis by extracellular signals,GO:0009611~response to wounding,GO:0009628~response to abiotic stimulus,GO:0009967~positive regulation of signal transduction,GO:0010310~regulation of hydrogen peroxide metabolic process,GO:0010324~membrane invagination,GO:0010591~regulation of lamellipodium assembly,GO:0010592~positive regulation of lamellipodium assembly,GO:0010638~positive regulation of organelle organization,GO:0010647~positive regulation of cell communication,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016265~death,GO:0016358~dendrite development,GO:0016477~cell migration,GO:0019216~regulation of lipid metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0021537~telencephalon development,GO:0021543~pallium development,GO:0021772~olfactory bulb development,GO:0021795~cerebral cortex cell migration,GO:0021799~cerebral cortex radially oriented cell migration,GO:0021826~substrate-independent telencephalic tangential migration,GO:0021831~embryonic olfactory bulb interneuron precursor migration,GO:0021843~substrate-independent telencephalic tangential interneuron migration,GO:0021885~forebrain cell migration,GO:0021889~olfactory bulb interneuron differentiation,GO:0021891~olfactory bulb interneuron development,GO:0021987~cerebral cortex development,GO:0021988~olfactory lobe development,GO:0022028~tangential migration from the subventricular zone to the olfactory bulb,GO:0022029~telencephalon cell migration,GO:0022610~biological adhesion,GO:0030029~actin filament-based process,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0030032~lamellipodium assembly,GO:0030036~actin cytoskeleton organization,GO:0030041~actin filament polymerization,GO:0030100~regulation of endocytosis,GO:0030182~neuron differentiation,GO:0030334~regulation of cell migration,GO:0030832~regulation of actin filament length,GO:0030833~regulation of actin filament polymerization,GO:0030838~positive regulation of actin filament polymerization,GO:0030900~forebrain development,GO:0031175~neuron projection development,GO:0031334~positive regulation of protein complex assembly,GO:0031344~regulation of cell projection organization,GO:0031346~positive regulation of cell projection organization,GO:0031529~ruffle organization,GO:0032271~regulation of protein polymerization,GO:0032273~positive regulation of protein polymerization,GO:0032535~regulation of cellular component size,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033043~regulation of organelle organization,GO:0033674~positive regulation of kinase activity,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0035023~regulation of Rho protein signal transduction,GO:0035025~positive regulation of Rho protein signal transduction,GO:0040012~regulation of locomotion,GO:0042325~regulation of phosphorylation,GO:0042330~taxis,GO:0042592~homeostatic process,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043254~regulation of protein complex assembly,GO:0043549~regulation of kinase activity,GO:0043550~regulation of lipid kinase activity,GO:0043551~regulation of phosphoinositide 3-kinase activity,GO:0043552~positive regulation of phosphoinositide 3-kinase activity,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0044087~regulation of cellular component biogenesis,GO:0044093~positive regulation of molecular function,GO:0045453~bone resorption,GO:0045806~negative regulation of endocytosis,GO:0045834~positive regulation of lipid metabolic process,GO:0046578~regulation of Ras protein signal transduction,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046849~bone remodeling,GO:0048259~regulation of receptor-mediated endocytosis,GO:0048261~negative regulation of receptor-mediated endocytosis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048771~tissue remodeling,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0048871~multicellular organismal homeostasis,GO:0051051~negative regulation of transport,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051129~negative regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051258~protein polymerization,GO:0051270~regulation of cell motion,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051493~regulation of cytoskeleton organization,GO:0051495~positive regulation of cytoskeleton organization,GO:0051668~localization within membrane,GO:0051674~localization of cell,GO:0060249~anatomical structure homeostasis,GO:0060263~regulation of respiratory burst,GO:0060491~regulation of cell projection assembly,GO:0060627~regulation of vesicle-mediated transport,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0080010~regulation of oxygen and reactive oxygen species metabolic process,","hsa04010:MAPK signaling pathway,hsa04062:Chemokine signaling pathway,hsa04310:Wnt signaling pathway,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04620:Toll-like receptor signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05416:Viral myocarditis,",recurrently mutated in melanomas - mutations enhance binding to downstream effectors and promote melanoctye proliferation and migration (22842228); transforming mutations in sarcoma cell line and other cancers (23382236); upregulated in lung cancer (23033341) and papillary thyroid carcinoma (23482591),reviewed (22467564); (21893191); (21622195)
EGFR,"Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)",1,1.96E-08,1.24E-09,0,0,1.61E-19,2.14E-16,0.960101702455754,4,YES,known,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003779~actin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004709~MAP kinase kinase kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005006~epidermal growth factor receptor activity,GO:0005524~ATP binding,GO:0008092~cytoskeletal protein binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0030235~nitric-oxide synthase regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0043566~structure-specific DNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0051015~actin filament binding,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005905~coated pit,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030117~membrane coat,GO:0030118~clathrin coat,GO:0030119~AP-type membrane coat adaptor complex,GO:0030120~vesicle coat,GO:0030122~AP-2 adaptor complex,GO:0030125~clathrin vesicle coat,GO:0030128~clathrin coat of endocytic vesicle,GO:0030131~clathrin adaptor complex,GO:0030132~clathrin coat of coated pit,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0030139~endocytic vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030665~clathrin coated vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044421~extracellular region part,GO:0044433~cytoplasmic vesicle part,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0045334~clathrin-coated endocytic vesicle,GO:0048475~coated membrane,GO:0070435~Shc-EGFR complex,GO:0000079~regulation of cyclin-dependent protein kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000165~MAPKKK cascade,GO:0000186~activation of MAPKK activity,GO:0000278~mitotic cell cycle,GO:0000902~cell morphogenesis,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001775~cell activation,GO:0001932~regulation of protein amino acid phosphorylation,GO:0006412~translation,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006970~response to osmotic stress,GO:0006979~response to oxidative stress,GO:0007049~cell cycle,GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007346~regulation of mitotic cell cycle,GO:0007423~sensory organ development,GO:0007431~salivary gland development,GO:0007435~salivary gland morphogenesis,GO:0007623~circadian rhythm,GO:0008104~protein localization,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0010001~glial cell differentiation,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010647~positive regulation of cell communication,GO:0010863~positive regulation of phospholipase C activity,GO:0010941~regulation of cell death,GO:0014002~astrocyte development,GO:0016044~membrane organization,GO:0016310~phosphorylation,GO:0016337~cell-cell adhesion,GO:0019220~regulation of phosphate metabolic process,GO:0019722~calcium-mediated signaling,GO:0019932~second-messenger-mediated signaling,GO:0021782~glial cell development,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0022610~biological adhesion,GO:0022612~gland morphogenesis,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0031175~neuron projection development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031399~regulation of protein modification process,GO:0031644~regulation of neurological system process,GO:0031646~positive regulation of neurological system process,GO:0031657~regulation of cyclin-dependent protein kinase activity during G1/S,GO:0031659~positive regulation of cyclin-dependent protein kinase activity during G1/S,GO:0032147~activation of protein kinase activity,GO:0032268~regulation of cellular protein metabolic process,GO:0032429~regulation of phospholipase A2 activity,GO:0032430~positive regulation of phospholipase A2 activity,GO:0032431~activation of phospholipase A2 activity,GO:0032504~multicellular organism reproduction,GO:0032768~regulation of monooxygenase activity,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033674~positive regulation of kinase activity,GO:0033993~response to lipid,GO:0034613~cellular protein localization,GO:0035272~exocrine system development,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042063~gliogenesis,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042698~ovulation cycle,GO:0042981~regulation of apoptosis,GO:0043006~activation of phospholipase A2 activity by calcium-mediated signaling,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0043586~tongue development,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0045428~regulation of nitric oxide biosynthetic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045737~positive regulation of cyclin-dependent protein kinase activity,GO:0045786~negative regulation of cell cycle,GO:0045787~positive regulation of cell cycle,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045930~negative regulation of mitotic cell cycle,GO:0045937~positive regulation of phosphate metabolic process,GO:0046777~protein amino acid autophosphorylation,GO:0048143~astrocyte activation,GO:0048511~rhythmic process,GO:0048609~reproductive process in a multicellular organism,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048666~neuron development,GO:0048708~astrocyte differentiation,GO:0048732~gland development,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050804~regulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0050999~regulation of nitric-oxide synthase activity,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051205~protein insertion into membrane,GO:0051240~positive regulation of multicellular organismal process,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051341~regulation of oxidoreductase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051347~positive regulation of transferase activity,GO:0051592~response to calcium ion,GO:0051668~localization within membrane,GO:0051726~regulation of cell cycle,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0051969~regulation of transmission of nerve impulse,GO:0051971~positive regulation of transmission of nerve impulse,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,GO:0060348~bone development,GO:0060548~negative regulation of cell death,GO:0070141~response to UV-A,GO:0070727~cellular macromolecule localization,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04020:Calcium signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04144:Endocytosis,hsa04320:Dorso-ventral axis formation,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04540:Gap junction,hsa04810:Regulation of actin cytoskeleton,hsa04912:GnRH signaling pathway,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05223:Non-small cell lung cancer,",amplified (22897982) (18381415) and mutated (22736441) (17020982) across many cancer subtypes,Reviewed (11597398) (15142631)
NFE2L2,Nuclear factor (erythroid-derived 2)-like 2,1,6.57E-23,1.03E-06,6.70E-09,3.07E-08,5.79E-19,7.21E-16,0.844592777350598,4,NO,known,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0046983~protein dimerization activity,GO:0005829~cytosol,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006984~ER-nuclear signaling pathway,GO:0006986~response to unfolded protein,GO:0009891~positive regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0033554~cellular response to stress,GO:0034620~cellular response to unfolded protein,GO:0034976~response to endoplasmic reticulum stress,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045995~regulation of embryonic development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051789~response to protein stimulus,",0,recurrently mutated in HCC (23728943); mutations resulting in constitutive activation in lung SCC (23545629); mutated and overexpressed in variety of other subtypes (23365135) (23077289) (23052169),transcription factor which binds AREs (antioxidant response elements) in promoters to drive gene expression during cellular stress and promote survival (22966037)
EZH2,Enhancer of zeste homolog 2 (Drosophila),1,0.001269580017332,6.89E-12,1.50E-06,6.11E-06,6.87E-18,8.02E-15,0.905546271998533,4,YES,known,"GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0008170~N-methyltransferase activity,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0016564~transcription repressor activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0030528~transcription regulator activity,GO:0042054~histone methyltransferase activity,GO:0005654~nucleoplasm,GO:0031519~PcG protein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034708~methyltransferase complex,GO:0035097~histone methyltransferase complex,GO:0035098~ESC/E(Z) complex,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0045120~pronucleus,GO:0070013~intracellular organelle lumen,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006479~protein amino acid methylation,GO:0006730~one-carbon metabolic process,GO:0008213~protein amino acid alkylation,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0032259~methylation,GO:0043414~biopolymer methylation,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0048385~regulation of retinoic acid receptor signaling pathway,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0051147~regulation of muscle cell differentiation,GO:0051148~negative regulation of muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051154~negative regulation of striated muscle cell differentiation,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,",0,Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin(20081860); the recurrent Tyr641 mutations act dominantly to promote H3K27me3 (21190999); subject to inactivating mutations in myeloid malignancies (23486531),"EZH2, the H3 lysine 27 methyltransferase of polycomb-repressive complex 2, promotes transcription of oncogenic signaling pathway components while silencing differentiation pathways (21175789)"
U2AF1,U2 small nuclear RNA auxiliary factor 1,1,0.001514579092323,3.25E-10,0.998083304824586,1,3.27E-16,3.59E-13,0.901729583271145,4,NO,known,"GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0019904~protein domain specific binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0050733~RS domain binding,GO:0005654~nucleoplasm,GO:0005681~spliceosome,GO:0015030~Cajal body,GO:0016604~nuclear body,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,","hsa03040:Spliceosome,",recurrent mutations in hematopoeitic lesions (22158538) (23029227) (23280334),spliceosome factor whose mutation alters splicing of genes in  cancer-related pathways like cell cycle progression (23775717) (22678168)
SF3B1,"Splicing factor 3b, subunit 1, 155kDa",1,5.94E-13,0.013827812605886,0.936735082985401,1,6.95E-13,7.22E-10,0.926042547564436,4,NO,known,"GO:0003682~chromatin binding,GO:0031202~RNA splicing factor activity, transesterification mechanism,GO:0005654~nucleoplasm,GO:0005681~spliceosome,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0003002~regionalization,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0007389~pattern specification process,GO:0008380~RNA splicing,GO:0009952~anterior/posterior pattern formation,GO:0016071~mRNA metabolic process,","hsa03040:Spliceosome,",frequently mutated in CLL (chronic lymphocytic leukemia) (23568491); also highly mutated in CMML and MDS (23327988),splicing factor whose mutation can lead to altered pre-mRNA splicing and epigenetic changes (23568491)
MAPK1,Mitogen-activated protein kinase 1,1,0.004459366638582,0.00038842965016,0.960174506795043,1,1.45E-09,1.00E-06,0.841471873715796,4,YES,known,"GO:0000166~nucleotide binding,GO:0001784~phosphotyrosine binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004707~MAP kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030554~adenyl nucleotide binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0045309~protein phosphorylated amino acid binding,GO:0051219~phosphoprotein binding,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005626~insoluble fraction,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0030424~axon,GO:0030425~dendrite,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032838~cell projection cytoplasm,GO:0032839~dendrite cytoplasm,GO:0033267~axon part,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043204~perikaryon,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044463~cell projection part,GO:0070013~intracellular organelle lumen,GO:0000060~protein import into nucleus, translocation,GO:0000165~MAPKKK cascade,GO:0000189~nuclear translocation of MAPK,GO:0002237~response to molecule of bacterial origin,GO:0002253~activation of immune response,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002684~positive regulation of immune system process,GO:0002757~immune response-activating signal transduction,GO:0002764~immune response-regulating signal transduction,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0006206~pyrimidine base metabolic process,GO:0006417~regulation of translation,GO:0006468~protein amino acid phosphorylation,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0006917~induction of apoptosis,GO:0006935~chemotaxis,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007166~cell surface receptor linked signal transduction,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007600~sensory perception,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0008104~protein localization,GO:0008284~positive regulation of cell proliferation,GO:0009112~nucleobase metabolic process,GO:0009617~response to bacterium,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0015031~protein transport,GO:0016310~phosphorylation,GO:0017038~protein import,GO:0019226~transmission of nerve impulse,GO:0019233~sensory perception of pain,GO:0019858~cytosine metabolic process,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032496~response to lipopolysaccharide,GO:0033365~protein localization in organelle,GO:0033554~cellular response to stress,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042127~regulation of cell proliferation,GO:0042330~taxis,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043330~response to exogenous dsRNA,GO:0043331~response to dsRNA,GO:0043627~response to estrogen stimulus,GO:0045184~establishment of protein localization,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045727~positive regulation of translation,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0046907~intracellular transport,GO:0048545~response to steroid hormone stimulus,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0070727~cellular macromolecule localization,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04114:Oocyte meiosis,hsa04150:mTOR signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04320:Dorso-ventral axis formation,hsa04350:TGF-beta signaling pathway,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04540:Gap junction,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04916:Melanogenesis,hsa04930:Type II diabetes mellitus,hsa04960:Aldosterone-regulated sodium reabsorption,hsa05010:Alzheimer's disease,hsa05020:Prion diseases,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,","activated from prevalent in esophageal carcinoma (22658382); ERK activation in HCC indicates aggressive tumor properties (17998146); Activated in a wide variety of cancer subtypes including melanoma (23921951), breast (23674072) and prostate (23620784)","mediator of MAPK signaling pathway in cancer, reviewed (19818165) (19282669)"
FGFR2,"Fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome)",1,0.111721095746119,3.94E-05,0.273562584368651,0.747385624312131,4.62E-09,3.08E-06,0.877851940925795,4,YES,known,"GO:0000166~nucleotide binding,GO:0001871~pattern binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005007~fibroblast growth factor receptor activity,GO:0005524~ATP binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0017076~purine nucleotide binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0016049~cell growth,GO:0016310~phosphorylation,GO:0032535~regulation of cellular component size,GO:0040007~growth,GO:0042127~regulation of cell proliferation,","hsa04010:MAPK signaling pathway,hsa04144:Endocytosis,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05215:Prostate cancer,","frequently amplified and mutated in gastric cancer, lung cancer, breast cancer, ovarian cancer, and endometrial cancer (18636142)",receptor for fibroblast growth factor ligands which activate mitogenic signaling (22273505)
ERBB2,"V-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)",1,0.05420519758938,0.000898394673453,1.84E-209,2.56E-207,4.65E-08,2.23E-05,0.920716626661166,4,YES,known,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0001948~glycoprotein binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005006~epidermal growth factor receptor activity,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0017076~purine nucleotide binding,GO:0019838~growth factor binding,GO:0019899~enzyme binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0030554~adenyl nucleotide binding,GO:0031072~heat shock protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0043125~ErbB-3 class receptor binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0051879~Hsp90 protein binding,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0009925~basal plasma membrane,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031224~intrinsic to membrane,GO:0042995~cell projection,GO:0043209~myelin sheath,GO:0043219~lateral loop,GO:0043235~receptor complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0045177~apical part of cell,GO:0045178~basal part of cell,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0048471~perinuclear region of cytoplasm,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001508~regulation of action potential,GO:0001889~liver development,GO:0002683~negative regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006873~cellular ion homeostasis,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007272~ensheathment of neurons,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007422~peripheral nervous system development,GO:0007423~sensory organ development,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007528~neuromuscular junction development,GO:0008045~motor axon guidance,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008366~axon ensheathment,GO:0009611~response to wounding,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009967~positive regulation of signal transduction,GO:0010001~glial cell differentiation,GO:0010033~response to organic substance,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0014065~phosphoinositide 3-kinase cascade,GO:0014066~regulation of phosphoinositide 3-kinase cascade,GO:0014068~positive regulation of phosphoinositide 3-kinase cascade,GO:0014706~striated muscle tissue development,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0019220~regulation of phosphate metabolic process,GO:0019226~transmission of nerve impulse,GO:0019228~regulation of action potential in neuron,GO:0019725~cellular homeostasis,GO:0019932~second-messenger-mediated signaling,GO:0022602~ovulation cycle process,GO:0022612~gland morphogenesis,GO:0030030~cell projection organization,GO:0030155~regulation of cell adhesion,GO:0030182~neuron differentiation,GO:0030879~mammary gland development,GO:0031175~neuron projection development,GO:0032504~multicellular organism reproduction,GO:0032570~response to progesterone stimulus,GO:0032944~regulation of mononuclear cell proliferation,GO:0032945~negative regulation of mononuclear cell proliferation,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033081~regulation of T cell differentiation in the thymus,GO:0033083~regulation of immature T cell proliferation,GO:0033084~regulation of immature T cell proliferation in the thymus,GO:0033087~negative regulation of immature T cell proliferation,GO:0033088~negative regulation of immature T cell proliferation in the thymus,GO:0033674~positive regulation of kinase activity,GO:0042060~wound healing,GO:0042063~gliogenesis,GO:0042127~regulation of cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042130~negative regulation of T cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042391~regulation of membrane potential,GO:0042493~response to drug,GO:0042552~myelination,GO:0042592~homeostatic process,GO:0042692~muscle cell differentiation,GO:0042698~ovulation cycle,GO:0042981~regulation of apoptosis,GO:0043062~extracellular structure organization,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043408~regulation of MAPKKK cascade,GO:0043410~positive regulation of MAPKKK cascade,GO:0043549~regulation of kinase activity,GO:0043586~tongue development,GO:0044093~positive regulation of molecular function,GO:0045580~regulation of T cell differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045765~regulation of angiogenesis,GO:0045785~positive regulation of cell adhesion,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046777~protein amino acid autophosphorylation,GO:0048015~phosphoinositide-mediated signaling,GO:0048483~autonomic nervous system development,GO:0048485~sympathetic nervous system development,GO:0048511~rhythmic process,GO:0048545~response to steroid hormone stimulus,GO:0048609~reproductive process in a multicellular organism,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048678~response to axon injury,GO:0048732~gland development,GO:0048741~skeletal muscle fiber development,GO:0048747~muscle fiber development,GO:0048771~tissue remodeling,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048878~chemical homeostasis,GO:0050670~regulation of lymphocyte proliferation,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050801~ion homeostasis,GO:0050808~synapse organization,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050868~negative regulation of T cell activation,GO:0050877~neurological system process,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051146~striated muscle cell differentiation,GO:0051174~regulation of phosphorus metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0055001~muscle cell development,GO:0055002~striated muscle cell development,GO:0055082~cellular chemical homeostasis,GO:0060056~mammary gland involution,GO:0060206~estrous cycle phase,GO:0060209~estrus,GO:0060443~mammary gland morphogenesis,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0060548~negative regulation of cell death,GO:0070663~regulation of leukocyte proliferation,GO:0070664~negative regulation of leukocyte proliferation,","hsa04012:ErbB signaling pathway,hsa04020:Calcium signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05219:Bladder cancer,hsa05223:Non-small cell lung cancer,",frequently amplified (22646280) (17899385),Reviewed (11156523) (15864276)
MYD88,myeloid differentiation primary response gene (88),1,0.342096927505986,0.000358995878152,0.999954862134118,1,3.21E-07,0.000139485701077,0.862324794401438,4,NO,known,"GO:0005121~Toll binding,GO:0005123~death receptor binding,GO:0032813~tumor necrosis factor receptor superfamily binding,GO:0005829~cytosol,GO:0031224~intrinsic to membrane,GO:0001816~cytokine production,GO:0001817~regulation of cytokine production,GO:0001819~positive regulation of cytokine production,GO:0002218~activation of innate immune response,GO:0002221~pattern recognition receptor signaling pathway,GO:0002224~toll-like receptor signaling pathway,GO:0002237~response to molecule of bacterial origin,GO:0002238~response to molecule of fungal origin,GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002253~activation of immune response,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002684~positive regulation of immune system process,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0002757~immune response-activating signal transduction,GO:0002758~innate immune response-activating signal transduction,GO:0002764~immune response-regulating signal transduction,GO:0006916~anti-apoptosis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007166~cell surface receptor linked signal transduction,GO:0009611~response to wounding,GO:0009617~response to bacterium,GO:0009620~response to fungus,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0016064~immunoglobulin mediated immune response,GO:0019724~B cell mediated immunity,GO:0031349~positive regulation of defense response,GO:0032496~response to lipopolysaccharide,GO:0032606~type I interferon production,GO:0032680~regulation of tumor necrosis factor production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034097~response to cytokine stimulus,GO:0042089~cytokine biosynthetic process,GO:0042107~cytokine metabolic process,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043388~positive regulation of DNA binding,GO:0044093~positive regulation of molecular function,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045351~type I interferon biosynthetic process,GO:0045449~regulation of transcription,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,GO:0051090~regulation of transcription factor activity,GO:0051091~positive regulation of transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051098~regulation of binding,GO:0051099~positive regulation of binding,GO:0051101~regulation of DNA binding,GO:0051240~positive regulation of multicellular organismal process,GO:0060548~negative regulation of cell death,GO:0070555~response to interleukin-1,","hsa04210:Apoptosis,hsa04620:Toll-like receptor signaling pathway,",Recurring somatic mutation at L265P in Waldenstrm's macroglobulinemia (WM) (23355535); frequent somatic mutations in primary central nervous system lymphoma (PCNSL) (22837180); increased expression in gastric cancer (23235763),cytoplasmic adaptor protein and signal transducer for Toll-Like receptor signaling (19052556) and IL-1 signaling (12217523) leading to activation of pro-oncogenic pathways including NF-kB and MAPK signaling
MB21D2,Mab-21 Domain Containing 2,1,0.724507651291874,0.00018275670807,2.61E-182,2.21E-180,9.92E-07,0.000378239432371,0.935741456085798,4,NO,novel,0,0,"amplified in subset of uveal melanomas bearing monosomy of chromosome 3,which high likelihood of metastatic progression and death (23357503)",0
HRAS,V-Ha-ras Harvey rat sarcoma viral oncogene homolog,1,1,7.11E-07,0.999999999317387,1,2.01E-06,0.000752127560219,0.861059594885162,4,YES,known,"GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0008022~protein C-terminus binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0044459~plasma membrane part,GO:0006275~regulation of DNA replication,GO:0006461~protein complex assembly,GO:0006897~endocytosis,GO:0006915~apoptosis,GO:0006935~chemotaxis,GO:0007010~cytoskeleton organization,GO:0007166~cell surface receptor linked signal transduction,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007568~aging,GO:0007569~cell aging,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007626~locomotory behavior,GO:0007632~visual behavior,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0008542~visual learning,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0009967~positive regulation of signal transduction,GO:0010324~membrane invagination,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010647~positive regulation of cell communication,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016265~death,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031644~regulation of neurological system process,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0035020~regulation of Rac protein signal transduction,GO:0035022~positive regulation of Rac protein signal transduction,GO:0042127~regulation of cell proliferation,GO:0042330~taxis,GO:0042692~muscle cell differentiation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0043933~macromolecular complex subunit organization,GO:0044057~regulation of system process,GO:0045740~positive regulation of DNA replication,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046578~regulation of Ras protein signal transduction,GO:0046579~positive regulation of Ras protein signal transduction,GO:0048167~regulation of synaptic plasticity,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0050804~regulation of synaptic transmission,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051052~regulation of DNA metabolic process,GO:0051054~positive regulation of DNA metabolic process,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051146~striated muscle cell differentiation,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051259~protein oligomerization,GO:0051291~protein heterooligomerization,GO:0051969~regulation of transmission of nerve impulse,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa04360:Axon guidance,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04530:Tight junction,hsa04540:Gap junction,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,",Frequently mutated (17693665) (17384584),Reviewed (20563706)
ERBB3,V-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian),1,0.71460494337196,0.000982593513662,0.000624724800904,0.002143110111311,4.99E-06,0.001663165002045,0.82612043267353,4,YES,known,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0008047~enzyme activator activity,GO:0017076~purine nucleotide binding,GO:0019207~kinase regulator activity,GO:0019209~kinase activator activity,GO:0019838~growth factor binding,GO:0019887~protein kinase regulator activity,GO:0030295~protein kinase activator activity,GO:0030296~protein tyrosine kinase activator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0043235~receptor complex,GO:0044421~extracellular region part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0007162~negative regulation of cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007409~axonogenesis,GO:0007422~peripheral nervous system development,GO:0007423~sensory organ development,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007623~circadian rhythm,GO:0008219~cell death,GO:0009611~response to wounding,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009967~positive regulation of signal transduction,GO:0009968~negative regulation of signal transduction,GO:0010001~glial cell differentiation,GO:0010033~response to organic substance,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010827~regulation of glucose transport,GO:0010828~positive regulation of glucose transport,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0014037~Schwann cell differentiation,GO:0014065~phosphoinositide 3-kinase cascade,GO:0014066~regulation of phosphoinositide 3-kinase cascade,GO:0014068~positive regulation of phosphoinositide 3-kinase cascade,GO:0014706~striated muscle tissue development,GO:0016265~death,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0021545~cranial nerve development,GO:0021675~nerve development,GO:0022612~gland morphogenesis,GO:0030030~cell projection organization,GO:0030155~regulation of cell adhesion,GO:0030182~neuron differentiation,GO:0030879~mammary gland development,GO:0031175~neuron projection development,GO:0032868~response to insulin stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0042060~wound healing,GO:0042063~gliogenesis,GO:0042127~regulation of cell proliferation,GO:0042476~odontogenesis,GO:0042493~response to drug,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043434~response to peptide hormone stimulus,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0043586~tongue development,GO:0046324~regulation of glucose import,GO:0046326~positive regulation of glucose import,GO:0048511~rhythmic process,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048732~gland development,GO:0048771~tissue remodeling,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0051046~regulation of secretion,GO:0051048~negative regulation of secretion,GO:0051050~positive regulation of transport,GO:0051051~negative regulation of transport,GO:0051402~neuron apoptosis,GO:0060056~mammary gland involution,GO:0060443~mammary gland morphogenesis,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0060548~negative regulation of cell death,","hsa04012:ErbB signaling pathway,hsa04020:Calcium signaling pathway,hsa04144:Endocytosis,",commonly overexpressed in solid tumors (8909809) (9426205); role in acquired resistance to HER2/EGFR targeting therapeutics (17667926),member of epidergmal growth factor receptor family that lacks a tyrosine kinase domain but can activate RTK signaling through heterodimerization with other EGFR family members (11597398)
GNAS,GNAS complex locus,1,0.392275302912697,0.0056487346023,1.24E-24,9.91E-24,6.34E-06,0.002042998438703,0.912438950596764,4,YES,known,"GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0031628~opioid receptor binding,GO:0031852~mu-type opioid receptor binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0000139~Golgi membrane,GO:0000267~cell fraction,GO:0001726~ruffle,GO:0005576~extracellular region,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031252~cell leading edge,GO:0031982~vesicle,GO:0032588~trans-Golgi network membrane,GO:0042383~sarcolemma,GO:0042995~cell projection,GO:0044431~Golgi apparatus part,GO:0044459~plasma membrane part,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001958~endochondral ossification,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0006091~generation of precursor metabolites and energy,GO:0006112~energy reserve metabolic process,GO:0006140~regulation of nucleotide metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,GO:0007188~G-protein signaling, coupled to cAMP nucleotide second messenger,GO:0007189~activation of adenylate cyclase activity by G-protein signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007191~activation of adenylate cyclase activity by dopamine receptor signaling pathway,GO:0007212~dopamine receptor signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007565~female pregnancy,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0008104~protein localization,GO:0009306~protein secretion,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009755~hormone-mediated signaling,GO:0009791~post-embryonic development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009886~post-embryonic morphogenesis,GO:0010033~response to organic substance,GO:0010171~body morphogenesis,GO:0010578~regulation of adenylate cyclase activity involved in G-protein signaling,GO:0010579~positive regulation of adenylate cyclase activity by G-protein signaling pathway,GO:0015031~protein transport,GO:0015980~energy derivation by oxidation of organic compounds,GO:0019932~second-messenger-mediated signaling,GO:0019933~cAMP-mediated signaling,GO:0019935~cyclic-nucleotide-mediated signaling,GO:0030278~regulation of ossification,GO:0030326~embryonic limb morphogenesis,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030814~regulation of cAMP metabolic process,GO:0030817~regulation of cAMP biosynthetic process,GO:0031279~regulation of cyclase activity,GO:0031281~positive regulation of cyclase activity,GO:0032870~cellular response to hormone stimulus,GO:0032940~secretion by cell,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0040032~post-embryonic body morphogenesis,GO:0042493~response to drug,GO:0043009~chordate embryonic development,GO:0043085~positive regulation of catalytic activity,GO:0044093~positive regulation of molecular function,GO:0045184~establishment of protein localization,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045672~positive regulation of osteoclast differentiation,GO:0045761~regulation of adenylate cyclase activity,GO:0045762~positive regulation of adenylate cyclase activity,GO:0046903~secretion,GO:0046907~intracellular transport,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048736~appendage development,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051094~positive regulation of developmental process,GO:0051216~cartilage development,GO:0051339~regulation of lyase activity,GO:0051349~positive regulation of lyase activity,GO:0060173~limb development,GO:0060348~bone development,GO:0060349~bone morphogenesis,GO:0060350~endochondral bone morphogenesis,","hsa04020:Calcium signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04730:Long-term depression,hsa04742:Taste transduction,hsa04912:GnRH signaling pathway,hsa04916:Melanogenesis,hsa05110:Vibrio cholerae infection,hsa05414:Dilated cardiomyopathy,","mutated in 4% of cancers across a wide variety of tumor types, with the vast majority of mutations occuring at one of two hotspot residues, both of which lead to constitutive activation (23640210)",G protein alpha-subunit (G(s)alpha) mediates signals from seven-transmembrane GPCRs. Reviewed in (23640210) and (15331575)
MYC,v-myc myelocytomatosis viral oncogene homolog (avian),1,0.503116045574968,0.032323457230388,1.11E-290,5.45E-288,6.65E-05,0.016276301496888,0.921818959493553,4,NO,known,"GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0005654~nucleoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016604~nuclear body,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000737~DNA catabolic process, endonucleolytic,GO:0001501~skeletal system development,GO:0001783~B cell apoptosis,GO:0001836~release of cytochrome c from mitochondria,GO:0002902~regulation of B cell apoptosis,GO:0002904~positive regulation of B cell apoptosis,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006259~DNA metabolic process,GO:0006308~DNA catabolic process,GO:0006309~DNA fragmentation involved in apoptosis,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006873~cellular ion homeostasis,GO:0006879~cellular iron ion homeostasis,GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0006917~induction of apoptosis,GO:0006919~activation of caspase activity,GO:0006921~cell structure disassembly during apoptosis,GO:0006997~nucleus organization,GO:0007005~mitochondrion organization,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007346~regulation of mitotic cell cycle,GO:0007423~sensory organ development,GO:0007600~sensory perception,GO:0007605~sensory perception of sound,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008629~induction of apoptosis by intracellular signals,GO:0008633~activation of pro-apoptotic gene products,GO:0008634~negative regulation of survival gene product expression,GO:0008637~apoptotic mitochondrial changes,GO:0009057~macromolecule catabolic process,GO:0009314~response to radiation,GO:0009581~detection of external stimulus,GO:0009582~detection of abiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0009628~response to abiotic stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010952~positive regulation of peptidase activity,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0016485~protein processing,GO:0019318~hexose metabolic process,GO:0019725~cellular homeostasis,GO:0022402~cell cycle process,GO:0022411~cellular component disassembly,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030262~apoptotic nuclear changes,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032204~regulation of telomere maintenance,GO:0032774~RNA biosynthetic process,GO:0032844~regulation of homeostatic process,GO:0033043~regulation of organelle organization,GO:0033044~regulation of chromosome organization,GO:0042127~regulation of cell proliferation,GO:0042471~ear morphogenesis,GO:0042474~middle ear morphogenesis,GO:0042592~homeostatic process,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043279~response to alkaloid,GO:0043280~positive regulation of caspase activity,GO:0043281~regulation of caspase activity,GO:0043473~pigmentation,GO:0043583~ear development,GO:0043933~macromolecular complex subunit organization,GO:0044093~positive regulation of molecular function,GO:0044265~cellular macromolecule catabolic process,GO:0045449~regulation of transcription,GO:0045884~regulation of survival gene product expression,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050906~detection of stimulus involved in sensory perception,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0050954~sensory perception of mechanical stimulus,GO:0050974~detection of mechanical stimulus involved in sensory perception,GO:0050982~detection of mechanical stimulus,GO:0051052~regulation of DNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051604~protein maturation,GO:0051606~detection of stimulus,GO:0051726~regulation of cell cycle,GO:0052547~regulation of peptidase activity,GO:0052548~regulation of endopeptidase activity,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055072~iron ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060548~negative regulation of cell death,GO:0065003~macromolecular complex assembly,GO:0070227~lymphocyte apoptosis,GO:0070228~regulation of lymphocyte apoptosis,GO:0070230~positive regulation of lymphocyte apoptosis,GO:0070271~protein complex biogenesis,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04110:Cell cycle,hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05216:Thyroid cancer,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,","frequently overproduced in a wide variety of cancers through various mechanisms including amplification, translocation, mutation of regulatory regions or coding sequences that affect protein stability (23021215)(18923074)(20164920)",Reviewed (22464321) (19029958)
PRKCI,"Protein kinase C, iota",1,0.01395172132005,0.350070687212711,8.64E-301,5.76E-298,9.45E-05,0.021015145833599,0.844854484121506,4,YES,known,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004697~protein kinase C activity,GO:0005524~ATP binding,GO:0005543~phospholipid binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0017076~purine nucleotide binding,GO:0019992~diacylglycerol binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0000133~polarisome,GO:0005768~endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0016324~apical plasma membrane,GO:0030427~site of polarized growth,GO:0044448~cell cortex part,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0000902~cell morphogenesis,GO:0001654~eye development,GO:0001754~eye photoreceptor cell differentiation,GO:0006468~protein amino acid phosphorylation,GO:0006605~protein targeting,GO:0006612~protein targeting to membrane,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006886~intracellular protein transport,GO:0006916~anti-apoptosis,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007163~establishment or maintenance of cell polarity,GO:0007242~intracellular signaling cascade,GO:0007423~sensory organ development,GO:0008104~protein localization,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0010827~regulation of glucose transport,GO:0010828~positive regulation of glucose transport,GO:0010941~regulation of cell death,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0030010~establishment of cell polarity,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030182~neuron differentiation,GO:0032868~response to insulin stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0032880~regulation of protein localization,GO:0032989~cellular component morphogenesis,GO:0034330~cell junction organization,GO:0034613~cellular protein localization,GO:0035088~establishment or maintenance of apical/basal cell polarity,GO:0035089~establishment of apical/basal cell polarity,GO:0042461~photoreceptor cell development,GO:0042462~eye photoreceptor cell development,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043434~response to peptide hormone stimulus,GO:0045184~establishment of protein localization,GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity,GO:0045216~cell-cell junction organization,GO:0046324~regulation of glucose import,GO:0046326~positive regulation of glucose import,GO:0046530~photoreceptor cell differentiation,GO:0046903~secretion,GO:0046907~intracellular transport,GO:0048592~eye morphogenesis,GO:0048666~neuron development,GO:0051050~positive regulation of transport,GO:0051130~positive regulation of cellular component organization,GO:0060548~negative regulation of cell death,GO:0070201~regulation of establishment of protein localization,GO:0070727~cellular macromolecule localization,GO:0090003~regulation of establishment of protein localization to plasma membrane,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,","hsa04144:Endocytosis,hsa04530:Tight junction,hsa04910:Insulin signaling pathway,",amplified in esophageal squamous cell carcinoma (17990328) and ovarian cancer (19419571); protein expression upregulated in breast cancer (22120720); amplified and/or overexpressed in many other subtypes (20945390),This protein kinase C family member can activate MAPK signaling and alter cytoskeletal dynamics through activation of Rac1 (20945390); downstream effector of activated Ras (15024028)
RIT1,Ras-like without CAAX 1,1,0.255152378265114,0.129153533446405,3.12E-75,9.59E-74,0.000145554256339,0.028923488873964,0.874623889214135,4,YES,0,"GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005516~calmodulin binding,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0005886~plasma membrane,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,",0,0,0
SEPT14,septin 14,1,0.271476723733921,0.296602665660762,1.13E-116,5.99E-115,0.00080864359475,0.096337089704895,0.838866044253362,4,NO,0,"cell cycle, cell division, septin complex, GTP binding, protein binding",0,0,0
PSPH,Phosphoserine phosphatase,1,1,0.009373291438252,3.11E-68,8.27E-67,0.001250193894892,0.121626936263974,0.8771703262737,4,NO,putative OG ,"GO:0000287~magnesium ion binding,GO:0004647~phosphoserine phosphatase activity,GO:0016791~phosphatase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0006563~L-serine metabolic process,GO:0006564~L-serine biosynthetic process,GO:0008283~cell proliferation,GO:0008652~cellular amino acid biosynthetic process,GO:0009069~serine family amino acid metabolic process,GO:0009070~serine family amino acid biosynthetic process,GO:0009309~amine biosynthetic process,GO:0016053~organic acid biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046394~carboxylic acid biosynthetic process,","hsa00260:Glycine, serine and threonine metabolism,",PSPH expression strongly induced in squamous cell carcinoma (21726982); PSPH along with the other 2 members of the L: -serine biosynthesis pathway are highly upregulated in bone-metastatic MDA-MB-231(SA) variant compared to parental (20352489),KD of PSPH in SCCs inhibits proliferation and reduces Cyclin D1 levels (21726982)
WNT11,"Wingless-type MMTV integration site family, member 11",1,0.420265180899895,0.295641681135455,5.37E-40,7.06E-39,0.001265913066366,0.122518083765037,0.849306665637926,4,NO,unclear,"GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0007166~cell surface receptor linked signal transduction,GO:0007223~Wnt receptor signaling pathway, calcium modulating pathway,GO:0016055~Wnt receptor signaling pathway,","hsa04310:Wnt signaling pathway,hsa04340:Hedgehog signaling pathway,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,","identified as frequently mutated putative tumor suppressive driver of endometrial carcinoma (23028188); downregulated in HCC, where its loss contributes to proliferation and migration (20103596); upregulated in CRC (22161723); overexpressed in prostate cancer and contributes to survival and migration (20219091)","Wnt pathway ligand that promoted non-canonical Wnt signaling, and can inhibit the canonical Wnt/B-catenin pathway (18572162); promotes proliferation, migration and transformation of cultured intesinal epithelial cells through activation of protein kinase C (15084607)"
SRC,V-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian),1,0.910322520092466,0.141117991752881,3.49E-29,3.09E-28,0.002412323778251,0.180963035558004,0.878541431566852,4,YES,known,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005070~SH3/SH2 adaptor activity,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0017076~purine nucleotide binding,GO:0019904~protein domain specific binding,GO:0030554~adenyl nucleotide binding,GO:0030674~protein binding, bridging,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042169~SH2 domain binding,GO:0060090~molecular adaptor activity,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0001101~response to acid,GO:0006461~protein complex assembly,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006928~cell motion,GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007172~signal complex assembly,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0008283~cell proliferation,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010647~positive regulation of cell communication,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0016337~cell-cell adhesion,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0022610~biological adhesion,GO:0030155~regulation of cell adhesion,GO:0030900~forebrain development,GO:0031960~response to corticosteroid stimulus,GO:0034097~response to cytokine stimulus,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0045056~transcytosis,GO:0045785~positive regulation of cell adhesion,GO:0046626~regulation of insulin receptor signaling pathway,GO:0046628~positive regulation of insulin receptor signaling pathway,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048011~nerve growth factor receptor signaling pathway,GO:0048545~response to steroid hormone stimulus,GO:0048584~positive regulation of response to stimulus,GO:0048870~cell motility,GO:0051385~response to mineralocorticoid stimulus,GO:0051674~localization of cell,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070555~response to interleukin-1,","hsa04012:ErbB signaling pathway,hsa04144:Endocytosis,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04530:Tight junction,hsa04540:Gap junction,hsa04912:GnRH signaling pathway,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,","upregulated in many cancer subtypes, but mutation is rare (21646863), (15380511)","involved in growth factor and adhesion signaling (9069259), (19581523)"
KCNMB2,"potassium large conductance calcium-activated channel, subfamily M, beta member 2",1,1,0.088933945143094,1.40E-288,6.54E-286,0.003441010142011,0.217234165964691,0.857363418868665,4,NO,0,"GO:0001508~regulation of action potential,GO:0005513~detection of calcium ion,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006873~cellular ion homeostasis,GO:0009593~detection of chemical stimulus,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0015672~monovalent inorganic cation transport,GO:0019226~transmission of nerve impulse,GO:0019228~regulation of action potential in neuron,GO:0019229~regulation of vasoconstriction,GO:0019725~cellular homeostasis,GO:0030001~metal ion transport,GO:0042391~regulation of membrane potential,GO:0042592~homeostatic process,GO:0044057~regulation of system process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0051592~response to calcium ion,GO:0051606~detection of stimulus,GO:0055082~cellular chemical homeostasis,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005227~calcium activated cation channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0008200~ion channel inhibitor activity,GO:0015267~channel activity,GO:0015269~calcium-activated potassium channel activity,GO:0015459~potassium channel regulator activity,GO:0016247~channel regulator activity,GO:0016248~channel inhibitor activity,GO:0022803~passive transmembrane transporter activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022839~ion gated channel activity,GO:0046873~metal ion transmembrane transporter activity,","hsa04270:Vascular smooth muscle contraction,",0,0
RSPO2,R-spondin 2 homolog (Xenopus laevis),1,0.094148995435551,0.616343584684641,2.77E-90,1.10E-88,0.004727441220173,0.251577990175547,0.877110677999546,4,NO,putative OG,"GO:0001871~pattern binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0005576~extracellular region,GO:0007166~cell surface receptor linked signal transduction,GO:0016055~Wnt receptor signaling pathway,",0,"RSPO gene fusions reported in 10% of colon cancers, consisting of EIF3E exon 1 and RSPO2 exon 2 (22895193); novel common integration site (CIS) for the mouse mammary tumor virus (MMTV) in viral induced mouse mammary tumors (16014973) ","Can act as a ligand to promote Wnt signaling (23535903); RSPO2 expression promotes proliferation, anchorage independence and EMT in Mammary epithelial cells in a Wnt/B-Catenin independent manner (21732367)"
AR,androgen receptor,1,0.876560862545503,0.297212022373803,0.999991731005309,1,0.004766516591205,0.252182298860806,0.810912521667245,4,NO,known,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003707~steroid hormone receptor activity,GO:0004879~ligand-dependent nuclear receptor activity,GO:0004882~androgen receptor activity,GO:0005496~steroid binding,GO:0005497~androgen binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0042562~hormone binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046983~protein dimerization activity,GO:0030424~axon,GO:0030425~dendrite,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0001655~urogenital system development,GO:0001701~in utero embryonic development,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007242~intracellular signaling cascade,GO:0007267~cell-cell signaling,GO:0007530~sex determination,GO:0007548~sex differentiation,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008361~regulation of cell size,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016049~cell growth,GO:0016265~death,GO:0018993~somatic sex determination,GO:0019102~male somatic sex determination,GO:0030238~male sex determination,GO:0030518~steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0030850~prostate gland development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032535~regulation of cellular component size,GO:0032774~RNA biosynthetic process,GO:0032868~response to insulin stimulus,GO:0040007~growth,GO:0043009~chordate embryonic development,GO:0043434~response to peptide hormone stimulus,GO:0045137~development of primary sexual characteristics,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0048608~reproductive structure development,GO:0048732~gland development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,","hsa04114:Oocyte meiosis,hsa05200:Pathways in cancer,hsa05215:Prostate cancer,",amplification and mutation of AR drive castration-resistance prostate cancer (23307762),Reviewed (23806491)(18674639)(16278481)
TRA2B,transformer 2 beta homolog (Drosophila),1,1,0.126985940527448,2.18E-202,2.54E-200,0.005870776982552,0.268192674653786,0.825760931692908,4,NO,0,"GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0031202~RNA splicing factor activity, transesterification mechanism,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,","hsa03040:Spliceosome,",0,0
LELP1,Late cornified envelope-like proline-rich 1,1,0.932145335372239,0.270573056590474,3.38E-75,1.04E-73,0.006089456632486,0.268192674653786,0.857294552956693,4,NO,0,0,0,0,0
KCNS2,"Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2",1,0.745415986888831,0.361326479851158,2.15E-56,4.33E-55,0.006213214449701,0.268649612745279,0.841766094282284,4,YES,0,"GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0044459~plasma membrane part,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,",0,0,0
PSMC4,"Proteasome (prosome, macropain) 26S subunit, ATPase, 4",1,0.991617699290978,0.270573056590474,2.12E-86,8.02E-85,0.007046161578639,0.286875755392808,0.816514685120941,4,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0000502~proteasome complex,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0000278~mitotic cell cycle,GO:0001701~in utero embryonic development,GO:0001824~blastocyst development,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0009057~macromolecule catabolic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0010498~proteasomal protein catabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0030163~protein catabolic process,GO:0031145~anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031396~regulation of protein ubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0043009~chordate embryonic development,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051340~regulation of ligase activity,GO:0051351~positive regulation of ligase activity,GO:0051352~negative regulation of ligase activity,GO:0051436~negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051439~regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051443~positive regulation of ubiquitin-protein ligase activity,GO:0051444~negative regulation of ubiquitin-protein ligase activity,GO:0051603~proteolysis involved in cellular protein catabolic process,","hsa03050:Proteasome,",0,0
DENND3,DENN/MADD domain containing 3,1,0.26518730604534,0.616343584684641,4.89E-180,4.06E-178,0.008819313316073,0.321058439753784,0.823550892628496,4,NO,0,0,0,0,0
THRA,"Thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian)",1,1,0.188473503474035,8.63E-71,2.40E-69,0.009111406411349,0.323329346821258,0.817912811099947,4,YES,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003707~steroid hormone receptor activity,GO:0003723~RNA binding,GO:0003727~single-stranded RNA binding,GO:0004879~ligand-dependent nuclear receptor activity,GO:0004887~thyroid hormone receptor activity,GO:0008270~zinc ion binding,GO:0010843~promoter binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0005829~cytosol,GO:0001501~skeletal system development,GO:0001502~cartilage condensation,GO:0001503~ossification,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007155~cell adhesion,GO:0007242~intracellular signaling cascade,GO:0008016~regulation of heart contraction,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009755~hormone-mediated signaling,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016337~cell-cell adhesion,GO:0016481~negative regulation of transcription,GO:0022610~biological adhesion,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032583~regulation of gene-specific transcription,GO:0032774~RNA biosynthetic process,GO:0032870~cellular response to hormone stimulus,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of transcription factor activity,GO:0044057~regulation of system process,GO:0044092~negative regulation of molecular function,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048705~skeletal system morphogenesis,GO:0051090~regulation of transcription factor activity,GO:0051098~regulation of binding,GO:0051100~negative regulation of binding,GO:0051101~regulation of DNA binding,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051216~cartilage development,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060348~bone development,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
COL14A1,"Collagen, type XIV, alpha 1 (undulin)",1,0.745415986888831,0.438466567609227,5.88E-173,4.68E-171,0.009439511555299,0.324715720702438,0.862262932745158,4,NO,0,"GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005518~collagen binding,GO:0030674~protein binding, bridging,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005593~FACIT collagen,GO:0005596~collagen type XIV,GO:0030934~anchoring collagen,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0007155~cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0043062~extracellular structure organization,",0,0,0
OSTN,osteocrin,1,0.745415986888831,0.450365116245565,3.22E-185,2.89E-183,0.010497680853564,0.340873872752955,0.826340450940207,4,NO,0,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0030278~regulation of ossification,GO:0045596~negative regulation of cell differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0060348~bone development,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0005179~hormone activity,",0,0,0
FZD6,Frizzled homolog 6 (Drosophila),1,1,0.258778258372001,8.29E-80,2.81E-78,0.010538168503906,0.340873872752955,0.910692119923254,4,YES,unclear,"GO:0042813~Wnt receptor activity,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0016327~apicolateral plasma membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0001736~establishment of planar polarity,GO:0001738~morphogenesis of a polarized epithelium,GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001843~neural tube closure,GO:0002009~morphogenesis of an epithelium,GO:0007164~establishment of tissue polarity,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007423~sensory organ development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0014020~primary neural tube formation,GO:0016055~Wnt receptor signaling pathway,GO:0016331~morphogenesis of embryonic epithelium,GO:0021915~neural tube development,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042471~ear morphogenesis,GO:0042472~inner ear morphogenesis,GO:0043009~chordate embryonic development,GO:0043583~ear development,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0048839~inner ear development,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0060606~tube closure,","hsa04310:Wnt signaling pathway,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05217:Basal cell carcinoma,","FZD6 expression marks highly a highly tumorigenic, stem-like population of neuroblastoma cells (22249030); missense mutation in one of 3 tested Castration Resistant Prostate tumors (but not in the paired castration-sensitive sample) (21949389); overexpressed in cutaneous SCC (16470182)",Implicated in activation of beta-catenin-independent Wnt signaling leading to ERK1/2 acticvation in pituitary adenomas (19034702); Transduces Wnt/Planar-Cell Polarity pathways signals from overexpressed Wnt5a in Gastric Cancer (16273260); negative regulator of canonical Wnt signaling but positive regulator of non-canonical Wnt pathway (22211385)
HPS3,Hermansky-Pudlak syndrome 3,1,1,0.150441783150863,2.65E-63,6.49E-62,0.012365875544015,0.36147447462701,0.828538213662132,4,NO,0,"GO:0043473~pigmentation,",0,0,0
ZNF302,Zinc finger protein 302,1,1,0.332676355469261,3.12E-37,3.63E-36,0.013919227183541,0.374540620790049,0.82722315283794,4,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
BAI1,brain-specific angiogenesis inhibitor 1,1,0.053125090503257,0.669292822937893,9.34E-169,6.90E-167,0.014290301959456,0.375426934318813,0.810924132549028,4,YES,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0007409~axonogenesis,GO:0007422~peripheral nervous system development,GO:0008285~negative regulation of cell proliferation,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0042127~regulation of cell proliferation,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005911~cell-cell junction,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,","hsa04115:p53 signaling pathway,",0,0
WIPI1,"WD repeat domain, phosphoinositide interacting 1",1,0.812549668064137,0.501831299149681,8.96E-37,1.01E-35,0.015477682039778,0.388063923249691,0.827033712037854,4,NO,0,"GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0030331~estrogen receptor binding,GO:0032266~phosphatidylinositol 3-phosphate binding,GO:0035091~phosphoinositide binding,GO:0035257~nuclear hormone receptor binding,GO:0035258~steroid hormone receptor binding,GO:0050681~androgen receptor binding,GO:0051427~hormone receptor binding,GO:0000407~pre-autophagosomal structure,GO:0000421~autophagic vacuole membrane,GO:0005768~endosome,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0005776~autophagic vacuole,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0010008~endosome membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0031090~organelle membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0034045~pre-autophagosomal structure membrane,GO:0044431~Golgi apparatus part,GO:0044437~vacuolar part,GO:0044440~endosomal part,GO:0006892~post-Golgi vesicle-mediated transport,GO:0006895~Golgi to endosome transport,GO:0006903~vesicle targeting,GO:0006914~autophagy,GO:0016192~vesicle-mediated transport,GO:0016197~endosome transport,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,GO:0048199~vesicle targeting, to, from or within Golgi,GO:0048203~vesicle targeting, trans-Golgi to endosome,GO:0051640~organelle localization,GO:0051648~vesicle localization,GO:0051650~establishment of vesicle localization,GO:0051656~establishment of organelle localization,",0,0,0
NAALADL2,N-acetylated alpha-linked acidic dipeptidase-like 2,1,0.503116045574968,0.615726049756984,6.58E-272,2.08E-269,0.017113080158254,0.399161208349429,0.819415633258278,4,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
KPNA4,Karyopherin alpha 4 (importin alpha 3),1,1,0.062558399038374,6.39E-98,2.79E-96,0.017329712625553,0.401615015052973,0.864916960497593,4,NO,0,"GO:0008565~protein transporter activity,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0046930~pore complex,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006607~NLS-bearing substrate import into nucleus,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0017038~protein import,GO:0033365~protein localization in organelle,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0070727~cellular macromolecule localization,",0,0,0
RTP1,receptor (chemosensory) transporter protein 1,1,0.970645685897825,0.438269106270904,2.65E-159,1.78E-157,0.017864577745562,0.408936823173226,0.830165435711222,4,NO,0,"GO:0008104~protein localization,GO:0016044~membrane organization,GO:0034613~cellular protein localization,GO:0051205~protein insertion into membrane,GO:0051668~localization within membrane,GO:0070727~cellular macromolecule localization,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031849~olfactory receptor binding,",0,0,0
CPA6,Carboxypeptidase A6,1,1,0.188473503474035,3.33E-50,5.94E-49,0.019744136145598,0.424524302558189,0.84472336209867,4,NO,0,"GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0008233~peptidase activity,GO:0008235~metalloexopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008238~exopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0005576~extracellular region,GO:0006508~proteolysis,",0,0,0
KCNV1,"potassium channel, subfamily V, member 1",1,0.274474210293647,0.641447788305282,4.84E-93,1.97E-91,0.022930275971848,0.449361581601962,0.852737629639033,4,YES,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0008200~ion channel inhibitor activity,GO:0015267~channel activity,GO:0015459~potassium channel regulator activity,GO:0016247~channel regulator activity,GO:0016248~channel inhibitor activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
DHCR7,7-dehydrocholesterol reductase,1,1,0.402080599844732,3.37E-142,2.04E-140,0.024958148950349,0.464703314161632,0.810827780148569,4,NO,0,"GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0006694~steroid biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0008202~steroid metabolic process,GO:0008203~cholesterol metabolic process,GO:0008610~lipid biosynthetic process,GO:0009791~post-embryonic development,GO:0016125~sterol metabolic process,GO:0016126~sterol biosynthetic process,GO:0019216~regulation of lipid metabolic process,GO:0019218~regulation of steroid metabolic process,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0035264~multicellular organism growth,GO:0035295~tube development,GO:0040007~growth,GO:0042127~regulation of cell proliferation,GO:0045540~regulation of cholesterol biosynthetic process,GO:0046890~regulation of lipid biosynthetic process,GO:0050810~regulation of steroid biosynthetic process,GO:0055114~oxidation reduction,GO:0060541~respiratory system development,GO:0005635~nuclear envelope,GO:0005640~nuclear outer membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0019867~outer membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031965~nuclear membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044432~endoplasmic reticulum part,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0047598~7-dehydrocholesterol reductase activity,","hsa00100:Steroid biosynthesis,",0,0
ASAP1,"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1",1,0.574713924958474,0.616343584684641,1.15E-243,2.45E-241,0.025269199344788,0.465486562683723,0.851276370963824,4,NO,0,"GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0008060~ARF GTPase activator activity,GO:0008270~zinc ion binding,GO:0030695~GTPase regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0032012~regulation of ARF protein signal transduction,GO:0032312~regulation of ARF GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0043087~regulation of GTPase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,","hsa04144:Endocytosis,hsa04666:Fc gamma R-mediated phagocytosis,",0,0
NMD3,NMD3 homolog (S. cerevisiae),1,1,0.462781043665193,2.70E-110,1.33E-108,0.025356911072106,0.465724426662599,0.86047175649494,4,NO,0,"GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0008104~protein localization,GO:0015031~protein transport,GO:0045184~establishment of protein localization,",0,0,0
OXR1,Oxidation resistance 1,1,0.886481428527679,0.559248062668889,1.05E-93,4.28E-92,0.025724321168329,0.467505804334509,0.884089388339456,4,NO,0,"GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0006979~response to oxidative stress,GO:0016998~cell wall macromolecule catabolic process,GO:0044036~cell wall macromolecule metabolic process,",0,0,0
CAPN5,Calpain 5,1,1,0.369499161853468,7.57E-68,2.00E-66,0.026261071062672,0.471088078387015,0.815098772999945,4,NO,0,"GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0006508~proteolysis,",0,0,0
ANO1,"anoctamin 1, calcium activated chloride channel",1,0.396266567609996,0.628457722964864,0,0,0.027763180805846,0.478240427850229,0.812075856381459,4,YES,0,"GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0007424~open tracheal system development,GO:0015698~inorganic anion transport,GO:0060541~respiratory system development,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0005216~ion channel activity,GO:0005229~intracellular calcium activated chloride channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0005509~calcium ion binding,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022839~ion gated channel activity,GO:0031404~chloride ion binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
IDH2,"Isocitrate dehydrogenase 2 (NADP+), mitochondrial",0.331603804711821,0.000535822381496,1.33E-16,0.224496835191718,0.623828679640896,1.10E-22,2.06E-19,0.791538728576403,3,NO,known,"GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0004448~isocitrate dehydrogenase activity,GO:0004450~isocitrate dehydrogenase (NADP+) activity,GO:0030145~manganese ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0048037~cofactor binding,GO:0050662~coenzyme binding,GO:0051287~NAD or NADH binding,GO:0005739~mitochondrion,GO:0006081~cellular aldehyde metabolic process,GO:0006084~acetyl-CoA metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006097~glyoxylate cycle,GO:0006099~tricarboxylic acid cycle,GO:0006102~isocitrate metabolic process,GO:0006732~coenzyme metabolic process,GO:0009060~aerobic respiration,GO:0009109~coenzyme catabolic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0045333~cellular respiration,GO:0046356~acetyl-CoA catabolic process,GO:0046487~glyoxylate metabolic process,GO:0051186~cofactor metabolic process,GO:0051187~cofactor catabolic process,GO:0055114~oxidation reduction,","hsa00020:Citrate cycle (TCA cycle),hsa00480:Glutathione metabolism,",mutated in gliomas (19228619); mutated in AML (23261068); ,Reviewed (22399191)
PGM5,Phosphoglucomutase 5,1,0.271476723733921,1.42E-09,0.999999999999946,1,3.08E-12,3.03E-09,0.871560561577797,3,YES,putative OG,"GO:0000287~magnesium ion binding,GO:0004614~phosphoglucomutase activity,GO:0005198~structural molecule activity,GO:0016866~intramolecular transferase activity,GO:0016868~intramolecular transferase activity, phosphotransferases,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0001725~stress fiber,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005914~spot adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0009898~internal side of plasma membrane,GO:0014704~intercalated disc,GO:0015629~actin cytoskeleton,GO:0016010~dystrophin-associated glycoprotein complex,GO:0016323~basolateral plasma membrane,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0030018~Z disc,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031674~I band,GO:0032432~actin filament bundle,GO:0042383~sarcolemma,GO:0042641~actomyosin,GO:0043034~costamere,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043292~contractile fiber,GO:0044430~cytoskeletal part,GO:0044449~contractile fiber part,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0007155~cell adhesion,GO:0019318~hexose metabolic process,GO:0022610~biological adhesion,",0,expression downregulated in prostate tumor samples relative to normals (11479199),"enzymatically inactive member of the phosphoglucomutase (PGM) family of proteins, interacts with cytoskeletal proteins and may play a structural role (8631316); colocalizes with utrophin at focal adhesions in smooth muscle cells and fibroblasts, conversely in MCF10 cells PGM5 and utrophin colocalized at adherens junctions (cell-cell) (7589238)"
PPP6C,"Protein phosphatase 6, catalytic subunit",1,0.000186947821467,0.000234483866025,0.999999999901171,1,6.95E-11,5.65E-08,0.900522228873554,3,YES,unclear,"GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0005506~iron ion binding,GO:0016791~phosphatase activity,GO:0030145~manganese ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005829~cytosol,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007049~cell cycle,GO:0016311~dephosphorylation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,",0,"PPP6c is overexpressed in GBM, where its elevated levels promote DNA-PK activity and resistance to radiation (22158480); frequently mutated in melanoma, inferred to be LOF as they were often homozygous or paired with LOH (22842228); found as recurrently mutated in an additional melanoma study, where the clustering of mutations and dearth of LOF mutations is used to argue for a putative gain-of-function role (22817889)","PPP6C is the T-loop phosphatase for Aurora A during mitotic spindle formation (21187329); ectopic PP6 expression in prostate cancer cells led to decreased CyclinD1 and pRb levels and slowed G1/S transition (17568194); interacts with DNA-PK to dephosphrylation gamma H2AX and promote release from the G2/M checkpoint (20065038); target of putatively oncogenic miR-373, whose overexpression enhances proliferation of HCC cells  (21481188)"
PPP2R1A,"Protein phosphatase 2 (formerly 2A), regulatory subunit A , alpha isoform",1,0.009507846683777,5.85E-05,0.999999906007491,1,3.63E-10,2.61E-07,0.887270917063152,3,YES,unclear,"GO:0003823~antigen binding,GO:0008601~protein phosphatase type 2A regulator activity,GO:0019208~phosphatase regulator activity,GO:0019888~protein phosphatase regulator activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0000159~protein phosphatase type 2A complex,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0008287~protein serine/threonine phosphatase complex,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0000165~MAPKKK cascade,GO:0000188~inactivation of MAPK activity,GO:0001558~regulation of cell growth,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001933~negative regulation of protein amino acid phosphorylation,GO:0006275~regulation of DNA replication,GO:0006396~RNA processing,GO:0006461~protein complex assembly,GO:0006469~negative regulation of protein kinase activity,GO:0006470~protein amino acid dephosphorylation,GO:0006643~membrane lipid metabolic process,GO:0006665~sphingolipid metabolic process,GO:0006672~ceramide metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006917~induction of apoptosis,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0008361~regulation of cell size,GO:0008380~RNA splicing,GO:0009968~negative regulation of signal transduction,GO:0010033~response to organic substance,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010648~negative regulation of cell communication,GO:0010741~negative regulation of protein kinase cascade,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0016311~dephosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0019932~second-messenger-mediated signaling,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0030155~regulation of cell adhesion,GO:0030308~negative regulation of cell growth,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032535~regulation of cellular component size,GO:0033673~negative regulation of kinase activity,GO:0040008~regulation of growth,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042509~regulation of tyrosine phosphorylation of STAT protein,GO:0042516~regulation of tyrosine phosphorylation of Stat3 protein,GO:0042518~negative regulation of tyrosine phosphorylation of Stat3 protein,GO:0042532~negative regulation of tyrosine phosphorylation of STAT protein,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043086~negative regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043407~negative regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0043933~macromolecular complex subunit organization,GO:0044092~negative regulation of molecular function,GO:0045449~regulation of transcription,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0045926~negative regulation of growth,GO:0045936~negative regulation of phosphate metabolic process,GO:0046425~regulation of JAK-STAT cascade,GO:0046426~negative regulation of JAK-STAT cascade,GO:0046519~sphingoid metabolic process,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation,GO:0051052~regulation of DNA metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051338~regulation of transferase activity,GO:0051348~negative regulation of transferase activity,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,","hsa04114:Oocyte meiosis,hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04530:Tight junction,hsa04730:Long-term depression,",recurrent mutations found by multiple groups in uterine serous carcinoma at the interface for interaction with regulatory B subunits; this is the same surface/interaction blocked by SV40 Small T (23359684) (22923510); similarly recurrently mutated in ovarian clear cell carcinoma (21435433) (20826764); mutations also observed in breast and lung carcinomas and melanoma where they are suggested to be tumor suppressive (10713707),mutations abrogate interaction between catalytic A subunit and substrate recognition B subunit - proposed to act dominant negatively to prevent holoenzyme phosphatase activity which restricts cell growth through various mechanisms including antagonizing MAPK signaling (21435433) (8395218)
AQP2,Aquaporin 2 (collecting duct),0.662854231918872,0.420265180899895,2.16E-06,0.999999995658995,1,5.26E-09,3.39E-06,0.865033794851253,3,YES,novel,"GO:0003779~actin binding,GO:0005372~water transporter activity,GO:0008092~cytoskeletal protein binding,GO:0015250~water channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022838~substrate specific channel activity,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0016324~apical plasma membrane,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0055037~recycling endosome,GO:0001977~renal system process involved in regulation of blood volume,GO:0003013~circulatory system process,GO:0003014~renal system process,GO:0003071~renal system process involved in regulation of systemic arterial blood pressure,GO:0003073~regulation of systemic arterial blood pressure,GO:0003097~renal water transport,GO:0006833~water transport,GO:0006970~response to osmotic stress,GO:0007588~excretion,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0009414~response to water deprivation,GO:0009415~response to water,GO:0009628~response to abiotic stimulus,GO:0009651~response to salt stress,GO:0009991~response to extracellular stimulus,GO:0031668~cellular response to extracellular stimulus,GO:0033554~cellular response to stress,GO:0042044~fluid transport,GO:0042631~cellular response to water deprivation,GO:0046903~secretion,GO:0050878~regulation of body fluid levels,GO:0055085~transmembrane transport,",0,unknown,Identification of estrogen response element in the aquaporin-2 gene that mediates estrogen-induced cell migration and invasion in human endometrial carcinoma (21715543)
MTOR,Mechanistic Target Of Rapamycin (Serine/Threonine Kinase),1,1.65E-10,0.270573056590474,0.727817493050393,1,7.78E-09,4.85E-06,0.734094521652347,3,YES,known,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008144~drug binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0051219~phosphoprotein binding,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005942~phosphoinositide 3-kinase complex,GO:0009898~internal side of plasma membrane,GO:0012505~endomembrane system,GO:0019867~outer membrane,GO:0030425~dendrite,GO:0031090~organelle membrane,GO:0031931~TORC1 complex,GO:0031932~TORC2 complex,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0044429~mitochondrial part,GO:0044445~cytosolic part,GO:0044459~plasma membrane part,GO:0001101~response to acid,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0001936~regulation of endothelial cell proliferation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0003006~reproductive developmental process,GO:0005979~regulation of glycogen biosynthetic process,GO:0006109~regulation of carbohydrate metabolic process,GO:0006417~regulation of translation,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007584~response to nutrient,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008284~positive regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0009057~macromolecule catabolic process,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0009894~regulation of catabolic process,GO:0009895~negative regulation of catabolic process,GO:0009967~positive regulation of signal transduction,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010243~response to organic nitrogen,GO:0010506~regulation of autophagy,GO:0010507~negative regulation of autophagy,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010565~regulation of cellular ketone metabolic process,GO:0010591~regulation of lamellipodium assembly,GO:0010592~positive regulation of lamellipodium assembly,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010627~regulation of protein kinase cascade,GO:0010638~positive regulation of organelle organization,GO:0010647~positive regulation of cell communication,GO:0010648~negative regulation of cell communication,GO:0010675~regulation of cellular carbohydrate metabolic process,GO:0010740~positive regulation of protein kinase cascade,GO:0010906~regulation of glucose metabolic process,GO:0010962~regulation of glucan biosynthetic process,GO:0014075~response to amine stimulus,GO:0016049~cell growth,GO:0016241~regulation of macroautophagy,GO:0016242~negative regulation of macroautophagy,GO:0016310~phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018210~peptidyl-threonine modification,GO:0019216~regulation of lipid metabolic process,GO:0019217~regulation of fatty acid metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0019953~sexual reproduction,GO:0030030~cell projection organization,GO:0030163~protein catabolic process,GO:0030832~regulation of actin filament length,GO:0030833~regulation of actin filament polymerization,GO:0030838~positive regulation of actin filament polymerization,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031329~regulation of cellular catabolic process,GO:0031330~negative regulation of cellular catabolic process,GO:0031334~positive regulation of protein complex assembly,GO:0031344~regulation of cell projection organization,GO:0031346~positive regulation of cell projection organization,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031529~ruffle organization,GO:0031667~response to nutrient levels,GO:0031929~TOR signaling pathway,GO:0031998~regulation of fatty acid beta-oxidation,GO:0032095~regulation of response to food,GO:0032101~regulation of response to external stimulus,GO:0032102~negative regulation of response to external stimulus,GO:0032104~regulation of response to extracellular stimulus,GO:0032105~negative regulation of response to extracellular stimulus,GO:0032107~regulation of response to nutrient levels,GO:0032108~negative regulation of response to nutrient levels,GO:0032231~regulation of actin filament bundle formation,GO:0032233~positive regulation of actin filament bundle formation,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032271~regulation of protein polymerization,GO:0032273~positive regulation of protein polymerization,GO:0032314~regulation of Rac GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0032319~regulation of Rho GTPase activity,GO:0032504~multicellular organism reproduction,GO:0032535~regulation of cellular component size,GO:0032868~response to insulin stimulus,GO:0032881~regulation of polysaccharide metabolic process,GO:0032885~regulation of polysaccharide biosynthetic process,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0035020~regulation of Rac protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0040007~growth,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0043087~regulation of GTPase activity,GO:0043200~response to amino acid stimulus,GO:0043254~regulation of protein complex assembly,GO:0043255~regulation of carbohydrate biosynthetic process,GO:0043434~response to peptide hormone stimulus,GO:0043467~regulation of generation of precursor metabolites and energy,GO:0043549~regulation of kinase activity,GO:0043610~regulation of carbohydrate utilization,GO:0044087~regulation of cellular component biogenesis,GO:0045727~positive regulation of translation,GO:0045792~negative regulation of cell size,GO:0045859~regulation of protein kinase activity,GO:0045937~positive regulation of phosphate metabolic process,GO:0046320~regulation of fatty acid oxidation,GO:0046578~regulation of Ras protein signal transduction,GO:0046777~protein amino acid autophosphorylation,GO:0048585~negative regulation of response to stimulus,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050994~regulation of lipid catabolic process,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051130~positive regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051492~regulation of stress fiber formation,GO:0051493~regulation of cytoskeleton organization,GO:0051495~positive regulation of cytoskeleton organization,GO:0051496~positive regulation of stress fiber formation,GO:0051896~regulation of protein kinase B signaling cascade,GO:0051897~positive regulation of protein kinase B signaling cascade,GO:0060491~regulation of cell projection assembly,GO:0080135~regulation of cellular response to stress,","hsa04012:ErbB signaling pathway,hsa04150:mTOR signaling pathway,hsa04910:Insulin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04930:Type II diabetes mellitus,hsa05200:Pathways in cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05221:Acute myeloid leukemia,","overexpression/activation of upstream activators (Akt, Rheb) or mutation/loss of upstream inhibitors (TSC1/2) can all lead to hyperactive MTOR (21422497);  activating point mutations identified in renal cell carcinoma and large intestine adenocarcinoma (20190810)",Reviewed (23460185) (22408430)
KRT15,Keratin 15,1,0.070801567544737,0.00018169384931,0.999998479460335,1,1.11E-08,6.67E-06,0.879290447027464,3,NO,putative OG,"GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045111~intermediate filament cytoskeleton,GO:0007398~ectoderm development,GO:0008544~epidermis development,",0,"overexpressed in Breast phyllodes tumors and expression correlated with tumor grade (21574054); putative stem cell marker in breast epithelial cells, is expressed in most normal breast tissue, but only about 12-15% of carcinomas, and is mostly mutually exclusive with p53 mutation (21036680)",expression induced by Hedgehog activation in hair follicle bulge stem cells (20050020)
MEF2BNB-MEF2B,MEF2BNB-MEF2B readthrough,1,0.006674639540717,0.001923490609088,0.004392754704714,0.014304788202466,1.57E-08,9.10E-06,0.836987821743072,3,NO,novel,0,0,See MEF2B,This gene represents numerous read-through transcripts that span GeneID:729991 and 100271849. Confirmed expression of at least one isoform of myocyte enhancer factor 2B (MEF2B) from this read-through locus. (NCBI gene)
CHD4,Chromodomain helicase DNA binding protein 4,1,2.81E-08,0.174061898307271,0.088902367179461,0.258500516274153,1.98E-08,1.09E-05,0.821263457029714,3,YES,putative TSG,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008094~DNA-dependent ATPase activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070035~purine NTP-dependent helicase activity,GO:0000118~histone deacetylase complex,GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0016581~NuRD complex,GO:0016585~chromatin remodeling complex,GO:0017053~transcriptional repressor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,",0,"important for DNA double strand break repair.  Also destabilizes p53 through NuRD complex, leading CHD4-deficient cells to experience cell cycle progression defects due to high levels of p53 and p21 (23954449)","chromatin remodeling factor and member of NuRD complex, reviewed (17694084) (17713581 )"
MAP2K1,Mitogen-activated protein kinase kinase 1,1,2.92E-06,0.08444653739672,0.999999733444077,1,2.95E-08,1.49E-05,0.728249304443555,3,YES,known,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004708~MAP kinase kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005524~ATP binding,GO:0016791~phosphatase activity,GO:0017016~Ras GTPase binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030554~adenyl nucleotide binding,GO:0031267~small GTPase binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0051020~GTPase binding,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0015630~microtubule cytoskeleton,GO:0030424~axon,GO:0030425~dendrite,GO:0032838~cell projection cytoplasm,GO:0032839~dendrite cytoplasm,GO:0033267~axon part,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043204~perikaryon,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044463~cell projection part,GO:0048471~perinuclear region of cytoplasm,GO:0000087~M phase of mitotic cell cycle,GO:0000165~MAPKKK cascade,GO:0000187~activation of MAPK activity,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0000902~cell morphogenesis,GO:0003056~regulation of vascular smooth muscle contraction,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006928~cell motion,GO:0006935~chemotaxis,GO:0006937~regulation of muscle contraction,GO:0006940~regulation of smooth muscle contraction,GO:0006979~response to oxidative stress,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0007030~Golgi organization,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0007162~negative regulation of cell adhesion,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007398~ectoderm development,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0008283~cell proliferation,GO:0008544~epidermis development,GO:0009611~response to wounding,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009913~epidermal cell differentiation,GO:0010033~response to organic substance,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010970~microtubule-based transport,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0019229~regulation of vasoconstriction,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0022407~regulation of cell-cell adhesion,GO:0022408~negative regulation of cell-cell adhesion,GO:0030030~cell projection organization,GO:0030155~regulation of cell adhesion,GO:0030182~neuron differentiation,GO:0030216~keratinocyte differentiation,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0030855~epithelial cell differentiation,GO:0031175~neuron projection development,GO:0031960~response to corticosteroid stimulus,GO:0032318~regulation of Ras GTPase activity,GO:0032320~positive regulation of Ras GTPase activity,GO:0032400~melanosome localization,GO:0032401~establishment of melanosome localization,GO:0032402~melanosome transport,GO:0032784~regulation of RNA elongation,GO:0032786~positive regulation of RNA elongation,GO:0032968~positive regulation of RNA elongation from RNA polymerase II promoter,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033059~cellular pigmentation,GO:0033674~positive regulation of kinase activity,GO:0034110~regulation of homotypic cell-cell adhesion,GO:0034111~negative regulation of homotypic cell-cell adhesion,GO:0034243~regulation of RNA elongation from RNA polymerase II promoter,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042325~regulation of phosphorylation,GO:0042330~taxis,GO:0043085~positive regulation of catalytic activity,GO:0043087~regulation of GTPase activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043473~pigmentation,GO:0043547~positive regulation of GTPase activity,GO:0043549~regulation of kinase activity,GO:0043933~macromolecular complex subunit organization,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046578~regulation of Ras protein signal transduction,GO:0046907~intracellular transport,GO:0047496~vesicle transport along microtubule,GO:0048285~organelle fission,GO:0048308~organelle inheritance,GO:0048313~Golgi inheritance,GO:0048545~response to steroid hormone stimulus,GO:0048666~neuron development,GO:0048678~response to axon injury,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051094~positive regulation of developmental process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051259~protein oligomerization,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051291~protein heterooligomerization,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051347~positive regulation of transferase activity,GO:0051384~response to glucocorticoid stimulus,GO:0051640~organelle localization,GO:0051648~vesicle localization,GO:0051650~establishment of vesicle localization,GO:0051656~establishment of organelle localization,GO:0051875~pigment granule localization,GO:0051904~pigment granule transport,GO:0051905~establishment of pigment granule localization,GO:0060429~epithelium development,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04114:Oocyte meiosis,hsa04270:Vascular smooth muscle contraction,hsa04320:Dorso-ventral axis formation,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04540:Gap junction,hsa04620:Toll-like receptor signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04916:Melanogenesis,hsa05020:Prion diseases,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,",mutated in cancers (22327936) (21277552) (22817889),Reviewed (17496923) (20149254)
TRIM48,Tripartite motif-containing 48,1,1,6.61E-10,0.000139844856701,0.000501374679139,4.44E-08,2.18E-05,0.840444328619646,3,YES,novel,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,unknown,unknown
SPOP,Speckle-type POZ protein,1,2.17E-07,0.272100981371595,1.80E-16,1.13E-15,1.60E-07,7.49E-05,0.843210487428766,3,YES,putative OG,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0016071~mRNA metabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,",0,"Subject to recurrent mutation in cancer and classified as oncogene (23539594); frequent somatic mutation in serous endometrial carcinoma, leading to predicted loss of function/impaired substrate binding (23104009); recurrently mutated in prostate cancer, where mutation appears to behave similarly to siRNA and reduce invasiveness (22610119); highly overexpressed in kidney cancer (19164706)","reported as oncogenic driver (23539594); CUL3-based ubiquitin ligase - substrates include SRC-3 oncogene, suggested tumor suppressor role for SPOP (21577200)"
KRTAP4-11,keratin associated protein 4-11,1,1,6.22E-09,2.18E-06,8.79E-06,1.69E-07,7.69E-05,0.887717612070187,3,NO,novel,keratin filament,0,unknown,unknown
FLT3,fms-related tyrosine kinase 3,1,1,1.01E-06,5.92E-14,3.44E-13,2.05E-07,9.10E-05,0.565634298332002,3,YES,known,"GO:0001775~cell activation,GO:0002244~hemopoietic progenitor cell differentiation,GO:0002318~myeloid progenitor cell differentiation,GO:0002320~lymphoid progenitor cell differentiation,GO:0002328~pro-B cell differentiation,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002572~pro-T cell differentiation,GO:0002683~negative regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0016310~phosphorylation,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030217~T cell differentiation,GO:0042110~T cell activation,GO:0042127~regulation of cell proliferation,GO:0045321~leukocyte activation,GO:0045577~regulation of B cell differentiation,GO:0045578~negative regulation of B cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045620~negative regulation of lymphocyte differentiation,GO:0046649~lymphocyte activation,GO:0046777~protein amino acid autophosphorylation,GO:0048534~hemopoietic or lymphoid organ development,GO:0050864~regulation of B cell activation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050869~negative regulation of B cell activation,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005021~vascular endothelial growth factor receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043548~phosphoinositide 3-kinase binding,","hsa04060:Cytokine-cytokine receptor interaction,hsa04640:Hematopoietic cell lineage,hsa05200:Pathways in cancer,hsa05221:Acute myeloid leukemia,",mutated in cancer (21422497); prone to activating internal tandem duplications and activating point mutations in AML (22797419) (23261068),"Receptor tyrosine kinase whose activation promotes proliferation and survival through activation of downstream activation of Ras/MAPK and PI3K signaling pathways , also important for differentiation of early hemopoietic progenitors (7888178) (21422497)"
MAX,MYC associated factor X,1,0.04957403893491,0.007553691934393,0.999999999999999,1,4.45E-07,0.000184620815321,0.865577417025785,3,NO,unclear/putative TS,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,","hsa04010:MAPK signaling pathway,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,",hereditary LOF mutations identified as cause of Hereditary pheochromocytoma (PCC) (21685915); both somatic and germline MAX mutations found in PCC and PGL (22452945); ,"reviewed (16908182) ;associates with other myc-family transcription factors to either promote or repress transcription (8521822); evidence suggests MAX primarily functions in repression, and MYC retains its proto-oncogenic activity in the absence of MAX (22706201)"
MYCN,"V-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)",0.74735679281311,0.180765780910828,0.001863187173646,9.09E-10,4.35E-09,5.43E-07,0.0002158346689,0.652519494620096,3,NO,known,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0000785~chromatin,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0001763~morphogenesis of a branching structure,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042127~regulation of cell proliferation,GO:0045449~regulation of transcription,GO:0048754~branching morphogenesis of a tube,GO:0051252~regulation of RNA metabolic process,GO:0060541~respiratory system development,",0,MYCN overexpression is a hallmark of malign neuroblastoma (22706201),"proto-oncogenic transcription factor required for central and peripheral nervous system development, expression restricted to embryogenesis (15975048)"
MEF2B,LOC729991-MEF2B readthrough transcript; myocyte enhancer factor 2B,0.840187572303684,0.038129880226435,0.014906392164406,0.004960890855129,0.016109958324575,8.96E-07,0.000348750540541,0.813636768670086,3,NO,putative OG,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007517~muscle organ development,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,"strong signature of recurrent, putatively activating mutations of MEF2B in Non-Hodgkin Lymphomas (21796119); mantle cell lymphoma (MCL) transcriptomes reveal recurrent MEF2b mutations (23407552)","MEF2B functions as a transcription factor which can recruit histone-modifying enzymes including histone deacetylases (HDACs) and HATs in a calcium-regulated manner... may cooperate with EZH2 mutations to alter H3 epigentic marks and regulate transcription(21796119); Myocyte enhancing factor 2B (MEF2B) transactivates the downstream target proteins of the epithelial myofibroblast transition (EMyT), a pathway involved in neoplasticity.  Treatment of epithelial cells with EGF stimulated myofibroblastic transition (anch ind growth), and requires MEF2B (22302709)"
CARM1,Coactivator-associated arginine methyltransferase 1,1,0.595630786429956,0.000957350923944,2.49E-08,1.11E-07,2.76E-06,0.000989633336219,0.840998917148904,3,YES,putative OG,"GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0008170~N-methyltransferase activity,GO:0008276~protein methyltransferase activity,GO:0008469~histone-arginine N-methyltransferase activity,GO:0016273~arginine N-methyltransferase activity,GO:0016274~protein-arginine N-methyltransferase activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0042054~histone methyltransferase activity,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006479~protein amino acid methylation,GO:0006730~one-carbon metabolic process,GO:0007242~intracellular signaling cascade,GO:0008213~protein amino acid alkylation,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0030518~steroid hormone receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0032259~methylation,GO:0034969~histone arginine methylation,GO:0034970~histone H3-R2 methylation,GO:0043414~biopolymer methylation,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,",0,"overespression observed in breast cancer (23887673), colorectal cancer (20462455), melanoma (23265702)",protein arginine methyltransferase CARM1 acts as a  transcriptional cofactor for ER-alpha in breast cancer (21282336) and for other steroid hormones (11747826); its required for Wnt/Beta-catenin driven transformation in colorectal cancer (21478268);
RHOA,"Ras homolog gene family, member A",1,0.690698949726243,0.002216157762326,0.998788090210588,1,9.42E-06,0.002837585591049,0.792084602842914,3,YES,known,"GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0008092~cytoskeletal protein binding,GO:0017022~myosin binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0000902~cell morphogenesis,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007266~Rho protein signal transduction,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0009967~positive regulation of signal transduction,GO:0010627~regulation of protein kinase cascade,GO:0010638~positive regulation of organelle organization,GO:0010647~positive regulation of cell communication,GO:0010720~positive regulation of cell development,GO:0010721~negative regulation of cell development,GO:0010740~positive regulation of protein kinase cascade,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010941~regulation of cell death,GO:0010975~regulation of neuron projection development,GO:0014706~striated muscle tissue development,GO:0022604~regulation of cell morphogenesis,GO:0022610~biological adhesion,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0031344~regulation of cell projection organization,GO:0031345~negative regulation of cell projection organization,GO:0031346~positive regulation of cell projection organization,GO:0031589~cell-substrate adhesion,GO:0032231~regulation of actin filament bundle formation,GO:0032233~positive regulation of actin filament bundle formation,GO:0032386~regulation of intracellular transport,GO:0032388~positive regulation of intracellular transport,GO:0032880~regulation of protein localization,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0032989~cellular component morphogenesis,GO:0033043~regulation of organelle organization,GO:0033157~regulation of intracellular protein transport,GO:0042306~regulation of protein import into nucleus,GO:0042307~positive regulation of protein import into nucleus,GO:0042345~regulation of NF-kappaB import into nucleus,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0042981~regulation of apoptosis,GO:0042990~regulation of transcription factor import into nucleus,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043149~stress fiber formation,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0044087~regulation of cellular component biogenesis,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0046822~regulation of nucleocytoplasmic transport,GO:0046824~positive regulation of nucleocytoplasmic transport,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050770~regulation of axonogenesis,GO:0050771~negative regulation of axonogenesis,GO:0050772~positive regulation of axonogenesis,GO:0051017~actin filament bundle formation,GO:0051050~positive regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051129~negative regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051222~positive regulation of protein transport,GO:0051223~regulation of protein transport,GO:0051252~regulation of RNA metabolic process,GO:0051492~regulation of stress fiber formation,GO:0051493~regulation of cytoskeleton organization,GO:0051495~positive regulation of cytoskeleton organization,GO:0051496~positive regulation of stress fiber formation,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0060341~regulation of cellular localization,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0060548~negative regulation of cell death,GO:0070201~regulation of establishment of protein localization,","hsa04062:Chemokine signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04360:Axon guidance,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04530:Tight junction,hsa04660:T cell receptor signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa05130:Pathogenic Escherichia coli infection,hsa05200:Pathways in cancer,",frequently overexpressed in cancers (21044680); ( 22528793); (14999150),Reviewed (23176484)
PTPN11,"Protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1)",1,0.022112152760986,0.140051375693358,0.999109823952729,1,1.52E-05,0.004297855943374,0.623185133205793,3,YES,known,"GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005158~insulin receptor binding,GO:0016791~phosphatase activity,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0032403~protein complex binding,GO:0043274~phospholipase binding,GO:0043560~insulin receptor substrate binding,GO:0051427~hormone receptor binding,GO:0051428~peptide hormone receptor binding,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0000165~MAPKKK cascade,GO:0000187~activation of MAPK activity,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0002791~regulation of peptide secretion,GO:0002792~negative regulation of peptide secretion,GO:0006468~protein amino acid phosphorylation,GO:0006470~protein amino acid dephosphorylation,GO:0006638~neutral lipid metabolic process,GO:0006639~acylglycerol metabolic process,GO:0006641~triglyceride metabolic process,GO:0006662~glycerol ether metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006974~response to DNA damage stimulus,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007409~axonogenesis,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009755~hormone-mediated signaling,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010647~positive regulation of cell communication,GO:0010817~regulation of hormone levels,GO:0016310~phosphorylation,GO:0016311~dephosphorylation,GO:0018904~organic ether metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0031570~DNA integrity checkpoint,GO:0032386~regulation of intracellular transport,GO:0032504~multicellular organism reproduction,GO:0032870~cellular response to hormone stimulus,GO:0032880~regulation of protein localization,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033157~regulation of intracellular protein transport,GO:0033500~carbohydrate homeostasis,GO:0033554~cellular response to stress,GO:0033674~positive regulation of kinase activity,GO:0035265~organ growth,GO:0040007~growth,GO:0040008~regulation of growth,GO:0040014~regulation of multicellular organism growth,GO:0042325~regulation of phosphorylation,GO:0042445~hormone metabolic process,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0042770~DNA damage response, signal transduction,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046486~glycerolipid metabolic process,GO:0046676~negative regulation of insulin secretion,GO:0046822~regulation of nucleocytoplasmic transport,GO:0046825~regulation of protein export from nucleus,GO:0046883~regulation of hormone secretion,GO:0046887~positive regulation of hormone secretion,GO:0046888~negative regulation of hormone secretion,GO:0048011~nerve growth factor receptor signaling pathway,GO:0048609~reproductive process in a multicellular organism,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048878~chemical homeostasis,GO:0050796~regulation of insulin secretion,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051048~negative regulation of secretion,GO:0051050~positive regulation of transport,GO:0051051~negative regulation of transport,GO:0051174~regulation of phosphorus metabolic process,GO:0051223~regulation of protein transport,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051462~regulation of cortisol secretion,GO:0051463~negative regulation of cortisol secretion,GO:0051726~regulation of cell cycle,GO:0060123~regulation of growth hormone secretion,GO:0060125~negative regulation of growth hormone secretion,GO:0060341~regulation of cellular localization,GO:0070201~regulation of establishment of protein localization,","hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05211:Renal cell carcinoma,hsa05220:Chronic myeloid leukemia,",activating mutations are associated with leukemias (23825065),Reviewed (17227708)
ZNF799,Zinc finger protein 799,1,0.654381419924811,0.012847361905121,0.002611506703588,0.008615389211642,4.46E-05,0.011460064273703,0.817634819265516,3,NO,novel,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,found in chromosome 19 locus frequently amplified in ovarian carcinoma (20725991),unknown
TOR1A,"Torsin family 1, member A (torsin A)",1,0.76383376707594,0.018155701616854,0.999950917267313,1,0.00010467625944,0.022158610830315,0.817610233761472,3,NO,novel,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005524~ATP binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017076~purine nucleotide binding,GO:0017171~serine hydrolase activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0051082~unfolded protein binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0012505~endomembrane system,GO:0015630~microtubule cytoskeleton,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0031090~organelle membrane,GO:0031965~nuclear membrane,GO:0031967~organelle envelope,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0044432~endoplasmic reticulum part,GO:0070013~intracellular organelle lumen,GO:0006457~protein folding,GO:0006458~'de novo' protein folding,GO:0006979~response to oxidative stress,GO:0006986~response to unfolded protein,GO:0010033~response to organic substance,GO:0051084~'de novo' posttranslational protein folding,GO:0051085~chaperone mediated protein folding requiring cofactor,GO:0051789~response to protein stimulus,",0,unknown,"a 3 bp deletion in TOR1A causes an autosomal dominant form of dystonia.  Its a member of the AAA ATPase family of chaperones and plays roles in cytoskeletal and nuclear envelope organization, and secretion/synaptic vesicle formation (20590813) (19457118)"
HIST1H2BF,"Histone cluster 1, H2bf",1,0.793026157219052,0.015036182651223,0.703185868257921,1,0.000105579333149,0.022158610830315,0.875200564514517,3,NO,novel,"GO:0003677~DNA binding,GO:0000785~chromatin,GO:0000786~nucleosome,GO:0005694~chromosome,GO:0032993~protein-DNA complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006334~nucleosome assembly,GO:0006952~defense response,GO:0009617~response to bacterium,GO:0031497~chromatin assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0034728~nucleosome organization,GO:0042742~defense response to bacterium,GO:0043933~macromolecular complex subunit organization,GO:0051276~chromosome organization,GO:0065003~macromolecular complex assembly,GO:0065004~protein-DNA complex assembly,","hsa05322:Systemic lupus erythematosus,",included in a set of histones whose overexpression correlated with tumor recurrence in breast cancer (20731868),unknown
INTS7,Integrator complex subunit 7,1,0.227591325759547,0.207292071105334,0.00049676285353,0.001716114914201,0.000295148361169,0.049667353498003,0.858253931586211,3,NO,novel,"GO:0005654~nucleoplasm,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032039~integrator complex,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0006396~RNA processing,GO:0016073~snRNA metabolic process,GO:0016180~snRNA processing,GO:0034470~ncRNA processing,GO:0034660~ncRNA metabolic process,",0,identified as amplified and overexpressed in HCC (18214995),member of the integrator complex which associates with RNA PolII and aids in small nuclear RNA processing (16239144); localizes to sites of IR-induced DNA damage and its depletion leads to bypass of cell cycle arrest (21659603)
METTL14,Methyltransferase Like 14,1,0.153491761188509,0.270573056590474,4.59E-43,6.56E-42,0.000307637771965,0.051306838772589,0.497050372160334,3,YES,novel,"GO:0008173~RNA methyltransferase activity,GO:0008174~mRNA methyltransferase activity,GO:0016422~mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,GO:0001510~RNA methylation,GO:0006730~one-carbon metabolic process,GO:0009451~RNA modification,GO:0032259~methylation,GO:0043414~biopolymer methylation,",0,unknown,unknown
JAKMIP2,Janus kinase and microtubule interacting protein 2,1,0.000186207951805,0.628457722964864,2.61E-38,3.20E-37,0.00033664794829,0.054600207076427,0.56842640386938,3,NO,0,"GO:0005794~Golgi apparatus,",0,0,0
SOX17,SRY (sex determining region Y)-box 17,1,0.505087244311173,0.108469860173985,1.63E-11,8.64E-11,0.000339077253647,0.054600207076427,0.891072471332379,3,NO,putative TSG,"GO:0003677~DNA binding,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001944~vasculature development,GO:0006350~transcription,GO:0009968~negative regulation of signal transduction,GO:0010608~posttranscriptional regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0030178~negative regulation of Wnt receptor signaling pathway,GO:0031647~regulation of protein stability,GO:0031648~protein destabilization,GO:0045449~regulation of transcription,GO:0048514~blood vessel morphogenesis,GO:0050821~protein stabilization,","hsa04310:Wnt signaling pathway,",highly methylated/silenced in variety of cancers ( 22846201) (23044318) (22921431) (22161215),"negative regulator of Wnt signaling ( 22846201), (19301122); high expression in tumor endothelial cells correlates with increased VEGF expression, angiogensis, and survival (23241958)"
LSM11,"LSM11, U7 small nuclear RNA associated",1,0.503116045574968,0.114326682956047,2.94E-54,5.70E-53,0.00035052432731,0.055486812795171,0.717965681591183,3,NO,0,"GO:0003723~RNA binding,GO:0030529~ribonucleoprotein complex,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,",0,0,0
CSMD3,CUB and Sushi multiple domains 3,0.776961865429334,0.000949654177846,0.616617274858735,2.63E-122,1.46E-120,0.00042160997068,0.063002021138712,0.773112576604734,3,YES,0,"GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
ZNF844,zinc finger protein 844,1,1,0.000932502824151,9.84E-09,4.48E-08,0.000472211369877,0.069061155235193,0.857267244362872,3,NO,novel,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,unknown,unknown
MYOT,myotilin,1,0.218555479368028,0.296602665660762,3.25E-33,3.28E-32,0.000569904734989,0.078853707739739,0.456344089881622,3,NO,0,"GO:0003012~muscle system process,GO:0006936~muscle contraction,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0030018~Z disc,GO:0031674~I band,GO:0042383~sarcolemma,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043292~contractile fiber,GO:0044449~contractile fiber part,GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0008092~cytoskeletal protein binding,GO:0008307~structural constituent of muscle,",0,0,0
PRRX1,Paired related homeobox 1,1,0.210323522573515,0.308650437420578,7.71E-20,5.35E-19,0.000601305400403,0.081983821708985,0.814568882932758,3,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0001501~skeletal system development,GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0006355~regulation of transcription, DNA-dependent,GO:0007423~sensory organ development,GO:0008284~positive regulation of cell proliferation,GO:0008589~regulation of smoothened signaling pathway,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009967~positive regulation of signal transduction,GO:0010464~regulation of mesenchymal cell proliferation,GO:0010647~positive regulation of cell communication,GO:0030326~embryonic limb morphogenesis,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0042127~regulation of cell proliferation,GO:0042471~ear morphogenesis,GO:0042472~inner ear morphogenesis,GO:0042474~middle ear morphogenesis,GO:0043009~chordate embryonic development,GO:0043583~ear development,GO:0045449~regulation of transcription,GO:0045880~positive regulation of smoothened signaling pathway,GO:0048514~blood vessel morphogenesis,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048736~appendage development,GO:0048839~inner ear development,GO:0048844~artery morphogenesis,GO:0051216~cartilage development,GO:0051252~regulation of RNA metabolic process,GO:0060021~palate development,GO:0060173~limb development,",0,0,0
CPB1,Carboxypeptidase B1 (tissue),0.987332615704823,0.227591325759547,0.296602665660762,5.44E-62,1.30E-60,0.000622439688835,0.083715295319809,0.733239180295953,3,YES,0,"GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0008233~peptidase activity,GO:0008235~metalloexopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008238~exopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0005576~extracellular region,GO:0006508~proteolysis,",0,0,0
ZNF181,Zinc finger protein 181,1,1,0.025719815361466,2.92E-17,1.89E-16,0.000627450149621,0.083715295319809,0.833390663423901,3,NO,novel,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,unknown,one of five genes included in region responsible for 19q13.11 deletion syndrome characterized by developmental delays (22378287)
RBM39,RNA binding motif protein 39,1,0.180765780910828,0.332676355469261,2.08E-43,3.00E-42,0.000652298988047,0.084732548269974,0.808923466110151,3,NO,0,"GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0005654~nucleoplasm,GO:0005856~cytoskeleton,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0006350~transcription,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0045449~regulation of transcription,",0,0,0
GNG4,"Guanine nucleotide binding protein (G protein), gamma 4",1,1,0.018809954722435,9.09E-21,6.49E-20,0.000653219495202,0.084732548269974,0.873807612742102,3,YES,0,"GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0044459~plasma membrane part,GO:0001558~regulation of cell growth,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007242~intracellular signaling cascade,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0008361~regulation of cell size,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009755~hormone-mediated signaling,GO:0010033~response to organic substance,GO:0030308~negative regulation of cell growth,GO:0032535~regulation of cellular component size,GO:0032870~cellular response to hormone stimulus,GO:0040008~regulation of growth,GO:0045792~negative regulation of cell size,GO:0045926~negative regulation of growth,","hsa04062:Chemokine signaling pathway,",0,0
NSFL1C,NSFL1 (p97) cofactor (p47),1,0.710053497962842,0.114326682956047,0.999999999996071,1,0.000703253054455,0.089360978259622,0.847117396242103,3,YES,novel,"GO:0008289~lipid binding,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0044431~Golgi apparatus part,",0,Target of EGFR tyrosine phosphorylation in breast cancer cells and overexpressed in breast cancer (17855441),"p47 binds to NEMO to trigger lysosomal degradation of NEMO, blocking IKK activation, and thus repressing NFkB pathway (22990857);  cofactor for AAA-ATPase p97 in its role in reassembly of Golgi cisternae from mitotic Golgi fragments (9214505)"
CRISPLD1,Cysteine-rich secretory protein LCCL domain containing 1,0.640237668049965,0.783828753636386,0.09538263656897,1.12E-27,9.62E-27,0.000743645022787,0.092603635870929,0.84041225799834,3,NO,putative OG,"GO:0005576~extracellular region,",0,predicted damaging mutation observed in cancer of the ampulla of Vater (22762308),ectopic parkin expression in MCF7 cells results in 5 fold reduction of CRISPLD1 expression and restricts proliferation and blocks anchorage independence (20630868)
SIAH2,seven in absentia homolog 2 (Drosophila),1,0.095656828143588,0.444921389161528,3.54E-86,1.33E-84,0.00083037933071,0.098168705812271,0.775333477715447,3,YES,0,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006915~apoptosis,GO:0007049~cell cycle,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0008219~cell death,GO:0009057~macromolecule catabolic process,GO:0012501~programmed cell death,GO:0016265~death,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0032446~protein modification by small protein conjugation,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0070647~protein modification by small protein conjugation or removal,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0004842~ubiquitin-protein ligase activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016564~transcription repressor activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
LIN9,Lin-9 homolog (C. elegans),1,0.745415986888831,0.129153533446405,3.45E-11,1.80E-10,0.000936380602125,0.106650324799354,0.885194028927059,3,NO,unclear,"GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0007049~cell cycle,",0,"LIN9 complex (LINC) upregulated in HCC (21480327); putative haploinsufficient tumor suppressor (20404087); re-expression of silenced hTRM9L in colon cancer is tumor suppressive and exerts its effect through upregulation of LIN9 (23381944); loss of LIN9 induces senescence, leads to induction of p16 and p21 (21860417)","functions in various transcriptional complexes, including repressive during G0-G1 and active during G2-M (19252525) (17671431)"
HARS2,"Histidyl-tRNA synthetase 2, mitochondrial (putative)",1,0.057907855996417,0.532650659483048,1.37E-36,1.53E-35,0.000968445706137,0.108346317503035,0.72206242321461,3,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004821~histidine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016875~ligase activity, forming carbon-oxygen bonds,GO:0016876~ligase activity, forming aminoacyl-tRNA and related compounds,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0006399~tRNA metabolic process,GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006427~histidyl-tRNA aminoacylation,GO:0009063~cellular amino acid catabolic process,GO:0009310~amine catabolic process,GO:0016054~organic acid catabolic process,GO:0019478~D-amino acid catabolic process,GO:0034660~ncRNA metabolic process,GO:0043038~amino acid activation,GO:0043039~tRNA aminoacylation,GO:0046395~carboxylic acid catabolic process,GO:0046416~D-amino acid metabolic process,","hsa00970:Aminoacyl-tRNA biosynthesis,",0,0
NBPF10,"neuroblastoma breakpoint family, member 10",1,1,0.003114064398508,0.409021149072436,1,0.001096202812214,0.115033552412092,0.879903111543782,3,NO,0,cytoplasm,0,0,0
MECOM,ecotropic viral integration site 1,1,0.001705880361571,0.628457722964864,0,0,0.001130664781508,0.116683356098303,0.77463066623779,3,YES,0,"GO:0001701~in utero embryonic development,GO:0001776~leukocyte homeostasis,GO:0001780~neutrophil homeostasis,GO:0002262~myeloid cell homeostasis,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007507~heart development,GO:0009611~response to wounding,GO:0009617~response to bacterium,GO:0009791~post-embryonic development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0030326~embryonic limb morphogenesis,GO:0030900~forebrain development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0035136~forelimb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0042127~regulation of cell proliferation,GO:0042592~homeostatic process,GO:0043009~chordate embryonic development,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048598~embryonic morphogenesis,GO:0048736~appendage development,GO:0048872~homeostasis of number of cells,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060039~pericardium development,GO:0060173~limb development,GO:0060429~epithelium development,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04010:MAPK signaling pathway,hsa05200:Pathways in cancer,hsa05220:Chronic myeloid leukemia,",0,0
PIK3CB,"Phosphoinositide-3-kinase, catalytic, beta polypeptide",1,0.279429256400848,0.402442571319756,5.28E-68,1.39E-66,0.001242919617116,0.121552332607925,0.793805742485568,3,NO,0,"GO:0000166~nucleotide binding,GO:0001727~lipid kinase activity,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004428~inositol or phosphatidylinositol kinase activity,GO:0005524~ATP binding,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035004~phosphoinositide 3-kinase activity,GO:0043560~insulin receptor substrate binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0005829~cytosol,GO:0005942~phosphoinositide 3-kinase complex,GO:0044445~cytosolic part,GO:0000165~MAPKKK cascade,GO:0000187~activation of MAPK activity,GO:0001775~cell activation,GO:0001952~regulation of cell-matrix adhesion,GO:0006468~protein amino acid phosphorylation,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0009611~response to wounding,GO:0010810~regulation of cell-substrate adhesion,GO:0016310~phosphorylation,GO:0016337~cell-cell adhesion,GO:0019220~regulation of phosphate metabolic process,GO:0019637~organophosphate metabolic process,GO:0019725~cellular homeostasis,GO:0019932~second-messenger-mediated signaling,GO:0022610~biological adhesion,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030155~regulation of cell adhesion,GO:0030168~platelet activation,GO:0030258~lipid modification,GO:0030384~phosphoinositide metabolic process,GO:0033674~positive regulation of kinase activity,GO:0040016~embryonic cleavage,GO:0042060~wound healing,GO:0042325~regulation of phosphorylation,GO:0042330~taxis,GO:0042592~homeostatic process,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046486~glycerolipid metabolic process,GO:0046834~lipid phosphorylation,GO:0046854~phosphoinositide phosphorylation,GO:0048015~phosphoinositide-mediated signaling,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,GO:0051174~regulation of phosphorus metabolic process,GO:0051301~cell division,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,","hsa00562:Inositol phosphate metabolism,hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04150:mTOR signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04930:Type II diabetes mellitus,hsa04960:Aldosterone-regulated sodium reabsorption,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,",0,0
STRIP2,striatin interacting protein 2,1,0.406452745413553,0.297154839951588,0.003262630506229,0.010710487737407,0.001306335491514,0.125778560030852,0.814855351507364,3,NO,0,"cell migration, cytoskeleton organization, regulation of cell shape, cytoplasm",0,0,0
HIST1H3B,"Histone cluster 1, H3b",1,1,0.067308132798854,0.494577614508112,1,0.00144446170376,0.134234329176791,0.839294353366276,3,NO,putative OG,"GO:0003677~DNA binding,GO:0000785~chromatin,GO:0000786~nucleosome,GO:0005694~chromosome,GO:0032993~protein-DNA complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006334~nucleosome assembly,GO:0031497~chromatin assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0034728~nucleosome organization,GO:0043933~macromolecular complex subunit organization,GO:0051276~chromosome organization,GO:0065003~macromolecular complex assembly,GO:0065004~protein-DNA complex assembly,","hsa05322:Systemic lupus erythematosus,","in DIPG, found somatic p.K27M mutation, also recurrent in related H3 histone H3F3A (22286216)",reviews on histone modifications in cancer (23347561) (22956497); general histone reviews (16267050); (16185088)
FGFR3,"Fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism)",1,0.271476723733921,0.399992964780997,5.72E-07,2.38E-06,0.001666622984272,0.148242146301032,0.751788804754024,3,YES,known,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005007~fibroblast growth factor receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0000165~MAPKKK cascade,GO:0001501~skeletal system development,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007259~JAK-STAT cascade,GO:0008284~positive regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0016049~cell growth,GO:0016310~phosphorylation,GO:0032535~regulation of cellular component size,GO:0040007~growth,GO:0042127~regulation of cell proliferation,","hsa04010:MAPK signaling pathway,hsa04144:Endocytosis,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05219:Bladder cancer,","activating somatic mutations observed in multiple myeloma, cervical carcinoma and carcinoma of the bladder (15748888)",receptor for fibroblast growth factor ligands which activate mitogenic signaling (22273505)
IL5RA,"Interleukin 5 receptor, alpha",1,0.342096927505986,0.362344315530979,6.10E-34,6.29E-33,0.001790844676779,0.15415293879054,0.580727111387913,3,YES,0,"GO:0004896~cytokine receptor activity,GO:0004914~interleukin-5 receptor activity,GO:0019838~growth factor binding,GO:0019955~cytokine binding,GO:0019980~interleukin-5 binding,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005895~interleukin-5 receptor complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0043235~receptor complex,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0008283~cell proliferation,","hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,hsa04640:Hematopoietic cell lineage,",0,0
ZFP2,zinc finger protein 2 homolog (mouse),1,0.271476723733921,0.415026258567341,1.85E-46,3.01E-45,0.00198410009143,0.16326434188465,0.80652642843757,3,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0045449~regulation of transcription,",0,0,0
RIMS2,Regulating synaptic membrane exocytosis 2,0.358434391640513,0.000187607570559,0.70302965945656,8.59E-89,3.33E-87,0.00225444781347,0.177063951231498,0.752188536366986,3,NO,0,"GO:0005083~small GTPase regulator activity,GO:0008270~zinc ion binding,GO:0017016~Ras GTPase binding,GO:0017137~Rab GTPase binding,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0031267~small GTPase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070727~cellular macromolecule localization,",0,0,0
TOX,Thymocyte selection-associated high mobility group box,1,0.730470076685937,0.27215746376187,5.99E-09,2.75E-08,0.002853932943263,0.200408321230083,0.879292186187713,3,NO,novel,"GO:0003677~DNA binding,",0,"TOX promoter frequently methylated in breast tumors, but rarely in lung cancer (22496870)",nuclear HMG box protein required for development of all CD4 T cell lineages (18195075)
PIK3R5,"Phosphoinositide-3-kinase, regulatory subunit 5, p101",1,1,0.01670864838749,1.47E-37,1.74E-36,0.00293373861977,0.202960383995144,0.535227674205734,3,NO,0,"GO:0005634,GO:0005737,GO:0016020","hsa04012,hsa04070,hsa04150,hsa04210,hsa04370,hsa04510,hsa04620,hsa04630,hsa04650,hsa04660,hsa04662,hsa04664,hsa04670,hsa04810,hsa04910,hsa04930,hsa05210,hsa05211,hsa05212,hsa05213,hsa05214,hsa05215,hsa05218,hsa05220,hsa05221,hsa05222,hsa05223",0,0
PCMTD1,Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1,1,1,0.044849877120305,9.35E-23,7.07E-22,0.00322095213553,0.212578292789849,0.861738079427798,3,YES,novel,"GO:0004719~protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,GO:0008171~O-methyltransferase activity,GO:0008276~protein methyltransferase activity,",0,unknown,unknown
GABRA1,"gamma-aminobutyric acid (GABA) A receptor, alpha 1",1,0.428948972702908,0.416074321122201,1.98E-39,2.56E-38,0.003460133140535,0.217615578895798,0.558638657806729,3,YES,0,"GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0015698~inorganic anion transport,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0004890~GABA-A receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008144~drug binding,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016917~GABA receptor activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0031404~chloride ion binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043168~anion binding,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
PANK3,Pantothenate kinase 3,1,1,0.126985940527448,3.79E-42,5.30E-41,0.003516255918381,0.22040316879009,0.710389354447718,3,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004594~pantothenate kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0006732~coenzyme metabolic process,GO:0009108~coenzyme biosynthetic process,GO:0009116~nucleoside metabolic process,GO:0009119~ribonucleoside metabolic process,GO:0015936~coenzyme A metabolic process,GO:0015937~coenzyme A biosynthetic process,GO:0033865~nucleoside bisphosphate metabolic process,GO:0042278~purine nucleoside metabolic process,GO:0046128~purine ribonucleoside metabolic process,GO:0051186~cofactor metabolic process,GO:0051188~cofactor biosynthetic process,","hsa00770:Pantothenate and CoA biosynthesis,",0,0
TENM4,Teneurin Transmembrane Protein 4,1,0.063139447956966,0.616343584684641,9.72E-57,1.97E-55,0.003697707766534,0.223633686886559,0.74584526788093,3,NO,0,"cardiac cell fate specification, cardiac muscle cell proliferation, central nervous system myelin formation, gastrulation with mouth forming second, neuron development, positive regulation of oligodendrocyte differentiation, signal transduction, cytoplasm, integral to plasma membrane, neuron projection, nucleus, protein homodimerization activity",0,0,0
UVRAG,UV radiation resistance associated gene,1,0.09830923561382,0.616343584684641,1.85E-39,2.40E-38,0.004216710361511,0.237625188884391,0.737756409510516,3,NO,0,"GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006974~response to DNA damage stimulus,GO:0033554~cellular response to stress,",0,0,0
CHRD,chordin,1,0.576592883353912,0.400996972600096,5.51E-255,1.37E-252,0.00450864114664,0.247696788170835,0.778399061508595,3,NO,0,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001649~osteoblast differentiation,GO:0001702~gastrulation with mouth forming second,GO:0001704~formation of primary germ layer,GO:0001707~mesoderm formation,GO:0003002~regionalization,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007369~gastrulation,GO:0007389~pattern specification process,GO:0007498~mesoderm development,GO:0008589~regulation of smoothened signaling pathway,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009953~dorsal/ventral pattern formation,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,GO:0021510~spinal cord development,GO:0021511~spinal cord patterning,GO:0021513~spinal cord dorsal/ventral patterning,GO:0021914~negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,GO:0021915~neural tube development,GO:0021919~BMP signaling pathway in spinal cord dorsal/ventral patterning,GO:0030155~regulation of cell adhesion,GO:0030278~regulation of ossification,GO:0030334~regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0030509~BMP signaling pathway,GO:0030510~regulation of BMP signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0030900~forebrain development,GO:0033504~floor plate development,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0043009~chordate embryonic development,GO:0045596~negative regulation of cell differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045785~positive regulation of cell adhesion,GO:0045879~negative regulation of smoothened signaling pathway,GO:0048332~mesoderm morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0051270~regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0051960~regulation of nervous system development,GO:0060348~bone development,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0001871~pattern binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0019955~cytokine binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0045545~syndecan binding,","hsa04350:TGF-beta signaling pathway,",0,0
POSTN,"periostin, osteoblast specific factor",1,0.227806005973688,0.594395772667206,1.15E-42,1.63E-41,0.004573338862852,0.249972473880711,0.609924782390803,3,NO,0,"GO:0001501~skeletal system development,GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0030198~extracellular matrix organization,GO:0043062~extracellular structure organization,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0001871~pattern binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,",0,0,0
LRP12,low density lipoprotein-related protein 12,1,0.006976906393322,0.660850491134096,7.58E-80,2.57E-78,0.004631685353691,0.251001589807387,0.658083950400111,3,YES,0,"GO:0006897~endocytosis,GO:0010324~membrane invagination,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0040008~regulation of growth,GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005905~coated pit,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044459~plasma membrane part,GO:0070013~intracellular organelle lumen,GO:0005041~low-density lipoprotein receptor activity,GO:0008034~lipoprotein binding,GO:0030169~low-density lipoprotein binding,GO:0030228~lipoprotein receptor activity,",0,0,0
TCF7,"transcription factor 7 (T-cell specific, HMG-box)",1,0.505087244311173,0.444921389161528,4.64E-46,7.43E-45,0.005105322989236,0.25869126093692,0.329002417515912,3,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006955~immune response,GO:0007166~cell surface receptor linked signal transduction,GO:0016055~Wnt receptor signaling pathway,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003702~RNA polymerase II transcription factor activity,GO:0030528~transcription regulator activity,","hsa04310:Wnt signaling pathway,hsa04520:Adherens junction,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05221:Acute myeloid leukemia,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),",0,0
RNF148,Ring finger protein 148,1,0.932145335372239,0.236520976817479,8.02E-43,1.14E-41,0.005188263280575,0.259535077026148,0.727613587507626,3,YES,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
KIF5A,Kinesin family member 5A,1,0.835881626728406,0.308650437420578,1.28E-69,3.47E-68,0.005340989627492,0.261775195189312,0.76045252543882,3,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005856~cytoskeleton,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0005929~cilium,GO:0015630~microtubule cytoskeleton,GO:0035253~ciliary rootlet,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044441~cilium part,GO:0044463~cell projection part,GO:0048471~perinuclear region of cytoplasm,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0008219~cell death,GO:0016265~death,GO:0019226~transmission of nerve impulse,GO:0050877~neurological system process,",0,0,0
FAM173B,"family with sequence similarity 173, member B",0.965171830822039,0.505087244311173,0.450365116245565,1.36E-20,9.67E-20,0.005414765901375,0.262707564342284,0.82511771860753,3,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
UBR5,"similar to E3 ubiquitin protein ligase, HECT domain containing, 1; ubiquitin protein ligase E3 component n-recognin 5",0.36533006107785,0.023483600277954,0.64908205921566,6.64E-90,2.62E-88,0.005793714995869,0.267968724049049,0.65406434684882,3,YES,0,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006974~response to DNA damage stimulus,GO:0007242~intracellular signaling cascade,GO:0008283~cell proliferation,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0030518~steroid hormone receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0033554~cellular response to stress,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0050847~progesterone receptor signaling pathway,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0003723~RNA binding,GO:0004842~ubiquitin-protein ligase activity,GO:0008270~zinc ion binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04120:Ubiquitin mediated proteolysis,",0,0
EIF2S2,"Eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa",1,0.161539563209108,0.616343584684641,2.96E-40,3.97E-39,0.005921278360433,0.268192674653786,0.765270320977441,3,NO,0,"GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0008135~translation factor activity, nucleic acid binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005829~cytosol,GO:0005850~eukaryotic translation initiation factor 2 complex,GO:0006412~translation,GO:0006413~translational initiation,",0,0,0
SDHA,"Succinate dehydrogenase complex, subunit A, flavoprotein (Fp)",1,0.745415986888831,0.35492210012521,1,1,0.006088006490736,0.268192674653786,0.87789789519779,3,NO,0,"GO:0000104~succinate dehydrogenase activity,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0008177~succinate dehydrogenase (ubiquinone) activity,GO:0009055~electron carrier activity,GO:0016635~oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0048037~cofactor binding,GO:0050660~FAD binding,GO:0050662~coenzyme binding,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0005749~mitochondrial respiratory chain complex II,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0044455~mitochondrial membrane part,GO:0045257~succinate dehydrogenase complex (ubiquinone),GO:0045273~respiratory chain complex II,GO:0045281~succinate dehydrogenase complex,GO:0045283~fumarate reductase complex,GO:0070469~respiratory chain,GO:0006084~acetyl-CoA metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006099~tricarboxylic acid cycle,GO:0006105~succinate metabolic process,GO:0006732~coenzyme metabolic process,GO:0009060~aerobic respiration,GO:0009109~coenzyme catabolic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0022900~electron transport chain,GO:0022904~respiratory electron transport chain,GO:0043648~dicarboxylic acid metabolic process,GO:0045333~cellular respiration,GO:0046356~acetyl-CoA catabolic process,GO:0051186~cofactor metabolic process,GO:0051187~cofactor catabolic process,GO:0055114~oxidation reduction,","hsa00020:Citrate cycle (TCA cycle),hsa00190:Oxidative phosphorylation,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,",0,0
KIRREL,kin of IRRE like (Drosophila),0.867953372377229,0.01808787213127,0.660850491134096,4.35E-47,7.27E-46,0.006444951770673,0.272982435656252,0.647621625119519,3,NO,0,"GO:0007588~excretion,GO:0046903~secretion,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
SETDB1,"SET domain, bifurcated 1",1,0.148703711008895,0.616343584684641,7.86E-118,4.19E-116,0.006562806426113,0.27609608385891,0.792625943194881,3,NO,0,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0008170~N-methyltransferase activity,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00310:Lysine degradation,",0,0
COL22A1,"collagen, type XXII, alpha 1",1,0.026107247445835,0.64908205921566,2.01E-167,1.44E-165,0.006697343913956,0.279240372698192,0.805403954380376,3,NO,0,"GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,",0,0,0
CD5L,CD5 molecule-like,1,0.663266466323351,0.425571792526707,3.41E-43,4.90E-42,0.006987506064737,0.286856320402696,0.807818461615583,3,YES,0,"GO:0005044~scavenger receptor activity,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0006915~apoptosis,GO:0006952~defense response,GO:0006968~cellular defense response,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,",0,0,0
VANGL2,"vang-like 2 (van gogh, Drosophila)",1,0.142038435823367,0.620539289527082,3.93E-50,6.99E-49,0.007898575868109,0.303748128063533,0.736535175698533,3,NO,0,"GO:0000902~cell morphogenesis,GO:0001736~establishment of planar polarity,GO:0001738~morphogenesis of a polarized epithelium,GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001843~neural tube closure,GO:0001947~heart looping,GO:0002009~morphogenesis of an epithelium,GO:0003007~heart morphogenesis,GO:0007164~establishment of tissue polarity,GO:0007507~heart development,GO:0008104~protein localization,GO:0008105~asymmetric protein localization,GO:0009792~embryonic development ending in birth or egg hatching,GO:0014020~primary neural tube formation,GO:0016331~morphogenesis of embryonic epithelium,GO:0021915~neural tube development,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0035058~sensory cilium assembly,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042384~cilium assembly,GO:0043009~chordate embryonic development,GO:0045176~apical protein localization,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0048858~cell projection morphogenesis,GO:0060271~cilium morphogenesis,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0060606~tube closure,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,","hsa04310:Wnt signaling pathway,",0,0
DPYS,dihydropyrimidinase,1,0.112576061524844,0.628457722964864,8.30E-79,2.79E-77,0.008048233365574,0.307429347720984,0.69390258381641,3,NO,0,"GO:0006206~pyrimidine base metabolic process,GO:0006208~pyrimidine base catabolic process,GO:0006210~thymine catabolic process,GO:0006212~uracil catabolic process,GO:0006461~protein complex assembly,GO:0009112~nucleobase metabolic process,GO:0019482~beta-alanine metabolic process,GO:0019859~thymine metabolic process,GO:0019860~uracil metabolic process,GO:0034655~nucleobase, nucleoside, nucleotide and nucleic acid catabolic process,GO:0034656~nucleobase, nucleoside and nucleotide catabolic process,GO:0043933~macromolecular complex subunit organization,GO:0044270~nitrogen compound catabolic process,GO:0046113~nucleobase catabolic process,GO:0046700~heterocycle catabolic process,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051262~protein tetramerization,GO:0051289~protein homotetramerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005829~cytosol,GO:0002054~nucleobase binding,GO:0002058~uracil binding,GO:0002059~thymine binding,GO:0002061~pyrimidine binding,GO:0004157~dihydropyrimidinase activity,GO:0008270~zinc ion binding,GO:0016597~amino acid binding,GO:0016812~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,GO:0031406~carboxylic acid binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043176~amine binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00240:Pyrimidine metabolism,hsa00410:beta-Alanine metabolism,hsa00770:Pantothenate and CoA biosynthesis,hsa00983:Drug metabolism,",0,0
HIST2H2BF,"Histone cluster 2, H2bf",1,0.971784231743341,0.296602665660762,0.999999887130007,1,0.008301937832268,0.313276559129172,0.84276402634692,3,NO,0,"GO:0003677~DNA binding,GO:0000785~chromatin,GO:0000786~nucleosome,GO:0005694~chromosome,GO:0032993~protein-DNA complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006334~nucleosome assembly,GO:0031497~chromatin assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0034728~nucleosome organization,GO:0043933~macromolecular complex subunit organization,GO:0051276~chromosome organization,GO:0065003~macromolecular complex assembly,GO:0065004~protein-DNA complex assembly,","hsa05322:Systemic lupus erythematosus,",0,0
RSRC1,arginine/serine-rich coiled-coil 1,0.623604738532564,0.104977053308268,0.628457722964864,3.12E-94,1.31E-92,0.008591718665395,0.31905509532986,0.6148666857262,3,NO,0,"GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000380~alternative nuclear mRNA splicing, via spliceosome,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006913~nucleocytoplasmic transport,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0016310~phosphorylation,GO:0046677~response to antibiotic,GO:0046907~intracellular transport,GO:0051169~nuclear transport,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,",0,0,0
LCE2D,late cornified envelope 2D,1,0.990178279265157,0.301585681419051,2.20E-56,4.42E-55,0.008909433794404,0.32189422407288,0.742212484874501,3,NO,0,"GO:0007398~ectoderm development,GO:0008544~epidermis development,GO:0009913~epidermal cell differentiation,GO:0030216~keratinocyte differentiation,GO:0030855~epithelial cell differentiation,GO:0031424~keratinization,GO:0060429~epithelium development,",0,0,0
RAP1B,"RAP1B, member of RAS oncogene family",1,0.621617423105817,0.494768425245321,7.25E-52,1.35E-50,0.009128868128899,0.323329346821258,0.72693011319228,3,YES,0,"GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0008283~cell proliferation,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,","hsa04010:MAPK signaling pathway,hsa04062:Chemokine signaling pathway,hsa04510:Focal adhesion,hsa04670:Leukocyte transendothelial migration,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa05211:Renal cell carcinoma,",0,0
SYNPO2L,Synaptopodin 2-like,1,1,0.053668211524461,1.56E-39,2.03E-38,0.009204103461674,0.323329346821258,0.765367047534401,3,NO,0,"GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0005856~cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,",0,0,0
IKZF5,IKAROS family zinc finger 5 (Pegasus),1,0.505087244311173,0.56767625725793,5.40E-50,9.59E-49,0.00939811290639,0.323942543530427,0.687327541914591,3,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0006350~transcription,GO:0045449~regulation of transcription,",0,0,0
SLC9A9,"solute carrier family 9 (sodium/hydrogen exchanger), member 9",0.830672778498767,0.660096042000246,0.49108803454918,1.19E-33,1.21E-32,0.009604110413724,0.328562597835088,0.635554766494014,3,YES,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006885~regulation of pH,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0042592~homeostatic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0055067~monovalent inorganic cation homeostasis,GO:0055080~cation homeostasis,GO:0055085~transmembrane transport,GO:0005768~endosome,GO:0005770~late endosome,GO:0010008~endosome membrane,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031902~late endosome membrane,GO:0044440~endosomal part,GO:0055037~recycling endosome,GO:0005451~monovalent cation:hydrogen antiporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015297~antiporter activity,GO:0015298~solute:cation antiporter activity,GO:0015299~solute:hydrogen antiporter activity,GO:0015300~solute:solute antiporter activity,GO:0015385~sodium:hydrogen antiporter activity,GO:0015491~cation:cation antiporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
ATP1A4,"ATPase, Na+/K+ transporting, alpha 4 polypeptide",1,0.165843334795829,0.626298877169616,1.64E-51,3.00E-50,0.010426124523188,0.340873872752955,0.790800519888797,3,NO,0,"GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006818~hydrogen transport,GO:0006873~cellular ion homeostasis,GO:0006885~regulation of pH,GO:0006928~cell motion,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0015672~monovalent inorganic cation transport,GO:0015988~energy coupled proton transport, against electrochemical gradient,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0019725~cellular homeostasis,GO:0030001~metal ion transport,GO:0030003~cellular cation homeostasis,GO:0030004~cellular monovalent inorganic cation homeostasis,GO:0030317~sperm motility,GO:0030641~regulation of cellular pH,GO:0034220~ion transmembrane transport,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0042592~homeostatic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046034~ATP metabolic process,GO:0048870~cell motility,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0051674~localization of cell,GO:0055067~monovalent inorganic cation homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0055085~transmembrane transport,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005524~ATP binding,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0022890~inorganic cation transmembrane transporter activity,GO:0030554~adenyl nucleotide binding,GO:0030955~potassium ion binding,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,","hsa04260:Cardiac muscle contraction,hsa04960:Aldosterone-regulated sodium reabsorption,",0,0
HDAC3,Histone deacetylase 3,1,0.621617423105817,0.532650659483048,5.69E-36,6.15E-35,0.010654714965702,0.342023063076219,0.379525632047582,3,YES,0,"GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0004407~histone deacetylase activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0016811~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,GO:0019213~deacetylase activity,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0033558~protein deacetylase activity,GO:0042826~histone deacetylase binding,GO:0000118~histone deacetylase complex,GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0015630~microtubule cytoskeleton,GO:0016585~chromatin remodeling complex,GO:0017053~transcriptional repressor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044430~cytoskeletal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000226~microtubule cytoskeleton organization,GO:0000279~M phase,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001889~liver development,GO:0001944~vasculature development,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006476~protein amino acid deacetylation,GO:0006916~anti-apoptosis,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0007346~regulation of mitotic cell cycle,GO:0009890~negative regulation of biosynthetic process,GO:0009968~negative regulation of signal transduction,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010629~negative regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0010741~negative regulation of protein kinase cascade,GO:0010830~regulation of myotube differentiation,GO:0010832~negative regulation of myotube differentiation,GO:0010941~regulation of cell death,GO:0016202~regulation of striated muscle tissue development,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016575~histone deacetylation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0042493~response to drug,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043408~regulation of MAPKKK cascade,GO:0043409~negative regulation of MAPKKK cascade,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045786~negative regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046328~regulation of JNK cascade,GO:0046329~negative regulation of JNK cascade,GO:0048514~blood vessel morphogenesis,GO:0048585~negative regulation of response to stimulus,GO:0048634~regulation of muscle development,GO:0048641~regulation of skeletal muscle tissue development,GO:0048742~regulation of skeletal muscle fiber development,GO:0051147~regulation of muscle cell differentiation,GO:0051148~negative regulation of muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051154~negative regulation of striated muscle cell differentiation,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051225~spindle assembly,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051726~regulation of cell cycle,GO:0060284~regulation of cell development,GO:0060548~negative regulation of cell death,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0070303~negative regulation of stress-activated protein kinase signaling pathway,GO:0080135~regulation of cellular response to stress,",0,0,0
DOK5,docking protein 5,1,0.420265180899895,0.599319901491912,2.54E-28,2.20E-27,0.011290499841027,0.349743360747156,0.821801987776456,3,NO,0,"GO:0000165~MAPKKK cascade,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0005158~insulin receptor binding,GO:0032403~protein complex binding,",0,0,0
RAB3IP,RAB3A interacting protein (rabin3),1,0.166669447275995,0.628457722964864,4.89E-57,9.95E-56,0.011403738714666,0.350715204754142,0.78854775215935,3,NO,0,"GO:0005085~guanyl-nucleotide exchange factor activity,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005932~microtubule basal body,GO:0015630~microtubule cytoskeleton,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044463~cell projection part,GO:0000902~cell morphogenesis,GO:0006892~post-Golgi vesicle-mediated transport,GO:0006893~Golgi to plasma membrane transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033365~protein localization in organelle,GO:0034613~cellular protein localization,GO:0042384~cilium assembly,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,GO:0048858~cell projection morphogenesis,GO:0060271~cilium morphogenesis,GO:0070727~cellular macromolecule localization,",0,0,0
CD1A,CD1a molecule,1,0.932145335372239,0.366923577158073,1.28E-29,1.15E-28,0.011409636516086,0.350715204754142,0.81245721923747,3,NO,0,"GO:0006955~immune response,GO:0019882~antigen processing and presentation,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0042611~MHC protein complex,GO:0042612~MHC class I protein complex,GO:0044440~endosomal part,GO:0044459~plasma membrane part,","hsa04640:Hematopoietic cell lineage,",0,0
ITK,IL2-inducible T-cell kinase,1,0.717559756320874,0.501831299149681,1.62E-38,2.01E-37,0.011415752689679,0.350715204754142,0.654314551465965,3,YES,0,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006952~defense response,GO:0006968~cellular defense response,GO:0007242~intracellular signaling cascade,GO:0016310~phosphorylation,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa04062:Chemokine signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04670:Leukocyte transendothelial migration,",0,0
GABRG2,"gamma-aminobutyric acid (GABA) A receptor, gamma 2",0.907099150328727,0.371783892346493,0.601943915278899,1.98E-39,2.56E-38,0.011593576003494,0.355010501916811,0.630607209920989,3,YES,0,"GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007610~behavior,GO:0009791~post-embryonic development,GO:0015698~inorganic anion transport,GO:0019226~transmission of nerve impulse,GO:0030534~adult behavior,GO:0050877~neurological system process,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0004890~GABA-A receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008503~benzodiazepine receptor activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016917~GABA receptor activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0031404~chloride ion binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043168~anion binding,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
PLXNA4,plexin A4,1,0.180765780910828,0.628457722964864,6.08E-82,2.14E-80,0.011704018925182,0.35645102126529,0.725701220945713,3,NO,0,"GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
POU4F3,POU class 4 homeobox 3,1,1,0.275236858887784,1.65E-38,2.04E-37,0.011783767613976,0.35645102126529,0.714525854918889,3,NO,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptosis,GO:0006928~cell motion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007423~sensory organ development,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0008219~cell death,GO:0008361~regulation of cell size,GO:0012501~programmed cell death,GO:0016049~cell growth,GO:0016265~death,GO:0021545~cranial nerve development,GO:0021562~vestibulocochlear nerve development,GO:0021675~nerve development,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0031290~retinal ganglion cell axon guidance,GO:0032535~regulation of cellular component size,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0040007~growth,GO:0042471~ear morphogenesis,GO:0042472~inner ear morphogenesis,GO:0042490~mechanoreceptor differentiation,GO:0042491~auditory receptor cell differentiation,GO:0043583~ear development,GO:0045449~regulation of transcription,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048588~developmental cell growth,GO:0048589~developmental growth,GO:0048598~embryonic morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048675~axon extension,GO:0048676~axon extension involved in development,GO:0048812~neuron projection morphogenesis,GO:0048839~inner ear development,GO:0048858~cell projection morphogenesis,GO:0050877~neurological system process,GO:0050885~neuromuscular process controlling balance,GO:0050890~cognition,GO:0050905~neuromuscular process,GO:0050953~sensory perception of light stimulus,GO:0050954~sensory perception of mechanical stimulus,GO:0051252~regulation of RNA metabolic process,GO:0051402~neuron apoptosis,GO:0060113~inner ear receptor cell differentiation,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",0,0,0
ADRA1B,"Adrenergic, alpha-1B-, receptor",1,1,0.332110228683457,3.03E-40,4.03E-39,0.012191104310225,0.360511701736542,0.679066832484085,3,YES,0,"GO:0004935~adrenoceptor activity,GO:0004936~alpha-adrenergic receptor activity,GO:0004937~alpha1-adrenergic receptor activity,GO:0008227~amine receptor activity,GO:0000267~cell fraction,GO:0000299~integral to membrane of membrane fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0001974~blood vessel remodeling,GO:0001975~response to amphetamine,GO:0001976~neurological system process involved in regulation of systemic arterial blood pressure,GO:0001978~regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,GO:0001982~baroreceptor response to decreased systemic arterial blood pressure,GO:0001987~vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure,GO:0001993~regulation of systemic arterial blood pressure by norepinephrine-epinephrine,GO:0001996~positive regulation of heart rate by epinephrine-norepinephrine,GO:0001997~positive regulation of the force of heart contraction by epinephrine-norepinephrine,GO:0002026~regulation of the force of heart contraction,GO:0002027~regulation of heart rate,GO:0003013~circulatory system process,GO:0003018~vascular process in circulatory system,GO:0003025~regulation of systemic arterial blood pressure by baroreceptor feedback,GO:0003044~regulation of systemic arterial blood pressure mediated by a chemical signal,GO:0003057~regulation of the force of heart contraction by chemical signal,GO:0003073~regulation of systemic arterial blood pressure,GO:0003084~positive regulation of systemic arterial blood pressure,GO:0003099~positive regulation of the force of heart contraction by chemical signal,GO:0005981~regulation of glycogen catabolic process,GO:0006109~regulation of carbohydrate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,GO:0007188~G-protein signaling, coupled to cAMP nucleotide second messenger,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007267~cell-cell signaling,GO:0007507~heart development,GO:0007512~adult heart development,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007626~locomotory behavior,GO:0007632~visual behavior,GO:0008015~blood circulation,GO:0008016~regulation of heart contraction,GO:0008217~regulation of blood pressure,GO:0008283~cell proliferation,GO:0008361~regulation of cell size,GO:0008542~visual learning,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009719~response to endogenous stimulus,GO:0009894~regulation of catabolic process,GO:0009895~negative regulation of catabolic process,GO:0009896~positive regulation of catabolic process,GO:0010033~response to organic substance,GO:0010243~response to organic nitrogen,GO:0010460~positive regulation of heart rate,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010675~regulation of cellular carbohydrate metabolic process,GO:0010676~positive regulation of cellular carbohydrate metabolic process,GO:0010677~negative regulation of cellular carbohydrate metabolic process,GO:0010906~regulation of glucose metabolic process,GO:0010907~positive regulation of glucose metabolic process,GO:0014070~response to organic cyclic substance,GO:0014072~response to isoquinoline alkaloid,GO:0014073~response to tropane,GO:0014075~response to amine stimulus,GO:0016049~cell growth,GO:0019932~second-messenger-mediated signaling,GO:0019933~cAMP-mediated signaling,GO:0019935~cyclic-nucleotide-mediated signaling,GO:0030534~adult behavior,GO:0031329~regulation of cellular catabolic process,GO:0031330~negative regulation of cellular catabolic process,GO:0031331~positive regulation of cellular catabolic process,GO:0032535~regulation of cellular component size,GO:0032881~regulation of polysaccharide metabolic process,GO:0033500~carbohydrate homeostasis,GO:0035150~regulation of tube size,GO:0035265~organ growth,GO:0040007~growth,GO:0042220~response to cocaine,GO:0042310~vasoconstriction,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0043278~response to morphine,GO:0043279~response to alkaloid,GO:0043467~regulation of generation of precursor metabolites and energy,GO:0043470~regulation of carbohydrate catabolic process,GO:0043471~regulation of cellular carbohydrate catabolic process,GO:0044057~regulation of system process,GO:0045777~positive regulation of blood pressure,GO:0045818~negative regulation of glycogen catabolic process,GO:0045819~positive regulation of glycogen catabolic process,GO:0045823~positive regulation of heart contraction,GO:0045912~negative regulation of carbohydrate metabolic process,GO:0045913~positive regulation of carbohydrate metabolic process,GO:0048148~behavioral response to cocaine,GO:0048514~blood vessel morphogenesis,GO:0048771~tissue remodeling,GO:0048878~chemical homeostasis,GO:0050877~neurological system process,GO:0050880~regulation of blood vessel size,GO:0050890~cognition,GO:0051240~positive regulation of multicellular organismal process,","hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04270:Vascular smooth muscle contraction,",0,0
ATP1A2,"ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide",1,0.745415986888831,0.510013216743045,7.88E-51,1.42E-49,0.012945362285241,0.36895964202397,0.794205877300042,3,NO,0,"GO:0001504~neurotransmitter uptake,GO:0001505~regulation of neurotransmitter levels,GO:0002026~regulation of the force of heart contraction,GO:0002087~regulation of respiratory gaseous exchange by neurological system process,GO:0003013~circulatory system process,GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006818~hydrogen transport,GO:0006836~neurotransmitter transport,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006937~regulation of muscle contraction,GO:0006940~regulation of smooth muscle contraction,GO:0006942~regulation of striated muscle contraction,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007626~locomotory behavior,GO:0007632~visual behavior,GO:0008015~blood circulation,GO:0008016~regulation of heart contraction,GO:0008217~regulation of blood pressure,GO:0008344~adult locomotory behavior,GO:0008542~visual learning,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0015672~monovalent inorganic cation transport,GO:0015988~energy coupled proton transport, against electrochemical gradient,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0019226~transmission of nerve impulse,GO:0019229~regulation of vasoconstriction,GO:0019725~cellular homeostasis,GO:0030001~metal ion transport,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030534~adult behavior,GO:0034220~ion transmembrane transport,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0042592~homeostatic process,GO:0043576~regulation of respiratory gaseous exchange,GO:0044057~regulation of system process,GO:0044065~regulation of respiratory system process,GO:0044271~nitrogen compound biosynthetic process,GO:0045822~negative regulation of heart contraction,GO:0045932~negative regulation of muscle contraction,GO:0045988~negative regulation of striated muscle contraction,GO:0046034~ATP metabolic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051241~negative regulation of multicellular organismal process,GO:0051480~cytosolic calcium ion homeostasis,GO:0051481~reduction of cytosolic calcium ion concentration,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0055085~transmembrane transport,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005768~endosome,GO:0005792~microsome,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0005901~caveola,GO:0016021~integral to membrane,GO:0030425~dendrite,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0042383~sarcolemma,GO:0042598~vesicular fraction,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045121~membrane raft,GO:0045202~synapse,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005524~ATP binding,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0019829~cation-transporting ATPase activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0030554~adenyl nucleotide binding,GO:0030955~potassium ion binding,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,","hsa04260:Cardiac muscle contraction,hsa04960:Aldosterone-regulated sodium reabsorption,",0,0
CXXC5,CXXC finger 5,1,1,0.332676355469261,6.67E-36,7.18E-35,0.013025675575187,0.36895964202397,0.553354304927591,3,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
GABRA6,"Gamma-aminobutyric acid (GABA) A receptor, alpha 6",1,0.399243341661191,0.616343584684641,1.98E-39,2.56E-38,0.013448792215707,0.369970529892765,0.6444564183561,3,YES,0,"GO:0004890~GABA-A receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008144~drug binding,GO:0008503~benzodiazepine receptor activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016917~GABA receptor activity,GO:0022803~passive transmembrane transporter activity,GO:0022824~transmitter-gated ion channel activity,GO:0022834~ligand-gated channel activity,GO:0022835~transmitter-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022851~GABA-gated chloride ion channel activity,GO:0030594~neurotransmitter receptor activity,GO:0031404~chloride ion binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0030425~dendrite,GO:0031012~extracellular matrix,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0032809~cell soma membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043083~synaptic cleft,GO:0043235~receptor complex,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0006461~protein complex assembly,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007270~nerve-nerve synaptic transmission,GO:0015698~inorganic anion transport,GO:0019226~transmission of nerve impulse,GO:0043933~macromolecular complex subunit organization,GO:0050877~neurological system process,GO:0051259~protein oligomerization,GO:0051291~protein heterooligomerization,GO:0051932~synaptic transmission, GABAergic,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
PCDH19,Protocadherin 19,1,0.825011387083431,0.462781043665193,1.53E-59,3.34E-58,0.013709555345046,0.373145959155635,0.618885458504928,3,NO,0,"GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,",0,0,0
PSMC5,"proteasome (prosome, macropain) 26S subunit, ATPase, 5",1,0.264844060836597,0.620539289527082,5.28E-39,6.70E-38,0.013711168519255,0.373145959155635,0.671996604728242,3,YES,0,"GO:0000278~mitotic cell cycle,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0009057~macromolecule catabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010498~proteasomal protein catabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0016481~negative regulation of transcription,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0030163~protein catabolic process,GO:0031145~anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031396~regulation of protein ubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032583~regulation of gene-specific transcription,GO:0032774~RNA biosynthetic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043193~positive regulation of gene-specific transcription,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051340~regulation of ligase activity,GO:0051351~positive regulation of ligase activity,GO:0051352~negative regulation of ligase activity,GO:0051436~negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051439~regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051443~positive regulation of ubiquitin-protein ligase activity,GO:0051444~negative regulation of ubiquitin-protein ligase activity,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060548~negative regulation of cell death,GO:0000502~proteasome complex,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003712~transcription cofactor activity,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0031531~thyrotropin-releasing hormone receptor binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0051427~hormone receptor binding,GO:0051428~peptide hormone receptor binding,","hsa03050:Proteasome,",0,0
ZNF454,Zinc finger protein 454,1,0.749774076913278,0.507847587748354,3.26E-48,5.64E-47,0.013983725938541,0.374540620790049,0.718925092522285,3,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
ANXA6,Annexin A6,1,0.910322520092466,0.413900866678315,2.77E-37,3.24E-36,0.014082280905813,0.374540620790049,0.722262145749627,3,YES,0,"GO:0005509~calcium ion binding,GO:0005543~phospholipid binding,GO:0005544~calcium-dependent phospholipid binding,GO:0008289~lipid binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005886~plasma membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0016324~apical plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042470~melanosome,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0048770~pigment granule,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006937~regulation of muscle contraction,GO:0015674~di-, tri-valent inorganic cation transport,GO:0030001~metal ion transport,GO:0044057~regulation of system process,",0,0,0
KIT,similar to Mast/stem cell growth factor receptor precursor (SCFR) (Proto-oncogene tyrosine-protein kinase Kit) (c-kit) (CD117 antigen); v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,1,0.638889938506245,0.560968975658598,9.71E-59,2.05E-57,0.01409769769593,0.374540620790049,0.575395772741752,3,YES,0,"GO:0002244~hemopoietic progenitor cell differentiation,GO:0002318~myeloid progenitor cell differentiation,GO:0002320~lymphoid progenitor cell differentiation,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002573~myeloid leukocyte differentiation,GO:0003006~reproductive developmental process,GO:0006468~protein amino acid phosphorylation,GO:0006643~membrane lipid metabolic process,GO:0006664~glycolipid metabolic process,GO:0006665~sphingolipid metabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007632~visual behavior,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008354~germ cell migration,GO:0008542~visual learning,GO:0008593~regulation of Notch signaling pathway,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009967~positive regulation of signal transduction,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010623~developmental programmed cell death,GO:0010628~positive regulation of gene expression,GO:0010647~positive regulation of cell communication,GO:0010720~positive regulation of cell development,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0017145~stem cell division,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0019220~regulation of phosphate metabolic process,GO:0019221~cytokine-mediated signaling pathway,GO:0019827~stem cell maintenance,GO:0019953~sexual reproduction,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0031272~regulation of pseudopodium assembly,GO:0031274~positive regulation of pseudopodium assembly,GO:0031344~regulation of cell projection organization,GO:0031346~positive regulation of cell projection organization,GO:0031644~regulation of neurological system process,GO:0032504~multicellular organism reproduction,GO:0033674~positive regulation of kinase activity,GO:0035019~somatic stem cell maintenance,GO:0035234~germ cell programmed cell death,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043473~pigmentation,GO:0043549~regulation of kinase activity,GO:0044057~regulation of system process,GO:0044087~regulation of cellular component biogenesis,GO:0044093~positive regulation of molecular function,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045747~positive regulation of Notch signaling pathway,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046777~protein amino acid autophosphorylation,GO:0048066~pigmentation during development,GO:0048070~regulation of pigmentation during development,GO:0048103~somatic stem cell division,GO:0048167~regulation of synaptic plasticity,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048170~positive regulation of long-term neuronal synaptic plasticity,GO:0048232~male gamete generation,GO:0048515~spermatid differentiation,GO:0048534~hemopoietic or lymphoid organ development,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0048863~stem cell differentiation,GO:0048864~stem cell development,GO:0048870~cell motility,GO:0050673~epithelial cell proliferation,GO:0050767~regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050804~regulation of synaptic transmission,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051094~positive regulation of developmental process,GO:0051130~positive regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051301~cell division,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051674~localization of cell,GO:0051960~regulation of nervous system development,GO:0051969~regulation of transmission of nerve impulse,GO:0060284~regulation of cell development,GO:0060491~regulation of cell projection assembly,GO:0060548~negative regulation of cell death,GO:0001669~acrosomal vesicle,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009898~internal side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005020~stem cell factor receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04060:Cytokine-cytokine receptor interaction,hsa04144:Endocytosis,hsa04640:Hematopoietic cell lineage,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05221:Acute myeloid leukemia,",0,0
RALYL,RALY RNA binding protein-like,1,1,0.350070687212711,2.08E-10,1.04E-09,0.014410304654937,0.37690889467067,0.862139992476281,3,NO,0,"GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0042802~identical protein binding,",0,0,0
PCDH18,protocadherin 18,1,0.134777521492513,0.641447788305282,2.00E-60,4.57E-59,0.014427424363699,0.37690889467067,0.57292309271104,3,NO,0,"GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
USP32,Ubiquitin specific peptidase 32,1,0.873980185331087,0.450810211687543,1.44E-58,3.02E-57,0.014470673074748,0.377510757490529,0.805245528311602,3,YES,0,"GO:0004221~ubiquitin thiolesterase activity,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016790~thiolester hydrolase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,",0,0,0
RGS22,regulator of G-protein signaling 22,0.867953372377229,0.262029463501847,0.620539289527082,1.17E-92,4.76E-91,0.014548754123497,0.37796408661028,0.726844836155036,3,NO,0,"GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,",0,0,0
SUV420H1,suppressor of variegation 4-20 homolog 1 (Drosophila),1,0.138864686954504,0.641447788305282,3.39E-55,6.66E-54,0.014742085483811,0.37994405724347,0.70246432135509,3,YES,0,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006479~protein amino acid methylation,GO:0006730~one-carbon metabolic process,GO:0008213~protein amino acid alkylation,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016571~histone methylation,GO:0032259~methylation,GO:0043414~biopolymer methylation,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0000228~nuclear chromosome,GO:0000775~chromosome, centromeric region,GO:0000779~condensed chromosome, centromeric region,GO:0000780~condensed nuclear chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,GO:0008170~N-methyltransferase activity,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0042799~histone methyltransferase activity (H4-K20 specific),","hsa00310:Lysine degradation,",0,0
B3GALNT1,"beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)",1,1,0.164411811656089,1.23E-114,6.39E-113,0.014822041493211,0.38034222428878,0.756024432528587,3,NO,0,"GO:0006486~protein amino acid glycosylation,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0009311~oligosaccharide metabolic process,GO:0009312~oligosaccharide biosynthetic process,GO:0016051~carbohydrate biosynthetic process,GO:0043413~biopolymer glycosylation,GO:0070085~glycosylation,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0000287~magnesium ion binding,GO:0008376~acetylgalactosaminyltransferase activity,GO:0008378~galactosyltransferase activity,GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0035250~UDP-galactosyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0047273~galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,GO:0048531~beta-1,3-galactosyltransferase activity,","hsa00603:Glycosphingolipid biosynthesis,",0,0
SFRP4,Secreted frizzled-related protein 4,1,1,0.140051375693358,0.999997618131448,1,0.015075521992325,0.383645334188889,0.855694602949014,3,YES,unclear/context dependent,"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0007166~cell surface receptor linked signal transduction,GO:0007565~female pregnancy,GO:0007566~embryo implantation,GO:0016055~Wnt receptor signaling pathway,","hsa04310:Wnt signaling pathway,","SFRP4 loss in ovarian cancer correlates with poor outcome (22363760) methylated and silenced in parathyroid tumors (21638518), HCC (18592156), mesothelioma (20596629) and lung cancer (20849603); promoter demethylated in uterine cancer (21709441); overexpressed in colorectal carcinoma (16356838)","SFRP4 is an extracellular Wnt modulator whose loss in ovarian cancer promoted Wnt signaling, proliferation and migration (23326605)"
LGALS3BP,"Lectin, galactoside-binding, soluble, 3 binding protein",1,1,0.379347082700499,2.21E-25,1.80E-24,0.015930211620104,0.393354025432725,0.818105138588598,3,YES,0,"GO:0005044~scavenger receptor activity,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0006952~defense response,GO:0006968~cellular defense response,GO:0007155~cell adhesion,GO:0022610~biological adhesion,",0,0,0
SLAMF1,signaling lymphocytic activation molecule family member 1,1,1,0.315577729514229,2.56E-224,4.35E-222,0.015942167847855,0.393354025432725,0.7650032663992,3,YES,0,"GO:0001775~cell activation,GO:0008284~positive regulation of cell proliferation,GO:0042127~regulation of cell proliferation,GO:0045321~leukocyte activation,GO:0046649~lymphocyte activation,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0044459~plasma membrane part,GO:0003823~antigen binding,",0,0,0
CD84,CD84 molecule,1,1,0.097620701531854,4.95E-52,9.21E-51,0.016434884500454,0.397651823295305,0.676814734340484,3,NO,0,"GO:0004872,GO:0005515,GO:0005886,GO:0005887,GO:0006952,GO:0007155,GO:0007156",0,0,0
TRPS1,trichorhinophalangeal syndrome I,1,0.111403665850996,0.657716290802336,3.22E-148,2.03E-146,0.016540925365588,0.399161208349429,0.795942367587838,3,NO,0,"GO:0001501~skeletal system development,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006607~NLS-bearing substrate import into nucleus,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0008104~protein localization,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0015031~protein transport,GO:0016481~negative regulation of transcription,GO:0017038~protein import,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0033365~protein localization in organelle,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046907~intracellular transport,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0070727~cellular macromolecule localization,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
IL17B,interleukin 17B,1,0.505087244311173,0.601943915278899,5.45E-36,5.90E-35,0.016932259066765,0.399161208349429,0.710755287010662,3,NO,0,"GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007267~cell-cell signaling,GO:0009611~response to wounding,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0005125~cytokine activity,","hsa04060:Cytokine-cytokine receptor interaction,",0,0
PDGFRA,"platelet-derived growth factor receptor, alpha polypeptide",1,0.621617423105817,0.59214274617062,4.94E-95,2.11E-93,0.018321201160334,0.413343985137457,0.688643969014892,3,YES,0,"GO:0001501~skeletal system development,GO:0001701~in utero embryonic development,GO:0001775~cell activation,GO:0003006~reproductive developmental process,GO:0006275~regulation of DNA replication,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007423~sensory organ development,GO:0007548~sex differentiation,GO:0008284~positive regulation of cell proliferation,GO:0009611~response to wounding,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010171~body morphogenesis,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0030198~extracellular matrix organization,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030539~male genitalia development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032355~response to estradiol stimulus,GO:0034097~response to cytokine stimulus,GO:0035295~tube development,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042060~wound healing,GO:0042063~gliogenesis,GO:0042127~regulation of cell proliferation,GO:0042475~odontogenesis of dentine-containing tooth,GO:0042476~odontogenesis,GO:0043009~chordate embryonic development,GO:0043062~extracellular structure organization,GO:0043583~ear development,GO:0043627~response to estrogen stimulus,GO:0045137~development of primary sexual characteristics,GO:0045740~positive regulation of DNA replication,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0046777~protein amino acid autophosphorylation,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048145~regulation of fibroblast proliferation,GO:0048146~positive regulation of fibroblast proliferation,GO:0048545~response to steroid hormone stimulus,GO:0048705~skeletal system morphogenesis,GO:0048806~genitalia development,GO:0048839~inner ear development,GO:0051052~regulation of DNA metabolic process,GO:0051054~positive regulation of DNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0055093~response to hyperoxia,GO:0060021~palate development,GO:0060322~head development,GO:0060323~head morphogenesis,GO:0060324~face development,GO:0060325~face morphogenesis,GO:0060541~respiratory system development,GO:0070482~response to oxygen levels,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005017~platelet-derived growth factor receptor activity,GO:0005021~vascular endothelial growth factor receptor activity,GO:0005161~platelet-derived growth factor receptor binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0019838~growth factor binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0048407~platelet-derived growth factor binding,","hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04144:Endocytosis,hsa04510:Focal adhesion,hsa04540:Gap junction,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,",0,0
KCTD16,potassium channel tetramerisation domain containing 16,1,0.595630786429956,0.601943915278899,6.07E-37,6.91E-36,0.018628519596069,0.415780826973287,0.47895237121562,3,YES,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
GBAS,glioblastoma amplified sequence,1,0.503116045574968,0.616343584684641,7.48E-94,3.09E-92,0.018956240378931,0.417129683215694,0.471290421432776,3,NO,0,"GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,",0,0,0
MUC20,"Mucin 20, cell surface associated",0.978888608669698,1,0.469881078527832,7.39E-06,2.90E-05,0.019022997758493,0.417129683215694,0.867783868503992,3,NO,0,"GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0009925~basal plasma membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031253~cell projection membrane,GO:0031528~microvillus membrane,GO:0042995~cell projection,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045177~apical part of cell,GO:0045178~basal part of cell,GO:0006461~protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,",0,0,0
PPP1R12B,"Protein phosphatase 1, regulatory (inhibitor) subunit 12B",1,0.745415986888831,0.586563008794232,3.60E-13,2.02E-12,0.019195787927136,0.419366225369549,0.842511323337465,3,YES,0,"GO:0008047~enzyme activator activity,GO:0006937~regulation of muscle contraction,GO:0044057~regulation of system process,","hsa04270:Vascular smooth muscle contraction,",0,0
KCNMB4,"potassium large conductance calcium-activated channel, subfamily M, beta member 4",1,1,0.140246135362749,5.40E-38,6.57E-37,0.01959411133876,0.424125861294527,0.746400051810324,3,YES,0,"GO:0001508~regulation of action potential,GO:0005513~detection of calcium ion,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006873~cellular ion homeostasis,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0009593~detection of chemical stimulus,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0015672~monovalent inorganic cation transport,GO:0019226~transmission of nerve impulse,GO:0019228~regulation of action potential in neuron,GO:0019229~regulation of vasoconstriction,GO:0019725~cellular homeostasis,GO:0030001~metal ion transport,GO:0031644~regulation of neurological system process,GO:0042391~regulation of membrane potential,GO:0042592~homeostatic process,GO:0044057~regulation of system process,GO:0046928~regulation of neurotransmitter secretion,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050804~regulation of synaptic transmission,GO:0050877~neurological system process,GO:0051046~regulation of secretion,GO:0051588~regulation of neurotransmitter transport,GO:0051592~response to calcium ion,GO:0051606~detection of stimulus,GO:0051969~regulation of transmission of nerve impulse,GO:0055082~cellular chemical homeostasis,GO:0060341~regulation of cellular localization,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005227~calcium activated cation channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0015267~channel activity,GO:0015269~calcium-activated potassium channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022839~ion gated channel activity,GO:0046873~metal ion transmembrane transporter activity,","hsa04270:Vascular smooth muscle contraction,",0,0
SMC4,structural maintenance of chromosomes 4,0.305857556518427,0.053125090503257,0.688986797626025,1.37E-100,6.16E-99,0.019645198920195,0.424222740613081,0.672366273344778,3,YES,0,"GO:0000070~mitotic sister chromatid segregation,GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0000819~sister chromatid segregation,GO:0006323~DNA packaging,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitosis,GO:0007076~mitotic chromosome condensation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030261~chromosome condensation,GO:0048285~organelle fission,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0000793~condensed chromosome,GO:0000796~condensin complex,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,",0,0,0
PHF20L1,PHD finger protein 20-like 1,0.337520807549262,0.271476723733921,0.628457722964864,4.49E-208,6.03E-206,0.019734580838486,0.424524302558189,0.789933103767126,3,YES,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
NFASC,neurofascin homolog (chicken),1,0.652999588970268,0.599319901491912,5.38E-55,1.05E-53,0.020302870827754,0.427993040625086,0.668474803876908,3,NO,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0006928~cell motion,GO:0007155~cell adhesion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0043062~extracellular structure organization,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050808~synapse organization,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0030424~axon,GO:0031224~intrinsic to membrane,GO:0042995~cell projection,GO:0043005~neuron projection,","hsa04514:Cell adhesion molecules (CAMs),",0,0
ASH1L,"ash1 (absent, small, or homeotic)-like (Drosophila)",0.60360720344515,0.227591325759547,0.641447788305282,1.79E-74,5.34E-73,0.020362533308266,0.427993040625086,0.676553333400644,3,YES,0,"GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0007267~cell-cell signaling,GO:0016568~chromatin modification,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~tight junction,GO:0016327~apicolateral plasma membrane,GO:0030054~cell junction,GO:0043296~apical junction complex,GO:0044459~plasma membrane part,GO:0070160~occluding junction,GO:0003677~DNA binding,GO:0003702~RNA polymerase II transcription factor activity,GO:0008170~N-methyltransferase activity,GO:0008270~zinc ion binding,GO:0008276~protein methyltransferase activity,GO:0016278~lysine N-methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0030528~transcription regulator activity,GO:0042054~histone methyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00310:Lysine degradation,hsa04530:Tight junction,",0,0
PLXNA2,plexin A2,1,0.007617013308157,0.797556093645664,6.09E-90,2.41E-88,0.020869140350556,0.431688452500583,0.72248897862373,3,YES,0,"GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0016477~cell migration,GO:0021535~cell migration in hindbrain,GO:0021934~hindbrain tangential cell migration,GO:0021935~granule cell precursor tangential migration,GO:0030902~hindbrain development,GO:0048870~cell motility,GO:0051640~organelle localization,GO:0051642~centrosome localization,GO:0051674~localization of cell,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,","hsa04360:Axon guidance,",0,0
SPARC,"secreted protein, acidic, cysteine-rich (osteonectin)",1,0.898692767374997,0.501831299149681,9.72E-44,1.42E-42,0.021068072972255,0.433403672961177,0.736251700112905,3,NO,0,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0042127~regulation of cell proliferation,GO:0060348~bone development,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0031091~platelet alpha granule,GO:0031093~platelet alpha granule lumen,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031982~vesicle,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0043233~organelle lumen,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0044433~cytoplasmic vesicle part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0005507~copper ion binding,GO:0005509~calcium ion binding,GO:0005518~collagen binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0050840~extracellular matrix binding,",0,0,0
GRIK3,"Glutamate receptor, ionotropic, kainate 3",1,0.622179854551183,0.601943915278899,7.21E-50,1.28E-48,0.021163844632398,0.433778001373485,0.71196992306149,3,YES,0,"GO:0001640~adenylate cyclase inhibiting metabotropic glutamate receptor activity,GO:0004970~ionotropic glutamate receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0008066~glutamate receptor activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0032838~cell projection cytoplasm,GO:0032839~dendrite cytoplasm,GO:0033267~axon part,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043195~terminal button,GO:0043204~perikaryon,GO:0043679~nerve terminal,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0006811~ion transport,GO:0006873~cellular ion homeostasis,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007215~glutamate signaling pathway,GO:0007216~metabotropic glutamate receptor signaling pathway,GO:0010648~negative regulation of cell communication,GO:0019725~cellular homeostasis,GO:0031644~regulation of neurological system process,GO:0031645~negative regulation of neurological system process,GO:0042391~regulation of membrane potential,GO:0042592~homeostatic process,GO:0044057~regulation of system process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050804~regulation of synaptic transmission,GO:0050805~negative regulation of synaptic transmission,GO:0051241~negative regulation of multicellular organismal process,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0051967~negative regulation of synaptic transmission, glutamatergic,GO:0051969~regulation of transmission of nerve impulse,GO:0051970~negative regulation of transmission of nerve impulse,GO:0055082~cellular chemical homeostasis,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
MME,membrane metallo-endopeptidase,1,0.053125090503257,0.70116562800383,8.68E-81,3.00E-79,0.021382292769716,0.436614719276012,0.787178397282218,3,YES,0,"GO:0006508~proteolysis,GO:0006518~peptide metabolic process,GO:0007267~cell-cell signaling,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0042277~peptide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa04614:Renin-angiotensin system,hsa04640:Hematopoietic cell lineage,hsa05010:Alzheimer's disease,",0,0
CPSF6,"cleavage and polyadenylation specific factor 6, 68kDa",1,0.043039943659203,0.70302965945656,2.76E-118,1.48E-116,0.021499828885664,0.437944715109394,0.63194801660564,3,NO,0,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0016071~mRNA metabolic process,GO:0005654~nucleoplasm,GO:0005849~mRNA cleavage factor complex,GO:0016604~nuclear body,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0042382~paraspeckles,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",0,0,0
CBLN4,cerebellin 4 precursor,1,0.505087244311173,0.616343584684641,6.10E-05,0.000225068374941,0.022600545900137,0.447813682526952,0.823549396737858,3,NO,0,"GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0044459~plasma membrane part,GO:0045202~synapse,",0,0,0
HRASLS,HRAS-like suppressor,1,0.505087244311173,0.616343584684641,7.02E-184,6.10E-182,0.022653258565968,0.448241755035725,0.677623709282459,3,NO,0,"GO:0005635~nuclear envelope,GO:0005641~nuclear envelope lumen,GO:0012505~endomembrane system,GO:0031967~organelle envelope,GO:0031970~organelle envelope lumen,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,",0,0,0
FBXW11,F-box and WD repeat domain containing 11,1,0.86861908420637,0.559248062668889,2.24E-43,3.24E-42,0.022705765613201,0.448713055333932,0.697974486139124,3,YES,0,"GO:0006508~proteolysis,GO:0007166~cell surface receptor linked signal transduction,GO:0009057~macromolecule catabolic process,GO:0016055~Wnt receptor signaling pathway,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0032446~protein modification by small protein conjugation,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0070647~protein modification by small protein conjugation or removal,GO:0000151~ubiquitin ligase complex,GO:0004842~ubiquitin-protein ligase activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,","hsa04114:Oocyte meiosis,hsa04120:Ubiquitin mediated proteolysis,hsa04310:Wnt signaling pathway,hsa04340:Hedgehog signaling pathway,",0,0
TSC22D2,"TSC22 domain family, member 2",1,1,0.166813564552107,3.50E-75,1.07E-73,0.022827161024001,0.448713055333932,0.774595167861212,3,NO,0,"GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",0,0,0
GRXCR2,"glutaredoxin, cysteine rich 2",1,1,0.332676355469261,1.60E-44,2.40E-43,0.022884020185832,0.449002744801629,0.552167757365442,3,NO,0,0,0,0,0
ADAMTS19,"ADAM metallopeptidase with thrombospondin type 1 motif, 19",0.312009080922827,0.0032032688137,0.876615403463248,2.81E-36,3.07E-35,0.023267220696457,0.45264188454474,0.184214908643062,3,NO,0,"GO:0006508~proteolysis,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
GH2,growth hormone 2,1,1,0.413900866678315,0.004069349007932,0.013279414765751,0.023276883294506,0.45264188454474,0.816371889673662,3,NO,0,"GO:0005576~extracellular region,GO:0005179~hormone activity,","hsa04060:Cytokine-cytokine receptor interaction,hsa04080:Neuroactive ligand-receptor interaction,hsa04630:Jak-STAT signaling pathway,",0,0
ZNF780A,zinc finger protein 780A,1,1,0.136156693595626,2.84E-11,1.49E-10,0.023311820382892,0.45264188454474,0.841922739936162,3,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
PIK3R3,"phosphoinositide-3-kinase, regulatory subunit 3 (gamma)",0.318663881456849,1,0.413900866678315,6.76E-45,1.03E-43,0.023424724632161,0.453394238866721,0.437688726631442,3,NO,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008286~insulin receptor signaling pathway,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0032868~response to insulin stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0043434~response to peptide hormone stimulus,GO:0005829~cytosol,GO:0005942~phosphoinositide 3-kinase complex,GO:0044445~cytosolic part,GO:0001727~lipid kinase activity,GO:0004428~inositol or phosphatidylinositol kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0019207~kinase regulator activity,GO:0035004~phosphoinositide 3-kinase activity,GO:0035014~phosphoinositide 3-kinase regulator activity,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,","hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04150:mTOR signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04930:Type II diabetes mellitus,hsa04960:Aldosterone-regulated sodium reabsorption,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,",0,0
POGZ,pogo transposable element with ZNF domain,0.812105621027031,0.250415274812614,0.64908205921566,4.29E-107,2.03E-105,0.02407458489666,0.457001190329983,0.678981947900305,3,YES,0,"GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
HMP19,HMP19 protein,1,0.120232565651346,0.669292822937893,2.60E-45,4.01E-44,0.024464199584695,0.460182872160454,0.395505818323804,3,NO,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007212~dopamine receptor signaling pathway,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0050780~dopamine receptor binding,",0,0,0
CCT2,"chaperonin containing TCP1, subunit 2 (beta)",1,1,0.462781043665193,5.75E-69,1.55E-67,0.024525953108821,0.460422390070014,0.779316505648369,3,YES,0,"GO:0006457~protein folding,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0005832~chaperonin-containing T-complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044445~cytosolic part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0051082~unfolded protein binding,",0,0,0
ZNF333,Zinc finger protein 333,1,1,0.129153533446405,1.61E-40,2.17E-39,0.025171845841365,0.465354548101517,0.777282791788577,3,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
MARCH11,membrane-associated ring finger (C3HC4) 11,1,0.342096927505986,0.628457722964864,1.14E-51,2.10E-50,0.025186098415306,0.465354548101517,0.690022373394897,3,NO,0,"protein ubiquitination, cytoplasmic vesicle membrane, integral to membrane, ligase activity, zinc ion binding",0,0,0
SMG8,SMG8 nonsense mediated mRNA decay factor,1,0.047885315347439,0.715747949835011,3.70E-34,3.84E-33,0.025212206364299,0.465354548101517,0.60082509152037,3,YES,0,"mRNA metabolic process, gene expression, nuclear-transcribed mRNA catabolic process, nonsense-mediated decay, regulation of protein kinase activity, cytosol, protein binding",0,0,0
CHRNB2,"cholinergic receptor, nicotinic, beta 2 (neuronal)",0.974277142852174,0.621617423105817,0.616343584684641,2.20E-65,5.57E-64,0.026452019598761,0.471917167225646,0.768376185407662,3,YES,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001508~regulation of action potential,GO:0001661~conditioned taste aversion,GO:0001666~response to hypoxia,GO:0001775~cell activation,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0003012~muscle system process,GO:0003014~renal system process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006873~cellular ion homeostasis,GO:0006936~muscle contraction,GO:0006939~smooth muscle contraction,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007271~synaptic transmission, cholinergic,GO:0007274~neuromuscular synaptic transmission,GO:0007409~axonogenesis,GO:0007588~excretion,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007613~memory,GO:0007622~rhythmic behavior,GO:0007623~circadian rhythm,GO:0007626~locomotory behavior,GO:0007631~feeding behavior,GO:0007632~visual behavior,GO:0008284~positive regulation of cell proliferation,GO:0008306~associative learning,GO:0008542~visual learning,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0010033~response to organic substance,GO:0010647~positive regulation of cell communication,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010975~regulation of neuron projection development,GO:0014059~regulation of dopamine secretion,GO:0014070~response to organic cyclic substance,GO:0014073~response to tropane,GO:0015674~di-, tri-valent inorganic cation transport,GO:0019226~transmission of nerve impulse,GO:0019233~sensory perception of pain,GO:0019725~cellular homeostasis,GO:0021536~diencephalon development,GO:0021545~cranial nerve development,GO:0021554~optic nerve development,GO:0021562~vestibulocochlear nerve development,GO:0021602~cranial nerve morphogenesis,GO:0021631~optic nerve morphogenesis,GO:0021675~nerve development,GO:0021771~lateral geniculate nucleus development,GO:0021794~thalamus development,GO:0021952~central nervous system projection neuron axonogenesis,GO:0021953~central nervous system neuron differentiation,GO:0021954~central nervous system neuron development,GO:0021955~central nervous system neuron axonogenesis,GO:0022410~circadian sleep/wake cycle process,GO:0022604~regulation of cell morphogenesis,GO:0030001~metal ion transport,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030534~adult behavior,GO:0030888~regulation of B cell proliferation,GO:0030890~positive regulation of B cell proliferation,GO:0030900~forebrain development,GO:0031175~neuron projection development,GO:0031344~regulation of cell projection organization,GO:0031644~regulation of neurological system process,GO:0031646~positive regulation of neurological system process,GO:0032225~regulation of synaptic transmission, dopaminergic,GO:0032226~positive regulation of synaptic transmission, dopaminergic,GO:0032944~regulation of mononuclear cell proliferation,GO:0032946~positive regulation of mononuclear cell proliferation,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033238~regulation of cellular amine metabolic process,GO:0033603~positive regulation of dopamine secretion,GO:0033605~positive regulation of catecholamine secretion,GO:0035094~response to nicotine,GO:0035095~behavioral response to nicotine,GO:0035176~social behavior,GO:0042053~regulation of dopamine metabolic process,GO:0042069~regulation of catecholamine metabolic process,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0042220~response to cocaine,GO:0042320~regulation of circadian sleep/wake cycle, REM sleep,GO:0042391~regulation of membrane potential,GO:0042592~homeostatic process,GO:0042745~circadian sleep/wake cycle,GO:0042749~regulation of circadian sleep/wake cycle,GO:0042752~regulation of circadian rhythm,GO:0043279~response to alkaloid,GO:0044057~regulation of system process,GO:0044087~regulation of cellular component biogenesis,GO:0045187~regulation of circadian sleep/wake cycle, sleep,GO:0045188~regulation of circadian sleep/wake cycle, non-REM sleep,GO:0045321~leukocyte activation,GO:0045471~response to ethanol,GO:0045664~regulation of neuron differentiation,GO:0045759~negative regulation of action potential,GO:0046649~lymphocyte activation,GO:0046903~secretion,GO:0048511~rhythmic process,GO:0048512~circadian behavior,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048814~regulation of dendrite morphogenesis,GO:0048857~neural nucleus development,GO:0048858~cell projection morphogenesis,GO:0048878~chemical homeostasis,GO:0050433~regulation of catecholamine secretion,GO:0050670~regulation of lymphocyte proliferation,GO:0050671~positive regulation of lymphocyte proliferation,GO:0050767~regulation of neurogenesis,GO:0050773~regulation of dendrite development,GO:0050795~regulation of behavior,GO:0050801~ion homeostasis,GO:0050803~regulation of synapse structure and activity,GO:0050804~regulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0050807~regulation of synapse organization,GO:0050864~regulation of B cell activation,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050871~positive regulation of B cell activation,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0050954~sensory perception of mechanical stimulus,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051050~positive regulation of transport,GO:0051240~positive regulation of multicellular organismal process,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051705~behavioral interaction between organisms,GO:0051899~membrane depolarization,GO:0051952~regulation of amine transport,GO:0051954~positive regulation of amine transport,GO:0051960~regulation of nervous system development,GO:0051963~regulation of synaptogenesis,GO:0051969~regulation of transmission of nerve impulse,GO:0051971~positive regulation of transmission of nerve impulse,GO:0055082~cellular chemical homeostasis,GO:0060073~micturition,GO:0060084~synaptic transmission involved in micturition,GO:0060284~regulation of cell development,GO:0060341~regulation of cellular localization,GO:0070482~response to oxygen levels,GO:0070663~regulation of leukocyte proliferation,GO:0070665~positive regulation of leukocyte proliferation,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005892~nicotinic acetylcholine-gated receptor-channel complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0043235~receptor complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005261~cation channel activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015464~acetylcholine receptor activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0042165~neurotransmitter binding,GO:0042166~acetylcholine binding,GO:0043176~amine binding,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
DHX36,DEAH (Asp-Glu-Ala-His) box polypeptide 36,1,0.806613549597766,0.594395772667206,1.07E-75,3.33E-74,0.026861992397707,0.474593863588835,0.661740128822729,3,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0070035~purine NTP-dependent helicase activity,",0,0,0
CHRNA4,"Cholinergic receptor, nicotinic, alpha 4",1,0.73524777513296,0.601943915278899,5.15E-24,4.03E-23,0.027138296602408,0.474593863588835,0.852922294019667,3,YES,0,"GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005261~cation channel activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015464~acetylcholine receptor activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0042165~neurotransmitter binding,GO:0042166~acetylcholine binding,GO:0043176~amine binding,GO:0046873~metal ion transmembrane transporter activity,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005892~nicotinic acetylcholine-gated receptor-channel complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0030425~dendrite,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043235~receptor complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0001508~regulation of action potential,GO:0001666~response to hypoxia,GO:0001775~cell activation,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006873~cellular ion homeostasis,GO:0006974~response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007271~synaptic transmission, cholinergic,GO:0007600~sensory perception,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0010033~response to organic substance,GO:0014059~regulation of dopamine secretion,GO:0014070~response to organic cyclic substance,GO:0015674~di-, tri-valent inorganic cation transport,GO:0019226~transmission of nerve impulse,GO:0019233~sensory perception of pain,GO:0019725~cellular homeostasis,GO:0030001~metal ion transport,GO:0030534~adult behavior,GO:0033554~cellular response to stress,GO:0035094~response to nicotine,GO:0035095~behavioral response to nicotine,GO:0042113~B cell activation,GO:0042391~regulation of membrane potential,GO:0042592~homeostatic process,GO:0043279~response to alkaloid,GO:0045321~leukocyte activation,GO:0046649~lymphocyte activation,GO:0048878~chemical homeostasis,GO:0050433~regulation of catecholamine secretion,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051046~regulation of secretion,GO:0051899~membrane depolarization,GO:0051952~regulation of amine transport,GO:0055082~cellular chemical homeostasis,GO:0060078~regulation of postsynaptic membrane potential,GO:0060080~regulation of inhibitory postsynaptic membrane potential,GO:0060081~membrane hyperpolarization,GO:0060341~regulation of cellular localization,GO:0070482~response to oxygen levels,",0,0,0
E2F1,E2F transcription factor 1,1,0.86861908420637,0.593957751752409,8.38E-38,1.01E-36,0.027151327753706,0.474593863588835,0.775114934489431,3,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005739~mitochondrion,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000080~G1 phase of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptosis,GO:0007049~cell cycle,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0012501~programmed cell death,GO:0016265~death,GO:0016481~negative regulation of transcription,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030900~forebrain development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051318~G1 phase,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051726~regulation of cell cycle,","hsa04110:Cell cycle,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,",0,0
CLDN10,claudin 10,1,0.812549668064137,0.594395772667206,2.83E-109,1.38E-107,0.027161500210671,0.474593863588835,0.696908076688344,3,NO,0,"GO:0007155~cell adhesion,GO:0016337~cell-cell adhesion,GO:0016338~calcium-independent cell-cell adhesion,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~tight junction,GO:0016021~integral to membrane,GO:0016327~apicolateral plasma membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0043296~apical junction complex,GO:0044459~plasma membrane part,GO:0070160~occluding junction,GO:0005198~structural molecule activity,GO:0042802~identical protein binding,","hsa04514:Cell adhesion molecules (CAMs),hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,",0,0
SPTA1,"Spectrin, alpha, erythrocytic 1 (elliptocytosis 2)",1,1,0.486820639132666,8.28E-34,8.48E-33,0.027379239403055,0.475736570055507,0.795282666980159,3,NO,0,"GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005509~calcium ion binding,GO:0008092~cytoskeletal protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0051015~actin filament binding,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0008091~spectrin,GO:0009898~internal side of plasma membrane,GO:0014731~spectrin-associated cytoskeleton,GO:0015629~actin cytoskeleton,GO:0030863~cortical cytoskeleton,GO:0030864~cortical actin cytoskeleton,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031235~intrinsic to internal side of plasma membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044448~cell cortex part,GO:0044459~plasma membrane part,GO:0002520~immune system development,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008360~regulation of cell shape,GO:0010639~negative regulation of organelle organization,GO:0022604~regulation of cell morphogenesis,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030097~hemopoiesis,GO:0030832~regulation of actin filament length,GO:0030833~regulation of actin filament polymerization,GO:0030834~regulation of actin filament depolymerization,GO:0030835~negative regulation of actin filament depolymerization,GO:0030837~negative regulation of actin filament polymerization,GO:0031333~negative regulation of protein complex assembly,GO:0032271~regulation of protein polymerization,GO:0032272~negative regulation of protein polymerization,GO:0032535~regulation of cellular component size,GO:0032956~regulation of actin cytoskeleton organization,GO:0032970~regulation of actin filament-based process,GO:0033043~regulation of organelle organization,GO:0043242~negative regulation of protein complex disassembly,GO:0043244~regulation of protein complex disassembly,GO:0043254~regulation of protein complex assembly,GO:0044087~regulation of cellular component biogenesis,GO:0048534~hemopoietic or lymphoid organ development,GO:0051129~negative regulation of cellular component organization,GO:0051493~regulation of cytoskeleton organization,GO:0051494~negative regulation of cytoskeleton organization,GO:0051693~actin filament capping,",0,0,0
NUF2,"NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae)",1,1,0.152213604103976,7.99E-39,1.01E-37,0.027779370641763,0.478240427850229,0.768611703608052,3,NO,0,"GO:0000775,GO:0003674,GO:0005515,GO:0005634,GO:0007049,GO:0007059,GO:0007067,GO:0051301",0,0,0
DKK2,Dickkopf homolog 2 (Xenopus laevis),1,0.027681589966226,0.049693247047996,0.999998799560844,1,3.11E-06,0.001084347251567,0.54916615038182,2,NO,unclear/context dependent,"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0007166~cell surface receptor linked signal transduction,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,GO:0016055~Wnt receptor signaling pathway,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0030178~negative regulation of Wnt receptor signaling pathway,","hsa04310:Wnt signaling pathway,",upregulated in Ewing family tumors (19247449) and colorectal cancer (19659606); epigenetically silenced in a variety of cancer types (19755393) (22964660) (18461655); downregulated in malignant melanoma (16568085),Wnt signaling regulator that appears to be context dependent.  Reported to antagonize Wnt inhibitor DKK1 and promote Wnt signaling in xenopus (11137016); promotes invase outgrowth and metastasis in Ewing's sarcoma (23204234)
EEF1B2,eukaryotic translation elongation factor 1 beta 2,1,1,1.21E-06,0.999986270635798,1,5.92E-06,0.001939767674104,0.191344562555531,2,NO,0,"cellular protein metabolic process, gene expression, translational elongation, cytosol, eukaryotic translation elongation factor 1 complex, protein binding, translation elongation factor activity",0,0,0
NUTM2F,NUT family member 2F,1,1,0.000260822018316,0.999990230692422,1,6.99E-06,0.002194840493168,0.806240471309325,2,NO,novel,0,0,0,0
TAF1,"TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa",1,2.97E-07,0.594395772667206,0.999999962296263,1,7.05E-06,0.002194840493168,0.348932262077736,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008080~N-acetyltransferase activity,GO:0008134~transcription factor binding,GO:0010843~promoter binding,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016563~transcription activator activity,GO:0017025~TATA-binding protein binding,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042393~histone binding,GO:0043565~sequence-specific DNA binding,GO:0070577~histone acetyl-lysine binding,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005669~transcription factor TFIID complex,GO:0005730~nucleolus,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000080~G1 phase of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000117~regulation of transcription during G2/M-phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006354~RNA elongation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~RNA elongation from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007049~cell cycle,GO:0009891~positive regulation of biosynthetic process,GO:0009894~regulation of catabolic process,GO:0009896~positive regulation of catabolic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018209~peptidyl-serine modification,GO:0018210~peptidyl-threonine modification,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030162~regulation of proteolysis,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031329~regulation of cellular catabolic process,GO:0031331~positive regulation of cellular catabolic process,GO:0031334~positive regulation of protein complex assembly,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032583~regulation of gene-specific transcription,GO:0032774~RNA biosynthetic process,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0034984~cellular response to DNA damage stimulus,GO:0042176~regulation of protein catabolic process,GO:0043193~positive regulation of gene-specific transcription,GO:0043254~regulation of protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0044087~regulation of cellular component biogenesis,GO:0045449~regulation of transcription,GO:0045732~positive regulation of protein catabolic process,GO:0045862~positive regulation of proteolysis,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046777~protein amino acid autophosphorylation,GO:0051123~transcriptional preinitiation complex assembly,GO:0051130~positive regulation of cellular component organization,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051318~G1 phase,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0060260~regulation of transcription initiation from RNA polymerase II promoter,GO:0060261~positive regulation of transcription initiation from RNA polymerase II promoter,GO:0065003~macromolecular complex assembly,GO:0065004~protein-DNA complex assembly,GO:0070271~protein complex biogenesis,","hsa03022:Basal transcription factors,",0,0
PTN,"Pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1)",0.97944659264195,0.227591325759547,0.021775343768937,0.000118154625512,0.000426063754815,1.15E-05,0.003411537039042,0.583718206803534,2,NO,0,"GO:0001871~pattern binding,GO:0004857~enzyme inhibitor activity,GO:0004864~phosphoprotein phosphatase inhibitor activity,GO:0005539~glycosaminoglycan binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0019208~phosphatase regulator activity,GO:0019212~phosphatase inhibitor activity,GO:0019888~protein phosphatase regulator activity,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0044421~extracellular region part,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0008284~positive regulation of cell proliferation,GO:0030282~bone mineralization,GO:0031214~biomineral formation,GO:0042127~regulation of cell proliferation,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051302~regulation of cell division,GO:0051781~positive regulation of cell division,GO:0060348~bone development,",0,0,0
ALK,anaplastic lymphoma receptor tyrosine kinase,1,0.323315259263198,0.013932488950817,0.997789431635495,1,1.19E-05,0.003472509481092,0.49336247320378,2,YES,0,"NIK/NF-kappaB cascade, activation of MAPK activity, neuron development, cell proliferation, phosphorylation, transmembrane receptor protein tyrosine kinase signaling pathway, integral to plasma membrane, NF-kappaB-inducing kinase activity, transmembrane receptor protein tyrosine kinase activity",0,0,0
ACADS,"Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain",1,1,0.00038842965016,0.999908180210911,1,2.21E-05,0.006075454262832,0.608565649006614,2,NO,novel,"GO:0000062~acyl-CoA binding,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003995~acyl-CoA dehydrogenase activity,GO:0004085~butyryl-CoA dehydrogenase activity,GO:0005504~fatty acid binding,GO:0008289~lipid binding,GO:0009055~electron carrier activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0031406~carboxylic acid binding,GO:0033293~monocarboxylic acid binding,GO:0048037~cofactor binding,GO:0050660~FAD binding,GO:0050662~coenzyme binding,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0006631~fatty acid metabolic process,GO:0006635~fatty acid beta-oxidation,GO:0009062~fatty acid catabolic process,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0016042~lipid catabolic process,GO:0016054~organic acid catabolic process,GO:0019395~fatty acid oxidation,GO:0030258~lipid modification,GO:0031667~response to nutrient levels,GO:0031960~response to corticosteroid stimulus,GO:0034440~lipid oxidation,GO:0042594~response to starvation,GO:0044242~cellular lipid catabolic process,GO:0046395~carboxylic acid catabolic process,GO:0048545~response to steroid hormone stimulus,GO:0051384~response to glucocorticoid stimulus,GO:0055114~oxidation reduction,","hsa00071:Fatty acid metabolism,hsa00280:Valine, leucine and isoleucine degradation,hsa00650:Butanoate metabolism,",upregulated in colorectal cancer along with other fatty acid metabolic pathways genes (15885896),"short chain acyl-coA dehydrogenase, cayalzes the first reaction in the beta oxidation of fatty-acids (8276399)"
MED12,Mediator complex subunit 12,1,0.000408727057092,0.503945457136503,1,1,3.54E-05,0.009576903109313,0.530806624451359,2,NO,0,"GO:0003702~RNA polymerase II transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016251~general RNA polymerase II transcription factor activity,GO:0016455~RNA polymerase II transcription mediator activity,GO:0016563~transcription activator activity,GO:0019904~protein domain specific binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0030528~transcription regulator activity,GO:0035257~nuclear hormone receptor binding,GO:0042809~vitamin D receptor binding,GO:0046966~thyroid hormone receptor binding,GO:0051427~hormone receptor binding,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016592~Srb-mediator complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0007242~intracellular signaling cascade,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0030518~steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030522~intracellular receptor-mediated signaling pathway,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,",0,0,0
SULT1C4,"Sulfotransferase family, cytosolic, 1C, member 4",1,1,0.00050438743639,0.998069588245772,1,3.99E-05,0.010648225089529,0.683050507143675,2,YES,novel,"GO:0008146~sulfotransferase activity,GO:0016782~transferase activity, transferring sulfur-containing groups,",0,SNP associated with castration-resistant prostate cancer responsiveness to docetaxel and thalidomide combination therapy (20038957); SULT family gene expression in a subset of GBMs is associated with their insensitivity to resveratrol treatment (22540632),"belongs to sulfotransferase family of enzymes which catalyze sulfate conjugation to various peptides including neurotransmitters and hormones, as well as to drugs and xenobiotic compounds.  Sulfate conjugation can promote their renal excretion or alternately biochemically activate the substrate, Reviewed (9034160 ); implicated in sulfation and resulting detoxification of environmental xenoestrogens (12399026)"
LHFPL1,Lipoma HMGIC fusion partner-like 1,1,0.505087244311173,0.021101755618502,1,1,4.48E-05,0.011460064273703,0.663499972223425,2,NO,novel,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,unknown,unknown
KCND3,"Potassium voltage-gated channel, Shal-related subfamily, member 3",1,0.099974439499732,0.140051375693358,0.99991114823877,1,6.15E-05,0.015307795198479,0.798535606859212,2,YES,putative OG,"GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005250~A-type (transient outward) potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0008270~zinc ion binding,GO:0015267~channel activity,GO:0015271~outward rectifier potassium channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0046914~transition metal ion binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0042383~sarcolemma,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0044459~plasma membrane part,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,",0,amplified in MCF7 breast cancer cell line (16417655),"voltage-gated potassium channel in cardiac myocytes and neuronal cells (10200233); upregulated in response to Large T antigen expression through induction of Sp1, and its inhibition/knockdown induces apoptosis and necrosis (22023388); phosphorylated and regulated by c-Src (18620005); gain of function mutations in KCND3 underly Brugada syndrome, characterised by potentially lethal arrhythmia due to enhances transient outward current (I(to)) (21349352); mutations in KCND3 associated with some types of spinocerebellar ataxia (23280837) (23280838)"
CAPRIN2,Caprin family member 2,1,0.271476723733921,0.072632504100047,0.84006797121976,1,6.71E-05,0.016276301496888,0.795161417335235,2,NO,0,"GO:0005739~mitochondrion,GO:0001558~regulation of cell growth,GO:0008361~regulation of cell size,GO:0030308~negative regulation of cell growth,GO:0032535~regulation of cellular component size,GO:0040008~regulation of growth,GO:0045792~negative regulation of cell size,GO:0045926~negative regulation of growth,",0,0,0
LUM,Lumican,1,0.745415986888831,0.014010424067892,0.999999995132779,1,7.02E-05,0.016598827790823,0.673797512799619,2,NO,0,"GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005518~collagen binding,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005583~fibrillar collagen,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0043062~extracellular structure organization,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,",0,0,0
TBX18,T-box 18,1,0.031386027151152,0.272100981371595,0.999954025426114,1,8.05E-05,0.018552940685206,0.650496093993178,2,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0001756~somitogenesis,GO:0002009~morphogenesis of an epithelium,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0003002~regionalization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007389~pattern specification process,GO:0008284~positive regulation of cell proliferation,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009798~axis specification,GO:0009948~anterior/posterior axis specification,GO:0009952~anterior/posterior pattern formation,GO:0010464~regulation of mesenchymal cell proliferation,GO:0016331~morphogenesis of embryonic epithelium,GO:0035282~segmentation,GO:0042127~regulation of cell proliferation,GO:0042692~muscle cell differentiation,GO:0043009~chordate embryonic development,GO:0045449~regulation of transcription,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051145~smooth muscle cell differentiation,GO:0051252~regulation of RNA metabolic process,GO:0060429~epithelium development,",0,0,0
TRIM23,Tripartite motif-containing 23,0.85847341118128,0.621617423105817,0.02752293748645,0.993955923698548,1,8.60E-05,0.019588607272633,0.36068667627189,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003924~GTPase activity,GO:0004842~ubiquitin-protein ligase activity,GO:0005525~GTP binding,GO:0008047~enzyme activator activity,GO:0008270~zinc ion binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0019003~GDP binding,GO:0019787~small conjugating protein ligase activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0000139~Golgi membrane,GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0005794~Golgi apparatus,GO:0012505~endomembrane system,GO:0031090~organelle membrane,GO:0044431~Golgi apparatus part,GO:0044437~vacuolar part,GO:0006471~protein amino acid ADP-ribosylation,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0016567~protein ubiquitination,GO:0032446~protein modification by small protein conjugation,GO:0070647~protein modification by small protein conjugation or removal,",0,0,0
MS4A8,"membrane-spanning 4-domains, subfamily A, member 8",1,1,0.00015631211853,0.999665010233421,1,9.39E-05,0.021015145833599,0.735163172308952,2,NO,unclear,integral to membrane,0,expressed in intestinal epithelium but not colon carcinomas tested.  Forced expression of murine homolog slowed proliferation of colonic carcinoma cells (23348583),member of 4-transmembrane gene family related to CD20 (11245982)
GOT2,"Glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)",1,0.613513232463045,0.033723303561894,0.999999585356734,1,0.00010188527239,0.022158610830315,0.713046147245046,2,NO,0,"GO:0004069~L-aspartate:2-oxoglutarate aminotransferase activity,GO:0008483~transaminase activity,GO:0016769~transferase activity, transferring nitrogenous groups,GO:0019842~vitamin binding,GO:0030170~pyridoxal phosphate binding,GO:0048037~cofactor binding,GO:0070279~vitamin B6 binding,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005886~plasma membrane,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0006103~2-oxoglutarate metabolic process,GO:0006106~fumarate metabolic process,GO:0006107~oxaloacetate metabolic process,GO:0006531~aspartate metabolic process,GO:0006532~aspartate biosynthetic process,GO:0006533~aspartate catabolic process,GO:0006536~glutamate metabolic process,GO:0006538~glutamate catabolic process,GO:0006869~lipid transport,GO:0008652~cellular amino acid biosynthetic process,GO:0009063~cellular amino acid catabolic process,GO:0009064~glutamine family amino acid metabolic process,GO:0009065~glutamine family amino acid catabolic process,GO:0009066~aspartate family amino acid metabolic process,GO:0009067~aspartate family amino acid biosynthetic process,GO:0009068~aspartate family amino acid catabolic process,GO:0009309~amine biosynthetic process,GO:0009310~amine catabolic process,GO:0010033~response to organic substance,GO:0010876~lipid localization,GO:0015718~monocarboxylic acid transport,GO:0015849~organic acid transport,GO:0015908~fatty acid transport,GO:0016053~organic acid biosynthetic process,GO:0016054~organic acid catabolic process,GO:0019550~glutamate catabolic process to aspartate,GO:0019551~glutamate catabolic process to 2-oxoglutarate,GO:0043648~dicarboxylic acid metabolic process,GO:0044271~nitrogen compound biosynthetic process,GO:0045471~response to ethanol,GO:0046394~carboxylic acid biosynthetic process,GO:0046395~carboxylic acid catabolic process,GO:0046942~carboxylic acid transport,","hsa00250:Alanine, aspartate and glutamate metabolism,hsa00270:Cysteine and methionine metabolism,hsa00330:Arginine and proline metabolism,hsa00350:Tyrosine metabolism,hsa00360:Phenylalanine metabolism,hsa00400:Phenylalanine, tyrosine and tryptophan biosynthesis,",0,0
LZTR1,Leucine-zipper-like transcription regulator 1,1,2.37E-05,0.620539289527082,0.999999969741354,1,0.000102088467737,0.022158610830315,0.650868179765149,2,YES,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",0,0,0
HGF,Hepatocyte growth factor (hepapoietin A; scatter factor),0.583809760116692,0.001112456468077,0.550860667188815,0.998824890287423,1,0.000104997132498,0.022158610830315,0.372110527374542,2,NO,0,"GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008083~growth factor activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0005576~extracellular region,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031091~platelet alpha granule,GO:0031093~platelet alpha granule lumen,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031982~vesicle,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0043233~organelle lumen,GO:0044433~cytoplasmic vesicle part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0000087~M phase of mitotic cell cycle,GO:0000165~MAPKKK cascade,GO:0000187~activation of MAPK activity,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001837~epithelial to mesenchymal transition,GO:0001889~liver development,GO:0006468~protein amino acid phosphorylation,GO:0006508~proteolysis,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006916~anti-apoptosis,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007267~cell-cell signaling,GO:0008283~cell proliferation,GO:0010941~regulation of cell death,GO:0014031~mesenchymal cell development,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0032989~cellular component morphogenesis,GO:0033674~positive regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0048012~hepatocyte growth factor receptor signaling pathway,GO:0048285~organelle fission,GO:0048762~mesenchymal cell differentiation,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051450~myoblast proliferation,GO:0060485~mesenchyme development,GO:0060548~negative regulation of cell death,GO:0060638~mesenchymal-epithelial cell signaling,GO:0060665~regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,GO:0060688~regulation of morphogenesis of a branching structure,GO:0060693~regulation of branching involved in salivary gland morphogenesis,","hsa04060:Cytokine-cytokine receptor interaction,hsa04510:Focal adhesion,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,hsa05218:Melanoma,",0,0
PDE7B,Phosphodiesterase 7B,1,0.132935879522302,0.166813564552107,0.998541021158232,1,0.000112503208672,0.023349415942014,0.521778296141256,2,NO,0,"GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0008081~phosphoric diester hydrolase activity,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0019226~transmission of nerve impulse,GO:0050877~neurological system process,","hsa00230:Purine metabolism,",0,0
ZNF117,Zinc finger protein 117,1,0.886481428527679,0.012399644377964,0.912912782685825,1,0.000125048788523,0.025667981547443,0.716995169685772,2,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
MAGI2,"Membrane associated guanylate kinase, WW and PDZ domain containing 2",1,0.003090229916082,0.507847587748354,2.27E-06,9.16E-06,0.000137700027745,0.027957595850522,0.653450440472504,2,YES,0,"GO:0019899~enzyme binding,GO:0019902~phosphatase binding,GO:0032403~protein complex binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0019717~synaptosome,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0007242~intracellular signaling cascade,","hsa04530:Tight junction,",0,0
BTBD11,BTB (POZ) domain containing 11,0.846120936133285,0.000146926531583,0.616343584684641,0.897791510612719,1,0.000175539541703,0.033803124736779,0.510668666937917,2,YES,0,"GO:0003677~DNA binding,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
UBQLN2,Ubiquilin 2,1,0.071749565120695,0.296278406649975,0.99999999996791,1,0.000184940290148,0.034893936158401,0.70061549942252,2,YES,0,"GO:0005886~plasma membrane,",0,0,0
DCLK1,Doublecortin-like kinase 1,1,0.001829092689034,0.586563008794232,0.581673379701115,1,0.00018821732527,0.035157114187266,0.689057730927775,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001764~neuron migration,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006928~cell motion,GO:0007242~intracellular signaling cascade,GO:0007409~axonogenesis,GO:0008361~regulation of cell size,GO:0016049~cell growth,GO:0016192~vesicle-mediated transport,GO:0016197~endosome transport,GO:0016310~phosphorylation,GO:0016358~dendrite development,GO:0016477~cell migration,GO:0021952~central nervous system projection neuron axonogenesis,GO:0021953~central nervous system neuron differentiation,GO:0021954~central nervous system neuron development,GO:0021955~central nervous system neuron axonogenesis,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030900~forebrain development,GO:0031175~neuron projection development,GO:0032535~regulation of cellular component size,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0040007~growth,GO:0046907~intracellular transport,GO:0048588~developmental cell growth,GO:0048589~developmental growth,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048675~axon extension,GO:0048812~neuron projection morphogenesis,GO:0048813~dendrite morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0051674~localization of cell,",0,0,0
MFAP5,Microfibrillar associated protein 5,1,0.271476723733921,0.140051375693358,0.737698373216663,1,0.000195419704304,0.035786712320561,0.766195714061039,2,NO,0,"GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0001527~microfibril,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0043205~fibril,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,",0,0,0
COL5A2,"collagen, type V, alpha 2",1,0.000514146219554,0.606746885762004,0.262455091588093,0.719459738152919,0.000205819162722,0.037325205247419,0.467478810816156,2,NO,0,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001654~eye development,GO:0007398~ectoderm development,GO:0007423~sensory organ development,GO:0008544~epidermis development,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0043062~extracellular structure organization,GO:0043588~skin development,GO:0048592~eye morphogenesis,GO:0060348~bone development,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005583~fibrillar collagen,GO:0005588~collagen type V,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0046332~SMAD binding,","hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,",0,0
ABCB1,"ATP-binding cassette, sub-family B (MDR/TAP), member 1",1,0.041319498656893,0.352752213519394,6.98E-05,0.000256053161847,0.000219053379202,0.039343250674114,0.735916390683518,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0008559~xenobiotic-transporting ATPase activity,GO:0015238~drug transporter activity,GO:0015239~multidrug transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042910~xenobiotic transporter activity,GO:0043492~ATPase activity, coupled to movement of substances,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031224~intrinsic to membrane,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,GO:0042493~response to drug,GO:0055085~transmembrane transport,","hsa02010:ABC transporters,",0,0
TUSC3,Tumor suppressor candidate 3,1,0.271476723733921,0.147004967112226,0.999811744844526,1,0.000221597535686,0.03942114637211,0.556598910047405,2,NO,0,"GO:0004576~oligosaccharyl transferase activity,GO:0004579~dolichyl-diphosphooligosaccharide-protein glycotransferase activity,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0008250~oligosaccharyltransferase complex,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044432~endoplasmic reticulum part,GO:0006486~protein amino acid glycosylation,GO:0006487~protein amino acid N-linked glycosylation,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0018196~peptidyl-asparagine modification,GO:0018279~protein amino acid N-linked glycosylation via asparagine,GO:0043413~biopolymer glycosylation,GO:0070085~glycosylation,","hsa00510:N-Glycan biosynthesis,",0,0
KCNQ5,"Potassium voltage-gated channel, KQT-like subfamily, member 5",1,0.018534403624638,0.450365116245565,0.999999965604938,1,0.000262246406144,0.045356487225672,0.635162715787267,2,YES,0,"GO:0005216~ion channel activity,GO:0005242~inward rectifier potassium channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0044459~plasma membrane part,GO:0006461~protein complex assembly,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0015672~monovalent inorganic cation transport,GO:0019226~transmission of nerve impulse,GO:0030001~metal ion transport,GO:0043933~macromolecular complex subunit organization,GO:0050877~neurological system process,GO:0055085~transmembrane transport,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,",0,0,0
SKAP2,Src kinase associated phosphoprotein 2,1,0.020322196064189,0.450365116245565,0.998191724186185,1,0.000282379838753,0.04839057805566,0.706468902158373,2,YES,0,"GO:0005070~SH3/SH2 adaptor activity,GO:0030674~protein binding, bridging,GO:0060090~molecular adaptor activity,GO:0005886~plasma membrane,GO:0001775~cell activation,GO:0006461~protein complex assembly,GO:0008285~negative regulation of cell proliferation,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0043933~macromolecular complex subunit organization,GO:0045321~leukocyte activation,GO:0046649~lymphocyte activation,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,",0,0,0
XYLT1,Xylosyltransferase I,1,0.005114169787542,0.586563008794232,0.999999954932231,1,0.000310963968101,0.051402619116478,0.70239952723614,2,NO,0,"GO:0008375~acetylglucosaminyltransferase activity,GO:0016763~transferase activity, transferring pentosyl groups,GO:0030158~protein xylosyltransferase activity,GO:0035252~UDP-xylosyltransferase activity,GO:0042285~xylosyltransferase activity,GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0000271~polysaccharide biosynthetic process,GO:0005976~polysaccharide metabolic process,GO:0006022~aminoglycan metabolic process,GO:0006023~aminoglycan biosynthetic process,GO:0006024~glycosaminoglycan biosynthetic process,GO:0009266~response to temperature stimulus,GO:0009408~response to heat,GO:0009628~response to abiotic stimulus,GO:0016051~carbohydrate biosynthetic process,GO:0030203~glycosaminoglycan metabolic process,GO:0033554~cellular response to stress,GO:0034605~cellular response to heat,","hsa00532:Chondroitin sulfate biosynthesis,hsa00534:Heparan sulfate biosynthesis,",0,0
FAM8A1,"family with sequence similarity 8, member A1",1,1,0.01436015377123,1.79E-10,8.98E-10,0.000336050497653,0.054600207076427,0.662693602857651,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
GRXCR1,"glutaredoxin, cysteine rich 1",0.877681070295713,0.066428757066903,0.37667694993088,0.999937604362306,1,0.000370286549985,0.058122541740928,0.442543051838613,2,NO,0,"GO:0006457~protein folding,GO:0019725~cellular homeostasis,GO:0042592~homeostatic process,GO:0045454~cell redox homeostasis,GO:0009055~electron carrier activity,GO:0015035~protein disulfide oxidoreductase activity,GO:0015036~disulfide oxidoreductase activity,GO:0016667~oxidoreductase activity, acting on sulfur group of donors,GO:0031072~heat shock protein binding,GO:0051082~unfolded protein binding,",0,0,0
GRID1,"Glutamate receptor, ionotropic, delta 1",1,0.010321600524587,0.561579026129088,3.07E-05,0.000115978545057,0.000379925359174,0.058856427228703,0.450832183297872,2,YES,0,"GO:0004970~ionotropic glutamate receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0008066~glutamate receptor activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0006811~ion transport,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
OR5I1,"olfactory receptor, family 5, subfamily I, member 1",1,0.88938276512752,0.034357112570694,1,1,0.000381474473131,0.058856427228703,0.587490801947625,2,NO,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0050877~neurological system process,GO:0050890~cognition,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004984~olfactory receptor activity,","hsa04740:Olfactory transduction,",0,0
GRM5,"Glutamate receptor, metabotropic 5",1,2.23E-05,0.64908205921566,0.209777761658092,0.585103600121174,0.000384414803892,0.058856427228703,0.696850194664992,2,YES,0,"GO:0008066~glutamate receptor activity,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007200~activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger,GO:0007202~activation of phospholipase C activity,GO:0007206~activation of phospholipase C activity by metabotropic glutamate receptor signaling pathway,GO:0007215~glutamate signaling pathway,GO:0007216~metabotropic glutamate receptor signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010863~positive regulation of phospholipase C activity,GO:0019226~transmission of nerve impulse,GO:0019932~second-messenger-mediated signaling,GO:0043085~positive regulation of catalytic activity,GO:0044093~positive regulation of molecular function,GO:0048015~phosphoinositide-mediated signaling,GO:0050877~neurological system process,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,","hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04540:Gap junction,hsa04720:Long-term potentiation,hsa04730:Long-term depression,hsa05016:Huntington's disease,",0,0
MYF5,Myogenic factor 5,1,0.745415986888831,0.068206770791141,6.43E-08,2.82E-07,0.000388678361804,0.059025391220642,0.632560390756808,2,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003705~RNA polymerase II transcription factor activity, enhancer binding,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0001501~skeletal system development,GO:0001502~cartilage condensation,GO:0001756~somitogenesis,GO:0001952~regulation of cell-matrix adhesion,GO:0003002~regionalization,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007155~cell adhesion,GO:0007389~pattern specification process,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0009952~anterior/posterior pattern formation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010810~regulation of cell-substrate adhesion,GO:0014706~striated muscle tissue development,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0030155~regulation of cell adhesion,GO:0030198~extracellular matrix organization,GO:0031328~positive regulation of cellular biosynthetic process,GO:0035282~segmentation,GO:0043009~chordate embryonic development,GO:0043062~extracellular structure organization,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051216~cartilage development,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,",0,0,0
MYH2,"Myosin, Heavy Chain 2, Skeletal Muscle, Adult",1,0.142038435823367,0.339559638586126,0.999999999968229,1,0.00039243437761,0.059115175317565,0.598990094929841,2,YES,0,"GO:0000146~microfilament motor activity,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008092~cytoskeletal protein binding,GO:0008307~structural constituent of muscle,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0005826~contractile ring,GO:0005856~cytoskeleton,GO:0005859~muscle myosin complex,GO:0005863~striated muscle thick filament,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0016323~basolateral plasma membrane,GO:0016459~myosin complex,GO:0016460~myosin II complex,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031672~A band,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032153~cell division site,GO:0032155~cell division site part,GO:0032982~myosin filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0043292~contractile fiber,GO:0044430~cytoskeletal part,GO:0044448~cell cortex part,GO:0044449~contractile fiber part,GO:0044459~plasma membrane part,GO:0070013~intracellular organelle lumen,GO:0070161~anchoring junction,GO:0001778~plasma membrane repair,GO:0003012~muscle system process,GO:0006936~muscle contraction,GO:0006941~striated muscle contraction,GO:0007009~plasma membrane organization,GO:0009611~response to wounding,GO:0014823~response to activity,GO:0016044~membrane organization,GO:0030029~actin filament-based process,GO:0030048~actin filament-based movement,GO:0030049~muscle filament sliding,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0033275~actin-myosin filament sliding,GO:0042060~wound healing,GO:0046907~intracellular transport,GO:0070252~actin-mediated cell contraction,","hsa04530:Tight junction,hsa05416:Viral myocarditis,",0,0
PLK2,Polo-like kinase 2 (Drosophila),0.523859259797601,0.420265180899895,0.155911762426087,0.999999843092823,1,0.000464761604044,0.068899063507394,0.258442470030754,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042801~polo kinase kinase activity,GO:0000278~mitotic cell cycle,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007049~cell cycle,GO:0009967~positive regulation of signal transduction,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0016310~phosphorylation,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,",0,0,0
EBPL,Emopamil binding protein-like,0.988340686155777,1,0.000932502824151,0.440187619809301,1,0.000473249524605,0.069061155235193,0.77243841545107,2,YES,0,"GO:0016860~intramolecular oxidoreductase activity,GO:0016863~intramolecular oxidoreductase activity, transposing C=C bonds,GO:0047750~cholestenol delta-isomerase activity,GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0008202~steroid metabolic process,GO:0016125~sterol metabolic process,",0,0,0
IFITM1,interferon induced transmembrane protein 1,1,1,0.000942993667653,0.850369299625868,1,0.000483756738163,0.069601915484453,0.759078917162185,2,NO,0,"GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0007166~cell surface receptor linked signal transduction,GO:0008285~negative regulation of cell proliferation,GO:0042127~regulation of cell proliferation,","hsa04662:B cell receptor signaling pathway,",0,0
MFF,mitochondrial fission factor,1,0.420265180899895,0.160781827967041,0.999988126468604,1,0.000484407570693,0.069601915484453,0.677542319832922,2,NO,0,"GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0016021~integral to membrane,GO:0019867~outer membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0044429~mitochondrial part,",0,0,0
GABRG1,"Gamma-aminobutyric acid (GABA) A receptor, gamma 1",1,0.007617013308157,0.594395772667206,0.999998018506055,1,0.000538337646661,0.075700766227441,0.425207968279683,2,YES,0,"GO:0004890~GABA-A receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016917~GABA receptor activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0031404~chloride ion binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0015698~inorganic anion transport,GO:0019226~transmission of nerve impulse,GO:0050877~neurological system process,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
CUL1,Cullin 1,0.830672778498767,0.053125090503257,0.450365116245565,2.46E-06,9.89E-06,0.000538486266048,0.075700766227441,0.727184672602463,2,YES,0,"GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0000151~ubiquitin ligase complex,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0019005~SCF ubiquitin ligase complex,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008629~induction of apoptosis by intracellular signals,GO:0009057~macromolecule catabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030163~protein catabolic process,GO:0031396~regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051340~regulation of ligase activity,GO:0051351~positive regulation of ligase activity,GO:0051437~positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051439~regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051443~positive regulation of ubiquitin-protein ligase activity,GO:0051603~proteolysis involved in cellular protein catabolic process,","hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04120:Ubiquitin mediated proteolysis,hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,",0,0
EPHA6,EPH receptor A6,1,2.29E-05,0.664868239577819,0.311240846867187,0.840732867481156,0.000544212804734,0.075860828206144,0.569074398737353,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0016310~phosphorylation,","hsa04360:Axon guidance,",0,0
KLHL5,Kelch-like 5 (Drosophila),1,0.886481428527679,0.053873223475923,0.999971115956894,1,0.000577757130619,0.079352392962068,0.518961887030061,2,YES,0,"GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0005856~cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,",0,0,0
NRAP,Nebulin-related anchoring protein,1,0.043510538501356,0.494522794312359,0.99999999998778,1,0.00062567719494,0.083715295319809,0.456134739747418,2,NO,0,"GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0008270~zinc ion binding,GO:0042805~actinin binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051371~muscle alpha-actinin binding,GO:0051393~alpha-actinin binding,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005916~fascia adherens,GO:0005924~cell-substrate adherens junction,GO:0005927~muscle tendon junction,GO:0014704~intercalated disc,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,",0,0,0
RGPD3,RANBP2-like and GRIP domain containing 3,0.777171109936601,1,0.000627112356509,0.999885946857862,1,0.000649274459022,0.084732548269974,0.545322092679524,2,NO,0,"GO:0008536~Ran GTPase binding,GO:0017016~Ras GTPase binding,GO:0019899~enzyme binding,GO:0031267~small GTPase binding,GO:0051020~GTPase binding,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0046930~pore complex,GO:0006403~RNA localization,GO:0008104~protein localization,GO:0015031~protein transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051236~establishment of RNA localization,GO:0055085~transmembrane transport,",0,0,0
HMCN1,Hemicentin 1,0.314586261877537,0.000514146219554,0.628457722964864,2.17E-08,9.70E-08,0.000672472050965,0.086628313379117,0.668745577112228,2,NO,0,"GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0008218~bioluminescence,GO:0009611~response to wounding,GO:0018298~protein-chromophore linkage,GO:0042060~wound healing,GO:0050817~coagulation,GO:0050877~neurological system process,GO:0050878~regulation of body fluid levels,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,",0,0,0
GRIA3,"Glutamate receptor, ionotrophic, AMPA 3",1,0.000186207951805,0.64908205921566,0.999899102613063,1,0.000687401957157,0.087945076422826,0.414688174933375,2,YES,0,"GO:0004970~ionotropic glutamate receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0008066~glutamate receptor activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0019904~protein domain specific binding,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030165~PDZ domain binding,GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0014069~postsynaptic density,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030054~cell junction,GO:0030139~endocytic vesicle,GO:0030424~axon,GO:0030425~dendrite,GO:0030659~cytoplasmic vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0031012~extracellular matrix,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0032279~asymmetric synapse,GO:0033267~axon part,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043083~synaptic cleft,GO:0043195~terminal button,GO:0043197~dendritic spine,GO:0043198~dendritic shaft,GO:0043204~perikaryon,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043679~nerve terminal,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0044430~cytoskeletal part,GO:0044433~cytoplasmic vesicle part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0001919~regulation of receptor recycling,GO:0006811~ion transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007215~glutamate signaling pathway,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010226~response to lithium ion,","hsa04080:Neuroactive ligand-receptor interaction,hsa04730:Long-term depression,",0,0
SEMG2,semenogelin II,1,0.255686563278362,0.299703171888205,0.000117981604157,0.000425521989582,0.000719062670688,0.090752510984976,0.697673962243401,2,NO,0,"GO:0019953~sexual reproduction,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,",0,0,0
HLF,hepatic leukemia factor,1,0.086210192121299,0.444921389161528,2.98E-14,1.76E-13,0.000761288633656,0.0941729164772,0.686747744651933,2,NO,0,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0048511~rhythmic process,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046983~protein dimerization activity,",0,0,0
CMAS,Cytidine monophosphate N-acetylneuraminic acid synthetase,0.813306303463948,0.420265180899895,0.222537593401832,0.060344789926655,0.17891751286349,0.000787609983603,0.096337089704895,0.618848076314218,2,NO,0,"GO:0008781~N-acylneuraminate cytidylyltransferase activity,GO:0016779~nucleotidyltransferase activity,GO:0070567~cytidylyltransferase activity,GO:0000271~polysaccharide biosynthetic process,GO:0005976~polysaccharide metabolic process,GO:0008610~lipid biosynthetic process,GO:0008653~lipopolysaccharide metabolic process,GO:0009103~lipopolysaccharide biosynthetic process,GO:0016051~carbohydrate biosynthetic process,GO:0033692~cellular polysaccharide biosynthetic process,GO:0034637~cellular carbohydrate biosynthetic process,GO:0044264~cellular polysaccharide metabolic process,","hsa00520:Amino sugar and nucleotide sugar metabolism,",0,0
CCDC36,Coiled-coil domain containing 36,0.917257570209687,0.943222637657724,0.062558399038374,0.999992407910864,1,0.000797219595858,0.096337089704895,0.395740834929251,2,NO,0,0,0,0,0
SMO,"smoothened, frizzled family receptor",1,0.067637895795725,0.503945457136503,0.018418687331224,0.057168936633423,0.000806132083911,0.096337089704895,0.625001079632963,2,NO,0,"GO:0001570,GO:0001649,GO:0001755,GO:0002052,GO:0003007,GO:0004872,GO:0004926,GO:0004930,GO:0005515,GO:0005624,GO:0005929,GO:0007166,GO:0007186,GO:0007368,GO:0007389,GO:0009953,GO:0016020,GO:0016021,GO:0021696,GO:0021938,GO:0021953,GO:0042475,GO:0043066,GO:0043392,GO:0048468,GO:0048589","hsa04340,hsa05217",0,0
EIF1AX,"Eukaryotic translation initiation factor 1A, X-linked",1,0.621617423105817,0.140051375693358,0.999999280649845,1,0.000809231323707,0.096337089704895,0.726912298318789,2,NO,0,"GO:0003723~RNA binding,GO:0003743~translation initiation factor activity,GO:0008135~translation factor activity, nucleic acid binding,GO:0005829~cytosol,GO:0006412~translation,GO:0006413~translational initiation,",0,0,0
AK8,adenylate kinase 8,1,0.886481428527679,0.074001282225644,0.999999998074534,1,0.000848746842835,0.099709070926483,0.617112188792392,2,YES,0,"nucleoside diphosphate phosphorylation, nucleoside triphosphate biosynthetic process, ventricular system development, cytosol, ATP binding, adenylate kinase activity, cytidylate kinase activity, nucleoside diphosphate kinase activity",0,0,0
MRPL32,mitochondrial ribosomal protein L32,1,1,0.025719815361466,0.045512110580046,0.136587518239825,0.000875855392434,0.102250642970476,0.647192125748578,2,NO,0,"GO:0006412~translation,GO:0000313~organellar ribosome,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005761~mitochondrial ribosome,GO:0005840~ribosome,GO:0015934~large ribosomal subunit,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0033279~ribosomal subunit,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0003735~structural constituent of ribosome,GO:0005198~structural molecule activity,GO:0045182~translation regulator activity,",0,0,0
WBSCR17,Williams-Beuren syndrome chromosome region 17,1,0.023483600277954,0.594395772667206,0.99505328917987,1,0.000912743997534,0.105241636604541,0.703830079959269,2,YES,0,"GO:0004653~polypeptide N-acetylgalactosaminyltransferase activity,GO:0005509~calcium ion binding,GO:0005529~sugar binding,GO:0008376~acetylgalactosaminyltransferase activity,GO:0030145~manganese ion binding,GO:0030246~carbohydrate binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,","hsa00512:O-Glycan biosynthesis,",0,0
NRG3,neuregulin 3,1,0.000816588957328,0.641447788305282,0.999999997404368,1,0.00093201129081,0.106650324799354,0.258586266335343,2,NO,0,"GO:0001558~regulation of cell growth,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0030879~mammary gland development,GO:0040008~regulation of growth,GO:0048732~gland development,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0008047~enzyme activator activity,GO:0008083~growth factor activity,GO:0019207~kinase regulator activity,GO:0019209~kinase activator activity,GO:0019887~protein kinase regulator activity,GO:0030295~protein kinase activator activity,GO:0030296~protein tyrosine kinase activator activity,GO:0030297~transmembrane receptor protein tyrosine kinase activator activity,GO:0030545~receptor regulator activity,GO:0030546~receptor activator activity,GO:0030971~receptor tyrosine kinase binding,","hsa04012:ErbB signaling pathway,",0,0
FMNL3,Formin-like 3,1,0.013926318684271,0.601943915278899,0.999999886471708,1,0.000944478163324,0.106920652198356,0.687642671150532,2,NO,0,"GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0017016~Ras GTPase binding,GO:0017048~Rho GTPase binding,GO:0019899~enzyme binding,GO:0031267~small GTPase binding,GO:0051020~GTPase binding,GO:0007010~cytoskeleton organization,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,",0,0,0
MDGA2,MAM domain containing glycosylphosphatidylinositol anchor 2,1,0.005629812000978,0.619578902355474,0.999999698267211,1,0.001014881143188,0.112171389784695,0.449692345329635,2,NO,0,"GO:0021510~spinal cord development,GO:0021515~cell differentiation in spinal cord,GO:0021517~ventral spinal cord development,GO:0021522~spinal cord motor neuron differentiation,GO:0030182~neuron differentiation,GO:0005886~plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,",0,0,0
CACNG3,"Calcium channel, voltage-dependent, gamma subunit 3",1,0.38222470049003,0.296278406649975,0.999999976628214,1,0.001064166181339,0.115033552412092,0.673547649303029,2,YES,0,"GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005245~voltage-gated calcium channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030139~endocytic vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034704~calcium channel complex,GO:0044433~cytoplasmic vesicle part,GO:0044459~plasma membrane part,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0015674~di-, tri-valent inorganic cation transport,GO:0030001~metal ion transport,","hsa04010:MAPK signaling pathway,hsa04260:Cardiac muscle contraction,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,",0,0
IRF2,Interferon regulatory factor 2,0.476172239693238,0.271476723733921,0.332676355469261,0.999240540437662,1,0.001065355922007,0.115033552412092,0.286381727610918,2,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0030528~transcription regulator activity,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008283~cell proliferation,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,",0,0,0
SMARCA2,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2",1,0.000884949823916,0.641447788305282,0.01202758944789,0.037981968435696,0.001066580067476,0.115033552412092,0.673645947999036,2,YES,0,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008285~negative regulation of cell proliferation,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0042127~regulation of cell proliferation,GO:0043193~positive regulation of gene-specific transcription,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0005654~nucleoplasm,GO:0016514~SWI/SNF complex,GO:0016585~chromatin remodeling complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0070603~SWI/SNF-type complex,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008094~DNA-dependent ATPase activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,",0,0,0
BCLAF1,BCL2-associated transcription factor 1,1,0.012013506217752,0.616343584684641,0.999447231266786,1,0.00107993419143,0.115033552412092,0.54258433847979,2,NO,0,"GO:0003677~DNA binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0006350~transcription,GO:0006917~induction of apoptosis,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,",0,0,0
PRPF8,PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae),1,0.00126587203569,0.641447788305282,0.999160480448123,1,0.001085230695282,0.115033552412092,0.628097262753674,2,YES,0,"GO:0003723~RNA binding,GO:0031202~RNA splicing factor activity, transesterification mechanism,GO:0005654~nucleoplasm,GO:0005681~spliceosome,GO:0005682~snRNP U5,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0030529~ribonucleoprotein complex,GO:0030532~small nuclear ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,","hsa03040:Spliceosome,",0,0
BRWD3,bromodomain and WD repeat domain containing 3,0.383839991399908,0.001681203562019,0.628457722964864,1,1,0.001121106076892,0.116683356098303,0.301157218787777,2,YES,0,0,0,0,0
GPR141,G protein-coupled receptor 141,0.968471023165246,0.180765780910828,0.411292375631012,0.997202974168073,1,0.00112909128473,0.116683356098303,0.547875008036928,2,YES,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
PTPRF,"Protein tyrosine phosphatase, receptor type, F",1,0.010473571202056,0.616343584684641,3.64E-06,1.45E-05,0.001155954052761,0.118637723909434,0.749180446590983,2,YES,0,"GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005158~insulin receptor binding,GO:0016791~phosphatase activity,GO:0019198~transmembrane receptor protein phosphatase activity,GO:0030971~receptor tyrosine kinase binding,GO:0032403~protein complex binding,GO:0042301~phosphate binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005768~endosome,GO:0005792~microsome,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0042598~vesicular fraction,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0060076~excitatory synapse,GO:0001959~regulation of cytokine-mediated signaling pathway,GO:0001960~negative regulation of cytokine-mediated signaling pathway,GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0008285~negative regulation of cell proliferation,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,GO:0010720~positive regulation of cell development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010975~regulation of neuron projection development,GO:0016311~dephosphorylation,GO:0016337~cell-cell adhesion,GO:0019226~transmission of nerve impulse,GO:0022604~regulation of cell morphogenesis,GO:0022610~biological adhesion,GO:0031344~regulation of cell projection organization,GO:0031345~negative regulation of cell projection organization,GO:0031346~positive regulation of cell projection organization,GO:0042058~regulation of epidermal growth factor receptor signaling pathway,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043523~regulation of neuron apoptosis,GO:0043525~positive regulation of neuron apoptosis,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0046626~regulation of insulin receptor signaling pathway,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0048585~negative regulation of response to stimulus,GO:0048814~regulation of dendrite morphogenesis,GO:0050767~regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050773~regulation of dendrite development,GO:0050775~positive regulation of dendrite morphogenesis,GO:0050803~regulation of synapse structure and activity,GO:0050877~neurological system process,GO:0051094~positive regulation of developmental process,GO:0051129~negative regulation of cellular component organization,GO:0051130~positive regulation of cellular component organization,GO:0051386~regulation of nerve growth factor receptor signaling pathway,GO:0051387~negative regulation of nerve growth factor receptor signaling pathway,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,","hsa04514:Cell adhesion molecules (CAMs),hsa04520:Adherens junction,hsa04910:Insulin signaling pathway,",0,0
XPOT,"Exportin, tRNA (nuclear export receptor for tRNAs)",1,1,0.003384695873953,0.013773368149771,0.043282763066887,0.001176730024264,0.119687446367955,0.797715689711379,2,NO,0,"GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031967~organelle envelope,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0046930~pore complex,GO:0070013~intracellular organelle lumen,GO:0006403~RNA localization,GO:0006405~RNA export from nucleus,GO:0006409~tRNA export from nucleus,GO:0006913~nucleocytoplasmic transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0046907~intracellular transport,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051031~tRNA transport,GO:0051168~nuclear export,GO:0051169~nuclear transport,GO:0051236~establishment of RNA localization,",0,0,0
ALDH1L2,"Aldehyde dehydrogenase 1 family, member L2",1,0.006543937923482,0.620539289527082,0.999999999410265,1,0.001178997276712,0.119687446367955,0.498702105368374,2,YES,0,"GO:0000036~acyl carrier activity,GO:0004372~glycine hydroxymethyltransferase activity,GO:0016155~formyltetrahydrofolate dehydrogenase activity,GO:0016597~amino acid binding,GO:0016645~oxidoreductase activity, acting on the CH-NH group of donors,GO:0016646~oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,GO:0019842~vitamin binding,GO:0031177~phosphopantetheine binding,GO:0031406~carboxylic acid binding,GO:0043176~amine binding,GO:0006730~one-carbon metabolic process,GO:0006732~coenzyme metabolic process,GO:0006760~folic acid and derivative metabolic process,GO:0009109~coenzyme catabolic process,GO:0009256~10-formyltetrahydrofolate metabolic process,GO:0009258~10-formyltetrahydrofolate catabolic process,GO:0009397~folic acid and derivative catabolic process,GO:0019439~aromatic compound catabolic process,GO:0042558~pteridine and derivative metabolic process,GO:0042560~pteridine and derivative catabolic process,GO:0044270~nitrogen compound catabolic process,GO:0046653~tetrahydrofolate metabolic process,GO:0046700~heterocycle catabolic process,GO:0051186~cofactor metabolic process,GO:0051187~cofactor catabolic process,GO:0055114~oxidation reduction,",0,0,0
LPA,"lipoprotein, Lp(a)",1,0.013835311834755,0.616343584684641,0.99999998579696,1,0.001203622657784,0.121526852025636,0.364054369811291,2,NO,0,"GO:0003013~circulatory system process,GO:0006508~proteolysis,GO:0006869~lipid transport,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0008015~blood circulation,GO:0009611~response to wounding,GO:0010876~lipid localization,GO:0042060~wound healing,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,GO:0005576~extracellular region,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0004857~enzyme inhibitor activity,GO:0004866~endopeptidase inhibitor activity,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0030414~peptidase inhibitor activity,GO:0034185~apolipoprotein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),1,0.08825557681226,0.514567348588068,0.999570602292736,1,0.001217900051415,0.121552332607925,0.567166075130878,2,NO,0,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001654~eye development,GO:0001659~temperature homeostasis,GO:0001754~eye photoreceptor cell differentiation,GO:0002526~acute inflammatory response,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006928~cell motion,GO:0006952~defense response,GO:0006953~acute-phase response,GO:0006954~inflammatory response,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007259~JAK-STAT cascade,GO:0007423~sensory organ development,GO:0007610~behavior,GO:0007631~feeding behavior,GO:0009611~response to wounding,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0014070~response to organic cyclic substance,GO:0016481~negative regulation of transcription,GO:0019221~cytokine-mediated signaling pathway,GO:0019953~sexual reproduction,GO:0030182~neuron differentiation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032355~response to estradiol stimulus,GO:0032870~cellular response to hormone stimulus,GO:0033500~carbohydrate homeostasis,GO:0034097~response to cytokine stimulus,GO:0040008~regulation of growth,GO:0040014~regulation of multicellular organism growth,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0042755~eating behavior,GO:0043434~response to peptide hormone stimulus,GO:0043627~response to estrogen stimulus,GO:0045449~regulation of transcription,GO:0045471~response to ethanol,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046530~photoreceptor cell differentiation,GO:0048545~response to steroid hormone stimulus,GO:0048592~eye morphogenesis,GO:0048871~multicellular organismal homeostasis,GO:0048878~chemical homeostasis,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060396~growth hormone receptor signaling pathway,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,GO:0060416~response to growth hormone stimulus,GO:0070102~interleukin-6-mediated signaling pathway,GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0005509~calcium ion binding,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046983~protein dimerization activity,","hsa04062:Chemokine signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa05200:Pathways in cancer,hsa05212:Pancreatic cancer,hsa05221:Acute myeloid leukemia,",0,0
PLCL1,phospholipase C-like 1,0.865384930113013,0.005629812000978,0.620539289527082,0.954319547144121,1,0.001225285368416,0.121552332607925,0.42472136855829,2,NO,0,"GO:0007242~intracellular signaling cascade,GO:0007610~behavior,GO:0004435~phosphoinositide phospholipase C activity,GO:0004620~phospholipase activity,GO:0004629~phospholipase C activity,GO:0005509~calcium ion binding,GO:0008081~phosphoric diester hydrolase activity,GO:0016298~lipase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
OR4M2,"olfactory receptor, family 4, subfamily M, member 2",1,0.07734522015286,0.532650659483048,1,1,0.001231689331887,0.121552332607925,0.60837856289517,2,NO,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0050877~neurological system process,GO:0050890~cognition,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004984~olfactory receptor activity,","hsa04740:Olfactory transduction,",0,0
MAPK8,mitogen-activated protein kinase 8,1,0.745415986888831,0.155369972856026,0.999999999967353,1,0.001341745810442,0.128525487144849,0.262514734654564,2,YES,0,"GO:0000165~MAPKKK cascade,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006928~cell motion,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0007258~JUN phosphorylation,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0008633~activation of pro-apoptotic gene products,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0016310~phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018210~peptidyl-threonine modification,GO:0031098~stress-activated protein kinase signaling pathway,GO:0031557~induction of programmed cell death in response to chemical stimulus,GO:0031558~induction of apoptosis in response to chemical stimulus,GO:0033554~cellular response to stress,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0046686~response to cadmium ion,GO:0060348~bone development,GO:0060548~negative regulation of cell death,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004705~JUN kinase activity,GO:0004707~MAP kinase activity,GO:0005524~ATP binding,GO:0016909~SAP kinase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04310:Wnt signaling pathway,hsa04510:Focal adhesion,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04920:Adipocytokine signaling pathway,hsa04930:Type II diabetes mellitus,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,",0,0
POTEG,"POTE ankyrin domain family, member G",1,0.569262740542718,0.233326919943334,0.999999972049038,1,0.001352123066022,0.128858707909345,0.706691807350037,2,NO,0,0,0,0,0
MARCO,Macrophage receptor with collagenous structure,1,0.721630932443466,0.175503078447812,0.185081627940834,0.520027034943869,0.00138695616311,0.131507381577357,0.653241979266858,2,YES,0,"GO:0005044~scavenger receptor activity,GO:0008329~pattern recognition receptor activity,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0006811~ion transport,GO:0006817~phosphate transport,GO:0006820~anion transport,GO:0007166~cell surface receptor linked signal transduction,GO:0015698~inorganic anion transport,",0,0,0
SPPL3,signal peptide peptidase 3,1,0.259421173804159,0.379347082700499,0.999999988110356,1,0.001414488256158,0.133141553676105,0.64131789995226,2,NO,0,"GO:0004175~endopeptidase activity,GO:0004190~aspartic-type endopeptidase activity,GO:0008233~peptidase activity,GO:0070001~aspartic-type peptidase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0010941~regulation of cell death,GO:0042981~regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043523~regulation of neuron apoptosis,",0,0,0
DTX1,Deltex homolog 1 (Drosophila),1,0.33996881175508,0.340839868265791,0.999983210370804,1,0.001430443786304,0.133596297421886,0.617650931010459,2,YES,0,"GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0005112~Notch binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016563~transcription activator activity,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,GO:0008593~regulation of Notch signaling pathway,GO:0010001~glial cell differentiation,GO:0032774~RNA biosynthetic process,GO:0042063~gliogenesis,GO:0045596~negative regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0050767~regulation of neurogenesis,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,","hsa04330:Notch signaling pathway,",0,0
SLC35G3,"solute carrier family 35, member G3",1,1,0.010540121677388,0.999990186605176,1,0.001503094982392,0.138333460407864,0.790377932524434,2,NO,novel,integral to membrane,0,unknown,uncharacterized member of nucleotide sugar transporter family (23506892)
TLL1,tolloid-like 1,1,0.005629812000978,0.628457722964864,0.976452303639477,1,0.001503383075261,0.138333460407864,0.390075144613067,2,NO,0,"GO:0001501~skeletal system development,GO:0006508~proteolysis,GO:0005576~extracellular region,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
PDYN,Prodynorphin,1,0.621617423105817,0.229552906959364,0.999999999687353,1,0.001522505662465,0.139406290535171,0.78982191464671,2,NO,0,"GO:0001515~opioid peptide activity,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0019226~transmission of nerve impulse,GO:0050877~neurological system process,",0,0,0
ABI1,Abl-interactor 1,1,0.710053497962842,0.188473503474035,0.999999981381255,1,0.001542194889325,0.140520284574176,0.735090619508586,2,NO,0,"GO:0008092~cytoskeletal protein binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005625~soluble fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0019717~synaptosome,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030175~filopodium,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0042127~regulation of cell proliferation,",0,0,0
DICER1,"Dicer1, Dcr-1 homolog (Drosophila)",1,0.029249668197342,0.601943915278899,0.999999999999972,1,0.001570707882087,0.142198801649313,0.555198437113722,2,YES,0,"GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0004525~ribonuclease III activity,GO:0004540~ribonuclease activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016887~ATPase activity,GO:0016891~endoribonuclease activity, producing 5'-phosphomonoesters,GO:0016893~endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,GO:0017076~purine nucleotide binding,GO:0030145~manganese ion binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070035~purine NTP-dependent helicase activity,GO:0016442~RNA-induced silencing complex,GO:0030529~ribonucleoprotein complex,GO:0031332~RNAi effector complex,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001763~morphogenesis of a branching structure,GO:0001944~vasculature development,GO:0006396~RNA processing,GO:0010033~response to organic substance,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016246~RNA interference,GO:0016441~posttranscriptional gene silencing,GO:0016458~gene silencing,GO:0019827~stem cell maintenance,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0030326~embryonic limb morphogenesis,GO:0030422~RNA interference, production of siRNA,GO:0030423~RNA interference, targeting of mRNA for destruction,GO:0031047~gene silencing by RNA,GO:0031050~dsRNA fragmentation,GO:0031054~pre-microRNA processing,GO:0034470~ncRNA processing,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0035194~posttranscriptional gene silencing by RNA,GO:0035195~gene silencing by miRNA,GO:0035196~gene silencing by miRNA, production of miRNAs,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0040029~regulation of gene expression, epigenetic,GO:0043331~response to dsRNA,GO:0043933~macromolecular complex subunit organization,GO:0045596~negative regulation of cell differentiation,GO:0048514~blood vessel morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048736~appendage development,GO:0048754~branching morphogenesis of a tube,GO:0048863~stem cell differentiation,GO:0048864~stem cell development,GO:0060173~limb development,GO:0060541~respiratory system development,GO:0065003~macromolecular complex assembly,",0,0,0
ZFR,zinc finger RNA binding protein,1,0.329352821947289,0.355297788326112,9.65E-06,3.76E-05,0.001575841958424,0.142198801649313,0.798425219128032,2,NO,0,"GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
TLL2,tolloid-like 2,1,0.103711956362744,0.553490032211157,0.999994273561798,1,0.001643629228334,0.14689641318686,0.517657811785041,2,NO,0,"GO:0006508~proteolysis,GO:0005576~extracellular region,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
STXBP1,Syntaxin binding protein 1,1,0.028895572122701,0.61373452714822,0.999991487214202,1,0.001678527073659,0.148593399094201,0.59164780312014,2,NO,0,"GO:0000149~SNARE binding,GO:0017075~syntaxin-1 binding,GO:0019905~syntaxin binding,GO:0030347~syntaxin-2 binding,GO:0042802~identical protein binding,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0019898~extrinsic to membrane,GO:0030141~secretory granule,GO:0031091~platelet alpha granule,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001775~cell activation,GO:0002576~platelet degranulation,GO:0006887~exocytosis,GO:0006897~endocytosis,GO:0006904~vesicle docking during exocytosis,GO:0007155~cell adhesion,GO:0007409~axonogenesis,GO:0007412~axon target recognition,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0008104~protein localization,GO:0009611~response to wounding,GO:0010324~membrane invagination,GO:0010648~negative regulation of cell communication,GO:0010807~regulation of synaptic vesicle priming,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016050~vesicle organization,GO:0016188~synaptic vesicle maturation,GO:0016192~vesicle-mediated transport,GO:0016337~cell-cell adhesion,GO:0017157~regulation of exocytosis,GO:0021700~developmental maturation,GO:0022406~membrane docking,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030168~platelet activation,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0031644~regulation of neurological system process,GO:0031645~negative regulation of neurological system process,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0032229~negative regulation of synaptic transmission, GABAergic,GO:0032940~secretion by cell,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0034109~homotypic cell-cell adhesion,GO:0042060~wound healing,GO:0043254~regulation of protein complex assembly,GO:0044057~regulation of system process,GO:0044087~regulation of cellular component biogenesis,GO:0045184~establishment of protein localization,GO:0046903~secretion,GO:0046928~regulation of neurotransmitter secretion,GO:0048278~vesicle docking,GO:0048488~synaptic vesicle endocytosis,GO:0048489~synaptic vesicle transport,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050804~regulation of synaptic transmission,GO:0050805~negative regulation of synaptic transmission,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,GO:0051046~regulation of secretion,GO:0051241~negative regulation of multicellular organismal process,GO:0051588~regulation of neurotransmitter transport,GO:0051969~regulation of transmission of nerve impulse,GO:0051970~negative regulation of transmission of nerve impulse,GO:0060341~regulation of cellular localization,GO:0060627~regulation of vesicle-mediated transport,GO:0070527~platelet aggregation,",0,0,0
PSMC3IP,PSMC3 Interacting Protein,1,0.621617423105817,0.236520976817479,0.999988234799052,1,0.001732072232709,0.151858967235335,0.48612970447456,2,NO,0,"GO:0003677~DNA binding,GO:0008134~transcription factor binding,GO:0030331~estrogen receptor binding,GO:0035257~nuclear hormone receptor binding,GO:0035258~steroid hormone receptor binding,GO:0035259~glucocorticoid receptor binding,GO:0046966~thyroid hormone receptor binding,GO:0050681~androgen receptor binding,GO:0051427~hormone receptor binding,GO:0000279~M phase,GO:0006259~DNA metabolic process,GO:0006310~DNA recombination,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0007126~meiosis,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,",0,0,0
GTF2I,"General transcription factor II, i",1,0.745415986888831,0.188473503474035,0.003486059825302,0.011413867042387,0.001747245867797,0.151858967235335,0.668783163970523,2,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0016251~general RNA polymerase II transcription factor activity,GO:0030528~transcription regulator activity,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0032774~RNA biosynthetic process,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,","hsa03022:Basal transcription factors,",0,0
MICU3,"mitochondrial calcium uptake family, member 3",0.74735679281311,0.420265180899895,0.332676355469261,0.999999907344083,1,0.00174793500485,0.151858967235335,0.24717024554118,2,NO,0,"integral to membrane, mitochondrion, calcium ion binding",0,0,0
ASCC3,Activating signal cointegrator 1 complex subunit 3,1,0.053281993127228,0.599319901491912,0.999999973353357,1,0.00178126191626,0.154037922841768,0.309556228284153,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0070035~purine NTP-dependent helicase activity,GO:0006350~transcription,GO:0045449~regulation of transcription,",0,0,0
GNA15,"Guanine nucleotide binding protein (G protein), alpha 15 (Gq class)",1,1,0.074001282225644,0.999999999999978,1,0.00181652842962,0.155646488701261,0.724260777052617,2,YES,0,"GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0044459~plasma membrane part,GO:0006471~protein amino acid ADP-ribosylation,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007200~activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger,GO:0007202~activation of phospholipase C activity,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0007207~activation of phospholipase C activity by muscarinic acetylcholine receptor signaling pathway,GO:0007213~muscarinic acetylcholine receptor signaling pathway,GO:0007242~intracellular signaling cascade,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010863~positive regulation of phospholipase C activity,GO:0019725~cellular homeostasis,GO:0019932~second-messenger-mediated signaling,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0042592~homeostatic process,GO:0043085~positive regulation of catalytic activity,GO:0044093~positive regulation of molecular function,GO:0048015~phosphoinositide-mediated signaling,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051480~cytosolic calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,","hsa04020:Calcium signaling pathway,",0,0
JUN,Jun oncogene,0.54645863555447,0.621617423105817,0.236520976817479,0.976906168590993,1,0.001832896160974,0.156331814569979,0.627551439145416,2,YES,0,"GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005100~Rho GTPase activator activity,GO:0008047~enzyme activator activity,GO:0008134~transcription factor binding,GO:0010843~promoter binding,GO:0030528~transcription regulator activity,GO:0030695~GTPase regulator activity,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046332~SMAD binding,GO:0046983~protein dimerization activity,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0070412~R-SMAD binding,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005694~chromosome,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0000060~protein import into nucleus, translocation,GO:0000302~response to reactive oxygen species,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001836~release of cytochrome c from mitochondria,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001933~negative regulation of protein amino acid phosphorylation,GO:0001944~vasculature development,GO:0002237~response to molecule of bacterial origin,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0006275~regulation of DNA replication,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006873~cellular ion homeostasis,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0006915~apoptosis,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007184~SMAD protein nuclear translocation,GO:0007568~aging,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007623~circadian rhythm,GO:0008104~protein localization,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008637~apoptotic mitochondrial changes,GO:0009267~cellular response to starvation,GO:0009612~response to mechanical stimulus,GO:0009617~response to bacterium,GO:0009628~response to abiotic stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0014070~response to organic cyclic substance,GO:0015031~protein transport,GO:0016265~death,GO:0017038~protein import,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0030855~epithelial cell differentiation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0031952~regulation of protein amino acid autophosphorylation,GO:0031953~negative regulation of protein amino acid autophosphorylation,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032496~response to lipopolysaccharide,GO:0033365~protein localization in organelle,GO:0033554~cellular response to stress,GO:0034097~response to cytokine stimulus,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0035026~leading edge cell differentiation,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042391~regulation of membrane potential,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0042592~homeostatic process,GO:0042594~response to starvation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043523~regulation of neuron apoptosis,GO:0043525~positive regulation of neuron apoptosis,GO:0045184~establishment of protein localization,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045655~regulation of monocyte differentiation,GO:0045657~positive regulation of monocyte differentiation,GO:0045740~positive regulation of DNA replication,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045936~negative regulation of phosphate metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046907~intracellular transport,GO:0048511~rhythmic process,GO:0048514~blood vessel morphogenesis,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051052~regulation of DNA metabolic process,GO:0051054~positive regulation of DNA metabolic process,GO:0051094~positive regulation of developmental process,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051365~cellular response to potassium ion starvation,GO:0051591~response to cAMP,GO:0051726~regulation of cell cycle,GO:0051899~membrane depolarization,GO:0055082~cellular chemical homeostasis,GO:0060395~SMAD protein signal transduction,GO:0060429~epithelium development,GO:0070727~cellular macromolecule localization,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04310:Wnt signaling pathway,hsa04510:Focal adhesion,hsa04620:Toll-like receptor signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04912:GnRH signaling pathway,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,",0,0
POLE,"Polymerase (DNA directed), epsilon",1,1,0.016901928635041,1,1,0.001859453965168,0.157161722241488,0.781545372087695,2,YES,putative TSG,"GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0008270~zinc ion binding,GO:0016779~nucleotidyltransferase activity,GO:0034061~DNA polymerase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000731~DNA synthesis during DNA repair,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0033554~cellular response to stress,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,","hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa03030:DNA replication,hsa03410:Base excision repair,hsa03420:Nucleotide excision repair,",mutations identified in proofreading domain of PolE result in deficient MMR and may contribute to mutator phenotype of colorectal cancer (21157497) and endometrial cancer (23447401); putative splicing mutation identified in 2 of 24 breast cancers (19129559),"one of the major replicative polymerases (12045093), and mutations affecting its proofreading exonuclease domain are implicated in human cancers (19805137)"
TM2D3,TM2 domain containing 3,1,0.38222470049003,0.353186564446536,0.999999972049038,1,0.001893846136609,0.159347531467232,0.572496763779641,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
ZNF479,Zinc finger protein 479,1,1,0.072702655219072,0.101786229908079,0.293904001925027,0.001908869722411,0.159497132105763,0.741953734526603,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
CDH7,"Cadherin 7, type 2",0.978888608669698,0.013926318684271,0.620539289527082,1,1,0.001912701835842,0.159497132105763,0.322253263507051,2,NO,0,"GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,",0,0,0
GK2,glycerol kinase 2,1,0.003090229916082,0.641447788305282,0.999998519373881,1,0.001955966329334,0.161661482591314,0.538792871430758,2,NO,0,"GO:0006071~glycerol metabolic process,GO:0006072~glycerol-3-phosphate metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0019400~alditol metabolic process,GO:0019637~organophosphate metabolic process,GO:0019751~polyol metabolic process,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0019867~outer membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004370~glycerol kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa00561:Glycerolipid metabolism,hsa03320:PPAR signaling pathway,",0,0
CSNK1E,"Casein kinase 1, epsilon",1,0.142038435823367,0.532650659483048,0.648455418661396,1,0.001998736925458,0.163747399257132,0.429257795542711,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005829~cytosol,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006974~response to DNA damage stimulus,GO:0016310~phosphorylation,GO:0033554~cellular response to stress,","hsa04310:Wnt signaling pathway,hsa04340:Hedgehog signaling pathway,hsa04710:Circadian rhythm,",0,0
KAT8,K(Lysine) Acetyltransferase 8,1,0.103166730462649,0.576395679177485,0.941856517639746,1,0.002014194701512,0.164293200128973,0.72549103249765,2,YES,0,"histone H4-K16 acetylation, histone H4-K5 acetylation, histone H4-K8 acetylation, myeloid cell differentiation, negative regulation of transcription DNA-dependent, positive regulation of transcription DNA-dependent, MLL1 complex, MSL complex, histone acetyltransferase complex, kinetochore, nucleus, histone acetyltransferase activity, metal ion binding, methylated histone residue binding, protein binding, transcription factor binding",0,0,0
CD163,CD163 molecule,1,0.09830923561382,0.590083720101276,0.959832411017225,1,0.002069752095328,0.168090866907134,0.554012358042226,2,YES,0,"GO:0002526~acute inflammatory response,GO:0006952~defense response,GO:0006953~acute-phase response,GO:0006954~inflammatory response,GO:0009611~response to wounding,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0005044~scavenger receptor activity,",0,0,0
GRID2,"Glutamate receptor, ionotropic, delta 2",1,0.030244727128705,0.616343584684641,0.999988189136873,1,0.00208914292408,0.168931171770052,0.325520041966918,2,YES,0,"GO:0004970~ionotropic glutamate receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0008066~glutamate receptor activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0014069~postsynaptic density,GO:0016021~integral to membrane,GO:0019717~synaptosome,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0001964~startle response,GO:0006811~ion transport,GO:0006873~cellular ion homeostasis,GO:0007166~cell surface receptor linked signal transduction,GO:0007215~glutamate signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007270~nerve-nerve synaptic transmission,GO:0010941~regulation of cell death,GO:0019226~transmission of nerve impulse,GO:0019725~cellular homeostasis,GO:0032101~regulation of response to external stimulus,GO:0032102~negative regulation of response to external stimulus,GO:0035249~synaptic transmission, glutamatergic,GO:0042391~regulation of membrane potential,GO:0042592~homeostatic process,GO:0042981~regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043523~regulation of neuron apoptosis,GO:0048585~negative regulation of response to stimulus,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0050905~neuromuscular process,GO:0051899~membrane depolarization,GO:0055082~cellular chemical homeostasis,GO:0060078~regulation of postsynaptic membrane potential,GO:0060079~regulation of excitatory postsynaptic membrane potential,GO:0060134~prepulse inhibition,","hsa04080:Neuroactive ligand-receptor interaction,hsa04730:Long-term depression,",0,0
IL21,Interleukin 21,1,1,0.010540121677388,0.999998926808998,1,0.0021906047591,0.175615048477356,0.648881646823771,2,NO,0,"GO:0005125~cytokine activity,GO:0005134~interleukin-2 receptor binding,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0001817~regulation of cytokine production,GO:0001819~positive regulation of cytokine production,GO:0001910~regulation of leukocyte mediated cytotoxicity,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0002697~regulation of immune effector process,GO:0002699~positive regulation of immune effector process,GO:0002700~regulation of production of molecular mediator of immune response,GO:0002702~positive regulation of production of molecular mediator of immune response,GO:0002703~regulation of leukocyte mediated immunity,GO:0002705~positive regulation of leukocyte mediated immunity,GO:0002706~regulation of lymphocyte mediated immunity,GO:0002708~positive regulation of lymphocyte mediated immunity,GO:0002715~regulation of natural killer cell mediated immunity,GO:0002717~positive regulation of natural killer cell mediated immunity,GO:0002718~regulation of cytokine production during immune response,GO:0002720~positive regulation of cytokine production during immune response,GO:0002727~regulation of natural killer cell cytokine production,GO:0002729~positive regulation of natural killer cell cytokine production,GO:0008284~positive regulation of cell proliferation,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0021700~developmental maturation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031341~regulation of cell killing,GO:0031343~positive regulation of cell killing,GO:0031349~positive regulation of defense response,GO:0032649~regulation of interferon-gamma production,GO:0032653~regulation of interleukin-10 production,GO:0032733~positive regulation of interleukin-10 production,GO:0032814~regulation of natural killer cell activation,GO:0032816~positive regulation of natural killer cell activation,GO:0032823~regulation of natural killer cell differentiation,GO:0032825~positive regulation of natural killer cell differentiation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032946~positive regulation of mononuclear cell proliferation,GO:0042035~regulation of cytokine biosynthetic process,GO:0042102~positive regulation of T cell proliferation,GO:0042108~positive regulation of cytokine biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042269~regulation of natural killer cell mediated cytotoxicity,GO:0045072~regulation of interferon-gamma biosynthetic process,GO:0045078~positive regulation of interferon-gamma biosynthetic process,GO:0045088~regulation of innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045597~positive regulation of cell differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045621~positive regulation of lymphocyte differentiation,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0048469~cell maturation,GO:0048584~positive regulation of response to stimulus,GO:0050670~regulation of lymphocyte proliferation,GO:0050671~positive regulation of lymphocyte proliferation,GO:0050778~positive regulation of immune response,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050870~positive regulation of T cell activation,GO:0051094~positive regulation of developmental process,GO:0051240~positive regulation of multicellular organismal process,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0070663~regulation of leukocyte proliferation,GO:0070665~positive regulation of leukocyte proliferation,","hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,",0,0
BRSK1,BR serine/threonine kinase 1,0.543165387911942,0.02903220135353,0.616343584684641,0.99853493735494,1,0.002204071796058,0.175939560164826,0.286545548360218,2,YES,0,"GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0000902~cell morphogenesis,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006974~response to DNA damage stimulus,GO:0007163~establishment or maintenance of cell polarity,GO:0007242~intracellular signaling cascade,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0010212~response to ionizing radiation,GO:0016310~phosphorylation,GO:0030010~establishment of cell polarity,GO:0030182~neuron differentiation,GO:0031570~DNA integrity checkpoint,GO:0031572~G2/M transition DNA damage checkpoint,GO:0031576~G2/M transition checkpoint,GO:0032989~cellular component morphogenesis,GO:0033554~cellular response to stress,GO:0042770~DNA damage response, signal transduction,GO:0051726~regulation of cell cycle,GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044459~plasma membrane part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
SOCS5,"Sin3A-associated protein, 30kDa",1,0.505087244311173,0.327163599458382,0.251889464221893,0.693039225541426,0.002245804693988,0.177063951231498,0.744413749781058,2,YES,0,"GO:0005154~epidermal growth factor receptor binding,GO:0002683~negative regulation of immune system process,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0002819~regulation of adaptive immune response,GO:0002822~regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002825~regulation of T-helper 1 type immune response,GO:0002828~regulation of T-helper 2 type immune response,GO:0006508~proteolysis,GO:0006512~ubiquitin cycle,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007242~intracellular signaling cascade,GO:0008361~regulation of cell size,GO:0009057~macromolecule catabolic process,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,GO:0016049~cell growth,GO:0019221~cytokine-mediated signaling pathway,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0032535~regulation of cellular component size,GO:0040007~growth,GO:0040008~regulation of growth,GO:0043370~regulation of CD4-positive, alpha beta T cell differentiation,GO:0043371~negative regulation of CD4-positive, alpha beta T cell differentiation,GO:0043372~positive regulation of CD4-positive, alpha beta T cell differentiation,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045580~regulation of T cell differentiation,GO:0045581~negative regulation of T cell differentiation,GO:0045582~positive regulation of T cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045620~negative regulation of lymphocyte differentiation,GO:0045621~positive regulation of lymphocyte differentiation,GO:0045622~regulation of T-helper cell differentiation,GO:0045623~negative regulation of T-helper cell differentiation,GO:0045624~positive regulation of T-helper cell differentiation,GO:0045625~regulation of T-helper 1 cell differentiation,GO:0045627~positive regulation of T-helper 1 cell differentiation,GO:0045628~regulation of T-helper 2 cell differentiation,GO:0045629~negative regulation of T-helper 2 cell differentiation,GO:0046634~regulation of alpha-beta T cell activation,GO:0046635~positive regulation of alpha-beta T cell activation,GO:0046636~negative regulation of alpha-beta T cell activation,GO:0046637~regulation of alpha-beta T cell differentiation,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0046639~negative regulation of alpha-beta T cell differentiation,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050868~negative regulation of T cell activation,GO:0050870~positive regulation of T cell activation,GO:0051094~positive regulation of developmental process,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051603~proteolysis involved in cellular protein catabolic process,","hsa04630:Jak-STAT signaling pathway,",0,0
UGT8,UDP glycosyltransferase 8 (UDP-galactose ceramide galactosyltransferase),1,1,0.025719815361466,0.999675295668396,1,0.002252875271787,0.177063951231498,0.617879060180261,2,YES,0,"GO:0003851~2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity,GO:0008378~galactosyltransferase activity,GO:0008489~UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,GO:0035250~UDP-galactosyltransferase activity,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0007422~peripheral nervous system development,","hsa00600:Sphingolipid metabolism,",0,0
CDC73,"cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)",0.951632204089476,0.142038435823367,0.559248062668889,4.02E-07,1.69E-06,0.00225607475738,0.177063951231498,0.616563376681075,2,YES,0,"GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006513~protein monoubiquitination,GO:0007049~cell cycle,GO:0010390~histone monoubiquitination,GO:0016567~protein ubiquitination,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016574~histone ubiquitination,GO:0032446~protein modification by small protein conjugation,GO:0033523~histone H2B ubiquitination,GO:0051276~chromosome organization,GO:0070647~protein modification by small protein conjugation or removal,GO:0005654~nucleoplasm,GO:0008023~transcription elongation factor complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0016593~Cdc73/Paf1 complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,",0,0,0
TXNRD1,thioredoxin reductase 1; hypothetical LOC100130902,1,1,0.083637341690824,0.914081843243715,1,0.002286877134032,0.178236140672354,0.392399297066282,2,NO,0,"GO:0001704~formation of primary germ layer,GO:0001707~mesoderm formation,GO:0006091~generation of precursor metabolites and energy,GO:0007369~gastrulation,GO:0007498~mesoderm development,GO:0008283~cell proliferation,GO:0019725~cellular homeostasis,GO:0022900~electron transport chain,GO:0042592~homeostatic process,GO:0045454~cell redox homeostasis,GO:0048332~mesoderm morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0055114~oxidation reduction,GO:0005829~cytosol,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004791~thioredoxin-disulfide reductase activity,GO:0008430~selenium binding,GO:0009055~electron carrier activity,GO:0015035~protein disulfide oxidoreductase activity,GO:0015036~disulfide oxidoreductase activity,GO:0016209~antioxidant activity,GO:0016651~oxidoreductase activity, acting on NADH or NADPH,GO:0016667~oxidoreductase activity, acting on sulfur group of donors,GO:0016668~oxidoreductase activity, acting on sulfur group of donors, NAD or NADP as acceptor,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0048037~cofactor binding,GO:0050660~FAD binding,GO:0050661~NADP or NADPH binding,GO:0050662~coenzyme binding,","hsa00240:Pyrimidine metabolism,",0,0
CCND3,Cyclin D3,0.08890512090745,1,0.118681653721043,2.88E-07,1.22E-06,0.002299636484932,0.178236140672354,0.489448497930106,2,NO,0,"GO:0001584,GO:0001992,GO:0004872,GO:0005000,GO:0005080,GO:0005768,GO:0005886,GO:0005887,GO:0007165,GO:0007186,GO:0007202,GO:0007204,GO:0016021,GO:0017046,GO:0042538,GO:0045028","hsa04110,hsa04115,hsa04310,hsa04510,hsa04630",0,0
KLK8,kallikrein-related peptidase 8,1,0.76383376707594,0.207292071105334,0.999999908292826,1,0.00231374098681,0.178588297076934,0.630210074340929,2,YES,0,"GO:0000902~cell morphogenesis,GO:0006508~proteolysis,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007613~memory,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0009611~response to wounding,GO:0010721~negative regulation of cell development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010975~regulation of neuron projection development,GO:0010977~negative regulation of neuron projection development,GO:0016265~death,GO:0019226~transmission of nerve impulse,GO:0022604~regulation of cell morphogenesis,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0031344~regulation of cell projection organization,GO:0031345~negative regulation of cell projection organization,GO:0031641~regulation of myelination,GO:0031642~negative regulation of myelination,GO:0031644~regulation of neurological system process,GO:0031645~negative regulation of neurological system process,GO:0032101~regulation of response to external stimulus,GO:0032102~negative regulation of response to external stimulus,GO:0032844~regulation of homeostatic process,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0043616~keratinocyte proliferation,GO:0044057~regulation of system process,GO:0045596~negative regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0048585~negative regulation of response to stimulus,GO:0048666~neuron development,GO:0048679~regulation of axon regeneration,GO:0048681~negative regulation of axon regeneration,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0050770~regulation of axonogenesis,GO:0050771~negative regulation of axonogenesis,GO:0050803~regulation of synapse structure and activity,GO:0050807~regulation of synapse organization,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051129~negative regulation of cellular component organization,GO:0051241~negative regulation of multicellular organismal process,GO:0051960~regulation of nervous system development,GO:0051969~regulation of transmission of nerve impulse,GO:0060284~regulation of cell development,GO:0070570~regulation of neuron projection regeneration,GO:0070571~negative regulation of neuron projection regeneration,GO:0080135~regulation of cellular response to stress,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
GRIA2,"Glutamate receptor, ionotropic, AMPA 2",1,0.000949654177846,0.669292822937893,0.999770731977909,1,0.002354140742471,0.180440880808866,0.361050609201691,2,YES,0,"GO:0004970~ionotropic glutamate receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0008066~glutamate receptor activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0019904~protein domain specific binding,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030165~PDZ domain binding,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0014069~postsynaptic density,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030054~cell junction,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0030139~endocytic vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030665~clathrin coated vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0030672~synaptic vesicle membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0032279~asymmetric synapse,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044433~cytoplasmic vesicle part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0001919~regulation of receptor recycling,GO:0006811~ion transport,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0008104~protein localization,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010226~response to lithium ion,GO:0010324~membrane invagination,GO:0010647~positive regulation of cell communication,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0019226~transmission of nerve impulse,GO:0031623~receptor internalization,GO:0031644~regulation of neurological system process,GO:0031646~positive regulation of neurological system process,GO:0043112~receptor metabolic process,GO:0044057~regulation of system process,GO:0045184~establishment of protein localization,GO:0050804~regulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0050877~neurological system process,GO:0051240~positive regulation of multicellular organismal process,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0051969~regulation of transmission of nerve impulse,GO:0051971~positive regulation of transmission of nerve impulse,","hsa04080:Neuroactive ligand-receptor interaction,hsa04720:Long-term potentiation,hsa04730:Long-term depression,hsa05014:Amyotrophic lateral sclerosis (ALS),",0,0
SMOC2,SPARC related modular calcium binding 2,1,0.474517504971198,0.350070687212711,0.006689874876545,0.021533719251936,0.002371995849689,0.180440880808866,0.4912676694954,2,NO,0,"GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,",0,0,0
BZW2,Basic leucine zipper and W2 domains 2,1,0.399243341661191,0.379347082700499,0.855560193289322,1,0.002437724116811,0.181643926692365,0.71503593492551,2,NO,0,0,0,0,0
IREB2,Iron-responsive element binding protein 2,1,0.113648128859315,0.594395772667206,0.999999537176577,1,0.002440849381647,0.181643926692365,0.620683328809275,2,NO,0,"GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005506~iron ion binding,GO:0030350~iron-responsive element binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,GO:0051540~metal cluster binding,GO:0005829~cytosol,GO:0006417~regulation of translation,GO:0006778~porphyrin metabolic process,GO:0006779~porphyrin biosynthetic process,GO:0006782~protoporphyrinogen IX biosynthetic process,GO:0006783~heme biosynthetic process,GO:0006873~cellular ion homeostasis,GO:0006879~cellular iron ion homeostasis,GO:0007586~digestion,GO:0009791~post-embryonic development,GO:0010608~posttranscriptional regulation of gene expression,GO:0018130~heterocycle biosynthetic process,GO:0019725~cellular homeostasis,GO:0022600~digestive system process,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0032268~regulation of cellular protein metabolic process,GO:0033013~tetrapyrrole metabolic process,GO:0033014~tetrapyrrole biosynthetic process,GO:0034101~erythrocyte homeostasis,GO:0042168~heme metabolic process,GO:0042440~pigment metabolic process,GO:0042592~homeostatic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046148~pigment biosynthetic process,GO:0046501~protoporphyrinogen IX metabolic process,GO:0048872~homeostasis of number of cells,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050892~intestinal absorption,GO:0051186~cofactor metabolic process,GO:0051188~cofactor biosynthetic process,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055072~iron ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,",0,0,0
ENAH,enabled homolog (Drosophila),1,0.116981176010963,0.593957751752409,1.55E-11,8.23E-11,0.002496386191112,0.184722005236454,0.665901328743208,2,NO,0,"GO:0046907~intracellular transport,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0016323~basolateral plasma membrane,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0030175~filopodium,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0070161~anchoring junction,GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0050699~WW domain binding,","hsa04810:Regulation of actin cytoskeleton,",0,0
NBPF1,"neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8",1,0.003769611950347,0.64908205921566,0.999998039554811,1,0.002501989792003,0.184722005236454,0.401070330214399,2,NO,0,0,0,0,0
MAPK8IP2,mitogen-activated protein kinase 8 interacting protein 2,1,0.745415986888831,0.236520976817479,1,1,0.002529103661415,0.18598869012429,0.126464302280499,2,NO,0,"GO:0000165~MAPKKK cascade,GO:0006461~protein complex assembly,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007172~signal complex assembly,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0009967~positive regulation of signal transduction,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0031098~stress-activated protein kinase signaling pathway,GO:0032872~regulation of stress-activated MAPK cascade,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0033554~cellular response to stress,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043408~regulation of MAPKKK cascade,GO:0043410~positive regulation of MAPKKK cascade,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0045767~regulation of anti-apoptosis,GO:0045768~positive regulation of anti-apoptosis,GO:0046328~regulation of JNK cascade,GO:0048584~positive regulation of response to stimulus,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070302~regulation of stress-activated protein kinase signaling pathway,GO:0070304~positive regulation of stress-activated protein kinase signaling pathway,GO:0080135~regulation of cellular response to stress,GO:0043025~cell soma,GO:0001540~beta-amyloid binding,GO:0005078~MAP-kinase scaffold activity,GO:0005198~structural molecule activity,GO:0008047~enzyme activator activity,GO:0008092~cytoskeletal protein binding,GO:0019207~kinase regulator activity,GO:0019209~kinase activator activity,GO:0019887~protein kinase regulator activity,GO:0019894~kinesin binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030159~receptor signaling complex scaffold activity,GO:0030295~protein kinase activator activity,GO:0032403~protein complex binding,GO:0032947~protein complex scaffold,","hsa04010:MAPK signaling pathway,",0,0
SEC63,SEC63 homolog (S. cerevisiae),0.406297742708815,0.173043279027597,0.558443744248658,0.952137753322275,1,0.002564544659916,0.187190549418745,0.163184794263922,2,NO,0,"GO:0006457~protein folding,GO:0006605~protein targeting,GO:0006612~protein targeting to membrane,GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070727~cellular macromolecule localization,GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031072~heat shock protein binding,GO:0051082~unfolded protein binding,",0,0,0
CCDC132,Coiled-coil domain containing 132,1,0.346386453943767,0.413900866678315,3.12E-20,2.19E-19,0.0025654896221,0.187190549418745,0.767205081052152,2,NO,0,0,0,0,0
RHBDL3,"rhomboid, veinlet-like 3 (Drosophila)",0.885042912582466,0.271476723733921,0.462781043665193,0.821653549280199,1,0.002641074686866,0.191211759984358,0.359869177067566,2,YES,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
SOS1,son of sevenless homolog 1 (Drosophila),1,0.106469573942933,0.594395772667206,0.999474254561653,1,0.002671996213526,0.192703541592505,0.38574663544861,2,NO,0,"GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0009967~positive regulation of signal transduction,GO:0010647~positive regulation of cell communication,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0035023~regulation of Rho protein signal transduction,GO:0042058~regulation of epidermal growth factor receptor signaling pathway,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0046578~regulation of Ras protein signal transduction,GO:0048011~nerve growth factor receptor signaling pathway,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0043025~cell soma,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044456~synapse part,GO:0045202~synapse,GO:0003677~DNA binding,GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005100~Rho GTPase activator activity,GO:0008047~enzyme activator activity,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04320:Dorso-ventral axis formation,hsa04510:Focal adhesion,hsa04540:Gap junction,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,",0,0
TKTL2,Transketolase-like 2,1,0.018651724385232,0.628457722964864,0.967665362347683,1,0.002715878363628,0.19511496905461,0.397105578107638,2,NO,0,"GO:0004802~transketolase activity,GO:0005509~calcium ion binding,GO:0016744~transferase activity, transferring aldehyde or ketonic groups,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa00030:Pentose phosphate pathway,",0,0
NNMT,Nicotinamide N-methyltransferase,1,1,0.011352465117564,0.999781942843082,1,0.00275087892658,0.196403370519604,0.589912673958388,2,NO,0,"GO:0008112~nicotinamide N-methyltransferase activity,GO:0008170~N-methyltransferase activity,","hsa00760:Nicotinate and nicotinamide metabolism,",0,0
LPHN3,Latrophilin 3,1,0.068033282281153,0.601943915278899,0.99618588042566,1,0.002754841430277,0.196403370519604,0.438749338216287,2,YES,0,"GO:0005529~sugar binding,GO:0030246~carbohydrate binding,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007218~neuropeptide signaling pathway,",0,0,0
MYO3A,myosin IIIA,1,0.420265180899895,0.397710777531267,0.999999999952831,1,0.002771570504777,0.19666767411064,0.359368536893406,2,YES,0,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0016310~phosphorylation,GO:0046777~protein amino acid autophosphorylation,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0050954~sensory perception of mechanical stimulus,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0015629~actin cytoskeleton,GO:0016459~myosin complex,GO:0030175~filopodium,GO:0031941~filamentous actin,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0000146~microfilament motor activity,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003779~actin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008092~cytoskeletal protein binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030898~actin-dependent ATPase activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0043531~ADP binding,GO:0060002~plus-end directed microfilament motor activity,",0,0,0
OPRM1,"Opioid receptor, mu 1",1,0.389201770142258,0.413900866678315,0.989109689946909,1,0.002779606293978,0.19666767411064,0.753967995288392,2,YES,novel,"GO:0001653~peptide receptor activity,GO:0004985~opioid receptor activity,GO:0008528~peptide receptor activity, G-protein coupled,GO:0042277~peptide binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0042383~sarcolemma,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0070161~anchoring junction,GO:0006140~regulation of nucleotide metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,GO:0007188~G-protein signaling, coupled to cAMP nucleotide second messenger,GO:0007189~activation of adenylate cyclase activity by G-protein signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007191~activation of adenylate cyclase activity by dopamine receptor signaling pathway,GO:0007193~inhibition of adenylate cyclase activity by G-protein signaling,GO:0007194~negative regulation of adenylate cyclase activity,GO:0007212~dopamine receptor signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007600~sensory perception,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0008285~negative regulation of cell proliferation,GO:0010578~regulation of adenylate cyclase activity involved in G-protein signaling,GO:0010579~positive regulation of adenylate cyclase activity by G-protein signaling pathway,GO:0019932~second-messenger-mediated signaling,GO:0019933~cAMP-mediated signaling,GO:0019935~cyclic-nucleotide-mediated signaling,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030814~regulation of cAMP metabolic process,GO:0030817~regulation of cAMP biosynthetic process,GO:0031279~regulation of cyclase activity,GO:0031280~negative regulation of cyclase activity,GO:0031281~positive regulation of cyclase activity,GO:0031635~inhibition of adenylate cyclase activity by opioid receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0045761~regulation of adenylate cyclase activity,GO:0045762~positive regulation of adenylate cyclase activity,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051339~regulation of lyase activity,GO:0051349~positive regulation of lyase activity,GO:0051350~negative regulation of lyase activity,","hsa04080:Neuroactive ligand-receptor interaction,",unknown,unknown
PPP1R9A,"Protein phosphatase 1, regulatory (inhibitor) subunit 9A",1,0.047885315347439,0.616343584684641,2.04E-10,1.02E-09,0.002884970290782,0.201073206458508,0.687371912522475,2,NO,0,"GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0019717~synaptosome,GO:0030054~cell junction,GO:0030175~filopodium,GO:0030425~dendrite,GO:0030863~cortical cytoskeleton,GO:0030864~cortical actin cytoskeleton,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044448~cell cortex part,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045202~synapse,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,",0,0,0
WDR17,WD repeat domain 17,1,0.003090229916082,0.660850491134096,0.993294464300162,1,0.002888750738137,0.201073206458508,0.292165105028623,2,NO,0,0,0,0,0
PTPRU,"Protein tyrosine phosphatase, receptor type, U",1,0.01395172132005,0.628457722964864,0.909472902540311,1,0.002895695301533,0.201073206458508,0.567948182905436,2,YES,0,"GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008013~beta-catenin binding,GO:0016791~phosphatase activity,GO:0019198~transmembrane receptor protein phosphatase activity,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005911~cell-cell junction,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway,GO:0008104~protein localization,GO:0008285~negative regulation of cell proliferation,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009890~negative regulation of biosynthetic process,GO:0010033~response to organic substance,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016055~Wnt receptor signaling pathway,GO:0016311~dephosphorylation,GO:0016337~cell-cell adhesion,GO:0016481~negative regulation of transcription,GO:0022610~biological adhesion,GO:0030334~regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0031099~regeneration,GO:0031100~organ regeneration,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031960~response to corticosteroid stimulus,GO:0034109~homotypic cell-cell adhesion,GO:0034394~protein localization at cell surface,GO:0034613~cellular protein localization,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0042127~regulation of cell proliferation,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048545~response to steroid hormone stimulus,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051270~regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0051384~response to glucocorticoid stimulus,GO:0060070~Wnt receptor signaling pathway through beta-catenin,GO:0070727~cellular macromolecule localization,",0,0,0
CADPS,Ca2+-dependent secretion activator,1,0.018495789652964,0.628457722964864,0.997991413494709,1,0.002958336886105,0.203886966587405,0.276745372222463,2,NO,0,"GO:0005509~calcium ion binding,GO:0008289~lipid binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0030054~cell junction,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0006887~exocytosis,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032940~secretion by cell,GO:0045184~establishment of protein localization,GO:0046903~secretion,",0,0,0
KRTAP4-5,Keratin associated protein 4-5,1,1,0.018809954722435,2.24E-06,9.01E-06,0.002968962734181,0.203886966587405,0.675974006542712,2,NO,0,"GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045095~keratin filament,GO:0045111~intermediate filament cytoskeleton,",0,0,0
ZBTB7A,zinc finger and BTB domain containing 7A,1,0.271476723733921,0.494768425245321,0.999999871879872,1,0.003012352002881,0.204603810487754,0.184764315649516,2,YES,0,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045637~regulation of myeloid cell differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0016564~transcription repressor activity,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0035035~histone acetyltransferase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
ZNF559,Zinc finger protein 559,1,0.634855678262747,0.306526773064196,5.53E-08,2.43E-07,0.003019915499463,0.204603810487754,0.634031801840211,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
GJB3,"Gap junction protein, beta 3, 31kDa",1,0.876560862545503,0.199113722218282,0.941734606604609,1,0.003023216001639,0.204603810487754,0.690244147353593,2,NO,0,"GO:0005243~gap junction channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022829~wide pore channel activity,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005921~gap junction,GO:0005922~connexon complex,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0044459~plasma membrane part,GO:0001701~in utero embryonic development,GO:0001890~placenta development,GO:0007398~ectoderm development,GO:0007600~sensory perception,GO:0007605~sensory perception of sound,GO:0008544~epidermis development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0043009~chordate embryonic development,GO:0043588~skin development,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050954~sensory perception of mechanical stimulus,",0,0,0
ACBD3,acyl-Coenzyme A binding domain containing 3,1,0.104977053308268,0.599319901491912,1.07E-10,5.39E-10,0.003050419247983,0.205699570877549,0.759621199197784,2,NO,0,"GO:0006694~steroid biosynthetic process,GO:0008202~steroid metabolic process,GO:0008610~lipid biosynthetic process,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,GO:0000062~acyl-CoA binding,GO:0005504~fatty acid binding,GO:0008289~lipid binding,GO:0031406~carboxylic acid binding,GO:0033293~monocarboxylic acid binding,GO:0048037~cofactor binding,GO:0050662~coenzyme binding,",0,0,0
SBNO1,Strawberry notch homolog 1 (Drosophila),0.508762855496194,0.067877849760584,0.616343584684641,0.99999786009079,1,0.003075519207975,0.206646126927238,0.386748832890032,2,YES,0,0,0,0,0
GABRA5,"Gamma-aminobutyric acid (GABA) A receptor, alpha 5",1,0.426177263688485,0.413900866678315,0.999982424453746,1,0.003204955535415,0.212578292789849,0.581176885417602,2,YES,0,"GO:0004890~GABA-A receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016917~GABA receptor activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0031404~chloride ion binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0001662~behavioral fear response,GO:0002209~behavioral defense response,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0006952~defense response,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0008306~associative learning,GO:0015698~inorganic anion transport,GO:0019226~transmission of nerve impulse,GO:0033555~multicellular organismal response to stress,GO:0042596~fear response,GO:0050877~neurological system process,GO:0050890~cognition,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
ZNF878,Zinc Finger Protein 878,1,0.75656219934849,0.265534467625041,9.84E-09,4.48E-08,0.00322165587228,0.212578292789849,0.689168455220913,2,NO,0,0,0,0,0
SCN3A,"Sodium channel, voltage-gated, type III, alpha subunit",1,0.02903220135353,0.620539289527082,0.998178253540049,1,0.0032403615013,0.212578292789849,0.53533386618028,2,YES,0,"GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005248~voltage-gated sodium channel activity,GO:0005261~cation channel activity,GO:0005272~sodium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0000267~cell fraction,GO:0001518~voltage-gated sodium channel complex,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034706~sodium channel complex,GO:0044459~plasma membrane part,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,",0,0,0
GABRA2,"Gamma-aminobutyric acid (GABA) A receptor, alpha 2",1,0.085263045669954,0.601943915278899,0.999944747844323,1,0.003254852601204,0.212578292789849,0.576652162819458,2,YES,0,"GO:0004890~GABA-A receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008503~benzodiazepine receptor activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016917~GABA receptor activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0031404~chloride ion binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030054~cell junction,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0030285~integral to synaptic vesicle membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030665~clathrin coated vesicle membrane,GO:0030672~synaptic vesicle membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031300~intrinsic to organelle membrane,GO:0031301~integral to organelle membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0044433~cytoplasmic vesicle part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0001505~regulation of neurotransmitter levels,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0006836~neurotransmitter transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0015698~inorganic anion transport,GO:0019226~transmission of nerve impulse,GO:0050877~neurological system process,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
CIZ1,CDKN1A interacting zinc finger protein 1,1,0.09830923561382,0.601943915278899,0.999999876349911,1,0.003285489694256,0.213831574909434,0.332808881597394,2,NO,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
SHB,Src homology 2 domain containing adaptor protein B,0.973873644480704,0.505087244311173,0.372574147431736,0.999990898224159,1,0.003315536999802,0.214307501215881,0.561755102531907,2,NO,0,"GO:0005070~SH3/SH2 adaptor activity,GO:0030674~protein binding, bridging,GO:0060090~molecular adaptor activity,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001775~cell activation,GO:0001944~vasculature development,GO:0006915~apoptosis,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0012501~programmed cell death,GO:0016265~death,GO:0032943~mononuclear cell proliferation,GO:0042100~B cell proliferation,GO:0042113~B cell activation,GO:0045321~leukocyte activation,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0048514~blood vessel morphogenesis,GO:0070661~leukocyte proliferation,",0,0,0
COL9A1,"collagen, type IX, alpha 1",1,0.075665565885936,0.616343584684641,0.999999964433652,1,0.003327959960214,0.214307501215881,0.298682146101511,2,NO,0,"GO:0001501~skeletal system development,GO:0001894~tissue homeostasis,GO:0002062~chondrocyte differentiation,GO:0006811~ion transport,GO:0006817~phosphate transport,GO:0006820~anion transport,GO:0007155~cell adhesion,GO:0015698~inorganic anion transport,GO:0022610~biological adhesion,GO:0042592~homeostatic process,GO:0048871~multicellular organismal homeostasis,GO:0051216~cartilage development,GO:0060249~anatomical structure homeostasis,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005593~FACIT collagen,GO:0005594~collagen type IX,GO:0030934~anchoring collagen,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0008270~zinc ion binding,GO:0030020~extracellular matrix structural constituent conferring tensile strength,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
TES,Testis derived transcript (3 LIM domains),1,0.621617423105817,0.332676355469261,0.0026568810076,0.008760437836004,0.003334131207658,0.214307501215881,0.778808284058921,2,NO,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0016323~basolateral plasma membrane,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,",0,0,0
TBX15,T-box 15,1,0.007617013308157,0.64908205921566,0.150356048334717,0.426888680170874,0.003338694943724,0.214307501215881,0.645914780073808,2,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0001501~skeletal system development,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0009792~embryonic development ending in birth or egg hatching,GO:0043009~chordate embryonic development,GO:0045449~regulation of transcription,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0051252~regulation of RNA metabolic process,",0,0,0
TRPC6,"transient receptor potential cation channel, subfamily C, member 6",1,0.003831369856755,0.660850491134096,2.21E-31,2.10E-30,0.003369101259009,0.215518638414454,0.260329385531259,2,YES,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0015674~di-, tri-valent inorganic cation transport,GO:0019725~cellular homeostasis,GO:0030001~metal ion transport,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0042592~homeostatic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0051480~cytosolic calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0055085~transmembrane transport,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
ZNF263,Zinc finger protein 263,1,1,0.114326682956047,0.995252758197217,1,0.003393033845885,0.216308802755243,0.640160313870907,2,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
CEP128,centrosomal protein 128kDa,0.399767929243017,0.365094295850086,0.450810211687543,1,1,0.003422768616157,0.217234165964691,0.254777062516477,2,NO,0,"centriole, spindle pole",0,0,0
ADRBK2,"Adrenergic, beta, receptor kinase 2",1,0.227591325759547,0.559248062668889,0.999999999986374,1,0.003442438734705,0.217234165964691,0.575166931607316,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004703~G-protein coupled receptor kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0047696~beta-adrenergic receptor kinase activity,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,","hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa04740:Olfactory transduction,",0,0
GTPBP1,GTP binding protein 1,1,0.173043279027597,0.594395772667206,0.994689391394251,1,0.003534685239991,0.220817343136434,0.53947592433283,2,YES,0,"GO:0006955~immune response,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,",0,0,0
FHL3,four and a half LIM domains 3,1,0.621617423105817,0.332676355469261,2.10E-28,1.83E-27,0.003555170951276,0.221356793996301,0.717127815502487,2,NO,0,"GO:0007010~cytoskeleton organization,GO:0007517~muscle organ development,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0001725~stress fiber,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0030018~Z disc,GO:0031674~I band,GO:0032432~actin filament bundle,GO:0042641~actomyosin,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043292~contractile fiber,GO:0044430~cytoskeletal part,GO:0044449~contractile fiber part,GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
OSBPL6,oxysterol binding protein-like 6,1,0.039799049956731,0.620539289527082,0.021318255361808,0.065753581886265,0.003573978813974,0.221788539090428,0.589928756694142,2,NO,0,"GO:0006869~lipid transport,GO:0008202~steroid metabolic process,GO:0010876~lipid localization,",0,0,0
NALCN,"Sodium leak channel, non-selective",1,0.07591503469536,0.616343584684641,0.198824951957039,0.556132266787291,0.003588172170649,0.221861879869688,0.697285230937841,2,YES,0,"GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005261~cation channel activity,GO:0005272~sodium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,",0,0,0
KRTAP5-5,Keratin associated protein 5-5,1,1,0.016118909490698,0.999998252840932,1,0.003598915873468,0.221861879869688,0.695460043149194,2,NO,0,"GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045095~keratin filament,GO:0045111~intermediate filament cytoskeleton,",0,0,0
VIM,vimentin,1,0.227591325759547,0.56767625725793,0.999742079382041,1,0.003672694364196,0.223633686886559,0.380478828373621,2,NO,0,"GO:0006928~cell motion,GO:0045103~intermediate filament-based process,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0005886~plasma membrane,GO:0030424~axon,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045111~intermediate filament cytoskeleton,GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0008022~protein C-terminus binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,",0,0,0
STIL,SCL/TAL1 interrupting locus,0.616319820598673,0.525159447973644,0.379347082700499,0.884444156546539,1,0.003691575050165,0.223633686886559,0.424476788969807,2,NO,0,"GO:0005829~cytosol,GO:0008283~cell proliferation,",0,0,0
CACNA1H,"Calcium channel, voltage-dependent, T type, alpha 1H subunit",0.846120936133285,0.064071265741545,0.616343584684641,0.999999999999995,1,0.003699491902562,0.223633686886559,0.507316774979284,2,YES,0,"GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005245~voltage-gated calcium channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0008332~low voltage-gated calcium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0016021~integral to membrane,GO:0030425~dendrite,GO:0031224~intrinsic to membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034704~calcium channel complex,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043204~perikaryon,GO:0044459~plasma membrane part,GO:0000768~syncytium formation by plasma membrane fusion,GO:0003012~muscle system process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006936~muscle contraction,GO:0006949~syncytium formation,GO:0007517~muscle organ development,GO:0007520~myoblast fusion,GO:0008016~regulation of heart contraction,GO:0014902~myotube differentiation,GO:0015674~di-, tri-valent inorganic cation transport,GO:0030001~metal ion transport,GO:0042692~muscle cell differentiation,GO:0044057~regulation of system process,GO:0051146~striated muscle cell differentiation,GO:0055085~transmembrane transport,","hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,",0,0
GLRA3,"Glycine receptor, alpha 3",1,0.271476723733921,0.532650659483048,0.999785490121304,1,0.00372503666652,0.224109407690016,0.387088770709354,2,YES,0,"GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016594~glycine binding,GO:0016597~amino acid binding,GO:0016933~extracellular-glycine-gated ion channel activity,GO:0016934~extracellular-glycine-gated chloride channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0031404~chloride ion binding,GO:0031406~carboxylic acid binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0043176~amine binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0016935~glycine-gated chloride channel complex,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0015698~inorganic anion transport,GO:0019226~transmission of nerve impulse,GO:0050877~neurological system process,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
NDUFA9,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa",1,0.342096927505986,0.494522794312359,2.31E-06,9.29E-06,0.00382042689307,0.226288851579065,0.779028692682919,2,NO,0,"GO:0003954~NADH dehydrogenase activity,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0016651~oxidoreductase activity, acting on NADH or NADPH,GO:0016655~oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor,GO:0048037~cofactor binding,GO:0050136~NADH dehydrogenase (quinone) activity,GO:0050662~coenzyme binding,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0005747~mitochondrial respiratory chain complex I,GO:0005759~mitochondrial matrix,GO:0019866~organelle inner membrane,GO:0030964~NADH dehydrogenase complex,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0044455~mitochondrial membrane part,GO:0045271~respiratory chain complex I,GO:0070013~intracellular organelle lumen,GO:0070469~respiratory chain,GO:0006091~generation of precursor metabolites and energy,GO:0006119~oxidative phosphorylation,GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016310~phosphorylation,GO:0022900~electron transport chain,GO:0022904~respiratory electron transport chain,GO:0030001~metal ion transport,GO:0042773~ATP synthesis coupled electron transport,GO:0042775~mitochondrial ATP synthesis coupled electron transport,GO:0045333~cellular respiration,GO:0055114~oxidation reduction,","hsa00190:Oxidative phosphorylation,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,",0,0
AHCYL2,adenosylhomocysteinase-like 2,1,0.08825557681226,0.616343584684641,6.17E-06,2.43E-05,0.003828217629369,0.226288851579065,0.443107376366815,2,NO,0,"GO:0006730~one-carbon metabolic process,GO:0004013~adenosylhomocysteinase activity,GO:0016801~hydrolase activity, acting on ether bonds,GO:0016802~trialkylsulfonium hydrolase activity,","hsa00270:Cysteine and methionine metabolism,hsa00450:Selenoamino acid metabolism,",0,0
ZNF442,"Interferon, alpha 10",1,1,0.062232251406431,4.34E-06,1.73E-05,0.003849233155691,0.226813331593568,0.791308491353903,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
GPC6,glypican 6,1,0.053281993127228,0.620539289527082,1.43E-16,9.06E-16,0.00389388362897,0.228722805992251,0.675417683280568,2,YES,0,"GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031012~extracellular matrix,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0001948~glycoprotein binding,GO:0043394~proteoglycan binding,GO:0043395~heparan sulfate proteoglycan binding,",0,0,0
FAM154B,"family with sequence similarity 154, member B",1,0.922946820691503,0.203754414082233,0.999159109954083,1,0.003920176515727,0.229359101303394,0.747482044282704,2,NO,0,0,0,0,0
SPACA3,sperm acrosome associated 3,1,0.505087244311173,0.402080599844732,8.01E-10,3.84E-09,0.003934695049331,0.229359101303394,0.527353505199474,2,YES,0,"GO:0000270~peptidoglycan metabolic process,GO:0000272~polysaccharide catabolic process,GO:0001775~cell activation,GO:0002274~myeloid leukocyte activation,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0005976~polysaccharide metabolic process,GO:0006022~aminoglycan metabolic process,GO:0006026~aminoglycan catabolic process,GO:0006027~glycosaminoglycan catabolic process,GO:0006952~defense response,GO:0009057~macromolecule catabolic process,GO:0009253~peptidoglycan catabolic process,GO:0009615~response to virus,GO:0009617~response to bacterium,GO:0016052~carbohydrate catabolic process,GO:0016998~cell wall macromolecule catabolic process,GO:0030100~regulation of endocytosis,GO:0030203~glycosaminoglycan metabolic process,GO:0042117~monocyte activation,GO:0042742~defense response to bacterium,GO:0043030~regulation of macrophage activation,GO:0043032~positive regulation of macrophage activation,GO:0044036~cell wall macromolecule metabolic process,GO:0045321~leukocyte activation,GO:0045807~positive regulation of endocytosis,GO:0050764~regulation of phagocytosis,GO:0050766~positive regulation of phagocytosis,GO:0050830~defense response to Gram-positive bacterium,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0051050~positive regulation of transport,GO:0051130~positive regulation of cellular component organization,GO:0060627~regulation of vesicle-mediated transport,GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005764~lysosome,GO:0005773~vacuole,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0003796~lysozyme activity,GO:0008367~bacterial binding,",0,0,0
PGS1,phosphatidylglycerophosphate synthase 1,1,0.342096927505986,0.494768425245321,6.67E-24,5.22E-23,0.003945251405268,0.229359101303394,0.70861716324719,2,NO,0,"GO:0006644~phospholipid metabolic process,GO:0008610~lipid biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0019637~organophosphate metabolic process,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0008444~CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,GO:0016780~phosphotransferase activity, for other substituted phosphate groups,GO:0017076~purine nucleotide binding,GO:0017169~CDP-alcohol phosphatidyltransferase activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa00564:Glycerophospholipid metabolism,",0,0
RGS7,Regulator of G-protein signaling 7,1,0.030324001619147,0.628457722964864,1.67E-24,1.33E-23,0.003953832144103,0.229359101303394,0.751289360521242,2,YES,0,"GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0044459~plasma membrane part,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007242~intracellular signaling cascade,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,",0,0,0
TRIO,triple functional domain (PTPRF interacting),1,0.001227926277335,0.688986797626025,3.46E-30,3.13E-29,0.004052222849094,0.233036105475516,0.779825200323439,2,YES,0,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0016310~phosphorylation,GO:0035023~regulation of Rho protein signal transduction,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0005829~cytosol,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030695~GTPase regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0060589~nucleoside-triphosphatase regulator activity,",0,0,0
PAN3,PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae),0.551173273446675,0.271476723733921,0.550950106307244,6.59E-12,3.54E-11,0.004063402621604,0.233036105475516,0.279215863259949,2,NO,0,"GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0009057~macromolecule catabolic process,GO:0016071~mRNA metabolic process,GO:0016310~phosphorylation,GO:0044265~cellular macromolecule catabolic process,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",0,0,0
PPT2,palmitoyl-protein thioesterase 2,1,0.621617423105817,0.352752213519394,0.999999961463688,1,0.00407959775633,0.233036105475516,0.470754818438662,2,YES,0,"GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005773~vacuole,GO:0005783~endoplasmic reticulum,GO:0008474~palmitoyl-(protein) hydrolase activity,GO:0016790~thiolester hydrolase activity,","hsa00062:Fatty acid elongation in mitochondria,hsa04142:Lysosome,",0,0
RBPJL,recombination signal binding protein for immunoglobulin kappa J region-like,1,0.342096927505986,0.5043282941208,5.54E-06,2.19E-05,0.004222677904992,0.237625188884391,0.736981176908052,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,","hsa04330:Notch signaling pathway,",0,0
SORCS1,sortilin-related VPS10 domain containing receptor 1,1,0.0164842059265,0.641447788305282,0.995423788681991,1,0.004223543161284,0.237625188884391,0.209708239075169,2,NO,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0001653~peptide receptor activity,GO:0008188~neuropeptide receptor activity,GO:0008528~peptide receptor activity, G-protein coupled,GO:0030594~neurotransmitter receptor activity,GO:0042165~neurotransmitter binding,GO:0042277~peptide binding,GO:0042923~neuropeptide binding,",0,0,0
DCT,"Dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2)",0.70019662646369,0.678621428843043,0.348597916806823,0.094194312462718,0.273037796786329,0.004329935280774,0.242152278771183,0.676353164614972,2,NO,0,"GO:0004167~dopachrome isomerase activity,GO:0005507~copper ion binding,GO:0008270~zinc ion binding,GO:0016860~intramolecular oxidoreductase activity,GO:0016863~intramolecular oxidoreductase activity, transposing C=C bonds,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005792~microsome,GO:0005829~cytosol,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042470~melanosome,GO:0042598~vesicular fraction,GO:0048770~pigment granule,GO:0006570~tyrosine metabolic process,GO:0006582~melanin metabolic process,GO:0006583~melanin biosynthetic process from tyrosine,GO:0007398~ectoderm development,GO:0008544~epidermis development,GO:0009072~aromatic amino acid family metabolic process,GO:0019748~secondary metabolic process,GO:0042438~melanin biosynthetic process,GO:0042440~pigment metabolic process,GO:0043473~pigmentation,GO:0046148~pigment biosynthetic process,GO:0048066~pigmentation during development,","hsa00350:Tyrosine metabolism,hsa04916:Melanogenesis,",0,0
GABRB1,"gamma-aminobutyric acid (GABA) A receptor, beta 1",1,0.111485759309418,0.616343584684641,0.99285081841847,1,0.004389708982451,0.244762310696128,0.449503851670236,2,YES,0,"GO:0006811~ion transport,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0004890~GABA-A receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016917~GABA receptor activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0031404~chloride ion binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043168~anion binding,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
FGD6,"FYVE, RhoGEF and PH domain containing 6",1,0.111721095746119,0.616343584684641,0.999999949273477,1,0.004439624371773,0.246808760834379,0.479531767073749,2,NO,0,"GO:0007010~cytoskeleton organization,GO:0008360~regulation of cell shape,GO:0022604~regulation of cell morphogenesis,GO:0030029~actin filament-based process,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0030035~microspike assembly,GO:0030036~actin cytoskeleton organization,GO:0032318~regulation of Ras GTPase activity,GO:0032319~regulation of Rho GTPase activity,GO:0032489~regulation of Cdc42 protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0043087~regulation of GTPase activity,GO:0043088~regulation of Cdc42 GTPase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0046847~filopodium assembly,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0001726~ruffle,GO:0005794~Golgi apparatus,GO:0005856~cytoskeleton,GO:0030027~lamellipodium,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0031267~small GTPase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,",0,0,0
COL11A1,"collagen, type XI, alpha 1",0.930929953899773,0.002295967200538,0.679130630618955,0.999948365683259,1,0.004459371885519,0.247170941986962,0.211923097888035,2,NO,0,"GO:0001501~skeletal system development,GO:0001502~cartilage condensation,GO:0002062~chondrocyte differentiation,GO:0002063~chondrocyte development,GO:0003007~heart morphogenesis,GO:0006029~proteoglycan metabolic process,GO:0007155~cell adhesion,GO:0007423~sensory organ development,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0007605~sensory perception of sound,GO:0009100~glycoprotein metabolic process,GO:0009581~detection of external stimulus,GO:0009582~detection of abiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0009628~response to abiotic stimulus,GO:0009792~embryonic development ending in birth or egg hatching,GO:0014706~striated muscle tissue development,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0042471~ear morphogenesis,GO:0042472~inner ear morphogenesis,GO:0043009~chordate embryonic development,GO:0043062~extracellular structure organization,GO:0043583~ear development,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048729~tissue morphogenesis,GO:0048738~cardiac muscle tissue development,GO:0048839~inner ear development,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050906~detection of stimulus involved in sensory perception,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0050953~sensory perception of light stimulus,GO:0050954~sensory perception of mechanical stimulus,GO:0050974~detection of mechanical stimulus involved in sensory perception,GO:0050982~detection of mechanical stimulus,GO:0051216~cartilage development,GO:0051606~detection of stimulus,GO:0055008~cardiac muscle tissue morphogenesis,GO:0055010~ventricular cardiac muscle morphogenesis,GO:0060415~muscle tissue morphogenesis,GO:0060537~muscle tissue development,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005583~fibrillar collagen,GO:0005592~collagen type XI,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0030674~protein binding, bridging,GO:0050840~extracellular matrix binding,","hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,",0,0
SH3GLB2,SH3-domain GRB2-like endophilin B2,1,1,0.108469860173985,0.999999997946188,1,0.004493011377045,0.247696788170835,0.689914170311253,2,NO,0,"GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,","hsa04144:Endocytosis,",0,0
SEL1L,Sel-1 suppressor of lin-12-like (C. elegans),0.900580773373732,0.071749565120695,0.620539289527082,1,1,0.004503521356859,0.247696788170835,0.343854404090301,2,NO,0,"GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,",0,0,0
DYNC1LI2,"dynein, cytoplasmic 1, light intermediate chain 2",0.818900729050157,0.337244195918755,0.532650659483048,1,1,0.004640087840075,0.251001589807387,0.176509364881667,2,NO,0,"GO:0005856~cytoskeleton,GO:0005868~cytoplasmic dynein complex,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0015630~microtubule cytoskeleton,GO:0030286~dynein complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",0,0,0
SAMSN1,"SAM domain, SH3 domain and nuclear localization signals 1",1,1,0.152213604103976,0.980602018753408,1,0.004658519619879,0.251001589807387,0.726272316173421,2,NO,0,"GO:0001784~phosphotyrosine binding,GO:0045309~protein phosphorylated amino acid binding,GO:0051219~phosphoprotein binding,",0,0,0
ODF4,outer dense fiber of sperm tails 4,1,1,0.010540121677388,0.999999999993678,1,0.004662859449819,0.251001589807387,0.552227221375369,2,NO,0,"GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0001520~outer dense fiber,GO:0005930~axoneme,GO:0009434~microtubule-based flagellum,GO:0016021~integral to membrane,GO:0019861~flagellum,GO:0031224~intrinsic to membrane,GO:0042995~cell projection,GO:0044447~axoneme part,GO:0044463~cell projection part,",0,0,0
HTRA3,HtrA serine peptidase 3,1,1,0.141117991752881,0.999480508145592,1,0.004682075513546,0.251311748613571,0.643495955159036,2,NO,0,"GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005520~insulin-like growth factor binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0019838~growth factor binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0005576~extracellular region,GO:0001558~regulation of cell growth,GO:0006508~proteolysis,GO:0040008~regulation of growth,",0,0,0
CEP135,Centrosomal protein 135kDa,1,0.227591325759547,0.594395772667206,1.99E-14,1.18E-13,0.00470293851607,0.251577990175547,0.557153787260376,2,NO,0,"GO:0008022~protein C-terminus binding,GO:0005813~centrosome,GO:0005814~centriole,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044450~microtubule organizing center part,GO:0000226~microtubule cytoskeleton organization,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007098~centrosome cycle,GO:0007099~centriole replication,GO:0010457~centriole-centriole cohesion,GO:0022402~cell cycle process,GO:0031023~microtubule organizing center organization,GO:0051297~centrosome organization,GO:0051298~centrosome duplication,",0,0,0
FBXO22,FBXO22 opposite strand (non-protein coding); F-box protein 22,1,0.621617423105817,0.379347082700499,0.707881781839456,1,0.004779299416282,0.252182298860806,0.534225202967843,2,YES,0,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0004842~ubiquitin-protein ligase activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,",0,0,0
HS3ST2,Heparan sulfate (glucosamine) 3-O-sulfotransferase 2,1,0.540324378122553,0.416074321122201,0.999999532597955,1,0.004825770552456,0.253388194035688,0.667293584296414,2,NO,0,"GO:0008146~sulfotransferase activity,GO:0016782~transferase activity, transferring sulfur-containing groups,GO:0033871~[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,GO:0034483~heparan sulfate sulfotransferase activity,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0007623~circadian rhythm,GO:0048511~rhythmic process,","hsa00534:Heparan sulfate biosynthesis,",0,0
ETV1,ets variant 1,1,0.783828753636386,0.311372455782488,0.476875465207155,1,0.004829284066422,0.253388194035688,0.736865899664505,2,NO,0,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",0,0,0
BCL2,B-cell CLL/lymphoma 2,1,1,0.021182999691308,0.999999999968849,1,0.004860690546636,0.254321677088544,0.708511140200088,2,NO,0,"GO:0002020~protease binding,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0051400~BH domain binding,GO:0051434~BH3 domain binding,GO:0070513~death domain binding,GO:0000159~protein phosphatase type 2A complex,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005635~nuclear envelope,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005792~microsome,GO:0005829~cytosol,GO:0005955~calcineurin complex,GO:0008287~protein serine/threonine phosphatase complex,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0019867~outer membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031965~nuclear membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0042598~vesicular fraction,GO:0043209~myelin sheath,GO:0044429~mitochondrial part,GO:0044432~endoplasmic reticulum part,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000302~response to reactive oxygen species,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001101~response to acid,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001541~ovarian follicle development,GO:0001558~regulation of cell growth,GO:0001655~urogenital system development,GO:0001656~metanephros development,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001662~behavioral fear response,GO:0001666~response to hypoxia,GO:0001763~morphogenesis of a branching structure,GO:0001775~cell activation,GO:0001776~leukocyte homeostasis,GO:0001782~B cell homeostasis,GO:0001822~kidney development,GO:0001836~release of cytochrome c from mitochondria,GO:0001894~tissue homeostasis,GO:0001932~regulation of protein amino acid phosphorylation,GO:0001934~positive regulation of protein amino acid phosphorylation,GO:0001942~hair follicle development,GO:0001952~regulation of cell-matrix adhesion,GO:0002009~morphogenesis of an epithelium,GO:0002209~behavioral defense response,GO:0002244~hemopoietic progenitor cell differentiation,GO:0002252~immune effector process,GO:0002260~lymphocyte homeostasis,GO:0002320~lymphoid progenitor cell differentiation,GO:0002326~B cell lineage commitment,GO:0002360~T cell lineage commitment,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0003006~reproductive developmental process,GO:0003014~renal system process,GO:0006468~protein amino acid phosphorylation,GO:0006470~protein amino acid dephosphorylation,GO:0006582~melanin metabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0006808~regulation of nitrogen utilization,GO:0006839~mitochondrial transport,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0006952~defense response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0007006~mitochondrial membrane organization,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007044~cell-substrate junction assembly,GO:0007049~cell cycle,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007292~female gamete generation,GO:0007346~regulation of mitotic cell cycle,GO:0007398~ectoderm development,GO:0007409~axonogenesis,GO:0007423~sensory organ development,GO:0007548~sex differentiation,GO:0007565~female pregnancy,GO:0007568~aging,GO:0007569~cell aging,GO:0007584~response to nutrient,GO:0007610~behavior,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0008406~gonad development,GO:0008544~epidermis development,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0008633~activation of pro-apoptotic gene products,GO:0008637~apoptotic mitochondrial changes,GO:0009266~response to temperature stimulus,GO:0009314~response to radiation,GO:0009408~response to heat,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009611~response to wounding,GO:0009615~response to virus,GO:0009628~response to abiotic stimulus,GO:0009636~response to toxin,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009791~post-embryonic development,GO:0009991~response to extracellular stimulus,GO:0009994~oocyte differentiation,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010039~response to iron ion,GO:0010044~response to aluminum ion,GO:0010212~response to ionizing radiation,GO:0010224~response to UV-B,GO:0010332~response to gamma radiation,GO:0010522~regulation of calcium ion transport into cytosol,GO:0010523~negative regulation of calcium ion transport into cytosol,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010720~positive regulation of cell development,GO:0010810~regulation of cell-substrate adhesion,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010959~regulation of metal ion transport,GO:0012501~programmed cell death,GO:0014031~mesenchymal cell development,GO:0014041~regulation of neuron maturation,GO:0014042~positive regulation of neuron maturation,GO:0014070~response to organic cyclic substance,GO:0014074~response to purine,GO:0014910~regulation of smooth muscle cell migration,GO:0014911~positive regulation of smooth muscle cell migration,GO:0016044~membrane organization,GO:0016049~cell growth,GO:0016050~vesicle organization,GO:0016202~regulation of striated muscle tissue development,GO:0016265~death,GO:0016310~phosphorylation,GO:0016311~dephosphorylation,GO:0016337~cell-cell adhesion,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0018209~peptidyl-serine modification,GO:0018210~peptidyl-threonine modification,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0019748~secondary metabolic process,GO:0019953~sexual reproduction,GO:0021548~pons development,GO:0021747~cochlear nucleus development,GO:0022037~metencephalon development,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0022404~molting cycle process,GO:0022405~hair cycle process,GO:0022602~ovulation cycle process,GO:0022610~biological adhesion,GO:0022612~gland morphogenesis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030029~actin filament-based process,GO:0030030~cell projection organization,GO:0030036~actin cytoskeleton organization,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030155~regulation of cell adhesion,GO:0030182~neuron differentiation,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0030278~regulation of ossification,GO:0030279~negative regulation of ossification,GO:0030308~negative regulation of cell growth,GO:0030318~melanocyte differentiation,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0030902~hindbrain development,GO:0031000~response to caffeine,GO:0031069~hair follicle morphogenesis,GO:0031099~regeneration,GO:0031102~neuron projection regeneration,GO:0031103~axon regeneration,GO:0031175~neuron projection development,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0031589~cell-substrate adhesion,GO:0031647~regulation of protein stability,GO:0031667~response to nutrient levels,GO:0031960~response to corticosteroid stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032504~multicellular organism reproduction,GO:0032535~regulation of cellular component size,GO:0032835~glomerulus development,GO:0032844~regulation of homeostatic process,GO:0032845~negative regulation of homeostatic process,GO:0032847~regulation of cellular pH reduction,GO:0032848~negative regulation of cellular pH reduction,GO:0032880~regulation of protein localization,GO:0032943~mononuclear cell proliferation,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033032~regulation of myeloid cell apoptosis,GO:0033033~negative regulation of myeloid cell apoptosis,GO:0033059~cellular pigmentation,GO:0033077~T cell differentiation in the thymus,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033273~response to vitamin,GO:0033554~cellular response to stress,GO:0033555~multicellular organismal response to stress,GO:0033688~regulation of osteoblast proliferation,GO:0033689~negative regulation of osteoblast proliferation,GO:0034097~response to cytokine stimulus,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0035094~response to nicotine,GO:0035239~tube morphogenesis,GO:0035265~organ growth,GO:0035295~tube development,GO:0040007~growth,GO:0040008~regulation of growth,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0040014~regulation of multicellular organism growth,GO:0040017~positive regulation of locomotion,GO:0040018~positive regulation of multicellular organism growth,GO:0042100~B cell proliferation,GO:0042110~T cell activation,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0042303~molting cycle,GO:0042325~regulation of phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0042391~regulation of membrane potential,GO:0042440~pigment metabolic process,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0042592~homeostatic process,GO:0042596~fear response,GO:0042633~hair cycle,GO:0042698~ovulation cycle,GO:0042981~regulation of apoptosis,GO:0043029~T cell homeostasis,GO:0043065~positive regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043269~regulation of ion transport,GO:0043271~negative regulation of ion transport,GO:0043279~response to alkaloid,GO:0043368~positive T cell selection,GO:0043369~CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,GO:0043374~CD8-positive, alpha-beta T cell differentiation,GO:0043375~CD8-positive, alpha-beta T cell lineage commitment,GO:0043393~regulation of protein binding,GO:0043434~response to peptide hormone stimulus,GO:0043473~pigmentation,GO:0043496~regulation of protein homodimerization activity,GO:0043497~regulation of protein heterodimerization activity,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0043583~ear development,GO:0043627~response to estrogen stimulus,GO:0044093~positive regulation of molecular function,GO:0045058~T cell selection,GO:0045069~regulation of viral genome replication,GO:0045137~development of primary sexual characteristics,GO:0045165~cell fate commitment,GO:0045321~leukocyte activation,GO:0045471~response to ethanol,GO:0045597~positive regulation of cell differentiation,GO:0045634~regulation of melanocyte differentiation,GO:0045636~positive regulation of melanocyte differentiation,GO:0045664~regulation of neuron differentiation,GO:0045786~negative regulation of cell cycle,GO:0045792~negative regulation of cell size,GO:0045844~positive regulation of striated muscle development,GO:0045926~negative regulation of growth,GO:0045927~positive regulation of growth,GO:0045930~negative regulation of mitotic cell cycle,GO:0045937~positive regulation of phosphate metabolic process,GO:0046545~development of primary female sexual characteristics,GO:0046546~development of primary male sexual characteristics,GO:0046631~alpha-beta T cell activation,GO:0046632~alpha-beta T cell differentiation,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0046660~female sex differentiation,GO:0046661~male sex differentiation,GO:0046668~regulation of retinal cell programmed cell death,GO:0046671~negative regulation of retinal cell programmed cell death,GO:0046688~response to copper ion,GO:0046902~regulation of mitochondrial membrane permeability,GO:0046907~intracellular transport,GO:0048041~focal adhesion formation,GO:0048066~pigmentation during development,GO:0048070~regulation of pigmentation during development,GO:0048087~positive regulation of pigmentation during development,GO:0048477~oogenesis,GO:0048511~rhythmic process,GO:0048534~hemopoietic or lymphoid organ development,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048545~response to steroid hormone stimulus,GO:0048546~digestive tract morphogenesis,GO:0048547~gut morphogenesis,GO:0048565~gut development,GO:0048589~developmental growth,GO:0048599~oocyte development,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0048634~regulation of muscle development,GO:0048636~positive regulation of muscle development,GO:0048641~regulation of skeletal muscle tissue development,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048678~response to axon injury,GO:0048729~tissue morphogenesis,GO:0048730~epidermis morphogenesis,GO:0048732~gland development,GO:0048742~regulation of skeletal muscle fiber development,GO:0048743~positive regulation of skeletal muscle fiber development,GO:0048753~pigment granule organization,GO:0048754~branching morphogenesis of a tube,GO:0048762~mesenchymal cell differentiation,GO:0048812~neuron projection morphogenesis,GO:0048857~neural nucleus development,GO:0048858~cell projection morphogenesis,GO:0048871~multicellular organismal homeostasis,GO:0048872~homeostasis of number of cells,GO:0048873~homeostasis of number of cells within a tissue,GO:0048878~chemical homeostasis,GO:0050767~regulation of neurogenesis,GO:0050792~regulation of viral reproduction,GO:0050801~ion homeostasis,GO:0050931~pigment cell differentiation,GO:0050932~regulation of pigment cell differentiation,GO:0050942~positive regulation of pigment cell differentiation,GO:0051051~negative regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051098~regulation of binding,GO:0051147~regulation of muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051174~regulation of phosphorus metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051247~positive regulation of protein metabolic process,GO:0051270~regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051384~response to glucocorticoid stimulus,GO:0051385~response to mineralocorticoid stimulus,GO:0051402~neuron apoptosis,GO:0051412~response to corticosterone stimulus,GO:0051593~response to folic acid,GO:0051607~defense response to virus,GO:0051726~regulation of cell cycle,GO:0051789~response to protein stimulus,GO:0051881~regulation of mitochondrial membrane potential,GO:0051899~membrane depolarization,GO:0051900~regulation of mitochondrial depolarization,GO:0051902~negative regulation of mitochondrial depolarization,GO:0051924~regulation of calcium ion transport,GO:0051926~negative regulation of calcium ion transport,GO:0051960~regulation of nervous system development,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0055123~digestive system development,GO:0060249~anatomical structure homeostasis,GO:0060284~regulation of cell development,GO:0060348~bone development,GO:0060429~epithelium development,GO:0060485~mesenchyme development,GO:0060548~negative regulation of cell death,GO:0060562~epithelial tube morphogenesis,GO:0060675~ureteric bud morphogenesis,GO:0070059~apoptosis in response to endoplasmic reticulum stress,GO:0070482~response to oxygen levels,GO:0070661~leukocyte proliferation,","hsa04210:Apoptosis,hsa04510:Focal adhesion,hsa04722:Neurotrophin signaling pathway,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05215:Prostate cancer,hsa05222:Small cell lung cancer,",0,0
TJP2,tight junction protein 2 (zona occludens 2),1,0.030324001619147,0.641447788305282,0.999989388377194,1,0.004933535701626,0.25727471531282,0.129125430186961,2,YES,0,"GO:0010033~response to organic substance,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005923~tight junction,GO:0009898~internal side of plasma membrane,GO:0016327~apicolateral plasma membrane,GO:0030054~cell junction,GO:0043296~apical junction complex,GO:0044459~plasma membrane part,GO:0070160~occluding junction,GO:0070161~anchoring junction,GO:0004385~guanylate kinase activity,GO:0008022~protein C-terminus binding,GO:0016776~phosphotransferase activity, phosphate group as acceptor,GO:0019201~nucleotide kinase activity,GO:0019205~nucleobase, nucleoside, nucleotide kinase activity,","hsa04530:Tight junction,hsa05110:Vibrio cholerae infection,",0,0
PCBP1,Poly(rC) binding protein 1,1,0.745415986888831,0.338946430598086,3.34E-11,1.74E-10,0.004944677059655,0.25727471531282,0.718849999824342,2,NO,0,"GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0043566~structure-specific DNA binding,GO:0030529~ribonucleoprotein complex,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,","hsa03040:Spliceosome,",0,0
TECTB,Tectorin beta,1,1,0.129153533446405,0.999979911825602,1,0.004999629394916,0.258228484650469,0.581372788698991,2,NO,0,"GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0031012~extracellular matrix,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,",0,0,0
ERAS,ES cell expressed Ras,1,0.745415986888831,0.332676355469261,0.863610713945745,1,0.005001346370856,0.258228484650469,0.64950780779398,2,YES,0,"GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,",0,0,0
PCCA,"Propionyl Coenzyme A carboxylase, alpha polypeptide",1,1,0.152132151663584,1.05E-17,6.82E-17,0.005004897498828,0.258228484650469,0.718262283638893,2,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004658~propionyl-CoA carboxylase activity,GO:0005524~ATP binding,GO:0009374~biotin binding,GO:0016885~ligase activity, forming carbon-carbon bonds,GO:0017076~purine nucleotide binding,GO:0019842~vitamin binding,GO:0030554~adenyl nucleotide binding,GO:0031406~carboxylic acid binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0033293~monocarboxylic acid binding,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,","hsa00280:Valine, leucine and isoleucine degradation,hsa00640:Propanoate metabolism,",0,0
TINAG,Tubulointerstitial nephritis antigen,0.616319820598673,0.886481428527679,0.27215746376187,0.908712109018094,1,0.005018306115323,0.258228484650469,0.538719567345322,2,NO,0,"GO:0000166~nucleotide binding,GO:0001871~pattern binding,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0005044~scavenger receptor activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0006508~proteolysis,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007439~ectodermal gut development,GO:0007442~hindgut morphogenesis,GO:0007443~Malpighian tubule morphogenesis,GO:0022610~biological adhesion,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0048546~digestive tract morphogenesis,GO:0048547~gut morphogenesis,GO:0048565~gut development,GO:0048567~ectodermal gut morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048619~embryonic hindgut morphogenesis,GO:0055123~digestive system development,",0,0,0
FBN2,Fibrillin 2 (congenital contractural arachnodactyly),1,0.039525310152689,0.628457722964864,2.08E-28,1.81E-27,0.005043270529811,0.258439940675551,0.547154336117367,2,NO,0,"GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0030326~embryonic limb morphogenesis,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048736~appendage development,GO:0060173~limb development,",0,0,0
ENOX2,Ecto-NOX disulfide-thiol exchanger 2,1,0.07591503469536,0.620539289527082,0.999999769131448,1,0.005062730830403,0.258439940675551,0.665092779786682,2,YES,0,"GO:0000166~nucleotide binding,GO:0005507~copper ion binding,GO:0015035~protein disulfide oxidoreductase activity,GO:0015036~disulfide oxidoreductase activity,GO:0016667~oxidoreductase activity, acting on sulfur group of donors,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0006091~generation of precursor metabolites and energy,GO:0007624~ultradian rhythm,GO:0008361~regulation of cell size,GO:0016049~cell growth,GO:0022900~electron transport chain,GO:0032535~regulation of cellular component size,GO:0040007~growth,GO:0040008~regulation of growth,GO:0048511~rhythmic process,GO:0055114~oxidation reduction,",0,0,0
BNC2,Basonuclin 2,1,0.503116045574968,0.450810211687543,0.996581462812602,1,0.005122031959305,0.25869126093692,0.57722382306444,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005886~plasma membrane,GO:0006350~transcription,GO:0045449~regulation of transcription,",0,0,0
SNTG1,"syntrophin, gamma 1",1,0.317178329630252,0.56767625725793,4.83E-28,4.17E-27,0.005135064147248,0.25869126093692,0.663748197605947,2,NO,0,"GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0016010~dystrophin-associated glycoprotein complex,GO:0016013~syntrophin complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,",0,0,0
RBL2,Retinoblastoma-like 2 (p130),0.872897864180646,0.86861908420637,0.296278406649975,1,1,0.005189244428947,0.259535077026148,0.467141652514289,2,NO,0,"GO:0003677~DNA binding,GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005694~chromosome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0007049~cell cycle,GO:0016568~chromatin modification,GO:0019216~regulation of lipid metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0042325~regulation of phosphorylation,GO:0043549~regulation of kinase activity,GO:0043550~regulation of lipid kinase activity,GO:0045449~regulation of transcription,GO:0051174~regulation of phosphorus metabolic process,GO:0051276~chromosome organization,GO:0051338~regulation of transferase activity,","hsa04110:Cell cycle,hsa04350:TGF-beta signaling pathway,",0,0
LPAR1,lysophosphatidic acid receptor 1,1,0.494743979854933,0.462721504850161,0.999999991066343,1,0.005196537224037,0.259535077026148,0.65995131411346,2,YES,0,"GO:0001619~lysosphingolipid and lysophosphatidic acid receptor activity,GO:0019904~protein domain specific binding,GO:0030165~PDZ domain binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0000165~MAPKKK cascade,GO:0000187~activation of MAPK activity,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0009967~positive regulation of signal transduction,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010863~positive regulation of phospholipase C activity,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0032060~bleb formation,GO:0033674~positive regulation of kinase activity,GO:0035023~regulation of Rho protein signal transduction,GO:0035025~positive regulation of Rho protein signal transduction,GO:0042325~regulation of phosphorylation,GO:0042592~homeostatic process,GO:0043085~positive regulation of catalytic activity,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043408~regulation of MAPKKK cascade,GO:0043410~positive regulation of MAPKKK cascade,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0046579~positive regulation of Ras protein signal transduction,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051174~regulation of phosphorus metabolic process,GO:0051336~regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051347~positive regulation of transferase activity,GO:0051480~cytosolic calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,","hsa04080:Neuroactive ligand-receptor interaction,hsa04540:Gap junction,",0,0
TRIP13,thyroid hormone receptor interactor 13,0.54645863555447,1,0.141117991752881,1.20E-17,7.80E-17,0.005219478544964,0.259985705977004,0.727847229735804,2,NO,0,"GO:0000239~pachytene,GO:0000279~M phase,GO:0001556~oocyte maturation,GO:0003006~reproductive developmental process,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007126~meiosis,GO:0007127~meiosis I,GO:0007128~meiotic prophase I,GO:0007131~reciprocal meiotic recombination,GO:0007140~male meiosis,GO:0007141~male meiosis I,GO:0007143~female meiosis,GO:0007144~female meiosis I,GO:0007276~gamete generation,GO:0007281~germ cell development,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007292~female gamete generation,GO:0009994~oocyte differentiation,GO:0019953~sexual reproduction,GO:0021700~developmental maturation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0032504~multicellular organism reproduction,GO:0032774~RNA biosynthetic process,GO:0033554~cellular response to stress,GO:0048232~male gamete generation,GO:0048469~cell maturation,GO:0048477~oogenesis,GO:0048515~spermatid differentiation,GO:0048599~oocyte development,GO:0048609~reproductive process in a multicellular organism,GO:0048610~reproductive cellular process,GO:0051321~meiotic cell cycle,GO:0051324~prophase,GO:0051327~M phase of meiotic cell cycle,GO:0001673~male germ cell nucleus,GO:0043073~germ cell nucleus,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003712~transcription cofactor activity,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,",0,0,0
PDE10A,phosphodiesterase 10A,1,0.000447465270995,0.755313294857079,0.999970203767304,1,0.005323426960107,0.261775195189312,0.228734261794845,2,NO,0,"GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0008081~phosphoric diester hydrolase activity,GO:0008270~zinc ion binding,GO:0016208~AMP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0019002~GMP binding,GO:0030551~cyclic nucleotide binding,GO:0030552~cAMP binding,GO:0030553~cGMP binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0047555~3',5'-cyclic-GMP phosphodiesterase activity,","hsa00230:Purine metabolism,",0,0
PDHA2,Pyruvate dehydrogenase (lipoamide) alpha 2,1,0.922946820691503,0.252167636480398,0.999998720169042,1,0.005331756816608,0.261775195189312,0.58557722505711,2,NO,0,"GO:0004738~pyruvate dehydrogenase activity,GO:0004739~pyruvate dehydrogenase (acetyl-transferring) activity,GO:0016624~oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006007~glucose catabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006096~glycolysis,GO:0016052~carbohydrate catabolic process,GO:0019318~hexose metabolic process,GO:0019320~hexose catabolic process,GO:0044275~cellular carbohydrate catabolic process,GO:0046164~alcohol catabolic process,GO:0046365~monosaccharide catabolic process,GO:0055114~oxidation reduction,","hsa00010:Glycolysis / Gluconeogenesis,hsa00020:Citrate cycle (TCA cycle),hsa00290:Valine, leucine and isoleucine biosynthesis,hsa00620:Pyruvate metabolism,hsa00650:Butanoate metabolism,",0,0
KIF1B,kinesin family member 1B,1,0.071025182148922,0.620539289527082,0.994956720688128,1,0.005343929499602,0.261775195189312,0.546102097095315,2,NO,0,"GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007270~nerve-nerve synaptic transmission,GO:0007274~neuromuscular synaptic transmission,GO:0008088~axon cargo transport,GO:0008089~anterograde axon cargo transport,GO:0010970~microtubule-based transport,GO:0019226~transmission of nerve impulse,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0034643~mitochondrion localization, microtubule-mediated,GO:0046907~intracellular transport,GO:0047497~mitochondrion transport along microtubule,GO:0050877~neurological system process,GO:0051640~organelle localization,GO:0051646~mitochondrion localization,GO:0051654~establishment of mitochondrion localization,GO:0051656~establishment of organelle localization,GO:0005739~mitochondrion,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0015630~microtubule cytoskeleton,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0031090~organelle membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044433~cytoplasmic vesicle part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008092~cytoskeletal protein binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0019894~kinesin binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",0,0,0
DCX,doublecortin,1,0.600158415358331,0.415026258567341,1,1,0.00535350524987,0.261775195189312,0.611294074034089,2,NO,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001764~neuron migration,GO:0006928~cell motion,GO:0007242~intracellular signaling cascade,GO:0007409~axonogenesis,GO:0008361~regulation of cell size,GO:0016049~cell growth,GO:0016358~dendrite development,GO:0016477~cell migration,GO:0021952~central nervous system projection neuron axonogenesis,GO:0021953~central nervous system neuron differentiation,GO:0021954~central nervous system neuron development,GO:0021955~central nervous system neuron axonogenesis,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0032535~regulation of cellular component size,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0040007~growth,GO:0048588~developmental cell growth,GO:0048589~developmental growth,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048675~axon extension,GO:0048812~neuron projection morphogenesis,GO:0048813~dendrite morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0051674~localization of cell,GO:0005856~cytoskeleton,GO:0005875~microtubule associated complex,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0008017~microtubule binding,GO:0008092~cytoskeletal protein binding,GO:0015631~tubulin binding,",0,0,0
ZKSCAN7,zinc finger with KRAB and SCAN domains 7,1,0.783828753636386,0.332676355469261,0.999992053219966,1,0.005377441889493,0.262259104579198,0.427821652387246,2,NO,0,"transcription, DNA-dependent, nucleus, metal ion binding, sequence-specific DNA binding transcription factor activity",0,0,0
MAP2K7,mitogen-activated protein kinase kinase 7,1,0.005629812000978,0.669292822937893,0.99999357679022,1,0.005414082501127,0.262707564342284,0.307970375112951,2,YES,0,"GO:0000165~MAPKKK cascade,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0016310~phosphorylation,GO:0031098~stress-activated protein kinase signaling pathway,GO:0033554~cellular response to stress,GO:0051403~stress-activated MAPK cascade,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004708~MAP kinase kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04912:GnRH signaling pathway,",0,0
CCDC105,coiled-coil domain containing 105,1,0.420265180899895,0.5043282941208,6.96E-20,4.83E-19,0.005458905717867,0.263386782742709,0.544049603100524,2,NO,0,0,0,0,0
MGAT4C,"Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)",0.907099150328727,0.068723807073135,0.620539289527082,0.474069254512833,1,0.005466937210542,0.263386782742709,0.35249868264224,2,YES,0,"GO:0008375~acetylglucosaminyltransferase activity,GO:0008454~alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
RIMS1,Regulating synaptic membrane exocytosis 1,0.497620079827641,0.094818560173703,0.620539289527082,0.999999965214607,1,0.005483207923165,0.263386782742709,0.255476653863181,2,NO,0,"GO:0005083~small GTPase regulator activity,GO:0008270~zinc ion binding,GO:0017016~Ras GTPase binding,GO:0017137~Rab GTPase binding,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0031267~small GTPase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0042734~presynaptic membrane,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0001505~regulation of neurotransmitter levels,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0006461~protein complex assembly,GO:0006836~neurotransmitter transport,GO:0006886~intracellular protein transport,GO:0006887~exocytosis,GO:0006944~membrane fusion,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016079~synaptic vesicle exocytosis,GO:0016192~vesicle-mediated transport,GO:0017156~calcium ion-dependent exocytosis,GO:0019226~transmission of nerve impulse,GO:0032940~secretion by cell,GO:0034613~cellular protein localization,GO:0043933~macromolecular complex subunit organization,GO:0045055~regulated secretory pathway,GO:0045184~establishment of protein localization,GO:0046903~secretion,GO:0046907~intracellular transport,GO:0048489~synaptic vesicle transport,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070727~cellular macromolecule localization,",0,0,0
GEN1,"Gen homolog 1, endonuclease (Drosophila)",1,1,0.099549143762887,0.949419922694841,1,0.005486899063405,0.263386782742709,0.615686605279189,2,YES,0,"GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006974~response to DNA damage stimulus,GO:0033554~cellular response to stress,",0,0,0
RRAD,Ras-related associated with diabetes,1,0.039525310152689,0.628457722964864,1,1,0.005515444217676,0.263386782742709,0.487395600689403,2,YES,0,"GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0005886~plasma membrane,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005516~calmodulin binding,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,",0,0,0
USP25,Ubiquitin specific peptidase 25,1,0.783828753636386,0.332676355469261,0.999999571551357,1,0.005530022152361,0.263386782742709,0.635276363712964,2,YES,0,"GO:0004221~ubiquitin thiolesterase activity,GO:0004843~ubiquitin-specific protease activity,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016790~thiolester hydrolase activity,GO:0019783~small conjugating protein-specific protease activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,",0,0,0
DHTKD1,Dehydrogenase E1 and transketolase domain containing 1,1,0.505087244311173,0.450810211687543,0.906186497912271,1,0.005534171418299,0.263386782742709,0.580307126126532,2,YES,0,"GO:0004591~oxoglutarate dehydrogenase (succinyl-transferring) activity,GO:0016624~oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,GO:0019842~vitamin binding,GO:0030976~thiamin pyrophosphate binding,GO:0048037~cofactor binding,GO:0050662~coenzyme binding,GO:0005739~mitochondrion,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006007~glucose catabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006096~glycolysis,GO:0016052~carbohydrate catabolic process,GO:0019318~hexose metabolic process,GO:0019320~hexose catabolic process,GO:0044275~cellular carbohydrate catabolic process,GO:0046164~alcohol catabolic process,GO:0046365~monosaccharide catabolic process,GO:0055114~oxidation reduction,",0,0,0
EXOC1,Exocyst complex component 1,1,0.424567095942059,0.5043282941208,5.07E-17,3.24E-16,0.005541571048658,0.263386782742709,0.737519467324093,2,NO,0,"GO:0000145~exocyst,GO:0005938~cell cortex,GO:0044448~cell cortex part,GO:0006887~exocytosis,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032940~secretion by cell,GO:0045184~establishment of protein localization,GO:0046903~secretion,",0,0,0
ATP9B,"ATPase, class II, type 9B",1,0.371783892346493,0.550517679371596,0.999996997313445,1,0.005608670241168,0.265546805822526,0.545589430760915,2,YES,0,"GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005319~lipid transporter activity,GO:0005524~ATP binding,GO:0005548~phospholipid transporter activity,GO:0015247~aminophospholipid transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0019829~cation-transporting ATPase activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006869~lipid transport,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0010876~lipid localization,GO:0015914~phospholipid transport,GO:0015917~aminophospholipid transport,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046034~ATP metabolic process,",0,0,0
PALM2,Paralemmin 2,1,0.175460844584417,0.601943915278899,0.999999999875768,1,0.005616557389272,0.265546805822526,0.463472197102789,2,NO,0,"GO:0019899~enzyme binding,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,GO:0008360~regulation of cell shape,GO:0022604~regulation of cell morphogenesis,",0,0,0
ZNF91,Zinc finger protein 91,1,0.480599768382981,0.486266912799715,1,1,0.005643882537156,0.265546805822526,0.625028612570383,2,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
STK32B,Serine/threonine kinase 32B,1,0.600158415358331,0.431470866885485,0.417246163305696,1,0.005672609941758,0.266218324693629,0.662476685521882,2,YES,0,"GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,",0,0,0
NELL1,NEL-like 1 (chicken),0.943765117387339,0.240904027396112,0.594395772667206,0.999999999994573,1,0.005686659433201,0.266218324693629,0.322047361453366,2,NO,0,"GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0005080~protein kinase C binding,GO:0005198~structural molecule activity,GO:0005509~calcium ion binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0048037~cofactor binding,GO:0050662~coenzyme binding,GO:0051287~NAD or NADH binding,GO:0005576~extracellular region,GO:0006917~induction of apoptosis,GO:0007155~cell adhesion,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0022610~biological adhesion,GO:0030278~regulation of ossification,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0045667~regulation of osteoblast differentiation,GO:0055114~oxidation reduction,",0,0,0
CNTN6,contactin 6,1,0.004031008487037,0.686489330651798,0.999999972049038,1,0.005721573863493,0.267183195490471,0.388239923441016,2,YES,0,"GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,",0,0,0
LHCGR,Luteinizing hormone/choriogonadotropin receptor,1,0.003960740667106,0.688986797626025,0.833762028452189,1,0.005754369269065,0.267968724049049,0.672278007651756,2,YES,0,"GO:0001653~peptide receptor activity,GO:0004964~lutropin-choriogonadotropic hormone receptor activity,GO:0008528~peptide receptor activity, G-protein coupled,GO:0016500~protein-hormone receptor activity,GO:0017046~peptide hormone binding,GO:0019899~enzyme binding,GO:0042277~peptide binding,GO:0042562~hormone binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,GO:0051117~ATPase binding,GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005768~endosome,GO:0005773~vacuole,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031233~intrinsic to external side of plasma membrane,GO:0043235~receptor complex,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0001541~ovarian follicle development,GO:0003006~reproductive developmental process,GO:0006140~regulation of nucleotide metabolic process,GO:0006605~protein targeting,GO:0006622~protein targeting to lysosome,GO:0006623~protein targeting to vacuole,GO:0006869~lipid transport,GO:0006886~intracellular protein transport,GO:0007034~vacuolar transport,GO:0007041~lysosomal transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,GO:0007188~G-protein signaling, coupled to cAMP nucleotide second messenger,GO:0007190~activation of adenylate cyclase activity,GO:0007200~activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger,GO:0007202~activation of phospholipase C activity,GO:0007242~intracellular signaling cascade,GO:0007548~sex differentiation,GO:0008104~protein localization,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009755~hormone-mediated signaling,GO:0009891~positive regulation of biosynthetic process,GO:0009967~positive regulation of signal transduction,GO:0010033~response to organic substance,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010522~regulation of calcium ion transport into cytosol,GO:0010524~positive regulation of calcium ion transport into cytosol,GO:0010647~positive regulation of cell communication,GO:0010863~positive regulation of phospholipase C activity,GO:0010876~lipid localization,GO:0010959~regulation of metal ion transport,GO:0015031~protein transport,GO:0015718~monocarboxylic acid transport,GO:0015849~organic acid transport,GO:0015908~fatty acid transport,GO:0015909~long-chain fatty acid transport,GO:0019216~regulation of lipid metabolic process,GO:0019218~regulation of steroid metabolic process,GO:0019932~second-messenger-mediated signaling,GO:0019933~cAMP-mediated signaling,GO:0019935~cyclic-nucleotide-mediated signaling,GO:0022602~ovulation cycle process,GO:0030539~male genitalia development,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030814~regulation of cAMP metabolic process,GO:0030817~regulation of cAMP biosynthetic process,GO:0031279~regulation of cyclase activity,GO:0031281~positive regulation of cyclase activity,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032309~icosanoid secretion,GO:0032350~regulation of hormone metabolic process,GO:0032352~positive regulation of hormone metabolic process,GO:0032504~multicellular organism reproduction,GO:0032844~regulation of homeostatic process,GO:0032846~positive regulation of homeostatic process,GO:0032870~cellular response to hormone stimulus,GO:0034613~cellular protein localization,GO:0042493~response to drug,GO:0042698~ovulation cycle,GO:0042700~luteinizing hormone signaling pathway,GO:0043085~positive regulation of catalytic activity,GO:0043269~regulation of ion transport,GO:0043270~positive regulation of ion transport,GO:0044093~positive regulation of molecular function,GO:0045137~development of primary sexual characteristics,GO:0045184~establishment of protein localization,GO:0045761~regulation of adenylate cyclase activity,GO:0045762~positive regulation of adenylate cyclase activity,GO:0046545~development of primary female sexual characteristics,GO:0046546~development of primary male sexual characteristics,GO:0046660~female sex differentiation,GO:0046661~male sex differentiation,GO:0046717~acid secretion,GO:0046885~regulation of hormone biosynthetic process,GO:0046886~positive regulation of hormone biosynthetic process,GO:0046890~regulation of lipid biosynthetic process,GO:0046903~secretion,GO:0046907~intracellular transport,GO:0046942~carboxylic acid transport,GO:0048015~phosphoinositide-mediated signaling,GO:0048511~rhythmic process,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0048806~genitalia development,GO:0050482~arachidonic acid secretion,GO:0050810~regulation of steroid biosynthetic process,GO:0050848~regulation of calcium-mediated signaling,GO:0050850~positive regulation of calcium-mediated signaling,GO:0051050~positive regulation of transport,GO:0051279~regulation of release of sequestered calcium ion into cytosol,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051336~regulation of hydrolase activity,GO:0051339~regulation of lyase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051349~positive regulation of lyase activity,GO:0051924~regulation of calcium ion transport,GO:0051928~positive regulation of calcium ion transport,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,GO:0070727~cellular macromolecule localization,","hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,",0,0
COMMD4,COMM domain containing 4,1,1,0.207292071105334,0.999821080915891,1,0.005804806872548,0.267968724049049,0.660497340677993,2,NO,0,0,0,0,0
ZNF528,zinc finger protein 534; zinc finger protein 528,0.978888608669698,0.382789390978339,0.550860667188815,5.61E-05,0.00020775929008,0.005815921447044,0.267968724049049,0.391256126849846,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
PRAMEF11,PRAME family member 11; PRAME family member 9; PRAME family member 15,1,1,0.027774089574207,0.993072617286682,1,0.005830864454624,0.267968724049049,0.7470679874749,2,NO,0,"negative regulation of apoptotic process, negative regulation of cell differentiation, negative regulation of retinoic acid receptor signaling pathway, negative regulation of transcription, DNA-dependent, positive regulation of cell proliferation, retinoic acid receptor binding",0,0,0
DAAM1,dishevelled associated activator of morphogenesis 1,0.58944092900803,9.39E-05,0.829141324060725,0.999999999999999,1,0.005832379993482,0.267968724049049,0.384860112431944,2,NO,0,"GO:0007010~cytoskeleton organization,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0017016~Ras GTPase binding,GO:0017048~Rho GTPase binding,GO:0019899~enzyme binding,GO:0031267~small GTPase binding,GO:0051020~GTPase binding,","hsa04310:Wnt signaling pathway,",0,0
MIB1,mindbomb homolog 1 (Drosophila),0.818380727334137,0.030324001619147,0.641447788305282,0.028279855533032,0.086497367201817,0.005838817425342,0.267968724049049,0.297851538656163,2,YES,0,"GO:0001568~blood vessel development,GO:0001701~in utero embryonic development,GO:0001756~somitogenesis,GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001944~vasculature development,GO:0001947~heart looping,GO:0002009~morphogenesis of an epithelium,GO:0003002~regionalization,GO:0003007~heart morphogenesis,GO:0006508~proteolysis,GO:0007166~cell surface receptor linked signal transduction,GO:0007219~Notch signaling pathway,GO:0007389~pattern specification process,GO:0007507~heart development,GO:0009057~macromolecule catabolic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009952~anterior/posterior pattern formation,GO:0016331~morphogenesis of embryonic epithelium,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0021915~neural tube development,GO:0030100~regulation of endocytosis,GO:0030163~protein catabolic process,GO:0032446~protein modification by small protein conjugation,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035282~segmentation,GO:0035295~tube development,GO:0043009~chordate embryonic development,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045596~negative regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045807~positive regulation of endocytosis,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0050767~regulation of neurogenesis,GO:0051050~positive regulation of transport,GO:0051130~positive regulation of cellular component organization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0060627~regulation of vesicle-mediated transport,GO:0070647~protein modification by small protein conjugation or removal,GO:0005886~plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0004842~ubiquitin-protein ligase activity,GO:0008270~zinc ion binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
LRP2,Low density lipoprotein-related protein 2,1,0.106469573942933,0.620539289527082,0.999828234697591,1,0.005916803488768,0.268192674653786,0.596900602072691,2,NO,0,"GO:0005509~calcium ion binding,GO:0008565~protein transporter activity,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0042954~lipoprotein transporter activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0000267~cell fraction,GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005764~lysosome,GO:0005768~endosome,GO:0005773~vacuole,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0005905~coated pit,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0016324~apical plasma membrane,GO:0030139~endocytic vesicle,GO:0031224~intrinsic to membrane,GO:0031253~cell projection membrane,GO:0031410~cytoplasmic vesicle,GO:0031526~brush border membrane,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042995~cell projection,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045177~apical part of cell,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0006486~protein amino acid glycosylation,GO:0006766~vitamin metabolic process,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0007267~cell-cell signaling,GO:0007568~aging,GO:0007584~response to nutrient,GO:0008104~protein localization,GO:0008283~cell proliferation,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0009314~response to radiation,GO:0009628~response to abiotic stimulus,GO:0009914~hormone transport,GO:0009991~response to extracellular stimulus,GO:0010165~response to X-ray,GO:0010212~response to ionizing radiation,GO:0010324~membrane invagination,GO:0010817~regulation of hormone levels,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016197~endosome transport,GO:0030900~forebrain development,GO:0031099~regeneration,GO:0031100~organ regeneration,GO:0031667~response to nutrient levels,GO:0032526~response to retinoic acid,GO:0032940~secretion by cell,GO:0033189~response to vitamin A,GO:0033273~response to vitamin,GO:0033280~response to vitamin D,GO:0042493~response to drug,GO:0042953~lipoprotein transport,GO:0043413~biopolymer glycosylation,GO:0045056~transcytosis,GO:0045184~establishment of protein localization,GO:0046879~hormone secretion,GO:0046903~secretion,GO:0046907~intracellular transport,GO:0070085~glycosylation,","hsa04340:Hedgehog signaling pathway,",0,0
MRS2,MRS2 magnesium homeostasis factor homolog (S. cerevisiae),1,0.745415986888831,0.353186564446536,0.000476975538645,0.00164867248082,0.005917424700781,0.268192674653786,0.620698848937026,2,NO,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0016021~integral to membrane,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0000287~magnesium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
MYO1D,Myosin ID,1,0.420265180899895,0.530773514888496,0.760955578095364,1,0.005935307616179,0.268192674653786,0.552412926296108,2,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008092~cytoskeletal protein binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0016459~myosin complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,",0,0,0
KLF4,Kruppel-like factor 4 (gut),1,0.166669447275995,0.603938306354712,0.999999079692506,1,0.005943974920054,0.268192674653786,0.302806683587877,2,NO,0,"GO:0001654~eye development,GO:0001704~formation of primary germ layer,GO:0001707~mesoderm formation,GO:0001709~cell fate determination,GO:0001710~mesodermal cell fate commitment,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007369~gastrulation,GO:0007398~ectoderm development,GO:0007423~sensory organ development,GO:0007498~mesoderm development,GO:0007500~mesodermal cell fate determination,GO:0007584~response to nutrient,GO:0008285~negative regulation of cell proliferation,GO:0008544~epidermis development,GO:0009791~post-embryonic development,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009913~epidermal cell differentiation,GO:0009991~response to extracellular stimulus,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0019827~stem cell maintenance,GO:0031077~post-embryonic camera-type eye development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031667~response to nutrient levels,GO:0032526~response to retinoic acid,GO:0033189~response to vitamin A,GO:0033273~response to vitamin,GO:0042127~regulation of cell proliferation,GO:0043010~camera-type eye development,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048332~mesoderm morphogenesis,GO:0048333~mesodermal cell differentiation,GO:0048569~post-embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0048729~tissue morphogenesis,GO:0048730~epidermis morphogenesis,GO:0048863~stem cell differentiation,GO:0048864~stem cell development,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0008270~zinc ion binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
EYA4,eyes absent homolog 4 (Drosophila),1,1,0.225484269056324,0.999995421794386,1,0.006006065694855,0.268192674653786,0.56478554969436,2,YES,0,"GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006974~response to DNA damage stimulus,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0016568~chromatin modification,GO:0033554~cellular response to stress,GO:0045449~regulation of transcription,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0051276~chromosome organization,GO:0000287~magnesium ion binding,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0016791~phosphatase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
KLK2,Kallikrein-related peptidase 2,1,0.621617423105817,0.413900866678315,0.999999998412672,1,0.006017071090455,0.268192674653786,0.703897303740654,2,YES,0,"GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0006508~proteolysis,",0,0,0
DLG2,"discs, large homolog 2 (Drosophila)",1,0.055259339345796,0.628457722964864,2.98E-06,1.19E-05,0.006069489045561,0.268192674653786,0.498104345015386,2,NO,0,"GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0004385~guanylate kinase activity,GO:0016776~phosphotransferase activity, phosphate group as acceptor,GO:0019201~nucleotide kinase activity,GO:0019205~nucleobase, nucleoside, nucleotide kinase activity,",0,0,0
SHPRH,SNF2 histone linker PHD RING helicase,1,0.002055575150556,0.71123138728128,0.999999766783805,1,0.006084438154707,0.268192674653786,0.279142357149459,2,YES,0,"GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006334~nucleosome assembly,GO:0006508~proteolysis,GO:0006974~response to DNA damage stimulus,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0031497~chromatin assembly,GO:0033554~cellular response to stress,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0034728~nucleosome organization,GO:0043632~modification-dependent macromolecule catabolic process,GO:0043933~macromolecular complex subunit organization,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051276~chromosome organization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0065003~macromolecular complex assembly,GO:0065004~protein-DNA complex assembly,GO:0000785~chromatin,GO:0000786~nucleosome,GO:0005694~chromosome,GO:0032993~protein-DNA complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
CDH12,"Cadherin 12, type 2 (N-cadherin 2)",1,0.038129880226435,0.641447788305282,6.29E-14,3.65E-13,0.00609268297089,0.268192674653786,0.808480222242678,2,NO,0,"GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,",0,0,0
ATRNL1,attractin-like 1,0.907099150328727,0.001112456468077,0.72842730925218,0.000555488690385,0.001911916942639,0.006119697791416,0.268192674653786,0.131160627030798,2,NO,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005529~sugar binding,GO:0030246~carbohydrate binding,",0,0,0
AICDA,Activation-induced cytidine deaminase,1,1,0.140051375693358,0.988876292259484,1,0.006130856688108,0.268192674653786,0.755544050896783,2,NO,0,"GO:0004126~cytidine deaminase activity,GO:0008270~zinc ion binding,GO:0016814~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,GO:0019239~deaminase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0001775~cell activation,GO:0002200~somatic diversification of immune receptors,GO:0002204~somatic recombination of immunoglobulin genes during immune response,GO:0002208~somatic diversification of immunoglobulins during immune response,GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002377~immunoglobulin production,GO:0002381~immunoglobulin production during immune response,GO:0002440~production of molecular mediator of immune response,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002562~somatic diversification of immune receptors via germline recombination within a single locus,GO:0006259~DNA metabolic process,GO:0006310~DNA recombination,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006955~immune response,GO:0016064~immunoglobulin mediated immune response,GO:0016071~mRNA metabolic process,GO:0016444~somatic cell DNA recombination,GO:0016445~somatic diversification of immunoglobulins,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0019724~B cell mediated immunity,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030183~B cell differentiation,GO:0042113~B cell activation,GO:0045190~isotype switching,GO:0045321~leukocyte activation,GO:0046649~lymphocyte activation,GO:0048534~hemopoietic or lymphoid organ development,","hsa04672:Intestinal immune network for IgA production,hsa05340:Primary immunodeficiency,",0,0
DCN,decorin,1,0.970645685897825,0.252167636480398,0.999999995137066,1,0.006149840404536,0.268300302176545,0.484028524323276,2,NO,0,"GO:0005976~polysaccharide metabolic process,GO:0006022~aminoglycan metabolic process,GO:0006029~proteoglycan metabolic process,GO:0006790~sulfur metabolic process,GO:0009100~glycoprotein metabolic process,GO:0018149~peptide cross-linking,GO:0018209~peptidyl-serine modification,GO:0019800~peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,GO:0030198~extracellular matrix organization,GO:0030203~glycosaminoglycan metabolic process,GO:0030204~chondroitin sulfate metabolic process,GO:0043062~extracellular structure organization,GO:0050654~chondroitin sulfate proteoglycan metabolic process,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0001871~pattern binding,GO:0005518~collagen binding,GO:0005539~glycosaminoglycan binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0047485~protein N-terminus binding,GO:0050840~extracellular matrix binding,","hsa04350:TGF-beta signaling pathway,",0,0
COL3A1,"collagen, type III, alpha 1",1,0.000143873805444,0.8233116404925,0.364772362659277,0.971149224930536,0.006185044427265,0.268300302176545,0.276390066250589,2,NO,0,"GO:0001501~skeletal system development,GO:0001568~blood vessel development,GO:0001775~cell activation,GO:0001944~vasculature development,GO:0002683~negative regulation of immune system process,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0007398~ectoderm development,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0008544~epidermis development,GO:0009314~response to radiation,GO:0009611~response to wounding,GO:0009628~response to abiotic stimulus,GO:0010033~response to organic substance,GO:0018149~peptide cross-linking,GO:0022610~biological adhesion,GO:0030168~platelet activation,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0031589~cell-substrate adhesion,GO:0032963~collagen metabolic process,GO:0032964~collagen biosynthetic process,GO:0034097~response to cytokine stimulus,GO:0042060~wound healing,GO:0043062~extracellular structure organization,GO:0043206~fibril organization,GO:0043588~skin development,GO:0044236~multicellular organismal metabolic process,GO:0044259~multicellular organismal macromolecule metabolic process,GO:0048565~gut development,GO:0048585~negative regulation of response to stimulus,GO:0050777~negative regulation of immune response,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005583~fibrillar collagen,GO:0005586~collagen type III,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005178~integrin binding,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0019838~growth factor binding,GO:0032403~protein complex binding,GO:0046332~SMAD binding,GO:0048407~platelet-derived growth factor binding,","hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,",0,0
CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,1,1,0.166813564552107,0.999999999999975,1,0.006238517741044,0.269120722598064,0.717460367716359,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
ZFHX4,zinc finger homeobox 4,1,0.138864686954504,0.616343584684641,1.39E-12,7.68E-12,0.006269160285197,0.269451422407469,0.770784452675035,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
ZNF471,zinc finger protein 471,1,0.86861908420637,0.322572783240635,0.997245838014682,1,0.006275034463689,0.269451422407469,0.683095052899571,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
RNF2,ring finger protein 2,1,0.84978015877207,0.332676355469261,7.20E-07,2.98E-06,0.006310412242262,0.270349060259653,0.680065446632136,2,YES,0,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0001702~gastrulation with mouth forming second,GO:0003002~regionalization,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006508~proteolysis,GO:0007049~cell cycle,GO:0007369~gastrulation,GO:0007389~pattern specification process,GO:0009057~macromolecule catabolic process,GO:0009798~axis specification,GO:0009890~negative regulation of biosynthetic process,GO:0009948~anterior/posterior axis specification,GO:0009952~anterior/posterior pattern formation,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0016567~protein ubiquitination,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016574~histone ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032446~protein modification by small protein conjugation,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048598~embryonic morphogenesis,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0070647~protein modification by small protein conjugation or removal,GO:0000151~ubiquitin ligase complex,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0000792~heterochromatin,GO:0000803~sex chromosome,GO:0001739~sex chromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005720~nuclear heterochromatin,GO:0016604~nuclear body,GO:0031519~PcG protein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0003682~chromatin binding,GO:0004842~ubiquitin-protein ligase activity,GO:0008270~zinc ion binding,GO:0016564~transcription repressor activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
KIF20B,kinesin family member 20B,0.741744163837874,1,0.125838945789225,0.99999999761858,1,0.006327415945573,0.270457213838349,0.422514222041707,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0019904~protein domain specific binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0050699~WW domain binding,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0070013~intracellular organelle lumen,GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007067~mitosis,GO:0007088~regulation of mitosis,GO:0007346~regulation of mitotic cell cycle,GO:0010564~regulation of cell cycle process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0033043~regulation of organelle organization,GO:0048285~organelle fission,GO:0051301~cell division,GO:0051726~regulation of cell cycle,GO:0051783~regulation of nuclear division,",0,0,0
DOK6,Docking protein 6,1,0.58177193050653,0.450810211687543,1,1,0.00638986129513,0.271868312590957,0.425013568771841,2,NO,0,"GO:0005158~insulin receptor binding,GO:0032403~protein complex binding,",0,0,0
PTPRM,"protein tyrosine phosphatase, receptor type, M",1,0.005629812000978,0.679130630618955,0.998912985060204,1,0.006490288296978,0.274280758143113,0.544331188658494,2,YES,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001654~eye development,GO:0001936~regulation of endothelial cell proliferation,GO:0001937~negative regulation of endothelial cell proliferation,GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006928~cell motion,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007423~sensory organ development,GO:0008285~negative regulation of cell proliferation,GO:0010594~regulation of endothelial cell migration,GO:0010596~negative regulation of endothelial cell migration,GO:0010842~retina layer formation,GO:0016311~dephosphorylation,GO:0016337~cell-cell adhesion,GO:0016525~negative regulation of angiogenesis,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030334~regulation of cell migration,GO:0030336~negative regulation of cell migration,GO:0031175~neuron projection development,GO:0031290~retinal ganglion cell axon guidance,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0040012~regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0043010~camera-type eye development,GO:0045765~regulation of angiogenesis,GO:0048592~eye morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0051270~regulation of cell motion,GO:0051271~negative regulation of cell motion,GO:0060041~retina development in camera-type eye,GO:0060042~retina morphogenesis in camera-type eye,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0016021~integral to membrane,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0044459~plasma membrane part,GO:0048471~perinuclear region of cytoplasm,GO:0070161~anchoring junction,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0016791~phosphatase activity,GO:0019198~transmembrane receptor protein phosphatase activity,GO:0045296~cadherin binding,GO:0050839~cell adhesion molecule binding,","hsa04514:Cell adhesion molecules (CAMs),hsa04520:Adherens junction,",0,0
NUBP2,"nucleotide binding protein 2 (MinD homolog, E. coli)",1,0.745415986888831,0.372574147431736,0.999999996758305,1,0.006551126976222,0.27609608385891,0.540421505345765,2,NO,0,"GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005506~iron ion binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,GO:0051540~metal cluster binding,",0,0,0
TPST2,Tyrosylprotein sulfotransferase 2,1,0.780284580214678,0.353186564446536,0.999998861664169,1,0.006632364516985,0.277724287587448,0.722022952966684,2,YES,0,"GO:0008146~sulfotransferase activity,GO:0008476~protein-tyrosine sulfotransferase activity,GO:0016782~transferase activity, transferring sulfur-containing groups,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0006477~protein amino acid sulfation,GO:0006478~peptidyl-tyrosine sulfation,GO:0006790~sulfur metabolic process,GO:0018212~peptidyl-tyrosine modification,GO:0051923~sulfation,",0,0,0
RAF1,V-raf-1 murine leukemia viral oncogene homolog 1,1,1,0.020778128396565,0.030992149907849,0.094422177153597,0.006641448838311,0.277724287587448,0.734260350292272,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0017076~purine nucleotide binding,GO:0019992~diacylglycerol binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0019867~outer membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0007010~cytoskeleton organization,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0012501~programmed cell death,GO:0016265~death,GO:0016310~phosphorylation,GO:0048011~nerve growth factor receptor signaling pathway,","hsa04010:MAPK signaling pathway,hsa04012:ErbB signaling pathway,hsa04062:Chemokine signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04540:Gap junction,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04720:Long-term potentiation,hsa04722:Neurotrophin signaling pathway,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04912:GnRH signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05223:Non-small cell lung cancer,",0,0
ERC2,ELKS/RAB6-interacting/CAST family member 2,1,0.264279585405886,0.599319901491912,0.99999282735796,1,0.006646113633042,0.277724287587448,0.319367499411219,2,NO,0,"GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0019717~synaptosome,GO:0030054~cell junction,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,",0,0,0
PSMD6,"proteasome (prosome, macropain) 26S subunit, non-ATPase, 6",1,0.142038435823367,0.616343584684641,0.999784877659506,1,0.006762223205436,0.281317521724606,0.182135666081281,2,YES,0,"GO:0000278~mitotic cell cycle,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0009057~macromolecule catabolic process,GO:0010498~proteasomal protein catabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0030163~protein catabolic process,GO:0031145~anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031396~regulation of protein ubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051340~regulation of ligase activity,GO:0051351~positive regulation of ligase activity,GO:0051352~negative regulation of ligase activity,GO:0051436~negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051439~regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051443~positive regulation of ubiquitin-protein ligase activity,GO:0051444~negative regulation of ubiquitin-protein ligase activity,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000502~proteasome complex,GO:0005829~cytosol,GO:0016887~ATPase activity,","hsa03050:Proteasome,",0,0
P2RY8,"purinergic receptor P2Y, G-protein coupled, 8",1,0.775559138960562,0.363863075080577,1,1,0.006856600813116,0.283978817268734,0.688183819432032,2,YES,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0001608~nucleotide receptor activity, G-protein coupled,GO:0001614~purinergic nucleotide receptor activity,GO:0016502~nucleotide receptor activity,GO:0045028~purinergic nucleotide receptor activity, G-protein coupled,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
LINGO2,leucine rich repeat and Ig domain containing 2,1,0.239978199885825,0.601943915278899,0.999999598746647,1,0.006876500510271,0.284172904936632,0.571776612331723,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
ZNF136,Zinc finger protein 136,1,0.420265180899895,0.559248062668889,4.17E-07,1.75E-06,0.007037788455757,0.286875755392808,0.715701205785377,2,NO,0,"GO:0003677~DNA binding,GO:0003702~RNA polymerase II transcription factor activity,GO:0003704~specific RNA polymerase II transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,",0,0,0
PTPRA,"protein tyrosine phosphatase, receptor type, A",1,0.14157858166002,0.620539289527082,0.928650075250768,1,0.007064770463124,0.286875755392808,0.580418100815832,2,YES,0,"GO:0006468~protein amino acid phosphorylation,GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008286~insulin receptor signaling pathway,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0016310~phosphorylation,GO:0016311~dephosphorylation,GO:0032868~response to insulin stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0043434~response to peptide hormone stimulus,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0016791~phosphatase activity,GO:0019198~transmembrane receptor protein phosphatase activity,",0,0,0
PDHA1,Pyruvate dehydrogenase (lipoamide) alpha 1,1,0.271476723733921,0.599319901491912,0.999999999998687,1,0.007200381806234,0.291433613195983,0.658657892900614,2,NO,0,"GO:0004738~pyruvate dehydrogenase activity,GO:0004739~pyruvate dehydrogenase (acetyl-transferring) activity,GO:0016624~oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006007~glucose catabolic process,GO:0006090~pyruvate metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006096~glycolysis,GO:0016052~carbohydrate catabolic process,GO:0019318~hexose metabolic process,GO:0019320~hexose catabolic process,GO:0044275~cellular carbohydrate catabolic process,GO:0046164~alcohol catabolic process,GO:0046365~monosaccharide catabolic process,GO:0055114~oxidation reduction,","hsa00010:Glycolysis / Gluconeogenesis,hsa00020:Citrate cycle (TCA cycle),hsa00290:Valine, leucine and isoleucine biosynthesis,hsa00620:Pyruvate metabolism,hsa00650:Butanoate metabolism,",0,0
LAT2,"linker for activation of T cells family, member 2",1,0.922946820691503,0.296602665660762,0.923045478451196,1,0.007208219353099,0.291433613195983,0.603658702226663,2,NO,0,"GO:0001775~cell activation,GO:0002252~immune effector process,GO:0002253~activation of immune response,GO:0002263~cell activation during immune response,GO:0002274~myeloid leukocyte activation,GO:0002275~myeloid cell activation during immune response,GO:0002366~leukocyte activation during immune response,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002443~leukocyte mediated immunity,GO:0002444~myeloid leukocyte mediated immunity,GO:0002448~mast cell mediated immunity,GO:0002684~positive regulation of immune system process,GO:0002757~immune response-activating signal transduction,GO:0002764~immune response-regulating signal transduction,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0006887~exocytosis,GO:0006955~immune response,GO:0007166~cell surface receptor linked signal transduction,GO:0007242~intracellular signaling cascade,GO:0016192~vesicle-mediated transport,GO:0019722~calcium-mediated signaling,GO:0019932~second-messenger-mediated signaling,GO:0032940~secretion by cell,GO:0042113~B cell activation,GO:0043299~leukocyte degranulation,GO:0043303~mast cell degranulation,GO:0045055~regulated secretory pathway,GO:0045321~leukocyte activation,GO:0045576~mast cell activation,GO:0046649~lymphocyte activation,GO:0046903~secretion,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0045121~membrane raft,GO:0019904~protein domain specific binding,GO:0042169~SH2 domain binding,",0,0,0
CDC7,cell division cycle 7 homolog (S. cerevisiae),0.987332615704823,0.898692767374997,0.308452845292573,0.921072495014327,1,0.007253625627398,0.292636011002516,0.554325699068088,2,YES,0,"GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007049~cell cycle,GO:0008284~positive regulation of cell proliferation,GO:0010564~regulation of cell cycle process,GO:0016310~phosphorylation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0033261~regulation of S phase,GO:0042127~regulation of cell proliferation,GO:0051301~cell division,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051726~regulation of cell cycle,GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa04110:Cell cycle,",0,0
XPR1,xenotropic and polytropic retrovirus receptor,1,0.180765780910828,0.616343584684641,4.40E-12,2.38E-11,0.007295238559273,0.293680519501422,0.71880504060282,2,YES,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0009615~response to virus,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,",0,0,0
POLR2A,"polymerase (RNA) II (DNA directed) polypeptide A, 220kDa",1,0.217325787855403,0.616343584684641,0.999999999993562,1,0.007352938323898,0.295366741832452,0.511946704246329,2,YES,0,"GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006354~RNA elongation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~RNA elongation from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006461~protein complex assembly,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0032774~RNA biosynthetic process,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0000428~DNA-directed RNA polymerase complex,GO:0005654~nucleoplasm,GO:0005665~DNA-directed RNA polymerase II, core complex,GO:0005730~nucleolus,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0030880~RNA polymerase complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0055029~nuclear DNA-directed RNA polymerase complex,GO:0070013~intracellular organelle lumen,GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0003968~RNA-directed RNA polymerase activity,GO:0004672~protein kinase activity,GO:0008270~zinc ion binding,GO:0016779~nucleotidyltransferase activity,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0034062~RNA polymerase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa03020:RNA polymerase,hsa05016:Huntington's disease,",0,0
ITFG2,integrin alpha FG-GAP repeat containing 2,1,1,0.039289744897804,4.57E-18,3.01E-17,0.007385612475096,0.296042608202402,0.651336848191477,2,NO,0,0,0,0,0
MMP10,matrix metallopeptidase 10 (stromelysin 2),0.451763036267207,0.264844060836597,0.601943915278899,3.42E-16,2.13E-15,0.007439868154736,0.296235427807751,0.366420543962898,2,YES,0,"GO:0006508~proteolysis,GO:0030574~collagen catabolic process,GO:0032963~collagen metabolic process,GO:0044236~multicellular organismal metabolic process,GO:0044243~multicellular organismal catabolic process,GO:0044259~multicellular organismal macromolecule metabolic process,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
CDH10,"Cadherin 10, type 2 (T2-cadherin)",1,0.126189590546852,0.620539289527082,8.78E-07,3.63E-06,0.007444520973216,0.296235427807751,0.761910214082008,2,NO,0,"GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,",0,0,0
MGAT5,"mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase; hypothetical LOC151162",0.477664462193511,0.142038435823367,0.620539289527082,0.980876717841297,1,0.007457749949538,0.296235427807751,0.151379426304491,2,NO,0,"GO:0006486~protein amino acid glycosylation,GO:0006487~protein amino acid N-linked glycosylation,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0043413~biopolymer glycosylation,GO:0070085~glycosylation,GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0044431~Golgi apparatus part,GO:0008375~acetylglucosaminyltransferase activity,GO:0030144~alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase activity,","hsa00510:N-Glycan biosynthesis,",0,0
GGTLC1,gamma-glutamyltransferase light chain 1,1,1,0.021101755618502,0.072178788938061,0.212152257840133,0.00745962783086,0.296235427807751,0.810629495821804,2,YES,0,"GO:0003840~gamma-glutamyltransferase activity,GO:0016755~transferase activity, transferring amino-acyl groups,",0,0,0
SRP19,signal recognition particle 19kDa,1,1,0.114326682956047,1.44E-11,7.64E-11,0.007469719283551,0.296235427807751,0.613942888813298,2,NO,0,"GO:0006605~protein targeting,GO:0006612~protein targeting to membrane,GO:0006613~cotranslational protein targeting to membrane,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0033365~protein localization in organelle,GO:0034613~cellular protein localization,GO:0042493~response to drug,GO:0045047~protein targeting to ER,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070727~cellular macromolecule localization,GO:0005730~nucleolus,GO:0005786~signal recognition particle, endoplasmic reticulum targeting,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0048500~signal recognition particle,GO:0070013~intracellular organelle lumen,GO:0003723~RNA binding,GO:0008312~7S RNA binding,","hsa03060:Protein export,",0,0
TMEM38A,Transmembrane protein 38A,1,0.886481428527679,0.327163599458382,2.50E-12,1.37E-11,0.007495237706748,0.296617680348185,0.724910144679703,2,YES,0,"GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022838~substrate specific channel activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0005635~nuclear envelope,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0016528~sarcoplasm,GO:0016529~sarcoplasmic reticulum,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031965~nuclear membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0033017~sarcoplasmic reticulum membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044432~endoplasmic reticulum part,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,",0,0,0
RPIA,Ribose 5-phosphate isomerase A (ribose 5-phosphate epimerase),1,1,0.140051375693358,0.99997146625061,1,0.007552464456393,0.297984641176659,0.600816869402841,2,NO,0,"GO:0004751~ribose-5-phosphate isomerase activity,GO:0016860~intramolecular oxidoreductase activity,GO:0016861~intramolecular oxidoreductase activity, interconverting aldoses and ketoses,GO:0005829~cytosol,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006007~glucose catabolic process,GO:0006098~pentose-phosphate shunt,GO:0006732~coenzyme metabolic process,GO:0006733~oxidoreduction coenzyme metabolic process,GO:0006739~NADP metabolic process,GO:0006769~nicotinamide metabolic process,GO:0009052~pentose-phosphate shunt, non-oxidative branch,GO:0009820~alkaloid metabolic process,GO:0016052~carbohydrate catabolic process,GO:0019318~hexose metabolic process,GO:0019320~hexose catabolic process,GO:0019321~pentose metabolic process,GO:0019362~pyridine nucleotide metabolic process,GO:0019748~secondary metabolic process,GO:0043603~cellular amide metabolic process,GO:0044275~cellular carbohydrate catabolic process,GO:0046164~alcohol catabolic process,GO:0046365~monosaccharide catabolic process,GO:0046496~nicotinamide nucleotide metabolic process,GO:0051186~cofactor metabolic process,","hsa00030:Pentose phosphate pathway,",0,0
HCRTR2,Hypocretin (orexin) receptor 2,1,0.682708225110812,0.439927752855076,0.444644422390916,1,0.00756354868261,0.297984641176659,0.671343094714739,2,NO,0,"GO:0001653~peptide receptor activity,GO:0008188~neuropeptide receptor activity,GO:0008528~peptide receptor activity, G-protein coupled,GO:0016499~orexin receptor activity,GO:0017046~peptide hormone binding,GO:0030594~neurotransmitter receptor activity,GO:0042165~neurotransmitter binding,GO:0042277~peptide binding,GO:0042562~hormone binding,GO:0042923~neuropeptide binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007200~activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger,GO:0007202~activation of phospholipase C activity,GO:0007218~neuropeptide signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007610~behavior,GO:0007631~feeding behavior,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010863~positive regulation of phospholipase C activity,GO:0019226~transmission of nerve impulse,GO:0019932~second-messenger-mediated signaling,GO:0043085~positive regulation of catalytic activity,GO:0044093~positive regulation of molecular function,GO:0048015~phosphoinositide-mediated signaling,GO:0050877~neurological system process,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
SOX6,SRY (sex determining region Y)-box 6,1,0.08825557681226,0.628457722964864,0.999999998858602,1,0.007577638233252,0.297984641176659,0.467774034192206,2,NO,0,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0001501~skeletal system development,GO:0002520~immune system development,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0009791~post-embryonic development,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016458~gene silencing,GO:0016481~negative regulation of transcription,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030218~erythrocyte differentiation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032989~cellular component morphogenesis,GO:0034101~erythrocyte homeostasis,GO:0035051~cardiac cell differentiation,GO:0042592~homeostatic process,GO:0042692~muscle cell differentiation,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048534~hemopoietic or lymphoid organ development,GO:0048821~erythrocyte development,GO:0048872~homeostasis of number of cells,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051216~cartilage development,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,",0,0,0
TUBA1B,"hypothetical gene supported by AF081484; NM_006082; tubulin, alpha 1b",1,0.943222637657724,0.296602665660762,0.999918651905096,1,0.007626236584238,0.299265699909619,0.345900716012365,2,NO,0,"GO:0000226~microtubule cytoskeleton organization,GO:0006461~protein complex assembly,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0051258~protein polymerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,","hsa04540:Gap junction,hsa05130:Pathogenic Escherichia coli infection,",0,0
NCF1,"Neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)",1,0.209374382696523,0.616343584684641,0.99999993574299,1,0.007666858827109,0.299773413490716,0.632923782510078,2,YES,0,"GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0009055~electron carrier activity,GO:0017076~purine nucleotide binding,GO:0017124~SH3 domain binding,GO:0019001~guanyl nucleotide binding,GO:0019904~protein domain specific binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0035091~phosphoinositide binding,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0043020~NADPH oxidase complex,GO:0044459~plasma membrane part,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0006801~superoxide metabolic process,GO:0006952~defense response,GO:0006955~immune response,GO:0006968~cellular defense response,GO:0042554~superoxide anion generation,GO:0045087~innate immune response,GO:0045730~respiratory burst,","hsa04062:Chemokine signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,",0,0
NTN4,Netrin 4,1,0.688115590211361,0.440497762117356,0.970822011431987,1,0.007686420966632,0.299773413490716,0.504745023317496,2,NO,0,"GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0016322~neuron remodeling,GO:0021700~developmental maturation,GO:0030182~neuron differentiation,GO:0042551~neuron maturation,GO:0048469~cell maturation,GO:0048666~neuron development,","hsa04360:Axon guidance,",0,0
IQCF2,IQ motif containing F2,1,1,0.236520976817479,0.999955015627927,1,0.007687320791373,0.299773413490716,0.13218088720682,2,NO,0,0,0,0,0
TAF1L,"TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 210kDa-like",1,0.336458385520195,0.594395772667206,0.697180104662691,1,0.007730791746095,0.300428362979366,0.640918834514274,2,YES,0,"GO:0000279~M phase,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0007049~cell cycle,GO:0007126~meiosis,GO:0007140~male meiosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0032774~RNA biosynthetic process,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005669~transcription factor TFIID complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0004402~histone acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0008080~N-acetyltransferase activity,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016563~transcription activator activity,GO:0017025~TATA-binding protein binding,GO:0030528~transcription regulator activity,","hsa03022:Basal transcription factors,",0,0
ATG16L1,ATG16 autophagy related 16-like 1 (S. cerevisiae),1,0.494743979854933,0.542850761888397,2.00E-14,1.18E-13,0.007736283665778,0.300428362979366,0.626173349617692,2,YES,0,"GO:0005773~vacuole,GO:0005776~autophagic vacuole,GO:0019898~extrinsic to membrane,GO:0000045~autophagic vacuole formation,GO:0006461~protein complex assembly,GO:0006914~autophagy,GO:0007033~vacuole organization,GO:0008104~protein localization,GO:0009267~cellular response to starvation,GO:0009991~response to extracellular stimulus,GO:0015031~protein transport,GO:0016236~macroautophagy,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0033554~cellular response to stress,GO:0042594~response to starvation,GO:0043933~macromolecular complex subunit organization,GO:0045184~establishment of protein localization,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,",0,0,0
TLR9,toll-like receptor 9,0.865129179476974,0.35533311031061,0.594395772667206,0.997371221831729,1,0.007792452939817,0.301981801790111,0.399827050180484,2,YES,0,"GO:0001817~regulation of cytokine production,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007249~I-kappaB kinase/NF-kappaB cascade,GO:0009611~response to wounding,GO:0009615~response to virus,GO:0009617~response to bacterium,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032479~regulation of type I interferon production,GO:0032647~regulation of interferon-alpha production,GO:0032648~regulation of interferon-beta production,GO:0032649~regulation of interferon-gamma production,GO:0042035~regulation of cytokine biosynthetic process,GO:0042108~positive regulation of cytokine biosynthetic process,GO:0042742~defense response to bacterium,GO:0045072~regulation of interferon-gamma biosynthetic process,GO:0045078~positive regulation of interferon-gamma biosynthetic process,GO:0045087~innate immune response,GO:0045354~regulation of interferon-alpha biosynthetic process,GO:0045356~positive regulation of interferon-alpha biosynthetic process,GO:0045357~regulation of interferon-beta biosynthetic process,GO:0045359~positive regulation of interferon-beta biosynthetic process,GO:0005576~extracellular region,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0044440~endosomal part,GO:0003723~RNA binding,GO:0005149~interleukin-1 receptor binding,GO:0035197~siRNA binding,","hsa04620:Toll-like receptor signaling pathway,",0,0
IGSF1,"Immunoglobulin superfamily, member 1",0.508762855496194,0.420265180899895,0.574288587185528,0.916944683719153,1,0.007839434750424,0.303173502491039,0.569613598392408,2,NO,0,"GO:0015026~coreceptor activity,GO:0034711~inhibin binding,GO:0048186~inhibin beta-A binding,GO:0048187~inhibin beta-B binding,GO:0005576~extracellular region,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0045449~regulation of transcription,",0,0,0
AVL9,AVL9 homolog (S. cerevisiase),1,0.420265180899895,0.574103899756076,6.79E-11,3.46E-10,0.007890378239382,0.303748128063533,0.767291454573143,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
SGCG,"Sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)",1,0.886481428527679,0.332676355469261,0.013478593999119,0.042399234979714,0.007917811602984,0.303748128063533,0.608631691127135,2,NO,0,"GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0016010~dystrophin-associated glycoprotein complex,GO:0016011~dystroglycan complex,GO:0016012~sarcoglycan complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0007010~cytoskeleton organization,GO:0007517~muscle organ development,","hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,hsa05416:Viral myocarditis,",0,0
LACTB,"Lactamase, beta",1,0.858711823250435,0.352752213519394,0.999821382170353,1,0.007919339277635,0.303748128063533,0.626520969222976,2,NO,0,"GO:0005739~mitochondrion,",0,0,0
PPFIA2,"protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2",1,0.03230571218278,0.64908205921566,0.274091758525267,0.748721842277489,0.007941502731354,0.303974035899517,0.310239027492301,2,YES,0,"GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0022610~biological adhesion,GO:0031589~cell-substrate adhesion,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0009986~cell surface,GO:0019717~synaptosome,",0,0,0
MCM7,minichromosome maintenance complex component 7,0.546771303462305,0.337793531458596,0.594395772667206,5.27E-10,2.56E-09,0.0080830631138,0.308129665107501,0.49448855021342,2,YES,0,"GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006268~DNA unwinding during replication,GO:0006270~DNA replication initiation,GO:0006350~transcription,GO:0006974~response to DNA damage stimulus,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0019220~regulation of phosphate metabolic process,GO:0032392~DNA geometric change,GO:0032508~DNA duplex unwinding,GO:0033554~cellular response to stress,GO:0042325~regulation of phosphorylation,GO:0045449~regulation of transcription,GO:0051174~regulation of phosphorus metabolic process,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0042555~MCM complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0044454~nuclear chromosome part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003697~single-stranded DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043566~structure-specific DNA binding,","hsa03030:DNA replication,hsa04110:Cell cycle,",0,0
HK2,hexokinase 2 pseudogene; hexokinase 2,1,0.419743362713117,0.59153065856549,0.999968602345258,1,0.008244535707179,0.313276559129172,0.501835233716458,2,NO,0,"GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006007~glucose catabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006096~glycolysis,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007595~lactation,GO:0016052~carbohydrate catabolic process,GO:0016310~phosphorylation,GO:0019318~hexose metabolic process,GO:0019320~hexose catabolic process,GO:0030879~mammary gland development,GO:0032504~multicellular organism reproduction,GO:0044275~cellular carbohydrate catabolic process,GO:0046164~alcohol catabolic process,GO:0046365~monosaccharide catabolic process,GO:0046835~carbohydrate phosphorylation,GO:0048609~reproductive process in a multicellular organism,GO:0048732~gland development,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0019867~outer membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004396~hexokinase activity,GO:0005524~ATP binding,GO:0005529~sugar binding,GO:0005536~glucose binding,GO:0017076~purine nucleotide binding,GO:0019200~carbohydrate kinase activity,GO:0030246~carbohydrate binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0048029~monosaccharide binding,","hsa00010:Glycolysis / Gluconeogenesis,hsa00051:Fructose and mannose metabolism,hsa00052:Galactose metabolism,hsa00500:Starch and sucrose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa04910:Insulin signaling pathway,hsa04930:Type II diabetes mellitus,",0,0
AMPD1,Adenosine monophosphate deaminase 1 (isoform M),1,0.136919046858385,0.620539289527082,0.952722317676711,1,0.008261875226788,0.313276559129172,0.671179724988878,2,NO,0,"GO:0003876~AMP deaminase activity,GO:0016814~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,GO:0019239~deaminase activity,GO:0006144~purine base metabolic process,GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0009112~nucleobase metabolic process,GO:0009123~nucleoside monophosphate metabolic process,GO:0009124~nucleoside monophosphate biosynthetic process,GO:0009126~purine nucleoside monophosphate metabolic process,GO:0009127~purine nucleoside monophosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009156~ribonucleoside monophosphate biosynthetic process,GO:0009161~ribonucleoside monophosphate metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009167~purine ribonucleoside monophosphate metabolic process,GO:0009168~purine ribonucleoside monophosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,","hsa00230:Purine metabolism,",0,0
SIPA1L1,signal-induced proliferation-associated 1 like 1,1,0.399243341661191,0.594395772667206,2.94E-09,1.37E-08,0.008271325259172,0.313276559129172,0.657679800266092,2,NO,0,"GO:0051056~regulation of small GTPase mediated signal transduction,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",0,0,0
CUL3,Cullin 3,0.312150786515571,0.005629812000978,0.70302965945656,0.999987910135013,1,0.008297730621902,0.313276559129172,0.15828687836966,2,YES,0,"GO:0019899~enzyme binding,GO:0030332~cyclin binding,GO:0031625~ubiquitin protein ligase binding,GO:0000151~ubiquitin ligase complex,GO:0005794~Golgi apparatus,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001701~in utero embryonic development,GO:0001824~blastocyst development,GO:0001825~blastocyst formation,GO:0001829~trophectodermal cell differentiation,GO:0001831~trophectodermal cellular morphogenesis,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006917~induction of apoptosis,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007369~gastrulation,GO:0008054~cyclin catabolic process,GO:0008284~positive regulation of cell proliferation,GO:0008629~induction of apoptosis by intracellular signals,GO:0009057~macromolecule catabolic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0010498~proteasomal protein catabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030163~protein catabolic process,GO:0032989~cellular component morphogenesis,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0048598~embryonic morphogenesis,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051603~proteolysis involved in cellular protein catabolic process,","hsa04120:Ubiquitin mediated proteolysis,",0,0
FAM184A,"family with sequence similarity 184, member A",1,0.08825557681226,0.628457722964864,0.999998745114259,1,0.00834245354031,0.313701802518198,0.633081795074557,2,NO,0,0,0,0,0
CAST,calpastatin,1,0.122408621449127,0.620539289527082,0.405323045747138,1,0.008349855957472,0.313701802518198,0.220844776605191,2,NO,0,"GO:0000768~syncytium formation by plasma membrane fusion,GO:0006949~syncytium formation,GO:0007520~myoblast fusion,GO:0014902~myotube differentiation,GO:0042692~muscle cell differentiation,GO:0043086~negative regulation of catalytic activity,GO:0044092~negative regulation of molecular function,GO:0051146~striated muscle cell differentiation,GO:0004857~enzyme inhibitor activity,GO:0004866~endopeptidase inhibitor activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0010859~calcium-dependent cysteine-type endopeptidase inhibitor activity,GO:0030414~peptidase inhibitor activity,",0,0,0
TUBB8,"tubulin, beta 8",1,0.023483600277954,0.660850491134096,0.999999628615624,1,0.008363590002359,0.313701802518198,0.56897667789562,2,NO,0,"GO:0006461~protein complex assembly,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0051258~protein polymerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005198~structural molecule activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,","hsa04540:Gap junction,hsa05130:Pathogenic Escherichia coli infection,",0,0
CLEC4M,"C-type lectin domain family 4, member M",1,1,0.200092469872577,0.999999960751267,1,0.008381637871217,0.313748725043014,0.451234834809584,2,NO,0,"GO:0006897~endocytosis,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007159~leukocyte adhesion,GO:0007242~intracellular signaling cascade,GO:0008037~cell recognition,GO:0009405~pathogenesis,GO:0009988~cell-cell recognition,GO:0010324~membrane invagination,GO:0015833~peptide transport,GO:0016032~viral reproduction,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016337~cell-cell adhesion,GO:0019048~virus-host interaction,GO:0019058~viral infectious cycle,GO:0019059~initiation of viral infection,GO:0019062~virion attachment to host cell surface receptor,GO:0019079~viral genome replication,GO:0019882~antigen processing and presentation,GO:0022415~viral reproductive process,GO:0022610~biological adhesion,GO:0030260~entry into host cell,GO:0044409~entry into host,GO:0046718~entry of virus into host cell,GO:0046794~virion transport,GO:0046795~intracellular virion transport,GO:0046907~intracellular transport,GO:0046968~peptide antigen transport,GO:0048002~antigen processing and presentation of peptide antigen,GO:0051806~entry into cell of other organism during symbiotic interaction,GO:0051828~entry into other organism during symbiotic interaction,GO:0052126~movement in host environment,GO:0052192~movement in environment of other organism during symbiotic interaction,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0003823~antigen binding,GO:0005509~calcium ion binding,GO:0005529~sugar binding,GO:0005537~mannose binding,GO:0030246~carbohydrate binding,GO:0030369~ICAM-3 receptor activity,GO:0042277~peptide binding,GO:0042605~peptide antigen binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046790~virion binding,GO:0046872~metal ion binding,GO:0048029~monosaccharide binding,",0,0,0
KCNJ5,"Potassium inwardly-rectifying channel, subfamily J, member 5",1,0.688115590211361,0.450365116245565,0.995245467578531,1,0.008403554288736,0.313939981118599,0.715977641109692,2,YES,0,"GO:0005216~ion channel activity,GO:0005242~inward rectifier potassium channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015467~G-protein activated inward rectifier potassium channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0030315~T-tubule,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0042383~sarcolemma,GO:0044459~plasma membrane part,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,",0,0,0
GLRA2,"Glycine receptor, alpha 2",1,0.333769293474224,0.599319901491912,0.999999891072746,1,0.008504511546736,0.316445759325643,0.673981402800127,2,YES,0,"GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016594~glycine binding,GO:0016597~amino acid binding,GO:0016933~extracellular-glycine-gated ion channel activity,GO:0016934~extracellular-glycine-gated chloride channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0031404~chloride ion binding,GO:0031406~carboxylic acid binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0043176~amine binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0007416~synaptogenesis,GO:0015698~inorganic anion transport,GO:0043062~extracellular structure organization,GO:0050808~synapse organization,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
IGF2BP1,insulin-like growth factor 2 mRNA binding protein 1,1,0.337089542023847,0.599319901491912,3.17E-21,2.30E-20,0.008667276239671,0.319948269380639,0.671880391195797,2,NO,0,"GO:0001817~regulation of cytokine production,GO:0006403~RNA localization,GO:0006417~regulation of translation,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010610~regulation of mRNA stability involved in response to stress,GO:0016071~mRNA metabolic process,GO:0017148~negative regulation of translation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0042035~regulation of cytokine biosynthetic process,GO:0043487~regulation of RNA stability,GO:0043488~regulation of mRNA stability,GO:0043489~RNA stabilization,GO:0048255~mRNA stabilization,GO:0051248~negative regulation of protein metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0005730~nucleolus,GO:0010494~stress granule,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0045182~translation regulator activity,GO:0048027~mRNA 5'-UTR binding,",0,0,0
ENOX1,ecto-NOX disulfide-thiol exchanger 1,1,0.026999735860493,0.660850491134096,0.977789773587073,1,0.008670579387659,0.319948269380639,0.321935602391112,2,NO,0,"GO:0006091~generation of precursor metabolites and energy,GO:0022900~electron transport chain,GO:0048511~rhythmic process,GO:0055114~oxidation reduction,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0044421~extracellular region part,GO:0000166~nucleotide binding,GO:0005507~copper ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
KIF23,Kinesin family member 23,1,0.844827538086744,0.379347082700499,0.999999999890127,1,0.00867281981739,0.319948269380639,0.647683724517552,2,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005654~nucleoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0015630~microtubule cytoskeleton,GO:0030496~midbody,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0070013~intracellular organelle lumen,GO:0000022~mitotic spindle elongation,GO:0000087~M phase of mitotic cell cycle,GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0007052~mitotic spindle organization,GO:0007067~mitosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0048285~organelle fission,GO:0051231~spindle elongation,GO:0051301~cell division,",0,0,0
EIF4ENIF1,Eukaryotic translation initiation factor 4E nuclear import factor 1,0.911377635387788,0.04453187072788,0.64908205921566,0.99999759254001,1,0.008684285699234,0.319948269380639,0.490355866829544,2,NO,0,"GO:0003743~translation initiation factor activity,GO:0008135~translation factor activity, nucleic acid binding,GO:0008565~protein transporter activity,GO:0005829~cytosol,GO:0008104~protein localization,GO:0015031~protein transport,GO:0045184~establishment of protein localization,",0,0,0
KIF25,Kinesin family member 25,1,1,0.049674502742746,0.999984865769238,1,0.008730704300598,0.321025247304874,0.702424689404026,2,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005856~cytoskeleton,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0000070~mitotic sister chromatid segregation,GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0000819~sister chromatid segregation,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0048285~organelle fission,GO:0051276~chromosome organization,",0,0,0
SAMD14,sterile alpha motif domain containing 14,1,0.227591325759547,0.616343584684641,1.18E-21,8.59E-21,0.008774235304514,0.321058439753784,0.728939517051832,2,NO,0,0,0,0,0
ZNF488,Zinc finger protein 488,1,1,0.108469860173985,0.99999806287474,1,0.008794207089269,0.321058439753784,0.453910411649338,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0010001~glial cell differentiation,GO:0010720~positive regulation of cell development,GO:0014003~oligodendrocyte development,GO:0014013~regulation of gliogenesis,GO:0014015~positive regulation of gliogenesis,GO:0021782~glial cell development,GO:0042063~gliogenesis,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045685~regulation of glial cell differentiation,GO:0045687~positive regulation of glial cell differentiation,GO:0048709~oligodendrocyte differentiation,GO:0048713~regulation of oligodendrocyte differentiation,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0050767~regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0051094~positive regulation of developmental process,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,",0,0,0
GNA13,"guanine nucleotide binding protein (G protein), alpha 13",0.915564401306741,0.001227926277335,0.765782523299255,4.71E-25,3.81E-24,0.008823547567108,0.321058439753784,0.470484819339068,2,YES,0,"GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001569~patterning of blood vessels,GO:0001701~in utero embryonic development,GO:0001763~morphogenesis of a branching structure,GO:0001775~cell activation,GO:0001944~vasculature development,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007266~Rho protein signal transduction,GO:0007389~pattern specification process,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0008360~regulation of cell shape,GO:0009611~response to wounding,GO:0009792~embryonic development ending in birth or egg hatching,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0019725~cellular homeostasis,GO:0022604~regulation of cell morphogenesis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0030168~platelet activation,GO:0030334~regulation of cell migration,GO:0031584~activation of phospholipase D activity,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0040012~regulation of locomotion,GO:0042060~wound healing,GO:0042592~homeostatic process,GO:0043009~chordate embryonic development,GO:0043085~positive regulation of catalytic activity,GO:0044093~positive regulation of molecular function,GO:0048514~blood vessel morphogenesis,GO:0048754~branching morphogenesis of a tube,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,GO:0051270~regulation of cell motion,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051480~cytosolic calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031253~cell projection membrane,GO:0031410~cytoplasmic vesicle,GO:0031526~brush border membrane,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042470~melanosome,GO:0042995~cell projection,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0048770~pigment granule,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0031701~angiotensin receptor binding,GO:0031702~type 1 angiotensin receptor binding,GO:0031752~D5 dopamine receptor binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0050780~dopamine receptor binding,","hsa04270:Vascular smooth muscle contraction,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,",0,0
RASGRF2,Ras protein-specific guanine nucleotide-releasing factor 2,1,0.07734522015286,0.641447788305282,0.999996881388283,1,0.00883473622964,0.321058439753784,0.584080440326797,2,NO,0,"GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005509~calcium ion binding,GO:0030695~GTPase regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0035023~regulation of Rho protein signal transduction,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,","hsa04010:MAPK signaling pathway,",0,0
GPR107,G protein-coupled receptor 107,1,0.621617423105817,0.494768425245321,0.999916613406756,1,0.008906653847937,0.32189422407288,0.659483576756226,2,YES,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
HHIP,hedgehog interacting protein,1,0.027681589966226,0.660850491134096,0.999376940157073,1,0.009087931883948,0.323329346821258,0.55330077501177,2,NO,0,"GO:0003002~regionalization,GO:0007166~cell surface receptor linked signal transduction,GO:0007224~smoothened signaling pathway,GO:0007389~pattern specification process,GO:0007405~neuroblast proliferation,GO:0008283~cell proliferation,GO:0008589~regulation of smoothened signaling pathway,GO:0009953~dorsal/ventral pattern formation,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,GO:0030323~respiratory tube development,GO:0030324~lung development,GO:0035295~tube development,GO:0040036~regulation of fibroblast growth factor receptor signaling pathway,GO:0045879~negative regulation of smoothened signaling pathway,GO:0060541~respiratory system development,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0019898~extrinsic to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,","hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,",0,0
ANAPC1,Anaphase promoting complex subunit 1,1,1,0.039459072105015,7.58E-12,4.06E-11,0.009098699896794,0.323329346821258,0.81012614256651,2,YES,unclear,"GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0009057~macromolecule catabolic process,GO:0010498~proteasomal protein catabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0030163~protein catabolic process,GO:0031145~anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031396~regulation of protein ubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0048285~organelle fission,GO:0051247~positive regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051301~cell division,GO:0051340~regulation of ligase activity,GO:0051351~positive regulation of ligase activity,GO:0051352~negative regulation of ligase activity,GO:0051436~negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051439~regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051443~positive regulation of ubiquitin-protein ligase activity,GO:0051444~negative regulation of ubiquitin-protein ligase activity,GO:0051603~proteolysis involved in cellular protein catabolic process,","hsa04110:Cell cycle,hsa04114:Oocyte meiosis,hsa04120:Ubiquitin mediated proteolysis,hsa04914:Progesterone-mediated oocyte maturation,",APC/C complex can suppress tumorigenesis (19826416); haploid loss in a patient with high cancer susceptibility (21984973); ,"member of APC/C complex which controls Mitotic progression and G1/S transition, APC/Cdh1 form of the complex suggested to act as a tumor suppressor (20935501) (19826416); Role of APC/C in turnover of DNA Damage Response proteins can contribute to tumor suppression in breast cancer (23637229)"
CPXM2,"carboxypeptidase X (M14 family), member 2",1,0.395685362190299,0.594395772667206,8.65E-32,8.31E-31,0.009106364873502,0.323329346821258,0.4319063596008,2,NO,0,"GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0005576~extracellular region,GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0008233~peptidase activity,GO:0008235~metalloexopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008238~exopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
PTER,phosphotriesterase related,1,1,0.160781827967041,0.955246825212676,1,0.009107992940237,0.323329346821258,0.562414143665007,2,YES,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
GPM6A,glycoprotein M6A,0.718478090855294,0.463044273101743,0.586563008794232,0.999786393459137,1,0.009132844894371,0.323329346821258,0.215053620356599,2,YES,0,"GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022838~substrate specific channel activity,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
DPYD,dihydropyrimidine dehydrogenase,1,0.030980812828431,0.660850491134096,0.999545293487313,1,0.00913409052118,0.323329346821258,0.462483522836211,2,NO,0,"GO:0006144~purine base metabolic process,GO:0006145~purine base catabolic process,GO:0006206~pyrimidine base metabolic process,GO:0006207~'de novo' pyrimidine base biosynthetic process,GO:0006208~pyrimidine base catabolic process,GO:0006210~thymine catabolic process,GO:0006212~uracil catabolic process,GO:0006213~pyrimidine nucleoside metabolic process,GO:0006214~thymidine catabolic process,GO:0006220~pyrimidine nucleotide metabolic process,GO:0006221~pyrimidine nucleotide biosynthetic process,GO:0006222~UMP biosynthetic process,GO:0009112~nucleobase metabolic process,GO:0009116~nucleoside metabolic process,GO:0009119~ribonucleoside metabolic process,GO:0009120~deoxyribonucleoside metabolic process,GO:0009123~nucleoside monophosphate metabolic process,GO:0009124~nucleoside monophosphate biosynthetic process,GO:0009129~pyrimidine nucleoside monophosphate metabolic process,GO:0009130~pyrimidine nucleoside monophosphate biosynthetic process,GO:0009156~ribonucleoside monophosphate biosynthetic process,GO:0009161~ribonucleoside monophosphate metabolic process,GO:0009164~nucleoside catabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009173~pyrimidine ribonucleoside monophosphate metabolic process,GO:0009174~pyrimidine ribonucleoside monophosphate biosynthetic process,GO:0009218~pyrimidine ribonucleotide metabolic process,GO:0009220~pyrimidine ribonucleotide biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0019856~pyrimidine base biosynthetic process,GO:0019859~thymine metabolic process,GO:0019860~uracil metabolic process,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0034655~nucleobase, nucleoside, nucleotide and nucleic acid catabolic process,GO:0034656~nucleobase, nucleoside and nucleotide catabolic process,GO:0044270~nitrogen compound catabolic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046049~UMP metabolic process,GO:0046104~thymidine metabolic process,GO:0046112~nucleobase biosynthetic process,GO:0046113~nucleobase catabolic process,GO:0046121~deoxyribonucleoside catabolic process,GO:0046125~pyrimidine deoxyribonucleoside metabolic process,GO:0046127~pyrimidine deoxyribonucleoside catabolic process,GO:0046131~pyrimidine ribonucleoside metabolic process,GO:0046135~pyrimidine nucleoside catabolic process,GO:0046700~heterocycle catabolic process,GO:0055114~oxidation reduction,GO:0005829~cytosol,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004152~dihydroorotate dehydrogenase activity,GO:0004158~dihydroorotate oxidase activity,GO:0004159~dihydrouracil dehydrogenase (NAD+) activity,GO:0005506~iron ion binding,GO:0009055~electron carrier activity,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0016634~oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,GO:0017076~purine nucleotide binding,GO:0017113~dihydropyrimidine dehydrogenase (NADP+) activity,GO:0030554~adenyl nucleotide binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046983~protein dimerization activity,GO:0048037~cofactor binding,GO:0050660~FAD binding,GO:0050661~NADP or NADPH binding,GO:0050662~coenzyme binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,GO:0051540~metal cluster binding,","hsa00240:Pyrimidine metabolism,hsa00410:beta-Alanine metabolism,hsa00770:Pantothenate and CoA biosynthesis,hsa00983:Drug metabolism,",0,0
SPATS2,"spermatogenesis associated, serine-rich 2",1,0.420265180899895,0.594395772667206,0.999537741383882,1,0.009211804189294,0.323329346821258,0.43422827283556,2,NO,0,0,0,0,0
ANO4,anoctamin 4,1,0.173043279027597,0.620539289527082,0.999970940467878,1,0.009229892302108,0.323329346821258,0.53451204168812,2,NO,0,"GO:0006811~ion transport,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0005216~ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0005509~calcium ion binding,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022838~substrate specific channel activity,GO:0031404~chloride ion binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
RASGRP3,RAS guanyl releasing protein 3 (calcium and DAG-regulated),1,0.749774076913278,0.425571792526707,0.99995899102589,1,0.009245861721015,0.323329346821258,0.471436183965395,2,NO,0,"GO:0000165~MAPKKK cascade,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0043087~regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0032045~guanyl-nucleotide exchange factor complex,GO:0044459~plasma membrane part,GO:0048471~perinuclear region of cytoplasm,GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005509~calcium ion binding,GO:0008047~enzyme activator activity,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0017016~Ras GTPase binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019992~diacylglycerol binding,GO:0030695~GTPase regulator activity,GO:0031267~small GTPase binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046582~Rap GTPase activator activity,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04010:MAPK signaling pathway,hsa04662:B cell receptor signaling pathway,",0,0
CPS1,"carbamoyl-phosphate synthetase 1, mitochondrial",1,0.155376514385239,0.620539289527082,3.85E-31,3.63E-30,0.009277212456344,0.323329346821258,0.521950175260932,2,NO,0,"GO:0000050~urea cycle,GO:0000052~citrulline metabolic process,GO:0000272~polysaccharide catabolic process,GO:0002237~response to molecule of bacterial origin,GO:0005976~polysaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005980~glycogen catabolic process,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006073~cellular glucan metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006112~energy reserve metabolic process,GO:0006541~glutamine metabolic process,GO:0006575~cellular amino acid derivative metabolic process,GO:0006638~neutral lipid metabolic process,GO:0006639~acylglycerol metabolic process,GO:0006641~triglyceride metabolic process,GO:0006662~glycerol ether metabolic process,GO:0009057~macromolecule catabolic process,GO:0009064~glutamine family amino acid metabolic process,GO:0009251~glucan catabolic process,GO:0009617~response to bacterium,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010243~response to organic nitrogen,GO:0014075~response to amine stimulus,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016042~lipid catabolic process,GO:0016052~carbohydrate catabolic process,GO:0018904~organic ether metabolic process,GO:0019240~citrulline biosynthetic process,GO:0019318~hexose metabolic process,GO:0019433~triglyceride catabolic process,GO:0019627~urea metabolic process,GO:0031667~response to nutrient levels,GO:0031960~response to corticosteroid stimulus,GO:0032496~response to lipopolysaccharide,GO:0033762~response to glucagon stimulus,GO:0033993~response to lipid,GO:0034201~response to oleic acid,GO:0042312~regulation of vasodilation,GO:0042398~cellular amino acid derivative biosynthetic process,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0042594~response to starvation,GO:0043434~response to peptide hormone stimulus,GO:0043603~cellular amide metabolic process,GO:0043604~amide biosynthetic process,GO:0044042~glucan metabolic process,GO:0044057~regulation of system process,GO:0044242~cellular lipid catabolic process,GO:0044247~cellular polysaccharide catabolic process,GO:0044264~cellular polysaccharide metabolic process,GO:0044269~glycerol ether catabolic process,GO:0044271~nitrogen compound biosynthetic process,GO:0044275~cellular carbohydrate catabolic process,GO:0045909~positive regulation of vasodilation,GO:0046209~nitric oxide metabolic process,GO:0046461~neutral lipid catabolic process,GO:0046464~acylglycerol catabolic process,GO:0046486~glycerolipid metabolic process,GO:0046503~glycerolipid catabolic process,GO:0048545~response to steroid hormone stimulus,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0051240~positive regulation of multicellular organismal process,GO:0051384~response to glucocorticoid stimulus,GO:0051591~response to cAMP,GO:0055081~anion homeostasis,GO:0070408~carbamoyl phosphate metabolic process,GO:0070409~carbamoyl phosphate biosynthetic process,GO:0070542~response to fatty acid,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0009295~nucleoid,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0031980~mitochondrial lumen,GO:0042645~mitochondrial nucleoid,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004086~carbamoyl-phosphate synthase activity,GO:0004087~carbamoyl-phosphate synthase (ammonia) activity,GO:0005524~ATP binding,GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032403~protein complex binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa00250:Alanine, aspartate and glutamate metabolism,hsa00330:Arginine and proline metabolism,hsa00910:Nitrogen metabolism,",0,0
GABRR2,"gamma-aminobutyric acid (GABA) receptor, rho 2",1,0.342096927505986,0.599319901491912,0.999999970580489,1,0.009284663516376,0.323329346821258,0.372296236673888,2,YES,0,"GO:0006811~ion transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0019226~transmission of nerve impulse,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0004890~GABA-A receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016917~GABA receptor activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0031404~chloride ion binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043168~anion binding,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
EPHA7,EPH receptor A7,1,0.023483600277954,0.669292822937893,0.999999971586709,1,0.009286985997085,0.323329346821258,0.179245688547434,2,YES,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001763~morphogenesis of a branching structure,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0016310~phosphorylation,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0031290~retinal ganglion cell axon guidance,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043523~regulation of neuron apoptosis,GO:0043525~positive regulation of neuron apoptosis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048755~branching morphogenesis of a nerve,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0030425~dendrite,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031594~neuromuscular junction,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0045499~chemorepellent activity,GO:0046875~ephrin receptor binding,","hsa04360:Axon guidance,",0,0
FAT4,FAT tumor suppressor homolog 4 (Drosophila),1,0.138864686954504,0.628457722964864,0.999687893520745,1,0.009300227944013,0.323329346821258,0.480562444624714,2,NO,0,"GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
LPHN2,latrophilin 2,1,0.073677884535897,0.641447788305282,0.999502750423679,1,0.009312660666515,0.323329346821258,0.489652608719832,2,YES,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005529~sugar binding,GO:0016524~latrotoxin receptor activity,GO:0030246~carbohydrate binding,",0,0,0
FNBP1L,Formin binding protein 1-like,1,0.745415986888831,0.444921389161528,0.99797527109108,1,0.009338401364131,0.323621519630068,0.634378696063076,2,NO,0,"GO:0008289~lipid binding,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0009898~internal side of plasma membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0006897~endocytosis,GO:0010324~membrane invagination,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,",0,0,0
SMAP1,small ArfGAP 1,1,0.73524777513296,0.450365116245565,0.999999964547817,1,0.009378676151819,0.323942543530427,0.316325733928701,2,NO,0,"GO:0032012~regulation of ARF protein signal transduction,GO:0032312~regulation of ARF GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0032844~regulation of homeostatic process,GO:0043087~regulation of GTPase activity,GO:0045597~positive regulation of cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045646~regulation of erythrocyte differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051094~positive regulation of developmental process,GO:0051336~regulation of hydrolase activity,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0008060~ARF GTPase activator activity,GO:0008270~zinc ion binding,GO:0030695~GTPase regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04144:Endocytosis,",0,0
LNX2,ligand of numb-protein X 2,0.793406891251112,0.271476723733921,0.616343584684641,7.35E-11,3.74E-10,0.009557339570291,0.328164606311534,0.428438253595607,2,YES,0,"GO:0006461~protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0008270~zinc ion binding,GO:0019904~protein domain specific binding,GO:0030165~PDZ domain binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
POLR2C,"polymerase (RNA) II (DNA directed) polypeptide C, 33kDa",1,0.943222637657724,0.332676355469261,1,1,0.009589119761075,0.328562597835088,0.163681587953494,2,YES,0,"GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006354~RNA elongation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~RNA elongation from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006461~protein complex assembly,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0032774~RNA biosynthetic process,GO:0043933~macromolecular complex subunit organization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0000428~DNA-directed RNA polymerase complex,GO:0005654~nucleoplasm,GO:0005665~DNA-directed RNA polymerase II, core complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0030880~RNA polymerase complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0055029~nuclear DNA-directed RNA polymerase complex,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0004672~protein kinase activity,GO:0016779~nucleotidyltransferase activity,GO:0034062~RNA polymerase activity,GO:0046983~protein dimerization activity,","hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa03020:RNA polymerase,hsa05016:Huntington's disease,",0,0
ZNF146,Zinc finger protein 146,0.383384775341622,0.12337077733248,0.628457722964864,2.17E-16,1.36E-15,0.009710839306234,0.330398483426482,0.784520270456343,2,NO,0,"GO:0001871~pattern binding,GO:0003677~DNA binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0008270~zinc ion binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
SCCPDH,saccharopine dehydrogenase (putative),1,0.255152378265114,0.616343584684641,7.68E-05,0.000280676561839,0.009746679698819,0.330623232180991,0.793813153637758,2,NO,0,"GO:0055114~oxidation reduction,GO:0004753~saccharopine dehydrogenase activity,GO:0016645~oxidoreductase activity, acting on the CH-NH group of donors,GO:0016646~oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,GO:0047131~saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,",0,0,0
SPATA17,spermatogenesis associated 17,0.512094081736782,0.910322520092466,0.350070687212711,0.000379105288922,0.001318433753821,0.009752845491286,0.330623232180991,0.562307784207381,2,NO,0,"GO:0005516~calmodulin binding,",0,0,0
HLA-DRA,"major histocompatibility complex, class II, DR alpha",1,0.724507651291874,0.462781043665193,1,1,0.009783194287119,0.331051242915015,0.546999785028593,2,YES,0,"GO:0002250~adaptive immune response,GO:0002252~immune effector process,GO:0002443~leukocyte mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002478~antigen processing and presentation of exogenous peptide antigen,GO:0002495~antigen processing and presentation of peptide antigen via MHC class II,GO:0002504~antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,GO:0002684~positive regulation of immune system process,GO:0006952~defense response,GO:0006955~immune response,GO:0016064~immunoglobulin mediated immune response,GO:0019724~B cell mediated immunity,GO:0019882~antigen processing and presentation,GO:0019884~antigen processing and presentation of exogenous antigen,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0048002~antigen processing and presentation of peptide antigen,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005773~vacuole,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0042611~MHC protein complex,GO:0042613~MHC class II protein complex,GO:0042824~MHC class I peptide loading complex,GO:0042825~TAP complex,GO:0044432~endoplasmic reticulum part,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032395~MHC class II receptor activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042277~peptide binding,GO:0042287~MHC protein binding,GO:0042288~MHC class I protein binding,","hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04640:Hematopoietic cell lineage,hsa04672:Intestinal immune network for IgA production,hsa04940:Type I diabetes mellitus,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05322:Systemic lupus erythematosus,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,",0,0
TNRC6A,trinucleotide repeat containing 6A,0.512599563854318,0.061200479048279,0.64908205921566,0.863579385850753,1,0.009898951511061,0.333907172653477,0.46270850615504,2,NO,0,"GO:0006417~regulation of translation,GO:0009267~cellular response to starvation,GO:0009890~negative regulation of biosynthetic process,GO:0009991~response to extracellular stimulus,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016441~posttranscriptional gene silencing,GO:0016458~gene silencing,GO:0017148~negative regulation of translation,GO:0031047~gene silencing by RNA,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031667~response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031669~cellular response to nutrient levels,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0033554~cellular response to stress,GO:0035194~posttranscriptional gene silencing by RNA,GO:0035195~gene silencing by miRNA,GO:0035278~gene silencing by miRNA, negative regulation of translation,GO:0040029~regulation of gene expression, epigenetic,GO:0040033~negative regulation of translation, ncRNA-mediated,GO:0042594~response to starvation,GO:0045974~regulation of translation, ncRNA-mediated,GO:0051248~negative regulation of protein metabolic process,GO:0000932~cytoplasmic mRNA processing body,GO:0030529~ribonucleoprotein complex,GO:0035068~micro-ribonucleoprotein complex,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",0,0,0
CSMD1,CUB and Sushi multiple domains 1,1,0.018651724385232,0.679130630618955,0.95274866658159,1,0.009947788682629,0.333907172653477,0.521569458006515,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
GABRA3,"Gamma-aminobutyric acid (GABA) A receptor, alpha 3",1,0.885242164881095,0.379347082700499,8.39E-05,0.000305998277538,0.009986433580615,0.333907172653477,0.710494621759348,2,YES,0,"GO:0004890~GABA-A receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008503~benzodiazepine receptor activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016917~GABA receptor activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0031404~chloride ion binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0015698~inorganic anion transport,GO:0019226~transmission of nerve impulse,GO:0050877~neurological system process,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
NUFIP1,nuclear fragile X mental retardation protein interacting protein 1,1,0.420265180899895,0.594395772667206,0.990927115185805,1,0.009999298623685,0.333907172653477,0.326553013892962,2,NO,0,"GO:0000491~small nucleolar ribonucleoprotein complex assembly,GO:0000492~box C/D snoRNP assembly,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0031328~positive regulation of cellular biosynthetic process,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0065003~macromolecular complex assembly,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005726~perichromatin fibrils,GO:0005730~nucleolus,GO:0005840~ribosome,GO:0008023~transcription elongation factor complex,GO:0016363~nuclear matrix,GO:0022626~cytosolic ribosome,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034399~nuclear periphery,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0044454~nuclear chromosome part,GO:0044456~synapse part,GO:0045202~synapse,GO:0048786~presynaptic active zone,GO:0070013~intracellular organelle lumen,GO:0070761~pre-snoRNP complex,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0030515~snoRNA binding,GO:0030674~protein binding, bridging,GO:0042802~identical protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
SF1,Splicing factor 1,0.434004138197617,0.271476723733921,0.616343584684641,0.982581987071801,1,0.010010339799873,0.333907172653477,0.455302503299924,2,NO,0,"GO:0003702~RNA polymerase II transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005681~spliceosome,GO:0005730~nucleolus,GO:0005840~ribosome,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000245~spliceosome assembly,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000389~nuclear mRNA 3'-splice site recognition,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006376~mRNA splice site selection,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0007049~cell cycle,GO:0007530~sex determination,GO:0007548~sex differentiation,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0016071~mRNA metabolic process,GO:0019216~regulation of lipid metabolic process,GO:0019218~regulation of steroid metabolic process,GO:0022402~cell cycle process,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0030238~male sex determination,GO:0033327~Leydig cell differentiation,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0042127~regulation of cell proliferation,GO:0043933~macromolecular complex subunit organization,GO:0045137~development of primary sexual characteristics,GO:0045449~regulation of transcription,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0046890~regulation of lipid biosynthetic process,GO:0048608~reproductive structure development,GO:0048610~reproductive cellular process,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0050810~regulation of steroid biosynthetic process,GO:0065003~macromolecular complex assembly,",0,0,0
ZNF845,zinc finger protein 845,1,1,0.060454527062301,0.668837637856295,1,0.010010878012588,0.333907172653477,0.754701563446163,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
KRTAP1-3,keratin associated protein 1-4; keratin associated protein 1-3,1,1,0.039289744897804,2.79E-07,1.18E-06,0.010021940138502,0.333907172653477,0.484899212407193,2,NO,0,"GO:0005576~extracellular region,GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045095~keratin filament,GO:0045111~intermediate filament cytoskeleton,GO:0005198~structural molecule activity,GO:0030280~structural constituent of epidermis,",0,0,0
SNAP25,"Synaptosomal-associated protein, 25kDa",1,0.812549668064137,0.413900866678315,0.999999999913724,1,0.010084745100301,0.335183191687745,0.75991083498746,2,NO,0,"GO:0000149~SNARE binding,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0008092~cytoskeletal protein binding,GO:0015267~channel activity,GO:0017022~myosin binding,GO:0017075~syntaxin-1 binding,GO:0019905~syntaxin binding,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0046873~metal ion transmembrane transporter activity,GO:0047485~protein N-terminus binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0019717~synaptosome,GO:0030054~cell junction,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0031201~SNARE complex,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0044431~Golgi apparatus part,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,GO:0070032~synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,GO:0070044~synaptobrevin 2-SNAP-25-syntaxin-1a complex,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001504~neurotransmitter uptake,GO:0001505~regulation of neurotransmitter levels,GO:0002790~peptide secretion,GO:0002791~regulation of peptide secretion,GO:0002793~positive regulation of peptide secretion,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0006836~neurotransmitter transport,GO:0006887~exocytosis,GO:0006904~vesicle docking during exocytosis,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0007409~axonogenesis,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007613~memory,GO:0007616~long-term memory,GO:0009914~hormone transport,GO:0010817~regulation of hormone levels,GO:0015833~peptide transport,GO:0016079~synaptic vesicle exocytosis,GO:0016081~synaptic vesicle docking during exocytosis,GO:0016192~vesicle-mediated transport,GO:0016197~endosome transport,GO:0019226~transmission of nerve impulse,GO:0022406~membrane docking,GO:0030030~cell projection organization,GO:0030072~peptide hormone secretion,GO:0030182~neuron differentiation,GO:0030252~growth hormone secretion,GO:0030431~sleep,GO:0031175~neuron projection development,GO:0032024~positive regulation of insulin secretion,GO:0032940~secretion by cell,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0046879~hormone secretion,GO:0046883~regulation of hormone secretion,GO:0046887~positive regulation of hormone secretion,GO:0046903~secretion,GO:0046907~intracellular transport,GO:0048278~vesicle docking,GO:0048489~synaptic vesicle transport,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048791~calcium ion-dependent exocytosis of neurotransmitter,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050796~regulation of insulin secretion,GO:0050803~regulation of synapse structure and activity,GO:0050807~regulation of synapse organization,GO:0050877~neurological system process,GO:0050890~cognition,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051050~positive regulation of transport,GO:0051960~regulation of nervous system development,GO:0051963~regulation of synaptogenesis,GO:0060341~regulation of cellular localization,","hsa04130:SNARE interactions in vesicular transport,",0,0
CDH11,"Cadherin 11, type 2, OB-cadherin (osteoblast)",1,0.512088789788058,0.574103899756076,0.999999999700082,1,0.010133496406181,0.336059105526394,0.561321029934445,2,NO,0,"GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0060348~bone development,",0,0,0
BAZ2B,"bromodomain adjacent to zinc finger domain, 2B",0.572493114338362,0.007370682982779,0.715616735094674,0.996906575606006,1,0.01014708150955,0.336059105526394,0.219399983343651,2,YES,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
TWF2,"twinfilin, actin-binding protein, homolog 2 (Drosophila)",1,0.329352821947289,0.601943915278899,0.998591078002944,1,0.010241238903251,0.338125108727472,0.448624613559793,2,YES,0,"GO:0005856~cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003779~actin binding,GO:0005524~ATP binding,GO:0008092~cytoskeletal protein binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",0,0,0
SYPL2,synaptophysin-like 2,1,0.876560862545503,0.379347082700499,0.999909611963325,1,0.010245666874016,0.338125108727472,0.602725021328629,2,NO,0,"GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0019725~cellular homeostasis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0042592~homeostatic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0008021~synaptic vesicle,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044456~synapse part,GO:0045202~synapse,",0,0,0
ALDH8A1,"Aldehyde dehydrogenase 8 family, member A1",1,0.318629720376967,0.61373452714822,0.990780285499005,1,0.010291945028339,0.339053335422117,0.781611725048889,2,YES,novel,"GO:0001758~retinal dehydrogenase activity,GO:0016620~oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,GO:0001523~retinoid metabolic process,GO:0006081~cellular aldehyde metabolic process,GO:0006720~isoprenoid metabolic process,GO:0006721~terpenoid metabolic process,GO:0006766~vitamin metabolic process,GO:0006775~fat-soluble vitamin metabolic process,GO:0006776~vitamin A metabolic process,GO:0008299~isoprenoid biosynthetic process,GO:0008610~lipid biosynthetic process,GO:0009110~vitamin biosynthetic process,GO:0010817~regulation of hormone levels,GO:0016101~diterpenoid metabolic process,GO:0019748~secondary metabolic process,GO:0034754~cellular hormone metabolic process,GO:0035238~vitamin A biosynthetic process,GO:0042362~fat-soluble vitamin biosynthetic process,GO:0042445~hormone metabolic process,GO:0042573~retinoic acid metabolic process,GO:0042574~retinal metabolic process,GO:0042904~9-cis-retinoic acid biosynthetic process,GO:0042905~9-cis-retinoic acid metabolic process,GO:0043288~apocarotenoid metabolic process,GO:0055114~oxidation reduction,",0,amplified in a study of colorectal cancer (19691111),"first identified aldehyde dehydrogenase with preferential specificity for 9-cis-retinal rather than all-trans-retinal (11007799), regulates retinoic acid signaling (21552008)"
CLEC4C,"C-type lectin domain family 4, member C",0.930296356193077,0.621617423105817,0.532650659483048,0.968458974558855,1,0.01031019932971,0.339056713520512,0.623204838288194,2,NO,0,"GO:0006955~immune response,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005529~sugar binding,GO:0030246~carbohydrate binding,",0,0,0
ZNF208,zinc finger protein 208,1,0.120232565651346,0.628457722964864,0.957640562142846,1,0.010338344350507,0.339384769987919,0.611836927079267,2,NO,0,"GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
PTPN3,"protein tyrosine phosphatase, non-receptor type 3",0.865384930113013,0.656276216627911,0.505403482019668,0.999990747266255,1,0.010490725496848,0.340873872752955,0.22204857406069,2,YES,0,"GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0009894~regulation of catabolic process,GO:0009895~negative regulation of catabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0016311~dephosphorylation,GO:0030162~regulation of proteolysis,GO:0031329~regulation of cellular catabolic process,GO:0031330~negative regulation of cellular catabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0042176~regulation of protein catabolic process,GO:0042177~negative regulation of protein catabolic process,GO:0045861~negative regulation of proteolysis,GO:0051043~regulation of membrane protein ectodomain proteolysis,GO:0051045~negative regulation of membrane protein ectodomain proteolysis,GO:0051248~negative regulation of protein metabolic process,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0019898~extrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044459~plasma membrane part,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008092~cytoskeletal protein binding,GO:0016791~phosphatase activity,",0,0,0
ERO1LB,ERO1-like beta (S. cerevisiae),0.489340439045559,0.337244195918755,0.601943915278899,8.67E-21,6.20E-20,0.010510425335667,0.340873872752955,0.760156971485021,2,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0009055~electron carrier activity,GO:0016667~oxidoreductase activity, acting on sulfur group of donors,GO:0016671~oxidoreductase activity, acting on sulfur group of donors, disulfide as acceptor,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0048037~cofactor binding,GO:0050660~FAD binding,GO:0050662~coenzyme binding,GO:0051082~unfolded protein binding,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0012505~endomembrane system,GO:0031090~organelle membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044432~endoplasmic reticulum part,GO:0006091~generation of precursor metabolites and energy,GO:0006457~protein folding,GO:0006467~protein thiol-disulfide exchange,GO:0022900~electron transport chain,GO:0055114~oxidation reduction,",0,0,0
HECW2,"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2",1,0.342096927505986,0.601943915278899,0.989604926491245,1,0.010537002678466,0.340873872752955,0.609619225682368,2,YES,0,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,",0,0,0
ZNF836,zinc finger protein 836,1,0.475808461183278,0.594395772667206,0.704095926926955,1,0.010566600285039,0.340873872752955,0.599651717164426,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
BTAF1,"BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae)",0.882830666753747,0.067877849760584,0.64908205921566,0.999994159549526,1,0.010584444895161,0.340873872752955,0.11091336205078,2,NO,0,"GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030528~transcription regulator activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",0,0,0
ROBO2,"roundabout, axon guidance receptor, homolog 2 (Drosophila)",1,0.031936088829255,0.669292822937893,0.999841244316927,1,0.010656749435749,0.342023063076219,0.264432936125642,2,YES,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001655~urogenital system development,GO:0001656~metanephros development,GO:0001657~ureteric bud development,GO:0001822~kidney development,GO:0006928~cell motion,GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0010720~positive regulation of cell development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010975~regulation of neuron projection development,GO:0016337~cell-cell adhesion,GO:0022604~regulation of cell morphogenesis,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0031344~regulation of cell projection organization,GO:0031346~positive regulation of cell projection organization,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0035295~tube development,GO:0042330~taxis,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050767~regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050770~regulation of axonogenesis,GO:0050772~positive regulation of axonogenesis,GO:0051094~positive regulation of developmental process,GO:0051130~positive regulation of cellular component organization,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0030424~axon,GO:0030673~axolemma,GO:0031224~intrinsic to membrane,GO:0031252~cell leading edge,GO:0031253~cell projection membrane,GO:0031256~leading edge membrane,GO:0032589~neuron projection membrane,GO:0033267~axon part,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0042802~identical protein binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,","hsa04360:Axon guidance,",0,0
STXBP5L,syntaxin binding protein 5-like,1,0.000902535814131,0.815505698774646,0.982535966707301,1,0.010737458051251,0.343922656430546,0.578014997284312,2,NO,0,"GO:0006887~exocytosis,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032940~secretion by cell,GO:0045184~establishment of protein localization,GO:0046903~secretion,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0019898~extrinsic to membrane,GO:0031224~intrinsic to membrane,",0,0,0
ETV6,Ets variant gene 6 (TEL oncogene),1,0.953842715951356,0.350070687212711,0.848965752647777,1,0.010780033095861,0.343922656430546,0.691021509847736,2,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0019904~protein domain specific binding,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,","hsa04320:Dorso-ventral axis formation,",0,0
TRIM41,tripartite motif-containing 41,1,1,0.065086045359333,0.000150361496689,0.00053722310571,0.01078884995841,0.343922656430546,0.701437324077242,2,YES,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
CACNA1E,"Calcium channel, voltage-dependent, R type, alpha 1E subunit",1,0.165219135608965,0.628457722964864,5.74E-07,2.39E-06,0.01086708052768,0.343922656430546,0.762053661833589,2,YES,0,"GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005245~voltage-gated calcium channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034704~calcium channel complex,GO:0043025~cell soma,GO:0043204~perikaryon,GO:0044459~plasma membrane part,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0015674~di-, tri-valent inorganic cation transport,GO:0019226~transmission of nerve impulse,GO:0030001~metal ion transport,GO:0033500~carbohydrate homeostasis,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0048878~chemical homeostasis,GO:0050877~neurological system process,GO:0055085~transmembrane transport,","hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,hsa04930:Type II diabetes mellitus,",0,0
EPHA5,EPH receptor A5,0.925081197895635,0.07009405772913,0.64908205921566,0.999873995164864,1,0.010877742153465,0.343922656430546,0.302573236270331,2,YES,0,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0016310~phosphorylation,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04360:Axon guidance,",0,0
ZNF485,Zinc finger protein 485,1,0.76383376707594,0.450365116245565,0.999955998951722,1,0.010894881825263,0.343922656430546,0.667710623503812,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
DGKI,"diacylglycerol kinase, iota",1,0.113648128859315,0.641447788305282,0.000189945240175,0.000672731729471,0.011056390023446,0.347616076352102,0.64411411037026,2,NO,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007205~activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway,GO:0007242~intracellular signaling cascade,GO:0019220~regulation of phosphate metabolic process,GO:0032147~activation of protein kinase activity,GO:0033674~positive regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004143~diacylglycerol kinase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00561:Glycerolipid metabolism,hsa00564:Glycerophospholipid metabolism,hsa04070:Phosphatidylinositol signaling system,",0,0
PPP2R5C,"protein phosphatase 2, regulatory subunit B', gamma isoform",1,0.342096927505986,0.603875498967983,0.999999997402684,1,0.011075182516404,0.347616076352102,0.419417002124787,2,NO,0,"GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0009057~macromolecule catabolic process,GO:0010498~proteasomal protein catabolic process,GO:0016485~protein processing,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051604~protein maturation,GO:0000159~protein phosphatase type 2A complex,GO:0008287~protein serine/threonine phosphatase complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0008233~peptidase activity,GO:0008601~protein phosphatase type 2A regulator activity,GO:0019208~phosphatase regulator activity,GO:0019888~protein phosphatase regulator activity,","hsa04114:Oocyte meiosis,hsa04310:Wnt signaling pathway,",0,0
NOL4,nucleolar protein 4,1,0.142038435823367,0.628457722964864,0.99999999985614,1,0.011091556373781,0.347616076352102,0.555722386737773,2,NO,0,"GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003723~RNA binding,",0,0,0
BAMBI,hypothetical LOC729590; BMP and activin membrane-bound inhibitor homolog (Xenopus laevis),1,0.858711823250435,0.413900866678315,0.999999978543019,1,0.011143270046688,0.348068797996806,0.387599140321717,2,NO,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
CSNK1G1,"casein kinase 1, gamma 1",0.877681070295713,0.858711823250435,0.413900866678315,0.989000535966062,1,0.011143270046688,0.348068797996806,0.161119008188311,2,YES,0,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0016055~Wnt receptor signaling pathway,GO:0016310~phosphorylation,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04340:Hedgehog signaling pathway,",0,0
SELP,"Selectin P (granule membrane protein 140kDa, antigen CD62)",0.846120936133285,0.367053233444936,0.601943915278899,1.48E-18,9.91E-18,0.011185090617953,0.348791832475351,0.72010741809156,2,NO,0,"GO:0001530~lipopolysaccharide binding,GO:0001871~pattern binding,GO:0001948~glycoprotein binding,GO:0005529~sugar binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0008289~lipid binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0033691~sialic acid binding,GO:0042806~fucose binding,GO:0043208~glycosphingolipid binding,GO:0043498~cell surface binding,GO:0043499~eukaryotic cell surface binding,GO:0046625~sphingolipid binding,GO:0048029~monosaccharide binding,GO:0048306~calcium-dependent protein binding,GO:0051861~glycolipid binding,GO:0070492~oligosaccharide binding,GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005624~membrane fraction,GO:0005625~soluble fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0030659~cytoplasmic vesicle membrane,GO:0030667~secretory granule membrane,GO:0031090~organelle membrane,GO:0031091~platelet alpha granule,GO:0031092~platelet alpha granule membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044421~extracellular region part,GO:0044433~cytoplasmic vesicle part,GO:0044459~plasma membrane part,GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0002237~response to molecule of bacterial origin,GO:0002685~regulation of leukocyte migration,GO:0002691~regulation of cellular extravasation,GO:0006928~cell motion,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007157~heterophilic cell adhesion,GO:0007159~leukocyte adhesion,GO:0009611~response to wounding,GO:0009617~response to bacterium,GO:0010033~response to organic substance,GO:0010543~regulation of platelet activation,GO:0010572~positive regulation of platelet activation,GO:0016337~cell-cell adhesion,GO:0016477~cell migration,GO:0022610~biological adhesion,GO:0030193~regulation of blood coagulation,GO:0030334~regulation of cell migration,GO:0032101~regulation of response to external stimulus,GO:0032496~response to lipopolysaccharide,GO:0040012~regulation of locomotion,GO:0042742~defense response to bacterium,GO:0045123~cellular extravasation,GO:0048514~blood vessel morphogenesis,GO:0048870~cell motility,GO:0050818~regulation of coagulation,GO:0050829~defense response to Gram-negative bacterium,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050900~leukocyte migration,GO:0050901~leukocyte tethering or rolling,GO:0051270~regulation of cell motion,GO:0051674~localization of cell,","hsa04514:Cell adhesion molecules (CAMs),",0,0
KIAA1967,KIAA1967,0.987684930790552,0.086227261596822,0.641447788305282,0.999999998541972,1,0.011221648438828,0.348851864114871,0.252492460966019,2,NO,0,"GO:0006915~apoptosis,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,",0,0,0
MDGA1,MAM domain containing glycosylphosphatidylinositol anchor 1,1,0.758706074822199,0.453407888672024,0.327990081888469,0.881768385088472,0.011243044177801,0.348851864114871,0.676174290241788,2,NO,0,"GO:0001764~neuron migration,GO:0006928~cell motion,GO:0016477~cell migration,GO:0021510~spinal cord development,GO:0021515~cell differentiation in spinal cord,GO:0021516~dorsal spinal cord development,GO:0021527~spinal cord association neuron differentiation,GO:0030182~neuron differentiation,GO:0048870~cell motility,GO:0051674~localization of cell,GO:0005886~plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0046658~anchored to plasma membrane,",0,0,0
DAO,D-amino-acid oxidase,1,0.745415986888831,0.462781043665193,0.99999999999997,1,0.011391020506868,0.350715204754142,0.327035319343313,2,NO,0,"GO:0003884~D-amino-acid oxidase activity,GO:0016638~oxidoreductase activity, acting on the CH-NH2 group of donors,GO:0016641~oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,GO:0005777~peroxisome,GO:0042579~microbody,GO:0006081~cellular aldehyde metabolic process,GO:0006551~leucine metabolic process,GO:0009081~branched chain family amino acid metabolic process,GO:0046487~glyoxylate metabolic process,GO:0055114~oxidation reduction,","hsa00260:Glycine, serine and threonine metabolism,hsa00330:Arginine and proline metabolism,hsa00472:D-Arginine and D-ornithine metabolism,",0,0
AP1G2,"adaptor-related protein complex 1, gamma 2 subunit",1,0.886481428527679,0.400996972600096,0.771781482756336,1,0.011394194155208,0.350715204754142,0.517532274794706,2,NO,0,"GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070727~cellular macromolecule localization,GO:0000139~Golgi membrane,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005798~Golgi-associated vesicle,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0012510~trans-Golgi network transport vesicle membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0019898~extrinsic to membrane,GO:0030117~membrane coat,GO:0030118~clathrin coat,GO:0030119~AP-type membrane coat adaptor complex,GO:0030120~vesicle coat,GO:0030121~AP-1 adaptor complex,GO:0030125~clathrin vesicle coat,GO:0030130~clathrin coat of trans-Golgi network vesicle,GO:0030131~clathrin adaptor complex,GO:0030133~transport vesicle,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0030140~trans-Golgi network transport vesicle,GO:0030658~transport vesicle membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030665~clathrin coated vesicle membrane,GO:0031090~organelle membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044431~Golgi apparatus part,GO:0044433~cytoplasmic vesicle part,GO:0048475~coated membrane,GO:0008565~protein transporter activity,",0,0,0
SCAF8,SR-related CTD-associated factor 8,0.58944092900803,0.033422181864404,0.669292822937893,0.978395453519128,1,0.011559302140819,0.354542208026862,0.208864274825821,2,NO,0,"RNA splicing, mRNA processing, nucleus, nuclear matrix, NOT nucleolus, spliceosomal complex, RNA binding, RNA polymerase core enzyme binding ",0,0,0
REG1A,"Regenerating islet-derived 1 alpha (pancreatic stone protein, pancreatic thread protein)",1,0.227591325759547,0.620539289527082,0.999999940074179,1,0.011634172497719,0.355456648007389,0.642185374825144,2,NO,0,"GO:0005529~sugar binding,GO:0008083~growth factor activity,GO:0030246~carbohydrate binding,GO:0008284~positive regulation of cell proliferation,GO:0042127~regulation of cell proliferation,",0,0,0
EPHB1,EPH receptor B1,1,0.221953528571503,0.620539289527082,9.57E-07,3.94E-06,0.01164620528832,0.355456648007389,0.748399563030002,2,YES,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001654~eye development,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007267~cell-cell signaling,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007423~sensory organ development,GO:0016310~phosphorylation,GO:0021545~cranial nerve development,GO:0021554~optic nerve development,GO:0021602~cranial nerve morphogenesis,GO:0021631~optic nerve morphogenesis,GO:0021675~nerve development,GO:0021952~central nervous system projection neuron axonogenesis,GO:0021953~central nervous system neuron differentiation,GO:0021954~central nervous system neuron development,GO:0021955~central nervous system neuron axonogenesis,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0031290~retinal ganglion cell axon guidance,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0043010~camera-type eye development,GO:0048592~eye morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04360:Axon guidance,",0,0
HLCS,Holocarboxylase synthetase (biotin-(proprionyl-Coenzyme A-carboxylase (ATP-hydrolysing)) ligase),1,1,0.071350057792824,0.582700373558368,1,0.011759195993784,0.35645102126529,0.704636733397587,2,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004077~biotin-[acetyl-CoA-carboxylase] ligase activity,GO:0004078~biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,GO:0004079~biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,GO:0004080~biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,GO:0005524~ATP binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0017076~purine nucleotide binding,GO:0018271~biotin-protein ligase activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005739~mitochondrion,GO:0005829~cytosol,","hsa00780:Biotin metabolism,",0,0
NBPF9,"neuroblastoma breakpoint family, member 9",1,1,0.071350057792824,1,1,0.011764311412692,0.35645102126529,0.781286645704095,2,NO,0,0,0,0,0
RYR2,ryanodine receptor 2 (cardiac),1,0.111721095746119,0.641447788305282,5.08E-23,3.87E-22,0.011788773229291,0.35645102126529,0.757089163913587,2,YES,0,"GO:0001666~response to hypoxia,GO:0003012~muscle system process,GO:0003013~circulatory system process,GO:0003015~heart process,GO:0005513~detection of calcium ion,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006917~induction of apoptosis,GO:0006936~muscle contraction,GO:0006937~regulation of muscle contraction,GO:0006941~striated muscle contraction,GO:0006942~regulation of striated muscle contraction,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0007584~response to nutrient,GO:0008015~blood circulation,GO:0008016~regulation of heart contraction,GO:0008624~induction of apoptosis by extracellular signals,GO:0009593~detection of chemical stimulus,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010522~regulation of calcium ion transport into cytosol,GO:0010880~regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,GO:0010882~regulation of cardiac muscle contraction by calcium ion signaling,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010959~regulation of metal ion transport,GO:0012502~induction of programmed cell death,GO:0014070~response to organic cyclic substance,GO:0014074~response to purine,GO:0014808~release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0015674~di-, tri-valent inorganic cation transport,GO:0019725~cellular homeostasis,GO:0030001~metal ion transport,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0031000~response to caffeine,GO:0031667~response to nutrient levels,GO:0032026~response to magnesium ion,GO:0032386~regulation of intracellular transport,GO:0032844~regulation of homeostatic process,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043269~regulation of ion transport,GO:0043279~response to alkaloid,GO:0044057~regulation of system process,GO:0046907~intracellular transport,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051279~regulation of release of sequestered calcium ion into cytosol,GO:0051282~regulation of sequestering of calcium ion,GO:0051283~negative regulation of sequestering of calcium ion,GO:0051480~cytosolic calcium ion homeostasis,GO:0051592~response to calcium ion,GO:0051606~detection of stimulus,GO:0051775~response to redox state,GO:0051924~regulation of calcium ion transport,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0055085~transmembrane transport,GO:0055117~regulation of cardiac muscle contraction,GO:0060047~heart contraction,GO:0060048~cardiac muscle contraction,GO:0060341~regulation of cellular localization,GO:0060401~cytosolic calcium ion transport,GO:0060402~calcium ion transport into cytosol,GO:0070296~sarcoplasmic reticulum calcium ion transport,GO:0070482~response to oxygen levels,GO:0000267~cell fraction,GO:0001950~plasma membrane enriched fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0016528~sarcoplasm,GO:0016529~sarcoplasmic reticulum,GO:0019717~synaptosome,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0030018~Z disc,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031674~I band,GO:0033017~sarcoplasmic reticulum membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034704~calcium channel complex,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0043292~contractile fiber,GO:0044432~endoplasmic reticulum part,GO:0044449~contractile fiber part,GO:0005216~ion channel activity,GO:0005217~intracellular ligand-gated ion channel activity,GO:0005218~intracellular ligand-gated calcium channel activity,GO:0005219~ryanodine-sensitive calcium-release channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005516~calmodulin binding,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0034236~protein kinase A catalytic subunit binding,GO:0034237~protein kinase A regulatory subunit binding,GO:0042802~identical protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043924~suramin binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0051018~protein kinase A binding,","hsa04020:Calcium signaling pathway,hsa04260:Cardiac muscle contraction,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,",0,0
CIRH1A,"cirrhosis, autosomal recessive 1A (cirhin)",1,0.970645685897825,0.352752213519394,1,1,0.011793282892122,0.35645102126529,0.514846529736815,2,NO,0,"GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,",0,0,0
ZNF563,Zinc finger protein 563,1,1,0.108469860173985,1.29E-17,8.38E-17,0.011898114752181,0.3588139245855,0.729814049032272,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
MYH10,"myosin, heavy chain 10, non-muscle",1,0.048303609736685,0.660850491134096,0.999999978123065,1,0.011922593566367,0.3588139245855,0.569287956736698,2,NO,0,"GO:0000281~cytokinesis after mitosis,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0000910~cytokinesis,GO:0001654~eye development,GO:0001701~in utero embryonic development,GO:0001764~neuron migration,GO:0001778~plasma membrane repair,GO:0006887~exocytosis,GO:0006928~cell motion,GO:0006929~substrate-bound cell migration,GO:0006930~substrate-bound cell migration, cell extension,GO:0007009~plasma membrane organization,GO:0007010~cytoskeleton organization,GO:0007049~cell cycle,GO:0007097~nuclear migration,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007423~sensory organ development,GO:0007507~heart development,GO:0007512~adult heart development,GO:0007517~muscle organ development,GO:0008283~cell proliferation,GO:0008360~regulation of cell shape,GO:0009611~response to wounding,GO:0009792~embryonic development ending in birth or egg hatching,GO:0010927~cellular component assembly involved in morphogenesis,GO:0014706~striated muscle tissue development,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016477~cell migration,GO:0021537~telencephalon development,GO:0021549~cerebellum development,GO:0021591~ventricular system development,GO:0021592~fourth ventricle development,GO:0021670~lateral ventricle development,GO:0021678~third ventricle development,GO:0021680~cerebellar Purkinje cell layer development,GO:0021695~cerebellar cortex development,GO:0022037~metencephalon development,GO:0022402~cell cycle process,GO:0022604~regulation of cell morphogenesis,GO:0030029~actin filament-based process,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0030036~actin cytoskeleton organization,GO:0030048~actin filament-based movement,GO:0030182~neuron differentiation,GO:0030239~myofibril assembly,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0030900~forebrain development,GO:0030902~hindbrain development,GO:0031032~actomyosin structure organization,GO:0031175~neuron projection development,GO:0032940~secretion by cell,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033205~cytokinesis during cell cycle,GO:0035051~cardiac cell differentiation,GO:0040023~establishment of nucleus localization,GO:0042060~wound healing,GO:0042692~muscle cell differentiation,GO:0043009~chordate embryonic development,GO:0043010~camera-type eye development,GO:0046903~secretion,GO:0046907~intracellular transport,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048738~cardiac muscle tissue development,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0050877~neurological system process,GO:0050885~neuromuscular process controlling balance,GO:0050905~neuromuscular process,GO:0051146~striated muscle cell differentiation,GO:0051301~cell division,GO:0051640~organelle localization,GO:0051647~nucleus localization,GO:0051656~establishment of organelle localization,GO:0051674~localization of cell,GO:0055001~muscle cell development,GO:0055002~striated muscle cell development,GO:0055003~cardiac myofibril assembly,GO:0055006~cardiac cell development,GO:0055007~cardiac muscle cell differentiation,GO:0055012~ventricular cardiac muscle cell differentiation,GO:0055013~cardiac muscle cell development,GO:0055015~ventricular cardiac muscle cell development,GO:0060041~retina development in camera-type eye,GO:0060537~muscle tissue development,GO:0001725~stress fiber,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0015629~actin cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016459~myosin complex,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0030496~midbody,GO:0031594~neuromuscular junction,GO:0032153~cell division site,GO:0032154~cleavage furrow,GO:0032155~cell division site part,GO:0032432~actin filament bundle,GO:0042641~actomyosin,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043197~dendritic spine,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044463~cell projection part,GO:0045202~synapse,GO:0000146~microfilament motor activity,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008092~cytoskeletal protein binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030898~actin-dependent ATPase activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0043531~ADP binding,GO:0051015~actin filament binding,","hsa04530:Tight junction,hsa04810:Regulation of actin cytoskeleton,hsa05416:Viral myocarditis,",0,0
SOX5,SRY (sex determining region Y)-box 5,1,0.048303609736685,0.660850491134096,9.67E-05,0.000351568336563,0.011935142331754,0.3588139245855,0.780842673759054,2,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0001501~skeletal system development,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0021953~central nervous system neuron differentiation,GO:0030182~neuron differentiation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0040034~regulation of development, heterochronic,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045664~regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048505~regulation of timing of cell differentiation,GO:0050767~regulation of neurogenesis,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051216~cartilage development,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051960~regulation of nervous system development,GO:0060164~regulation of timing of neuron differentiation,GO:0060284~regulation of cell development,",0,0,0
PER1,Period homolog 1 (Drosophila),1,1,0.317490853996285,0.999999999998126,1,0.011981436547252,0.3588139245855,0.644890136960302,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007623~circadian rhythm,GO:0009649~entrainment of circadian clock,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0042752~regulation of circadian rhythm,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048511~rhythmic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,","hsa04710:Circadian rhythm,",0,0
BMP5,bone morphogenetic protein 5,0.930617886567813,0.505087244311173,0.594395772667206,0.819798842823188,1,0.011984115502861,0.3588139245855,0.242917740691788,2,NO,0,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0007389~pattern specification process,GO:0040007~growth,GO:0051216~cartilage development,GO:0060348~bone development,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0005125~cytokine activity,GO:0008083~growth factor activity,","hsa04340:Hedgehog signaling pathway,hsa04350:TGF-beta signaling pathway,",0,0
LRP6,low density lipoprotein receptor-related protein 6,1,0.6394955370665,0.547582406090752,0.99999964068763,1,0.01208121287243,0.360160260901157,0.665293063460912,2,YES,0,"GO:0001667~ameboidal cell migration,GO:0001702~gastrulation with mouth forming second,GO:0003002~regionalization,GO:0006897~endocytosis,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007369~gastrulation,GO:0007389~pattern specification process,GO:0009952~anterior/posterior pattern formation,GO:0009968~negative regulation of signal transduction,GO:0010324~membrane invagination,GO:0010648~negative regulation of cell communication,GO:0016044~membrane organization,GO:0016055~Wnt receptor signaling pathway,GO:0016192~vesicle-mediated transport,GO:0016477~cell migration,GO:0030111~regulation of Wnt receptor signaling pathway,GO:0030178~negative regulation of Wnt receptor signaling pathway,GO:0030326~embryonic limb morphogenesis,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0035136~forelimb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0042074~cell migration involved in gastrulation,GO:0042733~embryonic digit morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048736~appendage development,GO:0048870~cell motility,GO:0051674~localization of cell,GO:0060070~Wnt receptor signaling pathway through beta-catenin,GO:0060173~limb development,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005041~low-density lipoprotein receptor activity,GO:0008034~lipoprotein binding,GO:0030169~low-density lipoprotein binding,GO:0030228~lipoprotein receptor activity,","hsa04310:Wnt signaling pathway,",0,0
COL12A1,"collagen, type XII, alpha 1",1,0.053281993127228,0.660850491134096,0.999999966836463,1,0.01210313231476,0.360160260901157,0.489500066080352,2,NO,0,"GO:0001501~skeletal system development,GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0043062~extracellular structure organization,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005593~FACIT collagen,GO:0005595~collagen type XII,GO:0030934~anchoring collagen,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0030020~extracellular matrix structural constituent conferring tensile strength,",0,0,0
CAMK1,calcium/calmodulin-dependent protein kinase I,1,1,0.338946430598086,0.340896333111435,0.913179780035635,0.012123374209299,0.360160260901157,0.405170967721796,2,YES,0,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006913~nucleocytoplasmic transport,GO:0016310~phosphorylation,GO:0045597~positive regulation of cell differentiation,GO:0046907~intracellular transport,GO:0051094~positive regulation of developmental process,GO:0051147~regulation of muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051169~nuclear transport,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004683~calmodulin-dependent protein kinase activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",0,0,0
RAB3GAP1,RAB3 GTPase activating protein subunit 1 (catalytic),1,0.43858482390646,0.599319901491912,0.999978106361139,1,0.012139639065757,0.360160260901157,0.262910368988728,2,NO,0,"GO:0043087~regulation of GTPase activity,GO:0051336~regulation of hydrolase activity,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005097~Rab GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0008047~enzyme activator activity,GO:0017016~Ras GTPase binding,GO:0017137~Rab GTPase binding,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0031267~small GTPase binding,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,",0,0,0
FGB,Fibrinogen beta chain,0.928567400858825,0.041319498656893,0.669292822937893,0.993823006620239,1,0.012147382856027,0.360160260901157,0.183425402756421,2,NO,0,"GO:0030674~protein binding, bridging,GO:0043498~cell surface binding,GO:0043499~eukaryotic cell surface binding,GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005577~fibrinogen complex,GO:0005615~extracellular space,GO:0005625~soluble fraction,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030141~secretory granule,GO:0031091~platelet alpha granule,GO:0031093~platelet alpha granule lumen,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031982~vesicle,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0043233~organelle lumen,GO:0044421~extracellular region part,GO:0044433~cytoplasmic vesicle part,GO:0044459~plasma membrane part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0001775~cell activation,GO:0006461~protein complex assembly,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0009611~response to wounding,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0030168~platelet activation,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0042060~wound healing,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0050817~coagulation,GO:0050878~regulation of body fluid levels,GO:0051258~protein polymerization,GO:0051592~response to calcium ion,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,","hsa04610:Complement and coagulation cascades,",0,0
INHBA,"inhibin, beta A",1,0.687607204909549,0.532650659483048,0.999999557693518,1,0.012235041133927,0.360511701736542,0.669188674934253,2,NO,0,"GO:0000082~G1/S transition of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0001501~skeletal system development,GO:0001541~ovarian follicle development,GO:0001558~regulation of cell growth,GO:0001817~regulation of cytokine production,GO:0002520~immune system development,GO:0002683~negative regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002762~negative regulation of myeloid leukocyte differentiation,GO:0003006~reproductive developmental process,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006917~induction of apoptosis,GO:0006952~defense response,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007166~cell surface receptor linked signal transduction,GO:0007267~cell-cell signaling,GO:0007548~sex differentiation,GO:0008361~regulation of cell size,GO:0008406~gonad development,GO:0008585~female gonad development,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0019220~regulation of phosphate metabolic process,GO:0020027~hemoglobin metabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0022602~ovulation cycle process,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030308~negative regulation of cell growth,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032276~regulation of gonadotropin secretion,GO:0032277~negative regulation of gonadotropin secretion,GO:0032278~positive regulation of gonadotropin secretion,GO:0032504~multicellular organism reproduction,GO:0032535~regulation of cellular component size,GO:0032649~regulation of interferon-gamma production,GO:0032844~regulation of homeostatic process,GO:0032925~regulation of activin receptor signaling pathway,GO:0034101~erythrocyte homeostasis,GO:0040007~growth,GO:0040008~regulation of growth,GO:0042035~regulation of cytokine biosynthetic process,GO:0042036~negative regulation of cytokine biosynthetic process,GO:0042325~regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042541~hemoglobin biosynthetic process,GO:0042592~homeostatic process,GO:0042634~regulation of hair cycle,GO:0042698~ovulation cycle,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0044057~regulation of system process,GO:0045072~regulation of interferon-gamma biosynthetic process,GO:0045077~negative regulation of interferon-gamma biosynthetic process,GO:0045137~development of primary sexual characteristics,GO:0045449~regulation of transcription,GO:0045577~regulation of B cell differentiation,GO:0045578~negative regulation of B cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045620~negative regulation of lymphocyte differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045646~regulation of erythrocyte differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045649~regulation of macrophage differentiation,GO:0045650~negative regulation of macrophage differentiation,GO:0045682~regulation of epidermis development,GO:0045683~negative regulation of epidermis development,GO:0045786~negative regulation of cell cycle,GO:0045792~negative regulation of cell size,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045926~negative regulation of growth,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045936~negative regulation of phosphate metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046545~development of primary female sexual characteristics,GO:0046660~female sex differentiation,GO:0046880~regulation of follicle-stimulating hormone secretion,GO:0046881~positive regulation of follicle-stimulating hormone secretion,GO:0046882~negative regulation of follicle-stimulating hormone secretion,GO:0046883~regulation of hormone secretion,GO:0046887~positive regulation of hormone secretion,GO:0046888~negative regulation of hormone secretion,GO:0048511~rhythmic process,GO:0048534~hemopoietic or lymphoid organ development,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0048872~homeostasis of number of cells,GO:0050864~regulation of B cell activation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050869~negative regulation of B cell activation,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051048~negative regulation of secretion,GO:0051050~positive regulation of transport,GO:0051051~negative regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051726~regulation of cell cycle,GO:0051797~regulation of hair follicle development,GO:0051799~negative regulation of hair follicle development,GO:0060341~regulation of cellular localization,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0043509~activin A complex,GO:0043511~inhibin complex,GO:0043512~inhibin A complex,GO:0044421~extracellular region part,GO:0048180~activin complex,GO:0005125~cytokine activity,GO:0005179~hormone activity,GO:0008083~growth factor activity,GO:0042802~identical protein binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0048184~follistatin binding,","hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,",0,0
KCNQ2,"potassium voltage-gated channel, KQT-like subfamily, member 2",1,0.11935708156029,0.641447788305282,6.55E-23,4.98E-22,0.012250704481773,0.360511701736542,0.80553635582561,2,YES,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0015672~monovalent inorganic cation transport,GO:0019226~transmission of nerve impulse,GO:0030001~metal ion transport,GO:0050877~neurological system process,GO:0055085~transmembrane transport,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
ZFP14,Zinc finger protein 14 homolog (mouse),1,0.745415986888831,0.496814929603414,5.48E-14,3.19E-13,0.012255738026806,0.360511701736542,0.72022535607576,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
KALRN,"kalirin, RhoGEF kinase",1,0.180765780910828,0.628457722964864,0.998425339574977,1,0.012356778739522,0.36147447462701,0.530408846020971,2,YES,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0007242~intracellular signaling cascade,GO:0007409~axonogenesis,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010975~regulation of neuron projection development,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016192~vesicle-mediated transport,GO:0016265~death,GO:0016310~phosphorylation,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0031344~regulation of cell projection organization,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0035023~regulation of Rho protein signal transduction,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0045664~regulation of neuron differentiation,GO:0046578~regulation of Ras protein signal transduction,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050767~regulation of neurogenesis,GO:0050773~regulation of dendrite development,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043025~cell soma,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030695~GTPase regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,",0,0,0
ZNF160,Zinc finger protein 160,0.974277142852174,0.389201770142258,0.603875498967983,0.999988667584248,1,0.012359795719686,0.36147447462701,0.473767205019669,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0002520~immune system development,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0030097~hemopoiesis,GO:0045449~regulation of transcription,GO:0048534~hemopoietic or lymphoid organ development,GO:0051252~regulation of RNA metabolic process,",0,0,0
TRPM7,"Transient receptor potential cation channel, subfamily M, member 7",1,0.505087244311173,0.594395772667206,0.999806641988525,1,0.012360109022602,0.36147447462701,0.633445767854828,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003779~actin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0008092~cytoskeletal protein binding,GO:0008270~zinc ion binding,GO:0015267~channel activity,GO:0017022~myosin binding,GO:0017076~purine nucleotide binding,GO:0022803~passive transmembrane transporter activity,GO:0022838~substrate specific channel activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0046914~transition metal ion binding,GO:0001726~ruffle,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0007010~cytoskeleton organization,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0015674~di-, tri-valent inorganic cation transport,GO:0016310~phosphorylation,GO:0016340~calcium-dependent cell-matrix adhesion,GO:0022610~biological adhesion,GO:0030001~metal ion transport,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0031032~actomyosin structure organization,GO:0031589~cell-substrate adhesion,GO:0046777~protein amino acid autophosphorylation,GO:0055085~transmembrane transport,",0,0,0
HPSE2,heparanase 2,0.540323431128064,0.822515305370682,0.450365116245565,0.999833639376066,1,0.012435311330744,0.362562354883904,0.255869523296958,2,YES,0,"GO:0019898~extrinsic to membrane,GO:0030305~heparanase activity,","hsa00531:Glycosaminoglycan degradation,",0,0
NAV3,Neuron navigator 3,1,0.088654690265483,0.64908205921566,0.80501206324861,1,0.012470857367313,0.362839789352096,0.552632047702343,2,NO,0,"GO:0000166~nucleotide binding,GO:0005635~nuclear envelope,GO:0005640~nuclear outer membrane,GO:0012505~endomembrane system,GO:0019867~outer membrane,GO:0031090~organelle membrane,GO:0031965~nuclear membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0042175~nuclear envelope-endoplasmic reticulum network,",0,0,0
ZNF823,zinc finger protein 823,1,0.227591325759547,0.620539289527082,1.88E-08,8.45E-08,0.012493351509931,0.362928946895802,0.741733245405811,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
DCC,deleted in colorectal carcinoma,1,0.271476723733921,0.620539289527082,1,1,0.012619173464823,0.36601481544943,0.489660193212912,2,YES,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001764~neuron migration,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006928~cell motion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0008219~cell death,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0016477~cell migration,GO:0021952~central nervous system projection neuron axonogenesis,GO:0021953~central nervous system neuron differentiation,GO:0021954~central nervous system neuron development,GO:0021955~central nervous system neuron axonogenesis,GO:0021965~spinal cord ventral commissure morphogenesis,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0051674~localization of cell,GO:0016021~integral to membrane,GO:0030424~axon,GO:0031224~intrinsic to membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0005042~netrin receptor activity,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,","hsa04360:Axon guidance,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,",0,0
FAM46D,"family with sequence similarity 46, member D",1,1,0.332676355469261,1,1,0.012669229075421,0.366274618634817,0.391963379061061,2,NO,0,0,0,0,0
ZBTB24,zinc finger and BTB domain containing 24,1,0.932145335372239,0.379347082700499,0.999772599179483,1,0.012675921710073,0.366274618634817,0.491773862847332,2,YES,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
HS3ST5,heparan sulfate (glucosamine) 3-O-sulfotransferase 5,1,1,0.296602665660762,0.999960879584896,1,0.012706566351269,0.366274618634817,0.517542106496038,2,NO,0,"GO:0006029~proteoglycan metabolic process,GO:0006477~protein amino acid sulfation,GO:0006790~sulfur metabolic process,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0015012~heparan sulfate proteoglycan biosynthetic process,GO:0015015~heparan sulfate proteoglycan biosynthetic process, enzymatic modification,GO:0030166~proteoglycan biosynthetic process,GO:0030201~heparan sulfate proteoglycan metabolic process,GO:0040012~regulation of locomotion,GO:0043900~regulation of multi-organism process,GO:0043903~regulation of symbiosis, encompassing mutualism through parasitism,GO:0044272~sulfur compound biosynthetic process,GO:0046596~regulation of virion penetration into host cell,GO:0050792~regulation of viral reproduction,GO:0050818~regulation of coagulation,GO:0050819~negative regulation of coagulation,GO:0051241~negative regulation of multicellular organismal process,GO:0051923~sulfation,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0008146~sulfotransferase activity,GO:0008467~[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,GO:0016782~transferase activity, transferring sulfur-containing groups,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0034483~heparan sulfate sulfotransferase activity,GO:0050656~3'-phosphoadenosine 5'-phosphosulfate binding,","hsa00534:Heparan sulfate biosynthesis,",0,0
CDCA7L,cell division cycle associated 7-like,1,0.621617423105817,0.564542664031073,0.997545014503831,1,0.012739684384535,0.366525645469014,0.383538943018974,2,NO,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0051301~cell division,",0,0,0
PTPDC1,protein tyrosine phosphatase domain containing 1,1,0.858711823250435,0.444921389161528,0.022394687559673,0.068948470236875,0.012766504741598,0.366525645469014,0.339868752308797,2,YES,0,"GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016311~dephosphorylation,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016791~phosphatase activity,",0,0,0
CRIM1,cysteine rich transmembrane BMP regulator 1 (chordin-like),1,0.043039943659203,0.669292822937893,0.999872913070458,1,0.012783701873826,0.366525645469014,0.275778187733047,2,YES,0,"GO:0001558~regulation of cell growth,GO:0040008~regulation of growth,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004857~enzyme inhibitor activity,GO:0004866~endopeptidase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005520~insulin-like growth factor binding,GO:0019838~growth factor binding,GO:0030414~peptidase inhibitor activity,",0,0,0
XKR6,"XK, Kell blood group complex subunit-related family, member 6",1,0.711750832738435,0.532650659483048,0.370764107917474,0.984715309510948,0.012793764165416,0.366525645469014,0.64491567431979,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
DYRK1A,dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A,0.359769466207178,0.086227261596822,0.64908205921566,0.999181570609318,1,0.012843396469248,0.367384077563668,0.35585302337746,2,YES,0,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0046777~protein amino acid autophosphorylation,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043621~protein self-association,",0,0,0
PRKAG3,"protein kinase, AMP-activated, gamma 3 non-catalytic subunit",1,0.505087244311173,0.594395772667206,0.999997124361081,1,0.012910291371085,0.368732924343276,0.578347002176342,2,YES,0,"GO:0000271~polysaccharide biosynthetic process,GO:0005976~polysaccharide metabolic process,GO:0005977~glycogen metabolic process,GO:0005978~glycogen biosynthetic process,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006073~cellular glucan metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006112~energy reserve metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0008610~lipid biosynthetic process,GO:0008643~carbohydrate transport,GO:0008645~hexose transport,GO:0009250~glucan biosynthetic process,GO:0010565~regulation of cellular ketone metabolic process,GO:0015749~monosaccharide transport,GO:0015758~glucose transport,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016051~carbohydrate biosynthetic process,GO:0016053~organic acid biosynthetic process,GO:0019216~regulation of lipid metabolic process,GO:0019217~regulation of fatty acid metabolic process,GO:0019318~hexose metabolic process,GO:0033692~cellular polysaccharide biosynthetic process,GO:0034637~cellular carbohydrate biosynthetic process,GO:0044042~glucan metabolic process,GO:0044264~cellular polysaccharide metabolic process,GO:0046320~regulation of fatty acid oxidation,GO:0046394~carboxylic acid biosynthetic process,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004679~AMP-activated protein kinase activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,","hsa04910:Insulin signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa05410:Hypertrophic cardiomyopathy (HCM),",0,0
LRBA,"LPS-responsive vesicle trafficking, beach and anchor containing",0.793725342439585,0.142038435823367,0.641447788305282,0.999763146583264,1,0.012977795643078,0.36895964202397,0.302050459204873,2,NO,0,"GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005773~vacuole,GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
WIPF1,"WAS/WASL interacting protein family, member 1",1,0.503116045574968,0.599319901491912,0.016759324811588,0.052183268570704,0.012981369279281,0.36895964202397,0.641757134953102,2,NO,0,"GO:0006461~protein complex assembly,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0008154~actin polymerization or depolymerization,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030048~actin filament-based movement,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0034621~cellular macromolecular complex subunit organization,GO:0043933~macromolecular complex subunit organization,GO:0046907~intracellular transport,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005730~nucleolus,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0015629~actin cytoskeleton,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044430~cytoskeletal part,GO:0070013~intracellular organelle lumen,GO:0003779~actin binding,GO:0005522~profilin binding,GO:0008092~cytoskeletal protein binding,",0,0,0
FAM179B,"family with sequence similarity 179, member B",1,0.01335971883853,0.715747949835011,0.99999156224779,1,0.013000684697949,0.36895964202397,0.500755348298126,2,NO,0,0,0,0,0
MMAA,methylmalonic aciduria (cobalamin deficiency) cblA type,0.820592272584007,0.858711823250435,0.444921389161528,0.999757837841319,1,0.013081656346551,0.36895964202397,0.34241452000644,2,NO,0,"GO:0005739~mitochondrion,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",0,0,0
OTUD7A,OTU domain containing 7A,1,0.142038435823367,0.641447788305282,0.999365842319738,1,0.01313986866368,0.36895964202397,0.32323247749547,2,YES,0,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0003677~DNA binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
KPNA1,karyopherin alpha 1 (importin alpha 5),1,0.505087244311173,0.594395772667206,0.999521704208233,1,0.013144169382015,0.36895964202397,0.673756268883533,2,NO,0,"GO:0000018~regulation of DNA recombination,GO:0006605~protein targeting,GO:0006606~protein import into nucleus,GO:0006607~NLS-bearing substrate import into nucleus,GO:0006886~intracellular protein transport,GO:0006913~nucleocytoplasmic transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0017038~protein import,GO:0033365~protein localization in organelle,GO:0034504~protein localization in nucleus,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0051052~regulation of DNA metabolic process,GO:0051169~nuclear transport,GO:0051170~nuclear import,GO:0070727~cellular macromolecule localization,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031967~organelle envelope,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0046930~pore complex,GO:0070013~intracellular organelle lumen,GO:0005048~signal sequence binding,GO:0008139~nuclear localization sequence binding,GO:0008565~protein transporter activity,GO:0042277~peptide binding,",0,0,0
BCL7A,B-cell CLL/lymphoma 7A,1,0.505087244311173,0.594395772667206,0.999920902100682,1,0.013155546040209,0.36895964202397,0.586208866395884,2,NO,0,"GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,",0,0,0
RCOR2,REST corepressor 2,1,1,0.160781827967041,0.998216553729475,1,0.013158904830434,0.36895964202397,0.618578508474118,2,YES,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0000785~chromatin,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005694~chromosome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044427~chromosomal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0006350~transcription,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,",0,0,0
ATXN2,ataxin 2,1,0.382762764878889,0.616343584684641,0.999577987726716,1,0.013175013717543,0.36895964202397,0.584448067782044,2,NO,0,"GO:0006403~RNA localization,GO:0006417~regulation of translation,GO:0008219~cell death,GO:0010608~posttranscriptional regulation of gene expression,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0016265~death,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022618~ribonucleoprotein complex assembly,GO:0032268~regulation of cellular protein metabolic process,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0034063~stress granule assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0040008~regulation of growth,GO:0040014~regulation of multicellular organism growth,GO:0040015~negative regulation of multicellular organism growth,GO:0043933~macromolecular complex subunit organization,GO:0045926~negative regulation of growth,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051236~establishment of RNA localization,GO:0051241~negative regulation of multicellular organismal process,GO:0065003~macromolecular complex assembly,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005844~polysome,GO:0010494~stress granule,GO:0030529~ribonucleoprotein complex,GO:0044431~Golgi apparatus part,GO:0048471~perinuclear region of cytoplasm,GO:0003723~RNA binding,GO:0008022~protein C-terminus binding,",0,0,0
PDE1B,"phosphodiesterase 1B, calmodulin-dependent",1,0.142038435823367,0.641447788305282,0.999841196552207,1,0.013198857290949,0.369074034936576,0.640634586402552,2,NO,0,"GO:0006915~apoptosis,GO:0007610~behavior,GO:0007611~learning or memory,GO:0007612~learning,GO:0007626~locomotory behavior,GO:0007632~visual behavior,GO:0008219~cell death,GO:0008542~visual learning,GO:0009314~response to radiation,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0012501~programmed cell death,GO:0016265~death,GO:0050877~neurological system process,GO:0050890~cognition,GO:0005829~cytosol,GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004117~calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,GO:0005516~calmodulin binding,GO:0008081~phosphoric diester hydrolase activity,","hsa00230:Purine metabolism,hsa04020:Calcium signaling pathway,",0,0
CACHD1,Cache domain containing 1,1,0.161539563209108,0.62951619711276,0.99881756308343,1,0.01325610935729,0.369804946784808,0.663385970058961,2,NO,0,"GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0015674~di-, tri-valent inorganic cation transport,GO:0030001~metal ion transport,",0,0,0
ZNF521,zinc finger protein 521,1,0.07009405772913,0.660850491134096,7.39E-08,3.23E-07,0.013298452094377,0.369804946784808,0.589505375914739,2,NO,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0019904~protein domain specific binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
NETO1,neuropilin (NRP) and tolloid (TLL)-like 1,1,0.342096927505986,0.616343584684641,0.999999951242472,1,0.013299309212363,0.369804946784808,0.439525583520997,2,NO,0,"GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
INPP4A,"inositol polyphosphate-4-phosphatase, type I, 107kDa",0.845564975663217,0.049992677538067,0.669292822937893,0.999364845134616,1,0.013304187817302,0.369804946784808,0.215380865800901,2,NO,0,"GO:0004437~inositol or phosphatidylinositol phosphatase activity,GO:0016316~phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,GO:0016791~phosphatase activity,GO:0034593~phosphatidylinositol bisphosphate phosphatase activity,GO:0034596~phosphoinositide 4-phosphatase activity,GO:0034597~phosphatidyl-inositol-4,5-bisphosphate 4-phosphatase activity,GO:0042577~lipid phosphatase activity,","hsa00562:Inositol phosphate metabolism,hsa04070:Phosphatidylinositol signaling system,",0,0
TMPRSS4,"Transmembrane protease, serine 4",1,1,0.074001282225644,0.989931864856019,1,0.013373563256524,0.369970529892765,0.678929874136013,2,NO,0,"GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005044~scavenger receptor activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0006508~proteolysis,",0,0,0
ZNF676,zinc finger protein 676,1,0.227591325759547,0.626298877169616,1,1,0.013406602495866,0.369970529892765,0.566430775582937,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
SEZ6L,seizure related 6 homolog (mouse)-like,1,0.932998377256721,0.397816536923272,0.999999996616901,1,0.013419940462033,0.369970529892765,0.595161952047856,2,NO,0,"GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
DNAH8,"dynein, axonemal, heavy chain 8",1,0.165988437655367,0.628457722964864,0.782627494824805,1,0.013420612607061,0.369970529892765,0.546749461973697,2,YES,0,"GO:0001539~ciliary or flagellar motility,GO:0006928~cell motion,GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0048870~cell motility,GO:0051674~localization of cell,GO:0005856~cytoskeleton,GO:0005858~axonemal dynein complex,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0005930~axoneme,GO:0009434~microtubule-based flagellum,GO:0015630~microtubule cytoskeleton,GO:0019861~flagellum,GO:0030286~dynein complex,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044447~axoneme part,GO:0044463~cell projection part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",0,0,0
BIRC6,baculoviral IAP repeat-containing 6,0.425422271462593,0.017865975146768,0.70302965945656,0.990095110621698,1,0.013434171220219,0.369970529892765,0.301957151654579,2,YES,0,"GO:0006508~proteolysis,GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0009057~macromolecule catabolic process,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060548~negative regulation of cell death,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0004842~ubiquitin-protein ligase activity,GO:0004857~enzyme inhibitor activity,GO:0004866~endopeptidase inhibitor activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0030414~peptidase inhibitor activity,","hsa04120:Ubiquitin mediated proteolysis,",0,0
CHST11,Carbohydrate (chondroitin 4) sulfotransferase 11,1,1,0.21733845772379,0.996609630467071,1,0.013438006708173,0.369970529892765,0.630583675239846,2,NO,0,"GO:0001537~N-acetylgalactosamine 4-O-sulfotransferase activity,GO:0008146~sulfotransferase activity,GO:0016782~transferase activity, transferring sulfur-containing groups,GO:0034481~chondroitin sulfotransferase activity,GO:0047756~chondroitin 4-sulfotransferase activity,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0000271~polysaccharide biosynthetic process,GO:0001501~skeletal system development,GO:0002062~chondrocyte differentiation,GO:0002063~chondrocyte development,GO:0005976~polysaccharide metabolic process,GO:0006022~aminoglycan metabolic process,GO:0006023~aminoglycan biosynthetic process,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006029~proteoglycan metabolic process,GO:0006790~sulfur metabolic process,GO:0007585~respiratory gaseous exchange,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0009791~post-embryonic development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,GO:0010941~regulation of cell death,GO:0016051~carbohydrate biosynthetic process,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0030166~proteoglycan biosynthetic process,GO:0030203~glycosaminoglycan metabolic process,GO:0030204~chondroitin sulfate metabolic process,GO:0030206~chondroitin sulfate biosynthetic process,GO:0030326~embryonic limb morphogenesis,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0033037~polysaccharide localization,GO:0035107~appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035121~tail morphogenesis,GO:0040007~growth,GO:0042127~regulation of cell proliferation,GO:0042733~embryonic digit morphogenesis,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0044272~sulfur compound biosynthetic process,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048589~developmental growth,GO:0048598~embryonic morphogenesis,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048703~embryonic viscerocranium morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048736~appendage development,GO:0050650~chondroitin sulfate proteoglycan biosynthetic process,GO:0050654~chondroitin sulfate proteoglycan metabolic process,GO:0051216~cartilage development,GO:0060173~limb development,GO:0060548~negative regulation of cell death,","hsa00532:Chondroitin sulfate biosynthesis,hsa00920:Sulfur metabolism,",0,0
BTN3A2,"Butyrophilin, subfamily 3, member A2",1,0.86861908420637,0.444921389161528,0.693953216412825,1,0.013486947794634,0.370239144056814,0.731125636270414,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
ZIM3,"Zinc finger, imprinted 3",1,0.886481428527679,0.422508527117849,0.99994645153392,1,0.013518020035695,0.370239144056814,0.513633670335254,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
PAPSS1,3'-phosphoadenosine 5'-phosphosulfate synthase 1,1,0.621617423105817,0.576395679177485,0.999998803252724,1,0.013652793380927,0.373011855832328,0.405470359218746,2,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004020~adenylylsulfate kinase activity,GO:0004779~sulfate adenylyltransferase activity,GO:0004781~sulfate adenylyltransferase (ATP) activity,GO:0005524~ATP binding,GO:0016779~nucleotidyltransferase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0070566~adenylyltransferase activity,GO:0000103~sulfate assimilation,GO:0001501~skeletal system development,GO:0006163~purine nucleotide metabolic process,GO:0006790~sulfur metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0033865~nucleoside bisphosphate metabolic process,GO:0033866~nucleoside bisphosphate biosynthetic process,GO:0033875~ribonucleoside bisphosphate metabolic process,GO:0034030~ribonucleoside bisphosphate biosynthetic process,GO:0034032~purine nucleoside bisphosphate metabolic process,GO:0034033~purine nucleoside bisphosphate biosynthetic process,GO:0034035~purine ribonucleoside bisphosphate metabolic process,GO:0034036~purine ribonucleoside bisphosphate biosynthetic process,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process,GO:0050428~3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,","hsa00230:Purine metabolism,hsa00450:Selenoamino acid metabolism,hsa00920:Sulfur metabolism,",0,0
RNF5,Ring finger protein 5,1,1,0.207292071105334,0.000151746910774,0.000542069333782,0.013659195320377,0.373011855832328,0.780109038587865,2,YES,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,",0,0,0
DSPP,Dentin sialophosphoprotein,1,1,0.401777884734111,0.26590518930094,0.727316302672756,0.013737819558405,0.373145959155635,0.508249226538991,2,NO,0,"GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0005518~collagen binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0031214~biomineral formation,GO:0042475~odontogenesis of dentine-containing tooth,GO:0042476~odontogenesis,GO:0060348~bone development,",0,0,0
SLC8A1,"solute carrier family 8 (sodium/calcium exchanger), member 1",1,0.28341317301379,0.620539289527082,0.991921032687632,1,0.013744013057395,0.373145959155635,0.532631366534928,2,NO,0,"GO:0000302~response to reactive oxygen species,GO:0001666~response to hypoxia,GO:0002026~regulation of the force of heart contraction,GO:0002028~regulation of sodium ion transport,GO:0003012~muscle system process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006816~calcium ion transport,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006936~muscle contraction,GO:0006979~response to oxidative stress,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0007584~response to nutrient,GO:0008016~regulation of heart contraction,GO:0009743~response to carbohydrate stimulus,GO:0009746~response to hexose stimulus,GO:0009749~response to glucose stimulus,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010959~regulation of metal ion transport,GO:0015672~monovalent inorganic cation transport,GO:0015674~di-, tri-valent inorganic cation transport,GO:0019725~cellular homeostasis,GO:0030001~metal ion transport,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0031667~response to nutrient levels,GO:0033198~response to ATP,GO:0034284~response to monosaccharide stimulus,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0042592~homeostatic process,GO:0043269~regulation of ion transport,GO:0044057~regulation of system process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0051480~cytosolic calcium ion homeostasis,GO:0051924~regulation of calcium ion transport,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0055085~transmembrane transport,GO:0060401~cytosolic calcium ion transport,GO:0070482~response to oxygen levels,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005901~caveola,GO:0016021~integral to membrane,GO:0030315~T-tubule,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0042383~sarcolemma,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0005432~calcium:sodium antiporter activity,GO:0005509~calcium ion binding,GO:0005516~calmodulin binding,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015081~sodium ion transmembrane transporter activity,GO:0015082~di-, tri-valent inorganic cation transmembrane transporter activity,GO:0015085~calcium ion transmembrane transporter activity,GO:0015297~antiporter activity,GO:0015298~solute:cation antiporter activity,GO:0015300~solute:solute antiporter activity,GO:0015368~calcium:cation antiporter activity,GO:0015491~cation:cation antiporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0031072~heat shock protein binding,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,","hsa04020:Calcium signaling pathway,hsa04260:Cardiac muscle contraction,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,",0,0
NAPSA,Napsin A aspartic peptidase,1,1,0.327163599458382,1,1,0.013819356129974,0.374540620790049,0.638085820661227,2,NO,0,"GO:0004175~endopeptidase activity,GO:0004190~aspartic-type endopeptidase activity,GO:0008233~peptidase activity,GO:0070001~aspartic-type peptidase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0006508~proteolysis,","hsa04142:Lysosome,",0,0
ATP5B,"ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide",1,1,0.219485578604672,0.795512415289493,1,0.013838913403591,0.374540620790049,0.738701413390195,2,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005509~calcium ion binding,GO:0005524~ATP binding,GO:0008034~lipoprotein binding,GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0019829~cation-transporting ATPase activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0030228~lipoprotein receptor activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042287~MHC protein binding,GO:0042288~MHC class I protein binding,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0043498~cell surface binding,GO:0043499~eukaryotic cell surface binding,GO:0046872~metal ion binding,GO:0046933~hydrogen ion transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,GO:0000275~mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0005754~mitochondrial proton-transporting ATP synthase, catalytic core,GO:0005759~mitochondrial matrix,GO:0005886~plasma membrane,GO:0009295~nucleoid,GO:0009986~cell surface,GO:0016469~proton-transporting two-sector ATPase complex,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0031980~mitochondrial lumen,GO:0033178~proton-transporting two-sector ATPase complex, catalytic domain,GO:0042645~mitochondrial nucleoid,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0044455~mitochondrial membrane part,GO:0045259~proton-transporting ATP synthase complex,GO:0045261~proton-transporting ATP synthase complex, catalytic core F(1),GO:0045267~proton-transporting ATP synthase, catalytic core,GO:0070013~intracellular organelle lumen,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0006091~generation of precursor metabolites and energy,GO:0006119~oxidative phosphorylation,GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006172~ADP biosynthetic process,GO:0006195~purine nucleotide catabolic process,GO:0006200~ATP catabolic process,GO:0006754~ATP biosynthetic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006818~hydrogen transport,GO:0006873~cellular ion homeostasis,GO:0006885~regulation of pH,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0006928~cell motion,GO:0006929~substrate-bound cell migration,GO:0006933~negative regulation of cell adhesion involved in substrate-bound cell migration,GO:0007162~negative regulation of cell adhesion,GO:0009132~nucleoside diphosphate metabolic process,GO:0009133~nucleoside diphosphate biosynthetic process,GO:0009135~purine nucleoside diphosphate metabolic process,GO:0009136~purine nucleoside diphosphate biosynthetic process,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009143~nucleoside triphosphate catabolic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009146~purine nucleoside triphosphate catabolic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009154~purine ribonucleotide catabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009166~nucleotide catabolic process,GO:0009179~purine ribonucleoside diphosphate metabolic process,GO:0009180~purine ribonucleoside diphosphate biosynthetic process,GO:0009185~ribonucleoside diphosphate metabolic process,GO:0009188~ribonucleoside diphosphate biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009203~ribonucleoside triphosphate catabolic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009207~purine ribonucleoside triphosphate catabolic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0009261~ribonucleotide catabolic process,GO:0010324~membrane invagination,GO:0015672~monovalent inorganic cation transport,GO:0015985~energy coupled proton transport, down electrochemical gradient,GO:0015986~ATP synthesis coupled proton transport,GO:0015992~proton transport,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0019725~cellular homeostasis,GO:0030003~cellular cation homeostasis,GO:0030004~cellular monovalent inorganic cation homeostasis,GO:0030155~regulation of cell adhesion,GO:0030641~regulation of cellular pH,GO:0034220~ion transmembrane transport,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0034655~nucleobase, nucleoside, nucleotide and nucleic acid catabolic process,GO:0034656~nucleobase, nucleoside and nucleotide catabolic process,GO:0042592~homeostatic process,GO:0044270~nitrogen compound catabolic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046031~ADP metabolic process,GO:0046034~ATP metabolic process,GO:0046700~heterocycle catabolic process,GO:0048514~blood vessel morphogenesis,GO:0048870~cell motility,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0051453~regulation of intracellular pH,GO:0051674~localization of cell,GO:0055067~monovalent inorganic cation homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0055085~transmembrane transport,","hsa00190:Oxidative phosphorylation,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,",0,0
IL36G,"interleukin 36, gamma",1,1,0.078426138322827,0.51052962531628,1,0.013909610866876,0.374540620790049,0.663476020105205,2,NO,0,"cell-cell signaling, inflammatory response, positive regulation of interleukin-6 production, extracellular space, cytokine activity, interleukin-1 receptor binding",0,0,0
KRT13,Keratin 13,1,0.745415986888831,0.532650659483048,0.999998479460335,1,0.013938220452786,0.374540620790049,0.679003727743933,2,NO,0,"GO:0005198~structural molecule activity,GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045111~intermediate filament cytoskeleton,GO:0007398~ectoderm development,GO:0007423~sensory organ development,GO:0008544~epidermis development,GO:0043586~tongue development,GO:0043587~tongue morphogenesis,",0,0,0
COL4A1,"collagen, type IV, alpha 1",1,0.005629812000978,0.755313294857079,4.91E-09,2.27E-08,0.014026011977369,0.374540620790049,0.733936084389233,2,NO,0,"GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005587~collagen type IV,GO:0005604~basement membrane,GO:0030935~sheet-forming collagen,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0019838~growth factor binding,GO:0048407~platelet-derived growth factor binding,","hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,",0,0
ANGPTL5,angiopoietin-like 5,1,0.634855678262747,0.574103899756076,7.90E-32,7.61E-31,0.014048694561488,0.374540620790049,0.558767185184724,2,NO,0,"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,",0,0,0
KLHL4,kelch-like 4 (Drosophila),1,0.057358409816681,0.669292822937893,0.999999999943523,1,0.014053167156823,0.374540620790049,0.435165493495527,2,YES,0,"GO:0005856~cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,",0,0,0
ZNF367,zinc finger protein 367,1,0.271476723733921,0.620539289527082,5.87E-11,3.02E-10,0.014062191119461,0.374540620790049,0.205342769266521,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
SLC4A4,"solute carrier family 4, sodium bicarbonate cotransporter, member 4",0.517940367697009,0.122408621449127,0.641994934266918,0.969950524115624,1,0.01412821600566,0.374540620790049,0.35571558562687,2,NO,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006820~anion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0008509~anion transmembrane transporter activity,GO:0008510~sodium:bicarbonate symporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0015293~symporter activity,GO:0015294~solute:cation symporter activity,GO:0015296~anion:cation symporter activity,GO:0015297~antiporter activity,GO:0015300~solute:solute antiporter activity,GO:0015301~anion:anion antiporter activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
ASB11,ankyrin repeat and SOCS box-containing 11,1,0.742087095988098,0.532650659483048,0.999955862263211,1,0.014199754884761,0.374715450029394,0.529539619140234,2,YES,0,"GO:0006508~proteolysis,GO:0007242~intracellular signaling cascade,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,",0,0,0
ACTR6,ARP6 actin-related protein 6 homolog (yeast),1,0.177218244215795,0.628457722964864,0.999879288663889,1,0.014200217313185,0.374715450029394,0.305354213471831,2,NO,0,"GO:0005856~cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,",0,0,0
INPP4B,"inositol polyphosphate-4-phosphatase, type II, 105kDa",0.34645920598726,0.514558837116276,0.599319901491912,0.980328047837649,1,0.014203037562011,0.374715450029394,0.212212141062718,2,NO,0,"GO:0004437~inositol or phosphatidylinositol phosphatase activity,GO:0016316~phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,GO:0016791~phosphatase activity,GO:0034593~phosphatidylinositol bisphosphate phosphatase activity,GO:0034596~phosphoinositide 4-phosphatase activity,GO:0034597~phosphatidyl-inositol-4,5-bisphosphate 4-phosphatase activity,GO:0042577~lipid phosphatase activity,","hsa00562:Inositol phosphate metabolism,hsa04070:Phosphatidylinositol signaling system,",0,0
GATA2,GATA binding protein 2,1,0.787415323919243,0.519194741115745,0.690891757965576,1,0.014239304225956,0.37493505269608,0.746979538842396,2,NO,unclear,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0001701~in utero embryonic development,GO:0001709~cell fate determination,GO:0001890~placenta development,GO:0001892~embryonic placenta development,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006897~endocytosis,GO:0006909~phagocytosis,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0010324~membrane invagination,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0021536~diencephalon development,GO:0021700~developmental maturation,GO:0021983~pituitary gland development,GO:0030100~regulation of endocytosis,GO:0030182~neuron differentiation,GO:0030900~forebrain development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032583~regulation of gene-specific transcription,GO:0035270~endocrine system development,GO:0043009~chordate embryonic development,GO:0043193~positive regulation of gene-specific transcription,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045765~regulation of angiogenesis,GO:0045766~positive regulation of angiogenesis,GO:0045807~positive regulation of endocytosis,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048568~embryonic organ development,GO:0048732~gland development,GO:0050764~regulation of phagocytosis,GO:0050766~positive regulation of phagocytosis,GO:0051050~positive regulation of transport,GO:0051094~positive regulation of developmental process,GO:0051130~positive regulation of cellular component organization,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060627~regulation of vesicle-mediated transport,",0,"overexpressed in prostate cancer, expression associated with metastasis and recurrence (19684615); 8 of 14 tested AML patients bear mutation in GATA2 (2 familial), mostly LOF (21892158); 2 gain-of-function mutations observed in CML (18250304); Overexpressed in AML, and its expression correlates with poor prognosis (21904383)","Ras mutated NSCLC are dependent on GATA2 activity for viability/tumor formation, GATA2 may act through activation of IL-1 and Rho pathways (22541434); GATA2 is overexpressed in breast cancers and blocks PTEN transcription to promote Akt activation and cell growth (22021428); Review on GATAs in cancer describes evidence for GATA2 as ""sparse"" - though its associated with proliferative stem cell populations in the heamatopeitic compartment (21779441)"
SECISBP2L,SECIS binding protein 2-like,1,0.02001066038707,0.70302965945656,0.999998546670133,1,0.014251506366198,0.37493505269608,0.189927070668084,2,NO,0,0,0,0,0
DIAPH2,Diaphanous homolog 2 (Drosophila),1,0.165371836105548,0.641447788305282,1,1,0.014328497131062,0.375901682459424,0.583799146719202,2,NO,0,"GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0017016~Ras GTPase binding,GO:0017048~Rho GTPase binding,GO:0019899~enzyme binding,GO:0031267~small GTPase binding,GO:0051020~GTPase binding,GO:0005768~endosome,GO:0005769~early endosome,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0000910~cytokinesis,GO:0007010~cytoskeleton organization,GO:0007276~gamete generation,GO:0007292~female gamete generation,GO:0019953~sexual reproduction,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0032504~multicellular organism reproduction,GO:0048477~oogenesis,GO:0048609~reproductive process in a multicellular organism,GO:0051301~cell division,","hsa04810:Regulation of actin cytoskeleton,",0,0
HOOK3,hook homolog 3 (Drosophila),1,0.110317535036752,0.64908205921566,4.68E-25,3.79E-24,0.014511432353527,0.37796408661028,0.71585748932311,2,YES,0,"GO:0000226~microtubule cytoskeleton organization,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007032~endosome organization,GO:0007033~vacuole organization,GO:0007034~vacuolar transport,GO:0007040~lysosome organization,GO:0007041~lysosomal transport,GO:0008104~protein localization,GO:0008333~endosome to lysosome transport,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0016197~endosome transport,GO:0031122~cytoplasmic microtubule organization,GO:0045022~early endosome to late endosome transport,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0051640~organelle localization,GO:0051645~Golgi localization,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0005794~Golgi apparatus,GO:0005801~cis-Golgi network,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0030897~HOPS complex,GO:0031090~organelle membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044431~Golgi apparatus part,GO:0044437~vacuolar part,GO:0070695~FHF complex,GO:0008017~microtubule binding,GO:0008092~cytoskeletal protein binding,GO:0015631~tubulin binding,GO:0042802~identical protein binding,",0,0,0
G3BP2,GTPase activating protein (SH3 domain) binding protein 2,1,0.255152378265114,0.620539289527082,0.959866383274328,1,0.014583864163289,0.378116258463431,0.566224316597083,2,YES,0,"GO:0006403~RNA localization,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007249~I-kappaB kinase/NF-kappaB cascade,GO:0007253~cytoplasmic sequestering of NF-kappaB,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0008104~protein localization,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0032386~regulation of intracellular transport,GO:0032387~negative regulation of intracellular transport,GO:0032507~maintenance of protein location in cell,GO:0032880~regulation of protein localization,GO:0033157~regulation of intracellular protein transport,GO:0042306~regulation of protein import into nucleus,GO:0042308~negative regulation of protein import into nucleus,GO:0042345~regulation of NF-kappaB import into nucleus,GO:0042347~negative regulation of NF-kappaB import into nucleus,GO:0042990~regulation of transcription factor import into nucleus,GO:0042992~negative regulation of transcription factor import into nucleus,GO:0042994~cytoplasmic sequestering of transcription factor,GO:0045185~maintenance of protein location,GO:0046822~regulation of nucleocytoplasmic transport,GO:0046823~negative regulation of nucleocytoplasmic transport,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051051~negative regulation of transport,GO:0051220~cytoplasmic sequestering of protein,GO:0051223~regulation of protein transport,GO:0051224~negative regulation of protein transport,GO:0051235~maintenance of location,GO:0051236~establishment of RNA localization,GO:0051651~maintenance of location in cell,GO:0060341~regulation of cellular localization,GO:0070201~regulation of establishment of protein localization,GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0005198~structural molecule activity,GO:0030159~receptor signaling complex scaffold activity,GO:0032947~protein complex scaffold,",0,0,0
MEF2C,myocyte enhancer factor 2C,1,0.03485558758223,0.679130630618955,0.999997162437862,1,0.014643306482672,0.37831579777293,0.225002248250108,2,NO,0,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptosis,GO:0006916~anti-apoptosis,GO:0007517~muscle organ development,GO:0008219~cell death,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010551~regulation of specific transcription from RNA polymerase II promoter,GO:0010552~positive regulation of specific transcription from RNA polymerase II promoter,GO:0010553~negative regulation of specific transcription from RNA polymerase II promoter,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032582~negative regulation of gene-specific transcription,GO:0032583~regulation of gene-specific transcription,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043193~positive regulation of gene-specific transcription,GO:0045449~regulation of transcription,GO:0045884~regulation of survival gene product expression,GO:0045885~positive regulation of survival gene product expression,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060548~negative regulation of cell death,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,","hsa04010:MAPK signaling pathway,",0,0
FLRT2,fibronectin leucine rich transmembrane protein 2,1,1,0.296602665660762,0.999999218184865,1,0.01474701223307,0.37994405724347,0.617749433481134,2,NO,0,"GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031012~extracellular matrix,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0030674~protein binding, bridging,",0,0,0
NRP2,neuropilin 2,0.814038956401093,0.576592883353912,0.594395772667206,0.99999354861861,1,0.014823552614285,0.38034222428878,0.353107838927775,2,NO,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001667~ameboidal cell migration,GO:0001755~neural crest cell migration,GO:0001944~vasculature development,GO:0006928~cell motion,GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007507~heart development,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0014031~mesenchymal cell development,GO:0014032~neural crest cell development,GO:0014033~neural crest cell differentiation,GO:0016477~cell migration,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0042330~taxis,GO:0048514~blood vessel morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048762~mesenchymal cell differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0050919~negative chemotaxis,GO:0051674~localization of cell,GO:0060485~mesenchyme development,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0030424~axon,GO:0031224~intrinsic to membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005021~vascular endothelial growth factor receptor activity,",0,0,0
SLC12A2,"Solute carrier family 12 (sodium/potassium/chloride transporters), member 2",1,0.783828753636386,0.507847587748354,2.10E-27,1.79E-26,0.015018848315431,0.383645334188889,0.73652660059868,2,NO,0,"GO:0008509~anion transmembrane transporter activity,GO:0008511~sodium:potassium:chloride symporter activity,GO:0015293~symporter activity,GO:0015294~solute:cation symporter activity,GO:0015296~anion:cation symporter activity,GO:0015377~cation:chloride symporter activity,GO:0030955~potassium ion binding,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0051739~ammonia transporter activity,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0006884~cell volume homeostasis,GO:0006970~response to osmotic stress,GO:0006972~hyperosmotic response,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007600~sensory perception,GO:0007605~sensory perception of sound,GO:0009581~detection of external stimulus,GO:0009582~detection of abiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0009628~response to abiotic stimulus,GO:0015672~monovalent inorganic cation transport,GO:0015695~organic cation transport,GO:0015696~ammonium transport,GO:0015698~inorganic anion transport,GO:0019725~cellular homeostasis,GO:0030001~metal ion transport,GO:0030321~transepithelial chloride transport,GO:0042592~homeostatic process,GO:0045795~positive regulation of cell volume,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050906~detection of stimulus involved in sensory perception,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0050954~sensory perception of mechanical stimulus,GO:0050974~detection of mechanical stimulus involved in sensory perception,GO:0050982~detection of mechanical stimulus,GO:0051606~detection of stimulus,GO:0055085~transmembrane transport,GO:0070633~transepithelial transport,GO:0070634~transepithelial ammonium transport,","hsa05110:Vibrio cholerae infection,",0,0
ATP12A,"ATPase, H+/K+ transporting, nongastric, alpha polypeptide",1,0.136598382188982,0.641447788305282,0.999999190252283,1,0.015036649472174,0.383645334188889,0.661102385686402,2,YES,0,"GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006818~hydrogen transport,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0015672~monovalent inorganic cation transport,GO:0015992~proton transport,GO:0030001~metal ion transport,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0042592~homeostatic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046034~ATP metabolic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0055065~metal ion homeostasis,GO:0055067~monovalent inorganic cation homeostasis,GO:0055075~potassium ion homeostasis,GO:0055080~cation homeostasis,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005889~hydrogen:potassium-exchanging ATPase complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0008900~hydrogen:potassium-exchanging ATPase activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0022890~inorganic cation transmembrane transporter activity,GO:0030554~adenyl nucleotide binding,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,","hsa00190:Oxidative phosphorylation,",0,0
KLHL14,Kelch-like 14 (Drosophila),1,0.180646030813674,0.641447788305282,0.999998664929781,1,0.015187931957347,0.385515825206987,0.669106802631672,2,YES,0,0,0,0,0
LRCH2,leucine-rich repeats and calponin homology (CH) domain containing 2,1,0.86861908420637,0.462781043665193,1,1,0.01521323742685,0.385515825206987,0.524818180577947,2,NO,0,0,0,0,0
EML3,Echinoderm microtubule associated protein like 3,1,0.662742749777802,0.576395679177485,0.996690326954899,1,0.01523157979564,0.385515825206987,0.558392299444183,2,NO,0,"GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,",0,0,0
OR2K2,"olfactory receptor, family 2, subfamily K, member 2",1,1,0.350070687212711,0.999999999878238,1,0.015312049924985,0.386256196469828,0.55612252019387,2,NO,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0050877~neurological system process,GO:0050890~cognition,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004984~olfactory receptor activity,","hsa04740:Olfactory transduction,",0,0
DCHS1,dachsous 1 (Drosophila),0.987332615704823,0.03230571218278,0.688986797626025,0.999999999992626,1,0.015313189138388,0.386256196469828,0.315421970968354,2,NO,0,"GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0016337~cell-cell adhesion,GO:0016339~calcium-dependent cell-cell adhesion,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
SMC1A,structural maintenance of chromosomes 1A,1,0.040165380239946,0.679130630618955,1,1,0.015322895722007,0.386256196469828,0.563128829799414,2,YES,0,"GO:0000070~mitotic sister chromatid segregation,GO:0000075~cell cycle checkpoint,GO:0000087~M phase of mitotic cell cycle,GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0000819~sister chromatid segregation,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006974~response to DNA damage stimulus,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007062~sister chromatid cohesion,GO:0007064~mitotic sister chromatid cohesion,GO:0007067~mitosis,GO:0007126~meiosis,GO:0007242~intracellular signaling cascade,GO:0008380~RNA splicing,GO:0009314~response to radiation,GO:0009628~response to abiotic stimulus,GO:0016071~mRNA metabolic process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0033554~cellular response to stress,GO:0042770~DNA damage response, signal transduction,GO:0048285~organelle fission,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,GO:0051726~regulation of cell cycle,GO:0000228~nuclear chromosome,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000779~condensed chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0005694~chromosome,GO:0008278~cohesin complex,GO:0008280~cohesin core heterodimer,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003682~chromatin binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,","hsa04110:Cell cycle,hsa04114:Oocyte meiosis,",0,0
ITIH5,Inter-alpha (globulin) inhibitor H5,1,0.395685362190299,0.616343584684641,0.052610035786959,0.15690609268156,0.015343546109568,0.386256196469828,0.708322545737047,2,NO,0,"GO:0004857~enzyme inhibitor activity,GO:0004866~endopeptidase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0030414~peptidase inhibitor activity,GO:0005576~extracellular region,GO:0005976~polysaccharide metabolic process,GO:0006022~aminoglycan metabolic process,GO:0030203~glycosaminoglycan metabolic process,GO:0030212~hyaluronan metabolic process,",0,0,0
DMXL2,Dmx-like 2,0.951632204089476,0.031388909731573,0.688986797626025,0.999999993693007,1,0.015562093555655,0.389657299632812,0.275680419723388,2,NO,0,"GO:0006412~translation,GO:0006413~translational initiation,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0003743~translation initiation factor activity,GO:0005083~small GTPase regulator activity,GO:0008135~translation factor activity, nucleic acid binding,GO:0017016~Ras GTPase binding,GO:0017137~Rab GTPase binding,GO:0019899~enzyme binding,GO:0030695~GTPase regulator activity,GO:0031267~small GTPase binding,GO:0051020~GTPase binding,GO:0060589~nucleoside-triphosphatase regulator activity,",0,0,0
RIMS3,Regulating synaptic membrane exocytosis 3,1,0.67951024440204,0.576395679177485,2.03E-13,1.15E-12,0.015623721217797,0.390676691602712,0.782110079262918,2,NO,0,"GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0006836~neurotransmitter transport,GO:0006887~exocytosis,GO:0016192~vesicle-mediated transport,GO:0017156~calcium ion-dependent exocytosis,GO:0032940~secretion by cell,GO:0046903~secretion,",0,0,0
TAF4,"TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa",1,0.142038435823367,0.641447788305282,1.69E-22,1.27E-21,0.015682534821574,0.391164917108114,0.761722916446673,2,NO,0,"GO:0001541~ovarian follicle development,GO:0003006~reproductive developmental process,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006354~RNA elongation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~RNA elongation from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0007548~sex differentiation,GO:0008406~gonad development,GO:0008585~female gonad development,GO:0022602~ovulation cycle process,GO:0032504~multicellular organism reproduction,GO:0032774~RNA biosynthetic process,GO:0042698~ovulation cycle,GO:0043933~macromolecular complex subunit organization,GO:0045137~development of primary sexual characteristics,GO:0045449~regulation of transcription,GO:0046545~development of primary female sexual characteristics,GO:0046660~female sex differentiation,GO:0048511~rhythmic process,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0051252~regulation of RNA metabolic process,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0000123~histone acetyltransferase complex,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005669~transcription factor TFIID complex,GO:0005730~nucleolus,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0033276~transcription factor TFTC complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0070461~SAGA-type complex,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0008134~transcription factor binding,GO:0016251~general RNA polymerase II transcription factor activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,","hsa03022:Basal transcription factors,hsa05016:Huntington's disease,",0,0
GDF11,Growth differentiation factor 11,1,0.318629720376967,0.620539289527082,0.931414352989989,1,0.015685128910219,0.391164917108114,0.620347549095741,2,NO,0,"GO:0005125~cytokine activity,GO:0008083~growth factor activity,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0001501~skeletal system development,GO:0001654~eye development,GO:0001655~urogenital system development,GO:0001656~metanephros development,GO:0001657~ureteric bud development,GO:0001822~kidney development,GO:0003002~regionalization,GO:0007389~pattern specification process,GO:0007423~sensory organ development,GO:0007498~mesoderm development,GO:0008285~negative regulation of cell proliferation,GO:0009952~anterior/posterior pattern formation,GO:0021510~spinal cord development,GO:0021511~spinal cord patterning,GO:0021512~spinal cord anterior/posterior patterning,GO:0021700~developmental maturation,GO:0031016~pancreas development,GO:0035295~tube development,GO:0040007~growth,GO:0042127~regulation of cell proliferation,GO:0043010~camera-type eye development,GO:0045596~negative regulation of cell differentiation,GO:0048469~cell maturation,GO:0048592~eye morphogenesis,GO:0048593~camera-type eye morphogenesis,",0,0,0
SLC25A13,"solute carrier family 25, member 13 (citrin)",1,0.886481428527679,0.444921389161528,2.57E-08,1.15E-07,0.01585686796941,0.393354025432725,0.646787146395631,2,NO,0,"GO:0006091~generation of precursor metabolites and energy,GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006839~mitochondrial transport,GO:0006865~amino acid transport,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0015711~organic anion transport,GO:0015800~acidic amino acid transport,GO:0015810~aspartate transport,GO:0015813~L-glutamate transport,GO:0015837~amine transport,GO:0015849~organic acid transport,GO:0015980~energy derivation by oxidation of organic compounds,GO:0022900~electron transport chain,GO:0022904~respiratory electron transport chain,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0043490~malate-aspartate shuttle,GO:0044271~nitrogen compound biosynthetic process,GO:0045333~cellular respiration,GO:0046034~ATP metabolic process,GO:0046907~intracellular transport,GO:0046942~carboxylic acid transport,GO:0051592~response to calcium ion,GO:0055085~transmembrane transport,GO:0055114~oxidation reduction,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0044459~plasma membrane part,GO:0005275~amine transmembrane transporter activity,GO:0005313~L-glutamate transmembrane transporter activity,GO:0005509~calcium ion binding,GO:0015171~amino acid transmembrane transporter activity,GO:0015172~acidic amino acid transmembrane transporter activity,GO:0015179~L-amino acid transmembrane transporter activity,GO:0015183~L-aspartate transmembrane transporter activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
LCTL,lactase-like,1,0.876560862545503,0.462781043665193,0.999250624250601,1,0.015858591334321,0.393354025432725,0.46643426901569,2,YES,0,"GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0043167~ion binding,GO:0043169~cation binding,",0,0,0
GJA1,"gap junction protein, alpha 1, 43kDa",1,1,0.379347082700499,0.999999978681005,1,0.015888070575919,0.393354025432725,0.432207815431768,2,NO,0,"GO:0000902~cell morphogenesis,GO:0003012~muscle system process,GO:0006461~protein complex assembly,GO:0006862~nucleotide transport,GO:0006915~apoptosis,GO:0006936~muscle contraction,GO:0007043~cell-cell junction assembly,GO:0007267~cell-cell signaling,GO:0007507~heart development,GO:0008219~cell death,GO:0008285~negative regulation of cell proliferation,GO:0009268~response to pH,GO:0009628~response to abiotic stimulus,GO:0009894~regulation of catabolic process,GO:0009896~positive regulation of catabolic process,GO:0009967~positive regulation of signal transduction,GO:0010232~vascular transport,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0010959~regulation of metal ion transport,GO:0012501~programmed cell death,GO:0015865~purine nucleotide transport,GO:0015867~ATP transport,GO:0015868~purine ribonucleotide transport,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0016264~gap junction assembly,GO:0016265~death,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0042127~regulation of cell proliferation,GO:0042176~regulation of protein catabolic process,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043269~regulation of ion transport,GO:0043933~macromolecular complex subunit organization,GO:0045216~cell-cell junction organization,GO:0045732~positive regulation of protein catabolic process,GO:0048666~neuron development,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0051247~positive regulation of protein metabolic process,GO:0051259~protein oligomerization,GO:0051503~adenine nucleotide transport,GO:0051924~regulation of calcium ion transport,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0000139~Golgi membrane,GO:0000323~lytic vacuole,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005764~lysosome,GO:0005768~endosome,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005771~multivesicular body,GO:0005773~vacuole,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005798~Golgi-associated vesicle,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005916~fascia adherens,GO:0005921~gap junction,GO:0005922~connexon complex,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0014704~intercalated disc,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0019867~outer membrane,GO:0030054~cell junction,GO:0030659~cytoplasmic vesicle membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044429~mitochondrial part,GO:0044431~Golgi apparatus part,GO:0044433~cytoplasmic vesicle part,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0070161~anchoring junction,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,GO:0030165~PDZ domain binding,","hsa04540:Gap junction,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),",0,0
STAG1,stromal antigen 1,1,0.995601060411906,0.400996972600096,1.50E-10,7.53E-10,0.015912940417491,0.393354025432725,0.648088796799729,2,NO,0,"GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0048285~organelle fission,GO:0051301~cell division,GO:0000785~chromatin,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,","hsa04110:Cell cycle,",0,0
CCDC60,coiled-coil domain containing 60,1,0.674155105710547,0.586563008794232,0.999997666491379,1,0.01595035469648,0.393354025432725,0.58746299442066,2,NO,0,0,0,0,0
PHIP,pleckstrin homology domain interacting protein,1,0.132935879522302,0.64908205921566,0.999999968197652,1,0.015972976812239,0.393354025432725,0.283770381591155,2,YES,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008286~insulin receptor signaling pathway,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0032868~response to insulin stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0043434~response to peptide hormone stimulus,GO:0005158~insulin receptor binding,GO:0032403~protein complex binding,",0,0,0
KIF16B,kinesin family member 16B,1,0.846235985943741,0.501831299149681,0.999999999994029,1,0.015991383129813,0.393354025432725,0.624110112600236,2,YES,0,"GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0035091~phosphoinositide binding,",0,0,0
TNFRSF10C,"tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain",1,1,0.094700873783088,0.227095255956491,0.630312137534244,0.015997691002294,0.393354025432725,0.669874461135652,2,YES,0,"GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0006915~apoptosis,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,","hsa04060:Cytokine-cytokine receptor interaction,hsa04210:Apoptosis,hsa04650:Natural killer cell mediated cytotoxicity,",0,0
RNF220,ring finger protein 220,1,0.342096927505986,0.620539289527082,1.76E-06,7.16E-06,0.016005365225542,0.393354025432725,0.487495430721575,2,YES,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
DRP2,dystrophin related protein 2,1,0.318629720376967,0.620539289527082,1,1,0.016033931800977,0.393354025432725,0.546826220299467,2,NO,0,"GO:0043062~extracellular structure organization,GO:0050808~synapse organization,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0005509~calcium ion binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
JAM2,junctional adhesion molecule 2,1,0.210323522573515,0.628457722964864,0.999970887176816,1,0.016046670987726,0.393354025432725,0.548742589268797,2,NO,0,"GO:0007155~cell adhesion,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005911~cell-cell junction,GO:0005923~tight junction,GO:0016021~integral to membrane,GO:0016327~apicolateral plasma membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0043296~apical junction complex,GO:0044459~plasma membrane part,GO:0070160~occluding junction,","hsa04514:Cell adhesion molecules (CAMs),hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,",0,0
PCBP4,Poly(rC) binding protein 4,1,0.964584671744861,0.413900866678315,4.03E-11,2.09E-10,0.016157621891922,0.395252992371211,0.465825065862674,2,NO,0,"GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0030529~ribonucleoprotein complex,GO:0000075~cell cycle checkpoint,GO:0000077~DNA damage checkpoint,GO:0006917~induction of apoptosis,GO:0006974~response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007093~mitotic cell cycle checkpoint,GO:0007242~intracellular signaling cascade,GO:0007346~regulation of mitotic cell cycle,GO:0008629~induction of apoptosis by intracellular signals,GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis,GO:0010564~regulation of cell cycle process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0022402~cell cycle process,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0031570~DNA integrity checkpoint,GO:0031571~G1 DNA damage checkpoint,GO:0031575~G1/S transition checkpoint,GO:0033554~cellular response to stress,GO:0042770~DNA damage response, signal transduction,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0051726~regulation of cell cycle,",0,0,0
FBLN2,Fibulin 2,1,1,0.350070687212711,0.002559775167657,0.008447710310364,0.016190719058744,0.395252992371211,0.415878322763668,2,NO,0,"GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0050840~extracellular matrix binding,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0010810~regulation of cell-substrate adhesion,GO:0010811~positive regulation of cell-substrate adhesion,GO:0030155~regulation of cell adhesion,GO:0045785~positive regulation of cell adhesion,",0,0,0
STAC,SH3 and cysteine rich domain,1,0.475808461183278,0.615734532589024,0.998987965703416,1,0.016218308020468,0.395252992371211,0.518452908241451,2,NO,0,"GO:0007242~intracellular signaling cascade,GO:0009266~response to temperature stimulus,GO:0009408~response to heat,GO:0009628~response to abiotic stimulus,GO:0033554~cellular response to stress,GO:0034605~cellular response to heat,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0019992~diacylglycerol binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
LCP1,lymphocyte cytosolic protein 1 (L-plastin),1,0.180765780910828,0.641447788305282,0.035946853438305,0.108931095939988,0.016231228200729,0.395252992371211,0.163285830912297,2,NO,0,"GO:0001775~cell activation,GO:0002263~cell activation during immune response,GO:0002285~lymphocyte activation during immune response,GO:0002286~T cell activation during immune response,GO:0002366~leukocyte activation during immune response,GO:0006955~immune response,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0032386~regulation of intracellular transport,GO:0032880~regulation of protein localization,GO:0033157~regulation of intracellular protein transport,GO:0042110~T cell activation,GO:0045321~leukocyte activation,GO:0046649~lymphocyte activation,GO:0051017~actin filament bundle formation,GO:0051223~regulation of protein transport,GO:0060341~regulation of cellular localization,GO:0070201~regulation of establishment of protein localization,GO:0001726~ruffle,GO:0001891~phagocytic cup,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0030054~cell junction,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044459~plasma membrane part,GO:0003779~actin binding,GO:0005509~calcium ion binding,GO:0008092~cytoskeletal protein binding,GO:0042802~identical protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0051015~actin filament binding,",0,0,0
COL5A1,"collagen, type V, alpha 1",1,0.271476723733921,0.628354177479539,0.999999998137733,1,0.016263765963873,0.395252992371211,0.366545714730493,2,NO,0,"GO:0001568~blood vessel development,GO:0001654~eye development,GO:0001944~vasculature development,GO:0003007~heart morphogenesis,GO:0006928~cell motion,GO:0007009~plasma membrane organization,GO:0007155~cell adhesion,GO:0007398~ectoderm development,GO:0007423~sensory organ development,GO:0007507~heart development,GO:0008544~epidermis development,GO:0009611~response to wounding,GO:0016044~membrane organization,GO:0016477~cell migration,GO:0022610~biological adhesion,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0032963~collagen metabolic process,GO:0032964~collagen biosynthetic process,GO:0035313~wound healing, spreading of epidermal cells,GO:0042060~wound healing,GO:0043062~extracellular structure organization,GO:0043206~fibril organization,GO:0043588~skin development,GO:0044236~multicellular organismal metabolic process,GO:0044259~multicellular organismal macromolecule metabolic process,GO:0045112~integrin biosynthetic process,GO:0048592~eye morphogenesis,GO:0048870~cell motility,GO:0051674~localization of cell,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005583~fibrillar collagen,GO:0005588~collagen type V,GO:0005604~basement membrane,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0001871~pattern binding,GO:0001948~glycoprotein binding,GO:0005178~integrin binding,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,GO:0019838~growth factor binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0032403~protein complex binding,GO:0043394~proteoglycan binding,GO:0048407~platelet-derived growth factor binding,","hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,",0,0
SCUBE3,"signal peptide, CUB domain, EGF-like 3",1,0.142038435823367,0.64908205921566,0.997281721138546,1,0.016272260352988,0.395252992371211,0.626689748107629,2,NO,0,"GO:0006461~protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051291~protein heterooligomerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005576~extracellular region,GO:0005618~cell wall,GO:0009505~plant-type cell wall,GO:0009530~primary cell wall,GO:0009986~cell surface,GO:0030312~external encapsulating structure,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0044426~cell wall part,GO:0044462~external encapsulating structure part,GO:0048196~middle lamella-containing extracellular matrix,GO:0048222~glycoprotein network,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
EPHA4,EPH receptor A4,1,0.104977053308268,0.660850491134096,0.999987736606234,1,0.016309991692196,0.395654980283808,0.327524377662259,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0007628~adult walking behavior,GO:0008344~adult locomotory behavior,GO:0016310~phosphorylation,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030534~adult behavior,GO:0031175~neuron projection development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,","hsa04360:Axon guidance,",0,0
SDK1,"Sidekick homolog 1, cell adhesion molecule (chicken)",1,0.556429893823435,0.599319901491912,0.218751173980373,0.608224647034742,0.016354124581062,0.396211015628614,0.776756122024487,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0007155~cell adhesion,GO:0022610~biological adhesion,",0,0,0
SCN5A,"sodium channel, voltage-gated, type V, alpha subunit",1,0.425154369482783,0.616343584684641,0.999954958359788,1,0.01654213706135,0.399161208349429,0.62039464296205,2,YES,0,"GO:0003012~muscle system process,GO:0003013~circulatory system process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006936~muscle contraction,GO:0008015~blood circulation,GO:0008016~regulation of heart contraction,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0044057~regulation of system process,GO:0055085~transmembrane transport,GO:0001518~voltage-gated sodium channel complex,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005911~cell-cell junction,GO:0014704~intercalated disc,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0030315~T-tubule,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034706~sodium channel complex,GO:0042383~sarcolemma,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005248~voltage-gated sodium channel activity,GO:0005261~cation channel activity,GO:0005272~sodium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
TMTC2,Transmembrane and tetratricopeptide repeat containing 2,1,0.271476723733921,0.628457722964864,0.573517515154643,1,0.016573965265543,0.399161208349429,0.591445463361135,2,NO,0,"GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
ZMYM5,"zinc finger, MYM-type 5",0.866827371393621,0.73524777513296,0.574103899756076,0.99999999999535,1,0.016627855031355,0.399161208349429,0.427183986742084,2,NO,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
KRT84,keratin 84,1,0.227591325759547,0.628457722964864,0.999999767296652,1,0.016659159421873,0.399161208349429,0.507653025424605,2,NO,0,"GO:0030856~regulation of epithelial cell differentiation,GO:0045604~regulation of epidermal cell differentiation,GO:0045616~regulation of keratinocyte differentiation,GO:0045682~regulation of epidermis development,GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045095~keratin filament,GO:0045111~intermediate filament cytoskeleton,GO:0005198~structural molecule activity,GO:0030280~structural constituent of epidermis,",0,0,0
ZNF561,zinc finger protein 561; zinc finger protein 812,1,0.239978199885825,0.628457722964864,4.66E-10,2.27E-09,0.0167008170281,0.399161208349429,0.28092374254345,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
ZNF266,zinc finger protein 266,1,1,0.099549143762887,0.122327393602533,0.350614298772703,0.016729951958273,0.399161208349429,0.793200050472048,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
ZNF180,Zinc finger protein 180,0.946515890269312,1,0.044849877120305,0.975539362039643,1,0.016746021703618,0.399161208349429,0.758586056981673,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
PAX1,paired box 1,1,1,0.207292071105334,1,1,0.016748503101477,0.399161208349429,0.68528683614775,2,NO,0,"GO:0001501~skeletal system development,GO:0001756~somitogenesis,GO:0001775~cell activation,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0003002~regionalization,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007389~pattern specification process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009891~positive regulation of biosynthetic process,GO:0009952~anterior/posterior pattern formation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030217~T cell differentiation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0035270~endocrine system development,GO:0035282~segmentation,GO:0042110~T cell activation,GO:0043009~chordate embryonic development,GO:0043367~CD4-positive, alpha beta T cell differentiation,GO:0043374~CD8-positive, alpha-beta T cell differentiation,GO:0045321~leukocyte activation,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046631~alpha-beta T cell activation,GO:0046632~alpha-beta T cell differentiation,GO:0046649~lymphocyte activation,GO:0048534~hemopoietic or lymphoid organ development,GO:0048538~thymus development,GO:0048705~skeletal system morphogenesis,GO:0048732~gland development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060017~parathyroid gland development,GO:0060348~bone development,GO:0060349~bone morphogenesis,GO:0003677~DNA binding,",0,0,0
FAM180A,"family with sequence similarity 180, member A",1,0.745415986888831,0.56767625725793,0.027457662251245,0.084051404980499,0.016822050100259,0.399161208349429,0.524794196429806,2,NO,0,"GO:0005576~extracellular region,",0,0,0
TCHP,"Trichoplein, keratin filament binding",1,0.724507651291874,0.576395679177485,0.999998459386614,1,0.016845352857416,0.399161208349429,0.513447237194797,2,NO,0,"GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0005938~cell cortex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044448~cell cortex part,GO:0045095~keratin filament,GO:0045111~intermediate filament cytoskeleton,GO:0045177~apical part of cell,GO:0045179~apical cortex,",0,0,0
APPL2,"adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2",1,0.342096927505986,0.620539289527082,0.953729999148077,1,0.016853120886614,0.399161208349429,0.404451190058007,2,NO,0,"GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0000118~histone deacetylase complex,GO:0005654~nucleoplasm,GO:0005768~endosome,GO:0010008~endosome membrane,GO:0016581~NuRD complex,GO:0016585~chromatin remodeling complex,GO:0017053~transcriptional repressor complex,GO:0019898~extrinsic to membrane,GO:0031090~organelle membrane,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044440~endosomal part,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,",0,0,0
NFIA,nuclear factor I/A,1,0.023483600277954,0.715747949835011,0.962740812775298,1,0.016853386908277,0.399161208349429,0.542658509685091,2,NO,0,"GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0016032~viral reproduction,GO:0019058~viral infectious cycle,GO:0019079~viral genome replication,GO:0022415~viral reproductive process,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0005886~plasma membrane,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008134~transcription factor binding,GO:0030528~transcription regulator activity,",0,0,0
EXOC3L2,exocyst complex component 3-like 2,1,0.184100756202423,0.641447788305282,0.999999976536818,1,0.016862403473465,0.399161208349429,0.479184364411975,2,NO,0,0,0,0,0
SNAP91,"synaptosomal-associated protein, 91kDa homolog (mouse)",1,0.259421173804159,0.628457722964864,0.99999996943804,1,0.01689573097623,0.399161208349429,0.199490946009586,2,NO,0,"GO:0006461~protein complex assembly,GO:0006900~membrane budding,GO:0006901~vesicle coating,GO:0016044~membrane organization,GO:0016050~vesicle organization,GO:0016192~vesicle-mediated transport,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0048268~clathrin coat assembly,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005886~plasma membrane,GO:0005905~coated pit,GO:0009898~internal side of plasma membrane,GO:0012505~endomembrane system,GO:0030117~membrane coat,GO:0030118~clathrin coat,GO:0042734~presynaptic membrane,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0048475~coated membrane,GO:0005543~phospholipid binding,GO:0005545~phosphatidylinositol binding,GO:0008289~lipid binding,GO:0030276~clathrin binding,GO:0035091~phosphoinositide binding,",0,0,0
COL21A1,"collagen, type XXI, alpha 1",1,0.068033282281153,0.669292822937893,0.579606226102471,1,0.016896578908345,0.399161208349429,0.433118969526712,2,NO,0,"GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,",0,0,0
POLDIP3,"polymerase (DNA-directed), delta interacting protein 3",0.914645707022236,0.342096927505986,0.620539289527082,0.999615402689434,1,0.016912237263545,0.399161208349429,0.20996486720696,2,NO,0,"GO:0000166~nucleotide binding,GO:0003723~RNA binding,",0,0,0
CACNB2,"calcium channel, voltage-dependent, beta 2 subunit",1,0.068033282281153,0.669292822937893,0.998796002473072,1,0.016982035063906,0.399161208349429,0.406396677713465,2,YES,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007528~neuromuscular junction development,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0014706~striated muscle tissue development,GO:0015674~di-, tri-valent inorganic cation transport,GO:0019226~transmission of nerve impulse,GO:0030001~metal ion transport,GO:0042692~muscle cell differentiation,GO:0043062~extracellular structure organization,GO:0048741~skeletal muscle fiber development,GO:0048747~muscle fiber development,GO:0050808~synapse organization,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0051146~striated muscle cell differentiation,GO:0055001~muscle cell development,GO:0055002~striated muscle cell development,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0009898~internal side of plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034704~calcium channel complex,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005245~voltage-gated calcium channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,","hsa04010:MAPK signaling pathway,hsa04260:Cardiac muscle contraction,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,",0,0
POLR2B,"Polymerase (RNA) II (DNA directed) polypeptide B, 140kDa",1,0.35533311031061,0.620539289527082,2.14E-06,8.65E-06,0.016985868623256,0.399161208349429,0.662279583358689,2,YES,0,"GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0004672~protein kinase activity,GO:0008270~zinc ion binding,GO:0016779~nucleotidyltransferase activity,GO:0032549~ribonucleoside binding,GO:0034062~RNA polymerase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0000428~DNA-directed RNA polymerase complex,GO:0005654~nucleoplasm,GO:0005665~DNA-directed RNA polymerase II, core complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0030880~RNA polymerase complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0055029~nuclear DNA-directed RNA polymerase complex,GO:0070013~intracellular organelle lumen,GO:0000375~RNA splicing, via transesterification reactions,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000398~nuclear mRNA splicing, via spliceosome,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006354~RNA elongation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~RNA elongation from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006461~protein complex assembly,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,GO:0032774~RNA biosynthetic process,GO:0043933~macromolecular complex subunit organization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,","hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa03020:RNA polymerase,hsa05016:Huntington's disease,",0,0
DIRC2,Disrupted in renal carcinoma 2,1,0.621617423105817,0.594395772667206,0.999522142656605,1,0.017008670784359,0.399161208349429,0.778525672486279,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
TBR1,"T-box, brain, 1",0.846120936133285,0.475808461183278,0.616343584684641,0.987009162367072,1,0.01701389980073,0.399161208349429,0.193547343665739,2,NO,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006928~cell motion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030902~hindbrain development,GO:0031175~neuron projection development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",0,0,0
EYA2,eyes absent homolog 2 (Drosophila),1,0.886481428527679,0.462781043665193,9.83E-05,0.00035707409568,0.017045969216233,0.399161208349429,0.730115520331692,2,YES,0,"GO:0001704~formation of primary germ layer,GO:0001707~mesoderm formation,GO:0001708~cell fate specification,GO:0001710~mesodermal cell fate commitment,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0006974~response to DNA damage stimulus,GO:0007369~gastrulation,GO:0007498~mesoderm development,GO:0007501~mesodermal cell fate specification,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0016265~death,GO:0016311~dephosphorylation,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016576~histone dephosphorylation,GO:0033554~cellular response to stress,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0048332~mesoderm morphogenesis,GO:0048333~mesodermal cell differentiation,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0051276~chromosome organization,GO:0000287~magnesium ion binding,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0016791~phosphatase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
ELMO1,engulfment and cell motility 1,1,0.886481428527679,0.457438639780216,0.999987527820727,1,0.017060233536725,0.399161208349429,0.61165688127863,2,NO,0,"GO:0006897~endocytosis,GO:0006909~phagocytosis,GO:0006911~phagocytosis, engulfment,GO:0006915~apoptosis,GO:0006928~cell motion,GO:0007010~cytoskeleton organization,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0008219~cell death,GO:0010324~membrane invagination,GO:0012501~programmed cell death,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016265~death,GO:0016601~Rac protein signal transduction,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,","hsa04062:Chemokine signaling pathway,",0,0
AHR,aryl hydrocarbon receptor,1,0.371783892346493,0.620539289527082,0.995919550006543,1,0.017102418547616,0.399161208349429,0.53930136686394,2,YES,0,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptosis,GO:0007049~cell cycle,GO:0008219~cell death,GO:0009410~response to xenobiotic stimulus,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0012501~programmed cell death,GO:0016265~death,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0043254~regulation of protein complex assembly,GO:0044087~regulation of cellular component biogenesis,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045898~regulation of transcriptional preinitiation complex assembly,GO:0045899~positive regulation of transcriptional preinitiation complex assembly,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051130~positive regulation of cellular component organization,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060260~regulation of transcription initiation from RNA polymerase II promoter,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0004879~ligand-dependent nuclear receptor activity,GO:0008134~transcription factor binding,GO:0030528~transcription regulator activity,GO:0031072~heat shock protein binding,GO:0051879~Hsp90 protein binding,",0,0,0
IFNA10,"interferon, alpha 10",1,1,0.072632504100047,0.999999999669256,1,0.017129993855713,0.399161208349429,0.746826844249261,2,NO,0,"GO:0005125~cytokine activity,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0006952~defense response,GO:0009615~response to virus,","hsa04060:Cytokine-cytokine receptor interaction,hsa04140:Regulation of autophagy,hsa04612:Antigen processing and presentation,hsa04620:Toll-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa05320:Autoimmune thyroid disease,",0,0
PPM1E,protein phosphatase 1E (PP2C domain containing),1,1,0.399992964780997,8.03E-28,6.90E-27,0.017138352647157,0.399161208349429,0.773945243609309,2,YES,0,"GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016311~dephosphorylation,GO:0005730~nucleolus,GO:0008287~protein serine/threonine phosphatase complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000287~magnesium ion binding,GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0030145~manganese ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
UPF2,UPF2 regulator of nonsense transcripts homolog (yeast),1,0.757626350873117,0.559248062668889,0.64260672899202,1,0.017298921622503,0.401615015052973,0.6161190625985,2,NO,0,"GO:0003723~RNA binding,GO:0042802~identical protein binding,GO:0048471~perinuclear region of cytoplasm,GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006401~RNA catabolic process,GO:0006402~mRNA catabolic process,GO:0006403~RNA localization,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0006913~nucleocytoplasmic transport,GO:0009057~macromolecule catabolic process,GO:0015931~nucleobase, nucleoside, nucleotide and nucleic acid transport,GO:0016071~mRNA metabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0046907~intracellular transport,GO:0050657~nucleic acid transport,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:0051168~nuclear export,GO:0051169~nuclear transport,GO:0051236~establishment of RNA localization,",0,0,0
GTF2E1,"general transcription factor IIE, polypeptide 1, alpha 56kDa",1,0.745415986888831,0.559248062668889,0.028918841805073,0.088336066406698,0.017307196166636,0.401615015052973,0.595022132011002,2,NO,0,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006354~RNA elongation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~RNA elongation from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0032774~RNA biosynthetic process,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005673~transcription factor TFIIE complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003702~RNA polymerase II transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa03022:Basal transcription factors,",0,0
PCNX,pecanex homolog (Drosophila),0.724261534730691,0.023691065120671,0.715747949835011,3.39E-10,1.67E-09,0.017316289084076,0.401615015052973,0.179984015414252,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
ATP6V0A4,"ATPase, H+ transporting, lysosomal V0 subunit a4",1,0.745415986888831,0.574103899756076,1.38E-05,5.33E-05,0.017401221201764,0.402772504123597,0.649047449988698,2,NO,0,"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0006091~generation of precursor metabolites and energy,GO:0006119~oxidative phosphorylation,GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006818~hydrogen transport,GO:0006885~regulation of pH,GO:0007588~excretion,GO:0007600~sensory perception,GO:0007605~sensory perception of sound,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0015672~monovalent inorganic cation transport,GO:0015985~energy coupled proton transport, down electrochemical gradient,GO:0015986~ATP synthesis coupled proton transport,GO:0015988~energy coupled proton transport, against electrochemical gradient,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0016310~phosphorylation,GO:0034220~ion transmembrane transport,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0042592~homeostatic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046034~ATP metabolic process,GO:0046903~secretion,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050954~sensory perception of mechanical stimulus,GO:0055067~monovalent inorganic cation homeostasis,GO:0055080~cation homeostasis,GO:0055085~transmembrane transport,GO:0060348~bone development,GO:0005768~endosome,GO:0005773~vacuole,GO:0005774~vacuolar membrane,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0016021~integral to membrane,GO:0016324~apical plasma membrane,GO:0016469~proton-transporting two-sector ATPase complex,GO:0016471~vacuolar proton-transporting V-type ATPase complex,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031253~cell projection membrane,GO:0031526~brush border membrane,GO:0033176~proton-transporting V-type ATPase complex,GO:0033177~proton-transporting two-sector ATPase complex, proton-transporting domain,GO:0042995~cell projection,GO:0044437~vacuolar part,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045177~apical part of cell,GO:0008553~hydrogen-exporting ATPase activity, phosphorylative mechanism,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0019899~enzyme binding,GO:0022890~inorganic cation transmembrane transporter activity,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043492~ATPase activity, coupled to movement of substances,GO:0051117~ATPase binding,","hsa00190:Oxidative phosphorylation,hsa04142:Lysosome,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,",0,0
KCNN2,"potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2",1,0.319298342345224,0.620539289527082,8.38E-14,4.84E-13,0.017526171207471,0.40512900745219,0.489889982249197,2,YES,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005216~ion channel activity,GO:0005227~calcium activated cation channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0005516~calmodulin binding,GO:0015267~channel activity,GO:0015269~calcium-activated potassium channel activity,GO:0016286~small conductance calcium-activated potassium channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022839~ion gated channel activity,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
EPX,eosinophil peroxidase,1,0.776777111998648,0.553490032211157,1.83E-20,1.30E-19,0.017546408642263,0.40512900745219,0.742228384093344,2,NO,0,"GO:0000302~response to reactive oxygen species,GO:0006800~oxygen and reactive oxygen species metabolic process,GO:0006979~response to oxidative stress,GO:0010035~response to inorganic substance,GO:0033554~cellular response to stress,GO:0034599~cellular response to oxidative stress,GO:0034614~cellular response to reactive oxygen species,GO:0042542~response to hydrogen peroxide,GO:0042743~hydrogen peroxide metabolic process,GO:0042744~hydrogen peroxide catabolic process,GO:0055114~oxidation reduction,GO:0070301~cellular response to hydrogen peroxide,GO:0004601~peroxidase activity,GO:0005506~iron ion binding,GO:0005509~calcium ion binding,GO:0016209~antioxidant activity,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0020037~heme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,","hsa05310:Asthma,",0,0
METTL3,methyltransferase like 3,1,0.07734522015286,0.669292822937893,0.002245417979101,0.007441831517324,0.017592892063365,0.40540470428955,0.452144360265013,2,YES,0,"GO:0001510~RNA methylation,GO:0006730~one-carbon metabolic process,GO:0009451~RNA modification,GO:0032259~methylation,GO:0043414~biopolymer methylation,GO:0005654~nucleoplasm,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003723~RNA binding,GO:0008173~RNA methyltransferase activity,GO:0008174~mRNA methyltransferase activity,GO:0016422~mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,",0,0,0
ZNF326,zinc finger protein 326,1,0.342096927505986,0.620539289527082,2.82E-11,1.48E-10,0.017607586240023,0.40540470428955,0.458286237216819,2,NO,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0016363~nuclear matrix,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0034399~nuclear periphery,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
DIRAS2,"DIRAS family, GTP-binding RAS-like 2",1,1,0.198968577825953,0.999999999843492,1,0.017650882790055,0.405536088112476,0.76005096142896,2,YES,0,"GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,",0,0,0
RECQL,RecQ protein-like (DNA helicase Q1-like),1,1,0.108220484594399,0.082561108208938,0.241226175541177,0.017704319579742,0.406264109864875,0.696589411616262,2,YES,0,"GO:0000166,GO:0003676,GO:0003677,GO:0004003,GO:0004386,GO:0005515,GO:0005524,GO:0005634,GO:0006281,GO:0006310,GO:0008026,GO:0016787",0,0,0
BLZF1,Basic leucine zipper nuclear factor 1 (JEM-1),1,0.86861908420637,0.501831299149681,1.49E-20,1.05E-19,0.017783484826949,0.407580016052254,0.790614610587334,2,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0005794~Golgi apparatus,GO:0005796~Golgi lumen,GO:0031974~membrane-enclosed lumen,GO:0043233~organelle lumen,GO:0044431~Golgi apparatus part,GO:0070013~intracellular organelle lumen,GO:0001558~regulation of cell growth,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008104~protein localization,GO:0008283~cell proliferation,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0040008~regulation of growth,GO:0045184~establishment of protein localization,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
PAX3,paired box 3,1,0.745415986888831,0.576395679177485,0.99998778086767,1,0.018098665089171,0.413343985137457,0.588237143996629,2,NO,0,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001667~ameboidal cell migration,GO:0001755~neural crest cell migration,GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001843~neural tube closure,GO:0002009~morphogenesis of an epithelium,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptosis,GO:0006928~cell motion,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007600~sensory perception,GO:0007605~sensory perception of sound,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0012501~programmed cell death,GO:0014020~primary neural tube formation,GO:0014031~mesenchymal cell development,GO:0014032~neural crest cell development,GO:0014033~neural crest cell differentiation,GO:0016265~death,GO:0016331~morphogenesis of embryonic epithelium,GO:0016477~cell migration,GO:0016481~negative regulation of transcription,GO:0021510~spinal cord development,GO:0021515~cell differentiation in spinal cord,GO:0021516~dorsal spinal cord development,GO:0021527~spinal cord association neuron differentiation,GO:0021915~neural tube development,GO:0030182~neuron differentiation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042127~regulation of cell proliferation,GO:0043009~chordate embryonic development,GO:0043473~pigmentation,GO:0045165~cell fate commitment,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048066~pigmentation during development,GO:0048598~embryonic morphogenesis,GO:0048663~neuron fate commitment,GO:0048729~tissue morphogenesis,GO:0048762~mesenchymal cell differentiation,GO:0048870~cell motility,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050954~sensory perception of mechanical stimulus,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051674~localization of cell,GO:0060429~epithelium development,GO:0060485~mesenchyme development,GO:0060562~epithelial tube morphogenesis,GO:0060606~tube closure,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003705~RNA polymerase II transcription factor activity, enhancer binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0016566~specific transcriptional repressor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",0,0,0
CAPN3,"calpain 3, (p94)",1,0.420265180899895,0.616343584684641,0.999999993200632,1,0.018151918696683,0.413343985137457,0.306867830434508,2,YES,0,"GO:0006508~proteolysis,GO:0007010~cytoskeleton organization,GO:0007517~muscle organ development,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0010927~cellular component assembly involved in morphogenesis,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030239~myofibril assembly,GO:0031032~actomyosin structure organization,GO:0032989~cellular component morphogenesis,GO:0042493~response to drug,GO:0042692~muscle cell differentiation,GO:0045214~sarcomere organization,GO:0051146~striated muscle cell differentiation,GO:0051592~response to calcium ion,GO:0055001~muscle cell development,GO:0055002~striated muscle cell development,GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
NIPA2,non imprinted in Prader-Willi/Angelman syndrome 2,0.724261534730691,0.724507651291874,0.593957751752409,1,1,0.018179428536367,0.413343985137457,0.242026823749337,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
OR5AC2,"Olfactory receptor, family 5, subfamily AC, member 2",1,0.953842715951356,0.444921389161528,0.911427735237463,1,0.018186871911206,0.413343985137457,0.68717446235474,2,NO,0,"GO:0004984~olfactory receptor activity,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0050877~neurological system process,GO:0050890~cognition,","hsa04740:Olfactory transduction,",0,0
OR5M3,"olfactory receptor, family 5, subfamily M, member 3",1,1,0.413900866678315,0.998403547368969,1,0.018279251759534,0.413343985137457,0.534398374864819,2,NO,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0050877~neurological system process,GO:0050890~cognition,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004984~olfactory receptor activity,","hsa04740:Olfactory transduction,",0,0
PDE3B,"Phosphodiesterase 3B, cGMP-inhibited",1,0.43858482390646,0.616343584684641,0.999999984256119,1,0.018322652159849,0.413343985137457,0.50709052093736,2,NO,0,"GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0004119~cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,GO:0008081~phosphoric diester hydrolase activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0043422~protein kinase B binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005792~microsome,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0032045~guanyl-nucleotide exchange factor complex,GO:0042598~vesicular fraction,GO:0002791~regulation of peptide secretion,GO:0006163~purine nucleotide metabolic process,GO:0006195~purine nucleotide catabolic process,GO:0006198~cAMP catabolic process,GO:0007162~negative regulation of cell adhesion,GO:0009123~nucleoside monophosphate metabolic process,GO:0009125~nucleoside monophosphate catabolic process,GO:0009166~nucleotide catabolic process,GO:0009187~cyclic nucleotide metabolic process,GO:0009214~cyclic nucleotide catabolic process,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009894~regulation of catabolic process,GO:0009895~negative regulation of catabolic process,GO:0009968~negative regulation of signal transduction,GO:0010033~response to organic substance,GO:0010648~negative regulation of cell communication,GO:0019216~regulation of lipid metabolic process,GO:0030155~regulation of cell adhesion,GO:0031016~pancreas development,GO:0031018~endocrine pancreas development,GO:0032868~response to insulin stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0033500~carbohydrate homeostasis,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0033629~negative regulation of cell adhesion mediated by integrin,GO:0034655~nucleobase, nucleoside, nucleotide and nucleic acid catabolic process,GO:0034656~nucleobase, nucleoside and nucleotide catabolic process,GO:0035270~endocrine system development,GO:0042592~homeostatic process,GO:0042593~glucose homeostasis,GO:0043434~response to peptide hormone stimulus,GO:0043949~regulation of cAMP-mediated signaling,GO:0043951~negative regulation of cAMP-mediated signaling,GO:0044270~nitrogen compound catabolic process,GO:0045833~negative regulation of lipid metabolic process,GO:0046058~cAMP metabolic process,GO:0046700~heterocycle catabolic process,GO:0046883~regulation of hormone secretion,GO:0048878~chemical homeostasis,GO:0050796~regulation of insulin secretion,GO:0050994~regulation of lipid catabolic process,GO:0050995~negative regulation of lipid catabolic process,GO:0051046~regulation of secretion,GO:0060341~regulation of cellular localization,","hsa00230:Purine metabolism,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,",0,0
PRPH2,"peripherin 2 (retinal degeneration, slow)",1,0.825011387083431,0.532650659483048,6.38E-06,2.51E-05,0.018358919824513,0.413662561401787,0.68572534806742,2,YES,0,"GO:0001654~eye development,GO:0007155~cell adhesion,GO:0007423~sensory organ development,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0022610~biological adhesion,GO:0043010~camera-type eye development,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0060041~retina development in camera-type eye,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,","hsa05014:Amyotrophic lateral sclerosis (ALS),",0,0
PLCG1,"phospholipase C, gamma 1",1,0.475808461183278,0.616343584684641,6.41E-29,5.64E-28,0.018429919403357,0.414762005464225,0.770137458893283,2,NO,0,"GO:0001701~in utero embryonic development,GO:0006644~phospholipid metabolic process,GO:0007242~intracellular signaling cascade,GO:0009395~phospholipid catabolic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0016042~lipid catabolic process,GO:0019637~organophosphate metabolic process,GO:0043009~chordate embryonic development,GO:0044242~cellular lipid catabolic process,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0004435~phosphoinositide phospholipase C activity,GO:0004620~phospholipase activity,GO:0004629~phospholipase C activity,GO:0005509~calcium ion binding,GO:0008081~phosphoric diester hydrolase activity,GO:0016298~lipase activity,GO:0035254~glutamate receptor binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa00562:Inositol phosphate metabolism,hsa04012:ErbB signaling pathway,hsa04020:Calcium signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04370:VEGF signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa05110:Vibrio cholerae infection,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05200:Pathways in cancer,hsa05214:Glioma,hsa05223:Non-small cell lung cancer,",0,0
TRPC5,"Transient receptor potential cation channel, subfamily C, member 5",1,0.933741165756504,0.450810211687543,2.87E-11,1.50E-10,0.018491912913975,0.415656367412913,0.7309428674336,2,YES,0,"GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0015674~di-, tri-valent inorganic cation transport,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,",0,0,0
MYO1E,myosin IE,1,0.038129880226435,0.70302965945656,0.999999994146125,1,0.018516498216085,0.415708738195022,0.293429653763054,2,YES,0,"GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001655~urogenital system development,GO:0001701~in utero embryonic development,GO:0001822~kidney development,GO:0001944~vasculature development,GO:0002520~immune system development,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0009791~post-embryonic development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0030029~actin filament-based process,GO:0030048~actin filament-based movement,GO:0030097~hemopoiesis,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0035166~post-embryonic hemopoiesis,GO:0043009~chordate embryonic development,GO:0046907~intracellular transport,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048514~blood vessel morphogenesis,GO:0048534~hemopoietic or lymphoid organ development,GO:0048569~post-embryonic organ development,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0016459~myosin complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0000146~microfilament motor activity,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003779~actin binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008092~cytoskeletal protein binding,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,",0,0,0
ONECUT1,one cut homeobox 1,1,0.05629362835822,0.679130630618955,0.999808066635225,1,0.018564078389084,0.415780826973287,0.518415517500815,2,NO,0,"GO:0000902~cell morphogenesis,GO:0001775~cell activation,GO:0001889~liver development,GO:0001952~regulation of cell-matrix adhesion,GO:0002064~epithelial cell development,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007492~endoderm development,GO:0009968~negative regulation of signal transduction,GO:0010648~negative regulation of cell communication,GO:0010810~regulation of cell-substrate adhesion,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0019318~hexose metabolic process,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030155~regulation of cell adhesion,GO:0030183~B cell differentiation,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030855~epithelial cell differentiation,GO:0031016~pancreas development,GO:0031018~endocrine pancreas development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0035270~endocrine system development,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042113~B cell activation,GO:0042384~cilium assembly,GO:0045165~cell fate commitment,GO:0045321~leukocyte activation,GO:0045449~regulation of transcription,GO:0046649~lymphocyte activation,GO:0048534~hemopoietic or lymphoid organ development,GO:0048536~spleen development,GO:0048858~cell projection morphogenesis,GO:0051252~regulation of RNA metabolic process,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0060271~cilium morphogenesis,GO:0060429~epithelium development,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,","hsa04950:Maturity onset diabetes of the young,",0,0
FOXK1,forkhead box K1,1,0.654381419924811,0.594395772667206,0.456819259159549,1,0.018606962767833,0.415780826973287,0.71751868910923,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007517~muscle organ development,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",0,0,0
KAT2B,K(lysine) acetyltransferase 2B,1,0.227591325759547,0.641447788305282,0.96543891302251,1,0.018640352424929,0.415780826973287,0.56480010872374,2,YES,0,"GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity,GO:0008080~N-acetyltransferase activity,GO:0008134~transcription factor binding,GO:0016407~acetyltransferase activity,GO:0016410~N-acyltransferase activity,GO:0016563~transcription activator activity,GO:0019899~enzyme binding,GO:0030528~transcription regulator activity,GO:0042826~histone deacetylase binding,GO:0000123~histone acetyltransferase complex,GO:0000125~PCAF complex,GO:0005654~nucleoplasm,GO:0016585~chromatin remodeling complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0070461~SAGA-type complex,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006473~protein amino acid acetylation,GO:0006474~N-terminal protein amino acid acetylation,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0016568~chromatin modification,GO:0016569~covalent chromatin modification,GO:0016570~histone modification,GO:0016573~histone acetylation,GO:0018076~N-terminal peptidyl-lysine acetylation,GO:0018205~peptidyl-lysine modification,GO:0018394~peptidyl-lysine acetylation,GO:0022402~cell cycle process,GO:0031365~N-terminal protein amino acid modification,GO:0032868~response to insulin stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032870~cellular response to hormone stimulus,GO:0042127~regulation of cell proliferation,GO:0043434~response to peptide hormone stimulus,GO:0043543~protein amino acid acylation,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0051276~chromosome organization,","hsa04330:Notch signaling pathway,",0,0
LMBRD2,LMBR1 domain containing 2,0.46255728259106,0.138864686954504,0.64908205921566,4.22E-12,2.29E-11,0.018771127861189,0.417129683215694,0.47777830152185,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
AFF2,"AF4/FMR2 family, member 2",1,0.217325787855403,0.641447788305282,0.00887765004842,0.028254493994622,0.018785658175293,0.417129683215694,0.61050110519256,2,NO,0,"GO:0007610~behavior,GO:0007611~learning or memory,GO:0050877~neurological system process,GO:0050890~cognition,",0,0,0
FUBP3,far upstream element (FUSE) binding protein 3,1,0.420265180899895,0.619526869101947,0.999999959056874,1,0.018806727689328,0.417129683215694,0.165415123538028,2,NO,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",0,0,0
BAI3,Brain-specific angiogenesis inhibitor 3,1,0.068033282281153,0.679130630618955,0.999999963731958,1,0.018816133251689,0.417129683215694,0.235945727312618,2,YES,0,"GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007218~neuropeptide signaling pathway,",0,0,0
KCNIP2,Kv channel interacting protein 2,0.846120936133285,0.503116045574968,0.616343584684641,0.999999997829336,1,0.018956240378931,0.417129683215694,0.10685838041327,2,YES,0,"GO:0003012~muscle system process,GO:0005513~detection of calcium ion,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006936~muscle contraction,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0008016~regulation of heart contraction,GO:0009593~detection of chemical stimulus,GO:0010035~response to inorganic substance,GO:0010038~response to metal ion,GO:0015672~monovalent inorganic cation transport,GO:0016044~membrane organization,GO:0019226~transmission of nerve impulse,GO:0021700~developmental maturation,GO:0030001~metal ion transport,GO:0030182~neuron differentiation,GO:0042551~neuron maturation,GO:0044057~regulation of system process,GO:0045161~neuronal ion channel clustering,GO:0045163~clustering of voltage-gated potassium channels,GO:0048469~cell maturation,GO:0048666~neuron development,GO:0050877~neurological system process,GO:0051592~response to calcium ion,GO:0051606~detection of stimulus,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0044459~plasma membrane part,GO:0005048~signal sequence binding,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005250~A-type (transient outward) potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0015271~outward rectifier potassium channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0042277~peptide binding,GO:0042802~identical protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0046923~ER retention sequence binding,GO:0047485~protein N-terminus binding,",0,0,0
ABCC9,"ATP-binding cassette, sub-family C (CFTR/MRP), member 9",1,1,0.358748714978385,0.028858509378297,0.088166191801965,0.018966719022349,0.417129683215694,0.686845361345252,2,YES,0,"GO:0002252~immune effector process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006952~defense response,GO:0006955~immune response,GO:0009615~response to virus,GO:0010107~potassium ion import,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0042493~response to drug,GO:0051607~defense response to virus,GO:0055085~transmembrane transport,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008282~ATP-sensitive potassium channel complex,GO:0016021~integral to membrane,GO:0030315~T-tubule,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0042383~sarcolemma,GO:0044459~plasma membrane part,GO:0000149~SNARE binding,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0005524~ATP binding,GO:0008144~drug binding,GO:0008281~sulfonylurea receptor activity,GO:0015267~channel activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015459~potassium channel regulator activity,GO:0016247~channel regulator activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0019905~syntaxin binding,GO:0022803~passive transmembrane transporter activity,GO:0022838~substrate specific channel activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046873~metal ion transmembrane transporter activity,","hsa02010:ABC transporters,",0,0
TRPC4,"transient receptor potential cation channel, subfamily C, member 4",1,0.161539563209108,0.64908205921566,5.65E-16,3.50E-15,0.018966886243989,0.417129683215694,0.429959911227417,2,YES,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0010959~regulation of metal ion transport,GO:0015674~di-, tri-valent inorganic cation transport,GO:0030001~metal ion transport,GO:0043269~regulation of ion transport,GO:0051924~regulation of calcium ion transport,GO:0055085~transmembrane transport,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0005938~cell cortex,GO:0016021~integral to membrane,GO:0030863~cortical cytoskeleton,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044448~cell cortex part,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
SETD4,SET domain containing 4,1,1,0.108469860173985,0.985010235538423,1,0.018999387747914,0.417129683215694,0.71238126089327,2,YES,0,methyltransferase activity,0,0,0
AVPR1B,Arginine vasopressin receptor 1B,0.856775619556526,0.505087244311173,0.616343584684641,1.45E-11,7.70E-11,0.019009501973756,0.417129683215694,0.764171527375575,2,YES,0,"GO:0001653~peptide receptor activity,GO:0005000~vasopressin receptor activity,GO:0005080~protein kinase C binding,GO:0008528~peptide receptor activity, G-protein coupled,GO:0017046~peptide hormone binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0042277~peptide binding,GO:0042562~hormone binding,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0001990~regulation of systemic arterial blood pressure by hormone,GO:0001992~regulation of systemic arterial blood pressure by vasopressin,GO:0002027~regulation of heart rate,GO:0003013~circulatory system process,GO:0003044~regulation of systemic arterial blood pressure mediated by a chemical signal,GO:0003073~regulation of systemic arterial blood pressure,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006970~response to osmotic stress,GO:0006972~hyperosmotic response,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007202~activation of phospholipase C activity,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0008015~blood circulation,GO:0008016~regulation of heart contraction,GO:0008217~regulation of blood pressure,GO:0009628~response to abiotic stimulus,GO:0009651~response to salt stress,GO:0010460~positive regulation of heart rate,GO:0010517~regulation of phospholipase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010863~positive regulation of phospholipase C activity,GO:0014048~regulation of glutamate secretion,GO:0014049~positive regulation of glutamate secretion,GO:0019725~cellular homeostasis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0032844~regulation of homeostatic process,GO:0032846~positive regulation of homeostatic process,GO:0032847~regulation of cellular pH reduction,GO:0032849~positive regulation of cellular pH reduction,GO:0042538~hyperosmotic salinity response,GO:0042592~homeostatic process,GO:0043085~positive regulation of catalytic activity,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0045777~positive regulation of blood pressure,GO:0045823~positive regulation of heart contraction,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050886~endocrine process,GO:0051046~regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051050~positive regulation of transport,GO:0051240~positive regulation of multicellular organismal process,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051480~cytosolic calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060191~regulation of lipase activity,GO:0060193~positive regulation of lipase activity,GO:0060341~regulation of cellular localization,","hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04270:Vascular smooth muscle contraction,",0,0
B3GALT2,"UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2",1,0.621617423105817,0.599319901491912,4.21E-21,3.04E-20,0.019010498983179,0.417129683215694,0.748080564410668,2,YES,0,"GO:0006486~protein amino acid glycosylation,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0009311~oligosaccharide metabolic process,GO:0009312~oligosaccharide biosynthetic process,GO:0016051~carbohydrate biosynthetic process,GO:0043413~biopolymer glycosylation,GO:0070085~glycosylation,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0008378~galactosyltransferase activity,GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0030145~manganese ion binding,GO:0035250~UDP-galactosyltransferase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0048531~beta-1,3-galactosyltransferase activity,","hsa00601:Glycosphingolipid biosynthesis,",0,0
CEACAM5,carcinoembryonic antigen-related cell adhesion molecule 5,1,0.885242164881095,0.505403482019668,0.999999993658643,1,0.019024994956878,0.417129683215694,0.705573619826621,2,NO,0,"GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,",0,0,0
KLK6,Kallikrein-related peptidase 6,1,1,0.108469860173985,0.999999997936585,1,0.01902641951388,0.417129683215694,0.636627414805267,2,NO,0,"GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005792~microsome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0042598~vesicular fraction,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0001508~regulation of action potential,GO:0006508~proteolysis,GO:0006873~cellular ion homeostasis,GO:0007272~ensheathment of neurons,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0008366~axon ensheathment,GO:0009100~glycoprotein metabolic process,GO:0009611~response to wounding,GO:0009967~positive regulation of signal transduction,GO:0010647~positive regulation of cell communication,GO:0010817~regulation of hormone levels,GO:0016485~protein processing,GO:0016540~protein autoprocessing,GO:0019226~transmission of nerve impulse,GO:0019228~regulation of action potential in neuron,GO:0019725~cellular homeostasis,GO:0030574~collagen catabolic process,GO:0031099~regeneration,GO:0032963~collagen metabolic process,GO:0040007~growth,GO:0042060~wound healing,GO:0042246~tissue regeneration,GO:0042391~regulation of membrane potential,GO:0042445~hormone metabolic process,GO:0042552~myelination,GO:0042592~homeostatic process,GO:0042982~amyloid precursor protein metabolic process,GO:0044236~multicellular organismal metabolic process,GO:0044243~multicellular organismal catabolic process,GO:0044259~multicellular organismal macromolecule metabolic process,GO:0045745~positive regulation of G-protein coupled receptor protein signaling pathway,GO:0048589~developmental growth,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0051604~protein maturation,GO:0055082~cellular chemical homeostasis,",0,0,0
SATB2,SATB homeobox 2,1,0.742087095988098,0.594395772667206,0.96627074657047,1,0.01918469991382,0.419366225369549,0.317561012708282,2,YES,0,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0001503~ossification,GO:0001649~osteoblast differentiation,GO:0001764~neuron migration,GO:0002076~osteoblast development,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006928~cell motion,GO:0007389~pattern specification process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009880~embryonic pattern specification,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016477~cell migration,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0043009~chordate embryonic development,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048870~cell motility,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051216~cartilage development,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051674~localization of cell,GO:0060021~palate development,GO:0060348~bone development,GO:0000118~histone deacetylase complex,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0016585~chromatin remodeling complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",0,0,0
UGP2,UDP-glucose pyrophosphorylase 2,0.942676713862289,0.84978015877207,0.532650659483048,0.005817771143105,0.018807571336458,0.019190845622931,0.419366225369549,0.33228897996597,2,NO,0,"GO:0005996~monosaccharide metabolic process,GO:0006006~glucose metabolic process,GO:0006011~UDP-glucose metabolic process,GO:0006063~uronic acid metabolic process,GO:0006065~UDP-glucuronate biosynthetic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0009225~nucleotide-sugar metabolic process,GO:0016051~carbohydrate biosynthetic process,GO:0016053~organic acid biosynthetic process,GO:0016310~phosphorylation,GO:0019318~hexose metabolic process,GO:0019585~glucuronate metabolic process,GO:0046394~carboxylic acid biosynthetic process,GO:0046398~UDP-glucuronate metabolic process,GO:0046399~glucuronate biosynthetic process,GO:0005829~cytosol,GO:0003983~UTP:glucose-1-phosphate uridylyltransferase activity,GO:0016779~nucleotidyltransferase activity,GO:0051748~UTP-monosaccharide-1-phosphate uridylyltransferase activity,GO:0070569~uridylyltransferase activity,","hsa00040:Pentose and glucuronate interconversions,hsa00052:Galactose metabolism,hsa00500:Starch and sucrose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,",0,0
DENND4C,DENN/MADD domain containing 4C,1,0.86861908420637,0.532650659483048,0.999999745841678,1,0.019224835649033,0.419510169495665,0.577666681981285,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
ZNF665,zinc finger protein 665,1,0.73524777513296,0.594395772667206,0.999999187310284,1,0.019301704483282,0.420696077063272,0.488030733623248,2,NO,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
CNBD1,cyclic nucleotide binding domain containing 1,1,0.943222637657724,0.460714787855349,1.31E-12,7.24E-12,0.019405664884349,0.422469014422781,0.708287460068577,2,NO,0,0,0,0,0
CNTN5,contactin 5,1,0.046058405572709,0.688986797626025,2.10E-06,8.48E-06,0.019442732055636,0.422783227086399,0.453351342287089,2,NO,0,"GO:0007155~cell adhesion,GO:0007600~sensory perception,GO:0007605~sensory perception of sound,GO:0022610~biological adhesion,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050954~sensory perception of mechanical stimulus,GO:0005886~plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,",0,0,0
ATP9A,"ATPase, class II, type 9A",1,0.780284580214678,0.571581860301639,2.40E-16,1.51E-15,0.019512200834795,0.423800464410612,0.757081854684118,2,YES,0,"GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006869~lipid transport,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0010876~lipid localization,GO:0015914~phospholipid transport,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046034~ATP metabolic process,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005319~lipid transporter activity,GO:0005524~ATP binding,GO:0005548~phospholipid transporter activity,GO:0015247~aminophospholipid transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,",0,0,0
HIST1H2AA,"histone cluster 1, H2aa",1,1,0.140246135362749,0.894026535546624,1,0.01959411133876,0.424125861294527,0.695737624838082,2,NO,0,"GO:0006323~DNA packaging,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006334~nucleosome assembly,GO:0031497~chromatin assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0034728~nucleosome organization,GO:0043933~macromolecular complex subunit organization,GO:0051276~chromosome organization,GO:0065003~macromolecular complex assembly,GO:0065004~protein-DNA complex assembly,GO:0000785~chromatin,GO:0000786~nucleosome,GO:0005694~chromosome,GO:0032993~protein-DNA complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0003677~DNA binding,","hsa05322:Systemic lupus erythematosus,",0,0
SPO11,SPO11 meiotic protein covalently bound to DSB homolog (S. cerevisiae),1,0.198192316930223,0.641447788305282,5.58E-21,4.02E-20,0.019618006539883,0.424125861294527,0.712999996085374,2,YES,0,"GO:0000279~M phase,GO:0006259~DNA metabolic process,GO:0006310~DNA recombination,GO:0007049~cell cycle,GO:0007126~meiosis,GO:0007127~meiosis I,GO:0007131~reciprocal meiotic recombination,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0007292~female gamete generation,GO:0019953~sexual reproduction,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0051321~meiotic cell cycle,GO:0051327~M phase of meiotic cell cycle,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",0,0,0
CD226,CD226 molecule,1,1,0.296278406649975,0.001290555409964,0.004338003329622,0.019743801942393,0.424524302558189,0.461230800254458,2,NO,0,"GO:0001816~cytokine production,GO:0001910~regulation of leukocyte mediated cytotoxicity,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0002697~regulation of immune effector process,GO:0002699~positive regulation of immune effector process,GO:0002703~regulation of leukocyte mediated immunity,GO:0002705~positive regulation of leukocyte mediated immunity,GO:0002706~regulation of lymphocyte mediated immunity,GO:0002708~positive regulation of lymphocyte mediated immunity,GO:0002712~regulation of B cell mediated immunity,GO:0002714~positive regulation of B cell mediated immunity,GO:0002715~regulation of natural killer cell mediated immunity,GO:0002717~positive regulation of natural killer cell mediated immunity,GO:0002819~regulation of adaptive immune response,GO:0002821~positive regulation of adaptive immune response,GO:0002822~regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002824~positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002831~regulation of response to biotic stimulus,GO:0002833~positive regulation of response to biotic stimulus,GO:0002834~regulation of response to tumor cell,GO:0002836~positive regulation of response to tumor cell,GO:0002837~regulation of immune response to tumor cell,GO:0002839~positive regulation of immune response to tumor cell,GO:0002855~regulation of natural killer cell mediated immune response to tumor cell,GO:0002857~positive regulation of natural killer cell mediated immune response to tumor cell,GO:0002858~regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,GO:0002860~positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,GO:0002889~regulation of immunoglobulin mediated immune response,GO:0002891~positive regulation of immunoglobulin mediated immune response,GO:0007155~cell adhesion,GO:0008037~cell recognition,GO:0009967~positive regulation of signal transduction,GO:0010647~positive regulation of cell communication,GO:0022610~biological adhesion,GO:0031341~regulation of cell killing,GO:0031343~positive regulation of cell killing,GO:0031349~positive regulation of defense response,GO:0033003~regulation of mast cell activation,GO:0033005~positive regulation of mast cell activation,GO:0042269~regulation of natural killer cell mediated cytotoxicity,GO:0045088~regulation of innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0048584~positive regulation of response to stimulus,GO:0050778~positive regulation of immune response,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0060368~regulation of Fc receptor mediated stimulatory signaling pathway,GO:0060369~positive regulation of Fc receptor mediated stimulatory signaling pathway,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0005178~integrin binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0032403~protein complex binding,GO:0050839~cell adhesion molecule binding,","hsa04514:Cell adhesion molecules (CAMs),",0,0
MYEF2,myelin expression factor 2,0.870073081188473,0.136598382188982,0.660850491134096,0.999997042435778,1,0.019750073286743,0.424524302558189,0.157249153425366,2,NO,0,"GO:0001709~cell fate determination,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0007518~myoblast cell fate determination,GO:0032774~RNA biosynthetic process,GO:0042692~muscle cell differentiation,GO:0045165~cell fate commitment,GO:0045445~myoblast differentiation,GO:0048625~myoblast cell fate commitment,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003702~RNA polymerase II transcription factor activity,GO:0003705~RNA polymerase II transcription factor activity, enhancer binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0008134~transcription factor binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",0,0,0
CDH2,"cadherin 2, type 1, N-cadherin (neuronal)",1,0.371783892346493,0.620539289527082,0.999999680367078,1,0.019838695259702,0.425108868211173,0.62339851516353,2,NO,0,"GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0006461~protein complex assembly,GO:0006928~cell motion,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0007157~heterophilic cell adhesion,GO:0007416~synaptogenesis,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010975~regulation of neuron projection development,GO:0016337~cell-cell adhesion,GO:0016339~calcium-dependent cell-cell adhesion,GO:0016477~cell migration,GO:0022604~regulation of cell morphogenesis,GO:0022610~biological adhesion,GO:0031344~regulation of cell projection organization,GO:0031641~regulation of myelination,GO:0031644~regulation of neurological system process,GO:0032844~regulation of homeostatic process,GO:0032880~regulation of protein localization,GO:0035023~regulation of Rho protein signal transduction,GO:0043062~extracellular structure organization,GO:0043933~macromolecular complex subunit organization,GO:0044057~regulation of system process,GO:0045664~regulation of neuron differentiation,GO:0046578~regulation of Ras protein signal transduction,GO:0048514~blood vessel morphogenesis,GO:0048870~cell motility,GO:0050767~regulation of neurogenesis,GO:0050770~regulation of axonogenesis,GO:0050808~synapse organization,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051259~protein oligomerization,GO:0051291~protein heterooligomerization,GO:0051674~localization of cell,GO:0051960~regulation of nervous system development,GO:0051969~regulation of transmission of nerve impulse,GO:0060284~regulation of cell development,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005916~fascia adherens,GO:0014704~intercalated disc,GO:0016021~integral to membrane,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0070161~anchoring junction,GO:0005509~calcium ion binding,GO:0008013~beta-catenin binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0019902~phosphatase binding,GO:0019903~protein phosphatase binding,GO:0042153~RPTP-like protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa04514:Cell adhesion molecules (CAMs),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),",0,0
ACSM2B,acyl-CoA synthetase medium-chain family member 2B,1,0.849800948421965,0.549291121684181,0.999582401184324,1,0.01994949735702,0.425108868211173,0.607716210404335,2,YES,0,"GO:0006631~fatty acid metabolic process,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0016877~ligase activity, forming carbon-sulfur bonds,GO:0016878~acid-thiol ligase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0047760~butyrate-CoA ligase activity,",0,0,0
PDE4C,"phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila)",1,0.745415986888831,0.594395772667206,0.001315911922158,0.004421643963659,0.019964513157256,0.425108868211173,0.654874016210857,2,NO,0,"GO:0005829~cytosol,GO:0004112~cyclic-nucleotide phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0008081~phosphoric diester hydrolase activity,","hsa00230:Purine metabolism,",0,0
ASB2,ankyrin repeat and SOCS box-containing 2,1,0.180765780910828,0.64908205921566,1,1,0.019986633075037,0.425108868211173,0.581267765557293,2,YES,0,"GO:0006508~proteolysis,GO:0007242~intracellular signaling cascade,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,",0,0,0
CDCA4,cell division cycle associated 4,1,1,0.296602665660762,0.140109661449597,0.399010270806071,0.019988946368035,0.425108868211173,0.541490814783021,2,NO,0,0,0,0,0
SLC5A8,"solute carrier family 5 (iodide transporter), member 8",1,0.336725279292136,0.628457722964864,0.999944130168116,1,0.020000752259764,0.425108868211173,0.515261259607035,2,NO,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0006915~apoptosis,GO:0008219~cell death,GO:0012501~programmed cell death,GO:0015672~monovalent inorganic cation transport,GO:0016265~death,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0015293~symporter activity,GO:0022803~passive transmembrane transporter activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
PUM2,pumilio homolog 2 (Drosophila),1,0.066343878305903,0.679130630618955,0.976635582636985,1,0.020009622879467,0.425108868211173,0.32824087700939,2,NO,0,"GO:0006417~regulation of translation,GO:0010608~posttranscriptional regulation of gene expression,GO:0032268~regulation of cellular protein metabolic process,GO:0003723~RNA binding,",0,0,0
STX3,Syntaxin 3,1,0.621617423105817,0.599319901491912,0.995356512361291,1,0.020044436577383,0.425108868211173,0.640441090703082,2,NO,0,"GO:0005484~SNAP receptor activity,GO:0005504~fatty acid binding,GO:0008289~lipid binding,GO:0031406~carboxylic acid binding,GO:0033293~monocarboxylic acid binding,GO:0050542~icosanoid binding,GO:0050543~icosatetraenoic acid binding,GO:0050544~arachidonic acid binding,GO:0000267~cell fraction,GO:0000323~lytic vacuole,GO:0001950~plasma membrane enriched fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005764~lysosome,GO:0005766~primary lysosome,GO:0005773~vacuole,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0016324~apical plasma membrane,GO:0030054~cell junction,GO:0030141~secretory granule,GO:0030426~growth cone,GO:0030427~site of polarized growth,GO:0031201~SNARE complex,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042581~specific granule,GO:0042582~azurophil granule,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0006836~neurotransmitter transport,GO:0006886~intracellular protein transport,GO:0006944~membrane fusion,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0048666~neuron development,GO:0070727~cellular macromolecule localization,","hsa04130:SNARE interactions in vesicular transport,",0,0
MANSC1,MANSC domain containing 1,1,1,0.379347082700499,0.999999999842769,1,0.020073131418291,0.425108868211173,0.585684291748695,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004568~chitinase activity,",0,0,0
RELN,reelin,1,0.300353975897608,0.628457722964864,1.96E-11,1.03E-10,0.020189373622741,0.426647750726963,0.69579113785591,2,NO,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001764~neuron migration,GO:0003002~regionalization,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006928~cell motion,GO:0007155~cell adhesion,GO:0007389~pattern specification process,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0009967~positive regulation of signal transduction,GO:0010001~glial cell differentiation,GO:0010647~positive regulation of cell communication,GO:0010817~regulation of hormone levels,GO:0016310~phosphorylation,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0019220~regulation of phosphate metabolic process,GO:0021510~spinal cord development,GO:0021511~spinal cord patterning,GO:0021537~telencephalon development,GO:0021543~pallium development,GO:0021795~cerebral cortex cell migration,GO:0021800~cerebral cortex tangential migration,GO:0021885~forebrain cell migration,GO:0021987~cerebral cortex development,GO:0022029~telencephalon cell migration,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030900~forebrain development,GO:0031175~neuron projection development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033555~multicellular organismal response to stress,GO:0033674~positive regulation of kinase activity,GO:0042063~gliogenesis,GO:0042325~regulation of phosphorylation,GO:0042403~thyroid hormone metabolic process,GO:0042445~hormone metabolic process,GO:0043085~positive regulation of catalytic activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0048265~response to pain,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051674~localization of cell,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0030425~dendrite,GO:0031012~extracellular matrix,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0044421~extracellular region part,GO:0004672~protein kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0008270~zinc ion binding,GO:0017171~serine hydrolase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,",0,0
NELL2,NEL-like 2 (chicken),0.724261534730691,0.227591325759547,0.641447788305282,0.99998092766964,1,0.020191477683101,0.426647750726963,0.369912564870428,2,NO,0,"GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0040008~regulation of growth,GO:0005576~extracellular region,GO:0005198~structural molecule activity,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
POLE2,"polymerase (DNA directed), epsilon 2 (p59 subunit)",1,1,0.332676355469261,0.999992161879818,1,0.020351203130007,0.427993040625086,0.585750350303893,2,YES,0,"GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006974~response to DNA damage stimulus,GO:0033554~cellular response to stress,GO:0005654~nucleoplasm,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0016779~nucleotidyltransferase activity,GO:0034061~DNA polymerase activity,","hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa03030:DNA replication,hsa03410:Base excision repair,hsa03420:Nucleotide excision repair,",0,0
ACSBG2,acyl-CoA synthetase bubblegum family member 2,1,1,0.116729118029788,0.999656587997955,1,0.020369710001376,0.427993040625086,0.625818771014635,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004467~long-chain-fatty-acid-CoA ligase activity,GO:0005524~ATP binding,GO:0015645~fatty-acid ligase activity,GO:0016289~CoA hydrolase activity,GO:0016291~acyl-CoA thioesterase activity,GO:0016790~thiolester hydrolase activity,GO:0016877~ligase activity, forming carbon-sulfur bonds,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005739~mitochondrion,GO:0005792~microsome,GO:0005829~cytosol,GO:0019898~extrinsic to membrane,GO:0042598~vesicular fraction,GO:0006631~fatty acid metabolic process,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,",0,0,0
GALNT7,UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7),1,0.910322520092466,0.494522794312359,0.031287106338056,0.095274186385482,0.020488311805163,0.42951871628354,0.267225174783859,2,NO,0,"GO:0006486~protein amino acid glycosylation,GO:0006493~protein amino acid O-linked glycosylation,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0043413~biopolymer glycosylation,GO:0070085~glycosylation,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004653~polypeptide N-acetylgalactosaminyltransferase activity,GO:0005509~calcium ion binding,GO:0005529~sugar binding,GO:0008376~acetylgalactosaminyltransferase activity,GO:0030145~manganese ion binding,GO:0030246~carbohydrate binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,","hsa00512:O-Glycan biosynthesis,",0,0
ERBB4,v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian),1,0.104977053308268,0.669292822937893,0.999712115250729,1,0.02057852009975,0.430493065953257,0.498005836157388,2,YES,0,"GO:0000302~response to reactive oxygen species,GO:0001894~tissue homeostasis,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006979~response to oxidative stress,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007507~heart development,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010647~positive regulation of cell communication,GO:0010827~regulation of glucose transport,GO:0010828~positive regulation of glucose transport,GO:0016310~phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0018212~peptidyl-tyrosine modification,GO:0021537~telencephalon development,GO:0021700~developmental maturation,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030879~mammary gland development,GO:0030900~forebrain development,GO:0031644~regulation of neurological system process,GO:0031646~positive regulation of neurological system process,GO:0032228~regulation of synaptic transmission, GABAergic,GO:0032230~positive regulation of synaptic transmission, GABAergic,GO:0032570~response to progesterone stimulus,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042127~regulation of cell proliferation,GO:0042476~odontogenesis,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0042592~homeostatic process,GO:0043062~extracellular structure organization,GO:0043129~surfactant homeostasis,GO:0044057~regulation of system process,GO:0045165~cell fate commitment,GO:0045767~regulation of anti-apoptosis,GO:0045768~positive regulation of anti-apoptosis,GO:0046324~regulation of glucose import,GO:0046326~positive regulation of glucose import,GO:0048545~response to steroid hormone stimulus,GO:0048732~gland development,GO:0048871~multicellular organismal homeostasis,GO:0048875~chemical homeostasis within a tissue,GO:0048878~chemical homeostasis,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050804~regulation of synaptic transmission,GO:0050806~positive regulation of synaptic transmission,GO:0050808~synapse organization,GO:0051050~positive regulation of transport,GO:0051240~positive regulation of multicellular organismal process,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051969~regulation of transmission of nerve impulse,GO:0051971~positive regulation of transmission of nerve impulse,GO:0060074~synapse maturation,GO:0060249~anatomical structure homeostasis,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0014069~postsynaptic density,GO:0016021~integral to membrane,GO:0016323~basolateral plasma membrane,GO:0031224~intrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045121~membrane raft,GO:0045202~synapse,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04012:ErbB signaling pathway,hsa04020:Calcium signaling pathway,hsa04144:Endocytosis,",0,0
SRL,sarcalumenin,1,0.787415323919243,0.574103899756076,0.999999981220202,1,0.020580882696946,0.430493065953257,0.603848439717398,2,NO,0,"GO:0005783~endoplasmic reticulum,GO:0005788~endoplasmic reticulum lumen,GO:0016528~sarcoplasm,GO:0016529~sarcoplasmic reticulum,GO:0031974~membrane-enclosed lumen,GO:0033018~sarcoplasmic reticulum lumen,GO:0043233~organelle lumen,GO:0044432~endoplasmic reticulum part,GO:0070013~intracellular organelle lumen,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
ZNF678,zinc finger protein 678,1,1,0.301585681419051,1.34E-10,6.73E-10,0.020611871532793,0.430593742919323,0.756901895296256,2,NO,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
NR4A2,"Nuclear receptor subfamily 4, group A, member 2",1,0.621836689516304,0.601943915278899,0.999923606771306,1,0.020631800412913,0.430593742919323,0.465381479557917,2,YES,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003707~steroid hormone receptor activity,GO:0004879~ligand-dependent nuclear receptor activity,GO:0008270~zinc ion binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001666~response to hypoxia,GO:0001764~neuron migration,GO:0001975~response to amphetamine,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006575~cellular amino acid derivative metabolic process,GO:0006576~biogenic amine metabolic process,GO:0006584~catecholamine metabolic process,GO:0006928~cell motion,GO:0007409~axonogenesis,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0008344~adult locomotory behavior,GO:0009309~amine biosynthetic process,GO:0009636~response to toxin,GO:0009712~catechol metabolic process,GO:0009719~response to endogenous stimulus,GO:0009791~post-embryonic development,GO:0009891~positive regulation of biosynthetic process,GO:0009991~response to extracellular stimulus,GO:0010033~response to organic substance,GO:0010035~response to inorganic substance,GO:0010243~response to organic nitrogen,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010941~regulation of cell death,GO:0014075~response to amine stimulus,GO:0016265~death,GO:0016477~cell migration,GO:0017085~response to insecticide,GO:0018958~phenol metabolic process,GO:0021700~developmental maturation,GO:0021952~central nervous system projection neuron axonogenesis,GO:0021953~central nervous system neuron differentiation,GO:0021954~central nervous system neuron development,GO:0021955~central nervous system neuron axonogenesis,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030534~adult behavior,GO:0031175~neuron projection development,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031668~cellular response to extracellular stimulus,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033238~regulation of cellular amine metabolic process,GO:0034311~diol metabolic process,GO:0042053~regulation of dopamine metabolic process,GO:0042069~regulation of catecholamine metabolic process,GO:0042398~cellular amino acid derivative biosynthetic process,GO:0042401~biogenic amine biosynthetic process,GO:0042416~dopamine biosynthetic process,GO:0042417~dopamine metabolic process,GO:0042423~catecholamine biosynthetic process,GO:0042551~neuron maturation,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043085~positive regulation of catalytic activity,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0043576~regulation of respiratory gaseous exchange,GO:0044093~positive regulation of molecular function,GO:0044271~nitrogen compound biosynthetic process,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0048870~cell motility,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051674~localization of cell,GO:0051789~response to protein stimulus,GO:0060548~negative regulation of cell death,GO:0070482~response to oxygen levels,",0,0,0
RCC1,regulator of chromosome condensation 1; SNHG3-RCC1 readthrough transcript,1,0.812549668064137,0.56767625725793,0.998335830670738,1,0.020658490237736,0.430669574944949,0.216543867788702,2,YES,0,"GO:0000082~G1/S transition of mitotic cell cycle,GO:0000087~M phase of mitotic cell cycle,GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0007052~mitotic spindle organization,GO:0007067~mitosis,GO:0007088~regulation of mitosis,GO:0007090~regulation of S phase of mitotic cell cycle,GO:0007346~regulation of mitotic cell cycle,GO:0010564~regulation of cell cycle process,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0033043~regulation of organelle organization,GO:0033261~regulation of S phase,GO:0048285~organelle fission,GO:0051301~cell division,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0051726~regulation of cell cycle,GO:0051783~regulation of nuclear division,GO:0000228~nuclear chromosome,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,GO:0003682~chromatin binding,GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005087~Ran guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0030695~GTPase regulator activity,GO:0042393~histone binding,GO:0060589~nucleoside-triphosphatase regulator activity,",0,0,0
ZNF101,Zinc finger protein 101,1,1,0.119180381269321,0.041402617752779,0.124654980174752,0.0206980225894,0.431012668837688,0.681626810329163,2,NO,0,"GO:0003676,GO:0003677,GO:0005622,GO:0005634,GO:0006350,GO:0006355,GO:0008270,GO:0046872",0,0,0
GABRA4,"Gamma-aminobutyric acid (GABA) A receptor, alpha 4",1,1,0.200213332138186,0.999998034857425,1,0.020805202004626,0.431321163423316,0.697582981718551,2,YES,0,"GO:0004890~GABA-A receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008503~benzodiazepine receptor activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0016917~GABA receptor activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0031404~chloride ion binding,GO:0042165~neurotransmitter binding,GO:0043167~ion binding,GO:0043168~anion binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0015698~inorganic anion transport,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
BEND5,BEN domain containing 5,1,0.953842715951356,0.462781043665193,0.99393939812702,1,0.02085292568482,0.431688452500583,0.624157988071374,2,NO,0,"GO:0005794~Golgi apparatus,",0,0,0
TMTC3,transmembrane and tetratricopeptide repeat containing 3,0.793406891251112,0.801858501175754,0.574103899756076,0.999817920158906,1,0.020964306398851,0.432949296472828,0.239640202982792,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
EID3,EP300 interacting inhibitor of differentiation 3,1,0.745415986888831,0.594395772667206,0.997279738735306,1,0.020976450201184,0.432949296472828,0.540578217422752,2,NO,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,",0,0,0
WDR7,WD repeat domain 7,1,0.136598382188982,0.660850491134096,0.999999999999952,1,0.021018808876067,0.432975079155907,0.270709025275307,2,NO,0,"GO:0006508~proteolysis,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
TPK1,thiamin pyrophosphokinase 1,1,0.886481428527679,0.532650659483048,2.91E-07,1.23E-06,0.021149293180252,0.433778001373485,0.678636255535217,2,NO,0,"GO:0006732~coenzyme metabolic process,GO:0006766~vitamin metabolic process,GO:0006767~water-soluble vitamin metabolic process,GO:0006772~thiamin metabolic process,GO:0006790~sulfur metabolic process,GO:0009108~coenzyme biosynthetic process,GO:0009110~vitamin biosynthetic process,GO:0009229~thiamin diphosphate biosynthetic process,GO:0018130~heterocycle biosynthetic process,GO:0019438~aromatic compound biosynthetic process,GO:0042357~thiamin diphosphate metabolic process,GO:0042364~water-soluble vitamin biosynthetic process,GO:0042723~thiamin and derivative metabolic process,GO:0042724~thiamin and derivative biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0044272~sulfur compound biosynthetic process,GO:0051186~cofactor metabolic process,GO:0051188~cofactor biosynthetic process,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004788~thiamin diphosphokinase activity,GO:0005524~ATP binding,GO:0016778~diphosphotransferase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa00730:Thiamine metabolism,",0,0
DYRK2,Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2,1,0.787415323919243,0.576395679177485,2.29E-31,2.17E-30,0.021171871343705,0.433778001373485,0.798396017868917,2,YES,0,"GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030145~manganese ion binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005979~regulation of glycogen biosynthetic process,GO:0006109~regulation of carbohydrate metabolic process,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006974~response to DNA damage stimulus,GO:0007242~intracellular signaling cascade,GO:0008219~cell death,GO:0008629~induction of apoptosis by intracellular signals,GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010675~regulation of cellular carbohydrate metabolic process,GO:0010676~positive regulation of cellular carbohydrate metabolic process,GO:0010906~regulation of glucose metabolic process,GO:0010907~positive regulation of glucose metabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0010962~regulation of glucan biosynthetic process,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0016310~phosphorylation,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032881~regulation of polysaccharide metabolic process,GO:0032885~regulation of polysaccharide biosynthetic process,GO:0033554~cellular response to stress,GO:0042770~DNA damage response, signal transduction,GO:0042771~DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043255~regulation of carbohydrate biosynthetic process,GO:0043467~regulation of generation of precursor metabolites and energy,GO:0045725~positive regulation of glycogen biosynthetic process,GO:0045913~positive regulation of carbohydrate metabolic process,",0,0,0
HECTD1,HECT domain containing 1,0.60360720344515,0.01395172132005,0.765782523299255,2.95E-09,1.38E-08,0.02117916040755,0.433778001373485,0.516347724044363,2,YES,0,"GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0001843~neural tube closure,GO:0002009~morphogenesis of an epithelium,GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0014020~primary neural tube formation,GO:0016331~morphogenesis of embryonic epithelium,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0021915~neural tube development,GO:0030163~protein catabolic process,GO:0032446~protein modification by small protein conjugation,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0043009~chordate embryonic development,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0060606~tube closure,GO:0070647~protein modification by small protein conjugation or removal,GO:0004842~ubiquitin-protein ligase activity,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
SGSM1,small G protein signaling modulator 1,1,0.255686563278362,0.641447788305282,0.999999999999985,1,0.021243358887152,0.434616320540094,0.493641729876166,2,NO,0,"GO:0032313~regulation of Rab GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0032483~regulation of Rab protein signal transduction,GO:0043087~regulation of GTPase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0005794~Golgi apparatus,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005097~Rab GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",0,0,0
POU4F2,POU class 4 homeobox 2,1,0.43858482390646,0.620539289527082,0.999096266675977,1,0.021387786719715,0.436614719276012,0.610713819671545,2,NO,0,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001654~eye development,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006928~cell motion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007423~sensory organ development,GO:0007600~sensory perception,GO:0007605~sensory perception of sound,GO:0008361~regulation of cell size,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016049~cell growth,GO:0016481~negative regulation of transcription,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0031290~retinal ganglion cell axon guidance,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032535~regulation of cellular component size,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0040007~growth,GO:0043010~camera-type eye development,GO:0045449~regulation of transcription,GO:0045597~positive regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048588~developmental cell growth,GO:0048589~developmental growth,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048675~axon extension,GO:0048676~axon extension involved in development,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050877~neurological system process,GO:0050885~neuromuscular process controlling balance,GO:0050890~cognition,GO:0050905~neuromuscular process,GO:0050954~sensory perception of mechanical stimulus,GO:0051094~positive regulation of developmental process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060041~retina development in camera-type eye,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",0,0,0
SEMA3A,"sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A",1,0.964584671744861,0.463928947338383,0.940987878134346,1,0.021428528624948,0.436968871381436,0.685803575457536,2,NO,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001558~regulation of cell growth,GO:0002027~regulation of heart rate,GO:0006915~apoptosis,GO:0006928~cell motion,GO:0006935~chemotaxis,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0007413~axonal fasciculation,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0008016~regulation of heart contraction,GO:0008037~cell recognition,GO:0008038~neuron recognition,GO:0008219~cell death,GO:0008361~regulation of cell size,GO:0010721~negative regulation of cell development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010975~regulation of neuron projection development,GO:0012501~programmed cell death,GO:0016265~death,GO:0022604~regulation of cell morphogenesis,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030308~negative regulation of cell growth,GO:0030516~regulation of axon extension,GO:0030517~negative regulation of axon extension,GO:0031175~neuron projection development,GO:0031344~regulation of cell projection organization,GO:0031345~negative regulation of cell projection organization,GO:0032535~regulation of cellular component size,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0040008~regulation of growth,GO:0042330~taxis,GO:0044057~regulation of system process,GO:0045596~negative regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045792~negative regulation of cell size,GO:0045926~negative regulation of growth,GO:0048638~regulation of developmental growth,GO:0048640~negative regulation of developmental growth,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048841~regulation of axon extension involved in axon guidance,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0048858~cell projection morphogenesis,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0050770~regulation of axonogenesis,GO:0050771~negative regulation of axonogenesis,GO:0050919~negative chemotaxis,GO:0051129~negative regulation of cellular component organization,GO:0051270~regulation of cell motion,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0005576~extracellular region,GO:0030424~axon,GO:0030425~dendrite,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0045499~chemorepellent activity,","hsa04360:Axon guidance,",0,0
CLCN1,"chloride channel 1, skeletal muscle",1,0.161539563209108,0.660850491134096,5.02E-11,2.59E-10,0.021529942249348,0.438080382653125,0.650981855757392,2,YES,0,"GO:0003012~muscle system process,GO:0006811~ion transport,GO:0006820~anion transport,GO:0006821~chloride transport,GO:0006936~muscle contraction,GO:0015698~inorganic anion transport,GO:0019226~transmission of nerve impulse,GO:0019227~neuronal action potential propagation,GO:0050877~neurological system process,GO:0055085~transmembrane transport,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034707~chloride channel complex,GO:0042383~sarcolemma,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005247~voltage-gated chloride channel activity,GO:0005253~anion channel activity,GO:0005254~chloride channel activity,GO:0008308~voltage-gated anion channel activity,GO:0008509~anion transmembrane transporter activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0031404~chloride ion binding,GO:0043167~ion binding,GO:0043168~anion binding,",0,0,0
PREX2,"Phosphatidylinositol-3,4,5-Trisphosphate-Dependent Rac Exchange Factor 2",1,0.484731760391503,0.620539289527082,5.28E-14,3.08E-13,0.021563399198088,0.438256963482745,0.756551296513722,2,NO,0,"GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005100~Rho GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030675~Rac GTPase activator activity,GO:0030676~Rac guanyl-nucleotide exchange factor activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007242~intracellular signaling cascade,GO:0035023~regulation of Rho protein signal transduction,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,",0,0,0
CATSPERB,"cation channel, sperm-associated, beta",1,0.745415986888831,0.594395772667206,0.999414817994256,1,0.021585545607587,0.438256963482745,0.567573777735301,2,NO,0,"GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0016021~integral to membrane,GO:0019861~flagellum,GO:0031224~intrinsic to membrane,GO:0042995~cell projection,",0,0,0
ARHGAP29,Rho GTPase activating protein 29,1,0.850024504037259,0.56670480217105,0.995049354756876,1,0.021668879724106,0.439471231668373,0.279201893780224,2,NO,0,"GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007266~Rho protein signal transduction,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0005100~Rho GTPase activator activity,GO:0008047~enzyme activator activity,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0019992~diacylglycerol binding,GO:0030695~GTPase regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,",0,0,0
MR1,"Major histocompatibility complex, class I-related",1,1,0.108469860173985,1.74E-07,7.44E-07,0.021869501122645,0.442709324926793,0.806604726948946,2,YES,0,"GO:0032393~MHC class I receptor activity,GO:0005576~extracellular region,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0042611~MHC protein complex,GO:0042612~MHC class I protein complex,GO:0044459~plasma membrane part,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0006955~immune response,GO:0019882~antigen processing and presentation,GO:0048002~antigen processing and presentation of peptide antigen,",0,0,0
TRIM67,tripartite motif-containing 67,1,0.381030318525547,0.628457722964864,4.69E-14,2.75E-13,0.02187594126599,0.442709324926793,0.801549690529426,2,YES,0,"GO:0005856~cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
CHERP,Calcium homeostasis endoplasmic reticulum protein,1,0.035769575519395,0.715747949835011,1.11E-09,5.31E-09,0.021963305645572,0.443623297197281,0.731035245177694,2,NO,0,"GO:0003723~RNA binding,GO:0005783~endoplasmic reticulum,GO:0048471~perinuclear region of cytoplasm,GO:0006396~RNA processing,","hsa03040:Spliceosome,",0,0
PLCH2,"phospholipase C, eta 2",1,0.111721095746119,0.669292822937893,1,1,0.021968603774693,0.443623297197281,0.599120595486041,2,NO,0,"GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0007242~intracellular signaling cascade,GO:0016042~lipid catabolic process,GO:0019637~organophosphate metabolic process,GO:0030384~phosphoinositide metabolic process,GO:0046486~glycerolipid metabolic process,GO:0005886~plasma membrane,GO:0004435~phosphoinositide phospholipase C activity,GO:0004620~phospholipase activity,GO:0004629~phospholipase C activity,GO:0005509~calcium ion binding,GO:0008081~phosphoric diester hydrolase activity,GO:0016298~lipase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
ASTN1,Astrotactin 1,1,0.115596765889253,0.669292822937893,4.45E-10,2.18E-09,0.022039156528999,0.444567391798234,0.72611923897056,2,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0006928~cell motion,GO:0007155~cell adhesion,GO:0007158~neuron adhesion,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0016337~cell-cell adhesion,GO:0016477~cell migration,GO:0022610~biological adhesion,GO:0048870~cell motility,GO:0051674~localization of cell,",0,0,0
HTR1E,5-hydroxytryptamine (serotonin) receptor 1E,0.973873644480704,0.886481428527679,0.52894015271147,0.999954389133102,1,0.022144089671973,0.44572139114524,0.464637046846802,2,YES,0,"GO:0004993~serotonin receptor activity,GO:0008227~amine receptor activity,GO:0043176~amine binding,GO:0051378~serotonin binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger,GO:0007242~intracellular signaling cascade,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0019226~transmission of nerve impulse,GO:0019932~second-messenger-mediated signaling,GO:0019935~cyclic-nucleotide-mediated signaling,GO:0050877~neurological system process,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
PRSS35,"protease, serine, 35",1,1,0.352752213519394,0.999999969413428,1,0.022219071411703,0.446025619336914,0.407323867074205,2,NO,0,"GO:0006508~proteolysis,GO:0005576~extracellular region,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0017171~serine hydrolase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
HAUS6,"HAUS augmin-like complex, subunit 6",1,0.225609323335424,0.64908205921566,0.999991035169082,1,0.022251845172815,0.446025619336914,0.497300380662533,2,NO,0,"GO:0000087~M phase of mitotic cell cycle,GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0007067~mitosis,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0031023~microtubule organizing center organization,GO:0048285~organelle fission,GO:0051225~spindle assembly,GO:0051297~centrosome organization,GO:0051301~cell division,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0070652~HAUS complex,",0,0,0
ZEB1,zinc finger E-box binding homeobox 1,1,0.086664523520609,0.679130630618955,0.999999999956056,1,0.022305980057827,0.446025619336914,0.345151780678341,2,NO,0,"GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0001654~eye development,GO:0002694~regulation of leukocyte activation,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006955~immune response,GO:0007389~pattern specification process,GO:0007423~sensory organ development,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0010464~regulation of mesenchymal cell proliferation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0030856~regulation of epithelial cell differentiation,GO:0030857~negative regulation of epithelial cell differentiation,GO:0031076~embryonic camera-type eye development,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0033081~regulation of T cell differentiation in the thymus,GO:0042127~regulation of cell proliferation,GO:0043009~chordate embryonic development,GO:0043010~camera-type eye development,GO:0045449~regulation of transcription,GO:0045580~regulation of T cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048048~embryonic eye morphogenesis,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048592~eye morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0048596~embryonic camera-type eye morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048706~embryonic skeletal system development,GO:0050863~regulation of T cell activation,GO:0050865~regulation of cell activation,GO:0051147~regulation of muscle cell differentiation,GO:0051150~regulation of smooth muscle cell differentiation,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051216~cartilage development,GO:0051249~regulation of lymphocyte activation,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016563~transcription activator activity,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
MIPEP,mitochondrial intermediate peptidase,1,0.271476723733921,0.641447788305282,0.998972082278911,1,0.022359717027261,0.446025619336914,0.512459181645388,2,YES,0,"GO:0006508~proteolysis,GO:0006605~protein targeting,GO:0006626~protein targeting to mitochondrion,GO:0006627~mitochondrial protein processing during import,GO:0006839~mitochondrial transport,GO:0006886~intracellular protein transport,GO:0007005~mitochondrion organization,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016485~protein processing,GO:0017038~protein import,GO:0033365~protein localization in organelle,GO:0034613~cellular protein localization,GO:0034982~mitochondrial protein processing,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0051604~protein maturation,GO:0070585~protein localization in mitochondrion,GO:0070727~cellular macromolecule localization,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0031974~membrane-enclosed lumen,GO:0031980~mitochondrial lumen,GO:0043233~organelle lumen,GO:0044429~mitochondrial part,GO:0070013~intracellular organelle lumen,GO:0000287~magnesium ion binding,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0005506~iron ion binding,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0030145~manganese ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0050897~cobalt ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
DYNC1I1,"dynein, cytoplasmic 1, intermediate chain 1",0.830672778498767,0.787415323919243,0.59153065856549,6.35E-09,2.92E-08,0.022372606659179,0.446025619336914,0.640922791806418,2,NO,0,"GO:0007017~microtubule-based process,GO:0007018~microtubule-based movement,GO:0010970~microtubule-based transport,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0046907~intracellular transport,GO:0047496~vesicle transport along microtubule,GO:0005856~cytoskeleton,GO:0005868~cytoplasmic dynein complex,GO:0005874~microtubule,GO:0005875~microtubule associated complex,GO:0015630~microtubule cytoskeleton,GO:0030286~dynein complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0048471~perinuclear region of cytoplasm,GO:0003774~motor activity,GO:0003777~microtubule motor activity,GO:0008017~microtubule binding,GO:0008092~cytoskeletal protein binding,GO:0015631~tubulin binding,",0,0,0
ADAMTS16,"ADAM metallopeptidase with thrombospondin type 1 motif, 16",1,0.621617423105817,0.605142915024696,1.92E-28,1.67E-27,0.02238382426868,0.446025619336914,0.740563995232975,2,NO,0,"GO:0006508~proteolysis,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
ZNF583,Zinc finger protein 583,1,1,0.233326919943334,4.67E-07,1.96E-06,0.022406014835194,0.446025619336914,0.640218940785517,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,",0,0,0
GBP5,guanylate binding protein 5,1,0.886481428527679,0.542850761888397,0.999528230772357,1,0.022444251872863,0.446025619336914,0.551720595482822,2,YES,0,"GO:0006955~immune response,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,",0,0,0
GSTO2,glutathione S-transferase omega 2,1,0.179340642005228,0.64908205921566,0.999994445654365,1,0.022445745606119,0.446025619336914,0.260568265420459,2,YES,0,"GO:0004364~glutathione transferase activity,GO:0016765~transferase activity, transferring alkyl or aryl (other than methyl) groups,","hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism,",0,0
PGAP2,post-GPI attachment to proteins 2,1,0.997374294263091,0.462781043665193,0.999999999992084,1,0.022574420401507,0.447813682526952,0.543077925624913,2,NO,0,"GO:0006497~protein amino acid lipidation,GO:0006505~GPI anchor metabolic process,GO:0006506~GPI anchor biosynthetic process,GO:0006644~phospholipid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006916~anti-apoptosis,GO:0006974~response to DNA damage stimulus,GO:0007242~intracellular signaling cascade,GO:0008610~lipid biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0010941~regulation of cell death,GO:0019637~organophosphate metabolic process,GO:0030384~phosphoinositide metabolic process,GO:0033554~cellular response to stress,GO:0042157~lipoprotein metabolic process,GO:0042158~lipoprotein biosynthetic process,GO:0042770~DNA damage response, signal transduction,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0045017~glycerolipid biosynthetic process,GO:0046474~glycerophospholipid biosynthetic process,GO:0046486~glycerolipid metabolic process,GO:0046489~phosphoinositide biosynthetic process,GO:0060548~negative regulation of cell death,GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0044431~Golgi apparatus part,GO:0044432~endoplasmic reticulum part,GO:0008565~protein transporter activity,",0,0,0
FUT3,"fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)",1,0.910322520092466,0.512720805147522,0.999999873757032,1,0.022607650442899,0.447813682526952,0.478418586640073,2,NO,0,"GO:0005996~monosaccharide metabolic process,GO:0006004~fucose metabolic process,GO:0006486~protein amino acid glycosylation,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0016052~carbohydrate catabolic process,GO:0019317~fucose catabolic process,GO:0019318~hexose metabolic process,GO:0019320~hexose catabolic process,GO:0042354~L-fucose metabolic process,GO:0042355~L-fucose catabolic process,GO:0043413~biopolymer glycosylation,GO:0044275~cellular carbohydrate catabolic process,GO:0046164~alcohol catabolic process,GO:0046365~monosaccharide catabolic process,GO:0070085~glycosylation,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0008417~fucosyltransferase activity,GO:0017060~3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,GO:0046920~alpha(1,3)-fucosyltransferase activity,","hsa00601:Glycosphingolipid biosynthesis,",0,0
CACNA1D,"calcium channel, voltage-dependent, L type, alpha 1D subunit",1,0.159572785575917,0.660850491134096,0.999992747612408,1,0.022729758786269,0.448713055333932,0.199414952090234,2,YES,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0015674~di-, tri-valent inorganic cation transport,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034704~calcium channel complex,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005245~voltage-gated calcium channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,","hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,hsa04260:Cardiac muscle contraction,hsa04270:Vascular smooth muscle contraction,hsa04912:GnRH signaling pathway,hsa04930:Type II diabetes mellitus,hsa05010:Alzheimer's disease,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,",0,0
HMBOX1,homeobox containing 1,1,0.239978199885825,0.641447788305282,0.999999998668681,1,0.022781027506223,0.448713055333932,0.295375867169908,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",0,0,0
ZNF774,zinc finger protein 774,1,0.621617423105817,0.601943915278899,0.008315367718152,0.02653728918629,0.022783459385069,0.448713055333932,0.601576799053381,2,NO,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
CPLX4,Complexin 4,1,1,0.350070687212711,1.04E-30,9.64E-30,0.022845233450536,0.448713055333932,0.61169636424764,2,NO,0,"GO:0000149~SNARE binding,GO:0019905~syntaxin binding,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0006836~neurotransmitter transport,GO:0006887~exocytosis,GO:0016192~vesicle-mediated transport,GO:0031644~regulation of neurological system process,GO:0032940~secretion by cell,GO:0044057~regulation of system process,GO:0046903~secretion,GO:0046928~regulation of neurotransmitter secretion,GO:0050804~regulation of synaptic transmission,GO:0051046~regulation of secretion,GO:0051588~regulation of neurotransmitter transport,GO:0051969~regulation of transmission of nerve impulse,GO:0060341~regulation of cellular localization,",0,0,0
STOML2,stomatin (EPB72)-like 2,1,0.621617423105817,0.601943915278899,1.30E-05,5.03E-05,0.022950422873188,0.449361581601962,0.468419698309948,2,NO,0,"GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005856~cytoskeleton,GO:0019866~organelle inner membrane,GO:0019898~extrinsic to membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044429~mitochondrial part,",0,0,0
SH3GL3,SH3-domain GRB2-like 3,1,0.886481428527679,0.553050799945268,0.999454297995638,1,0.023052546101216,0.450416850025752,0.522355096336578,2,NO,0,"GO:0008289~lipid binding,GO:0042802~identical protein binding,GO:0005768~endosome,GO:0019898~extrinsic to membrane,GO:0006897~endocytosis,GO:0010324~membrane invagination,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,","hsa04144:Endocytosis,",0,0
NT5C3A,"5'-nucleotidase, cytosolic IIIA",1,0.997374294263091,0.462781043665193,2.60E-06,1.05E-05,0.023140581784098,0.451664500674155,0.757593315895053,2,NO,0,"nucleotide metabolic process, nucleobase-containing small molecule metabolic process, pyrimidine nucleobase metabolic process, pyrimidine nucleoside catabolic process, cytoplasm, cytosol, endoplasmic reticulum, mitochondrion, 2'-phosphotransferase activity, 5'-nucleotidase activity, magnesium ion binding, nucleotide binding","Purine metabolism,  Pyrimidine metabolism, Nicotinate and nicotinamide metabolism, Metabolic pathways",0,0
ZBTB37,zinc finger and BTB domain containing 37,1,0.318629720376967,0.628457722964864,5.80E-16,3.59E-15,0.023213074069828,0.452606482829143,0.692705474883935,2,YES,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
OR9A2,"olfactory receptor, family 9, subfamily A, member 2",1,1,0.357631577352916,0.000100214241418,0.000363476080671,0.023360083132879,0.45310798841022,0.642466859344297,2,NO,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007600~sensory perception,GO:0007606~sensory perception of chemical stimulus,GO:0007608~sensory perception of smell,GO:0050877~neurological system process,GO:0050890~cognition,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004984~olfactory receptor activity,","hsa04740:Olfactory transduction,",0,0
GRM1,"glutamate receptor, metabotropic 1",1,0.244850135690841,0.64908205921566,0.999973233211051,1,0.023452786164854,0.453394238866721,0.29517036972126,2,YES,0,"GO:0000165~MAPKKK cascade,GO:0000186~activation of MAPKK activity,GO:0000187~activation of MAPK activity,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0010627~regulation of protein kinase cascade,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0019226~transmission of nerve impulse,GO:0019722~calcium-mediated signaling,GO:0019932~second-messenger-mediated signaling,GO:0031644~regulation of neurological system process,GO:0032147~activation of protein kinase activity,GO:0033674~positive regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043408~regulation of MAPKKK cascade,GO:0043549~regulation of kinase activity,GO:0044057~regulation of system process,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0050804~regulation of synaptic transmission,GO:0050877~neurological system process,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051930~regulation of sensory perception of pain,GO:0051931~regulation of sensory perception,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0051969~regulation of transmission of nerve impulse,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005792~microsome,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0014069~postsynaptic density,GO:0016021~integral to membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0042598~vesicular fraction,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045202~synapse,GO:0008066~glutamate receptor activity,","hsa04020:Calcium signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04540:Gap junction,hsa04720:Long-term potentiation,hsa04730:Long-term depression,",0,0
ST6GAL2,"ST6 beta-galactosamide alpha-2,6-sialyltranferase 2",1,1,0.450365116245565,0.129205141650603,0.369420303213166,0.023455448088438,0.453394238866721,0.604577919215022,2,YES,0,"GO:0006486~protein amino acid glycosylation,GO:0009100~glycoprotein metabolic process,GO:0009101~glycoprotein biosynthetic process,GO:0009311~oligosaccharide metabolic process,GO:0040007~growth,GO:0043413~biopolymer glycosylation,GO:0070085~glycosylation,GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0030173~integral to Golgi membrane,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031228~intrinsic to Golgi membrane,GO:0031300~intrinsic to organelle membrane,GO:0031301~integral to organelle membrane,GO:0044431~Golgi apparatus part,GO:0003835~beta-galactoside alpha-2,6-sialyltransferase activity,GO:0008373~sialyltransferase activity,",0,0,0
MYH6,"Myosin, Heavy Chain 6, Cardiac Muscle, Alpha",1,0.04423567937554,0.715747949835011,0.760553232396811,1,0.023486484019256,0.453394238866721,0.666654318555481,2,YES,0,"GO:0000146~microfilament motor activity,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003774~motor activity,GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0008092~cytoskeletal protein binding,GO:0008307~structural constituent of muscle,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030898~actin-dependent ATPase activity,GO:0030899~calcium-dependent ATPase activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0005730~nucleolus,GO:0005856~cytoskeleton,GO:0005859~muscle myosin complex,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0016323~basolateral plasma membrane,GO:0016459~myosin complex,GO:0016460~myosin II complex,GO:0030016~myofibril,GO:0030017~sarcomere,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0032982~myosin filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0043292~contractile fiber,GO:0044430~cytoskeletal part,GO:0044449~contractile fiber part,GO:0044459~plasma membrane part,GO:0048471~perinuclear region of cytoplasm,GO:0070013~intracellular organelle lumen,GO:0070161~anchoring junction,GO:0001701~in utero embryonic development,GO:0002026~regulation of the force of heart contraction,GO:0002027~regulation of heart rate,GO:0003007~heart morphogenesis,GO:0003012~muscle system process,GO:0003013~circulatory system process,GO:0006163~purine nucleotide metabolic process,GO:0006195~purine nucleotide catabolic process,GO:0006200~ATP catabolic process,GO:0006936~muscle contraction,GO:0006941~striated muscle contraction,GO:0007010~cytoskeleton organization,GO:0007507~heart development,GO:0007512~adult heart development,GO:0007517~muscle organ development,GO:0007522~visceral muscle development,GO:0008015~blood circulation,GO:0008016~regulation of heart contraction,GO:0008217~regulation of blood pressure,GO:0009141~nucleoside triphosphate metabolic process,GO:0009143~nucleoside triphosphate catabolic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009146~purine nucleoside triphosphate catabolic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009154~purine ribonucleotide catabolic process,GO:0009166~nucleotide catabolic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009203~ribonucleoside triphosphate catabolic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009207~purine ribonucleoside triphosphate catabolic process,GO:0009259~ribonucleotide metabolic process,GO:0009261~ribonucleotide catabolic process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0010927~cellular component assembly involved in morphogenesis,GO:0014706~striated muscle tissue development,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0030048~actin filament-based movement,GO:0030049~muscle filament sliding,GO:0030239~myofibril assembly,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0031032~actomyosin structure organization,GO:0032989~cellular component morphogenesis,GO:0033275~actin-myosin filament sliding,GO:0034655~nucleobase, nucleoside, nucleotide and nucleic acid catabolic process,GO:0034656~nucleobase, nucleoside and nucleotide catabolic process,GO:0042692~muscle cell differentiation,GO:0043009~chordate embryonic development,GO:0043462~regulation of ATPase activity,GO:0044057~regulation of system process,GO:0044270~nitrogen compound catabolic process,GO:0045214~sarcomere organization,GO:0046034~ATP metabolic process,GO:0046700~heterocycle catabolic process,GO:0046907~intracellular transport,GO:0048729~tissue morphogenesis,GO:0048738~cardiac muscle tissue development,GO:0048739~cardiac muscle fiber development,GO:0048747~muscle fiber development,GO:0051146~striated muscle cell differentiation,GO:0051336~regulation of hydrolase activity,GO:0055001~muscle cell development,GO:0055002~striated muscle cell development,GO:0055008~cardiac muscle tissue morphogenesis,GO:0055009~atrial cardiac muscle morphogenesis,GO:0055010~ventricular cardiac muscle morphogenesis,GO:0060415~muscle tissue morphogenesis,GO:0060537~muscle tissue development,GO:0070252~actin-mediated cell contraction,","hsa04260:Cardiac muscle contraction,hsa04530:Tight junction,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05414:Dilated cardiomyopathy,hsa05416:Viral myocarditis,",0,0
MSH3,mutS homolog 3 (E. coli),0.885823804909831,0.707289184858051,0.601943915278899,0.999999736334601,1,0.023606655895122,0.454687666943171,0.191602567244776,2,YES,0,"GO:0000018~regulation of DNA recombination,GO:0002200~somatic diversification of immune receptors,GO:0002252~immune effector process,GO:0002377~immunoglobulin production,GO:0002440~production of molecular mediator of immune response,GO:0002520~immune system development,GO:0002562~somatic diversification of immune receptors via germline recombination within a single locus,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0006310~DNA recombination,GO:0006955~immune response,GO:0006974~response to DNA damage stimulus,GO:0010605~negative regulation of macromolecule metabolic process,GO:0016444~somatic cell DNA recombination,GO:0016445~somatic diversification of immunoglobulins,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0033554~cellular response to stress,GO:0043085~positive regulation of catalytic activity,GO:0043570~maintenance of DNA repeat elements,GO:0044093~positive regulation of molecular function,GO:0045910~negative regulation of DNA recombination,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051052~regulation of DNA metabolic process,GO:0051053~negative regulation of DNA metabolic process,GO:0051095~regulation of helicase activity,GO:0051096~positive regulation of helicase activity,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051276~chromosome organization,GO:0051336~regulation of hydrolase activity,GO:0051345~positive regulation of hydrolase activity,GO:0032300~mismatch repair complex,GO:0032302~MutSbeta complex,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0019237~centromeric DNA binding,GO:0030554~adenyl nucleotide binding,GO:0030983~mismatched DNA binding,GO:0032134~mispaired DNA binding,GO:0032135~DNA insertion or deletion binding,GO:0032137~guanine/thymine mispair binding,GO:0032138~single base insertion or deletion binding,GO:0032139~dinucleotide insertion or deletion binding,GO:0032142~single guanine insertion binding,GO:0032181~dinucleotide repeat insertion binding,GO:0032356~oxidized DNA binding,GO:0032357~oxidized purine DNA binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0046983~protein dimerization activity,","hsa03430:Mismatch repair,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,",0,0
CCDC104,coiled-coil domain containing 104,0.928567400858825,0.86861908420637,0.56767625725793,0.553104580047331,1,0.023611919103532,0.454687666943171,0.289571020453376,2,NO,0,"GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,",0,0,0
ZNF732,zinc finger protein LOC654254,1,1,0.21733845772379,0.355190948529152,0.947530952238792,0.02374082265002,0.456034825537431,0.657080263176939,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
COPB1,"coatomer protein complex, subunit beta 1",1,0.897377981262048,0.532650659483048,0.999997350893581,1,0.023757918591901,0.456034825537431,0.564668165730226,2,NO,0,"GO:0006886~intracellular protein transport,GO:0006890~retrograde vesicle-mediated transport, Golgi to ER,GO:0006891~intra-Golgi vesicle-mediated transport,GO:0006900~membrane budding,GO:0006901~vesicle coating,GO:0006903~vesicle targeting,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016044~membrane organization,GO:0016050~vesicle organization,GO:0016192~vesicle-mediated transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0048193~Golgi vesicle transport,GO:0048194~Golgi vesicle budding,GO:0048199~vesicle targeting, to, from or within Golgi,GO:0048200~Golgi transport vesicle coating,GO:0048205~COPI coating of Golgi vesicle,GO:0051640~organelle localization,GO:0051648~vesicle localization,GO:0051650~establishment of vesicle localization,GO:0051656~establishment of organelle localization,GO:0070727~cellular macromolecule localization,GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005798~Golgi-associated vesicle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0012505~endomembrane system,GO:0012506~vesicle membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030117~membrane coat,GO:0030120~vesicle coat,GO:0030126~COPI vesicle coat,GO:0030135~coated vesicle,GO:0030137~COPI-coated vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0030660~Golgi-associated vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030663~COPI coated vesicle membrane,GO:0031090~organelle membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044431~Golgi apparatus part,GO:0044433~cytoplasmic vesicle part,GO:0044459~plasma membrane part,GO:0048475~coated membrane,GO:0005198~structural molecule activity,",0,0,0
SHANK1,SH3 and multiple ankyrin repeat domains 1,0.305857556518427,0.503116045574968,0.620539289527082,0.999999959756253,1,0.023782748656957,0.456034825537431,0.243795784847825,2,NO,0,"GO:0007010~cytoskeleton organization,GO:0007016~cytoskeletal anchoring at plasma membrane,GO:0008104~protein localization,GO:0032507~maintenance of protein location in cell,GO:0045185~maintenance of protein location,GO:0051235~maintenance of location,GO:0051651~maintenance of location in cell,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030425~dendrite,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,",0,0,0
CBLL1,Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1,1,0.420265180899895,0.620539289527082,0.098094855760038,0.28372775019228,0.023833756887196,0.456034825537431,0.570632660307031,2,YES,0,"GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0007162~negative regulation of cell adhesion,GO:0009057~macromolecule catabolic process,GO:0016337~cell-cell adhesion,GO:0016567~protein ubiquitination,GO:0019941~modification-dependent protein catabolic process,GO:0022610~biological adhesion,GO:0030100~regulation of endocytosis,GO:0030155~regulation of cell adhesion,GO:0030163~protein catabolic process,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0032446~protein modification by small protein conjugation,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045807~positive regulation of endocytosis,GO:0051050~positive regulation of transport,GO:0051130~positive regulation of cellular component organization,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060627~regulation of vesicle-mediated transport,GO:0070647~protein modification by small protein conjugation or removal,GO:0000151~ubiquitin ligase complex,GO:0004842~ubiquitin-protein ligase activity,GO:0008270~zinc ion binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0019787~small conjugating protein ligase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
HBS1L,HBS1-like (S. cerevisiae),1,0.420265180899895,0.620539289527082,0.966123744725483,1,0.023858665308343,0.456034825537431,0.642543595251458,2,NO,0,"GO:0006412~translation,GO:0000166~nucleotide binding,GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0008135~translation factor activity, nucleic acid binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,",0,0,0
TRPV5,"transient receptor potential cation channel, subfamily V, member 5",1,1,0.399992964780997,1.72E-05,6.59E-05,0.023885479943741,0.456034825537431,0.685542402192627,2,YES,0,"GO:0006461~protein complex assembly,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0015674~di-, tri-valent inorganic cation transport,GO:0030001~metal ion transport,GO:0043933~macromolecular complex subunit organization,GO:0051259~protein oligomerization,GO:0051262~protein tetramerization,GO:0055085~transmembrane transport,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0016324~apical plasma membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0005216~ion channel activity,GO:0005261~cation channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022838~substrate specific channel activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
SIX6,SIX homeobox 6,1,0.898692767374997,0.532650659483048,2.91E-09,1.36E-08,0.023901605771248,0.456034825537431,0.662109778125274,2,NO,0,"GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0006355~regulation of transcription, DNA-dependent,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0045449~regulation of transcription,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0051252~regulation of RNA metabolic process,",0,0,0
ERCC3,"excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing)",1,1,0.444921389161528,0.99997685797885,1,0.023950407075778,0.456499646702508,0.30983551620438,2,YES,0,"GO:0000075~cell cycle checkpoint,GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0000718~nucleotide-excision repair, DNA damage removal,GO:0000737~DNA catabolic process, endonucleolytic,GO:0001666~response to hypoxia,GO:0006163~purine nucleotide metabolic process,GO:0006195~purine nucleotide catabolic process,GO:0006200~ATP catabolic process,GO:0006259~DNA metabolic process,GO:0006265~DNA topological change,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006308~DNA catabolic process,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006352~transcription initiation,GO:0006354~RNA elongation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~RNA elongation from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006917~induction of apoptosis,GO:0006974~response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0007398~ectoderm development,GO:0008104~protein localization,GO:0008544~epidermis development,GO:0009057~macromolecule catabolic process,GO:0009141~nucleoside triphosphate metabolic process,GO:0009143~nucleoside triphosphate catabolic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009146~purine nucleoside triphosphate catabolic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009154~purine ribonucleotide catabolic process,GO:0009166~nucleotide catabolic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009203~ribonucleoside triphosphate catabolic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009207~purine ribonucleoside triphosphate catabolic process,GO:0009259~ribonucleotide metabolic process,GO:0009261~ribonucleotide catabolic process,GO:0009314~response to radiation,GO:0009411~response to UV,GO:0009416~response to light stimulus,GO:0009628~response to abiotic stimulus,GO:0009650~UV protection,GO:0009891~positive regulation of biosynthetic process,GO:0009913~epidermal cell differentiation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012502~induction of programmed cell death,GO:0016310~phosphorylation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0032392~DNA geometric change,GO:0032508~DNA duplex unwinding,GO:0032774~RNA biosynthetic process,GO:0033554~cellular response to stress,GO:0033683~nucleotide-excision repair, DNA incision,GO:0034655~nucleobase, nucleoside, nucleotide and nucleic acid catabolic process,GO:0034656~nucleobase, nucleoside and nucleotide catabolic process,GO:0035315~hair cell differentiation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043933~macromolecular complex subunit organization,GO:0044265~cellular macromolecule catabolic process,GO:0044270~nitrogen compound catabolic process,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046034~ATP metabolic process,GO:0046700~heterocycle catabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051726~regulation of cell cycle,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070482~response to oxygen levels,GO:0000441~SSL2-core TFIIH complex,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005675~holo TFIIH complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003684~damaged DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0008022~protein C-terminus binding,GO:0008026~ATP-dependent helicase activity,GO:0008094~DNA-dependent ATPase activity,GO:0008134~transcription factor binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032552~deoxyribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0032554~purine deoxyribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032558~adenyl deoxyribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0032564~dATP binding,GO:0042277~peptide binding,GO:0042623~ATPase activity, coupled,GO:0043138~3'-5' DNA helicase activity,GO:0047485~protein N-terminus binding,GO:0070035~purine NTP-dependent helicase activity,","hsa03420:Nucleotide excision repair,",0,0
ATP4A,"ATPase, H+/K+ exchanging, alpha polypeptide",1,0.078628148099216,0.688986797626025,4.87E-22,3.59E-21,0.024056595289686,0.457001190329983,0.737111118865915,2,NO,0,"GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006754~ATP biosynthetic process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0006818~hydrogen transport,GO:0006885~regulation of pH,GO:0009141~nucleoside triphosphate metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009145~purine nucleoside triphosphate biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009201~ribonucleoside triphosphate biosynthetic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009206~purine ribonucleoside triphosphate biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009260~ribonucleotide biosynthetic process,GO:0010155~regulation of proton transport,GO:0015672~monovalent inorganic cation transport,GO:0015988~energy coupled proton transport, against electrochemical gradient,GO:0015991~ATP hydrolysis coupled proton transport,GO:0015992~proton transport,GO:0030001~metal ion transport,GO:0034220~ion transmembrane transport,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0042493~response to drug,GO:0042592~homeostatic process,GO:0043269~regulation of ion transport,GO:0044271~nitrogen compound biosynthetic process,GO:0045851~pH reduction,GO:0046034~ATP metabolic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0055067~monovalent inorganic cation homeostasis,GO:0055080~cation homeostasis,GO:0055085~transmembrane transport,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0016324~apical plasma membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0008900~hydrogen:potassium-exchanging ATPase activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016887~ATPase activity,GO:0017076~purine nucleotide binding,GO:0022890~inorganic cation transmembrane transporter activity,GO:0030554~adenyl nucleotide binding,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0042623~ATPase activity, coupled,GO:0042625~ATPase activity, coupled to transmembrane movement of ions,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,","hsa00190:Oxidative phosphorylation,",0,0
SCN10A,"Sodium channel, voltage-gated, type X, alpha subunit",1,0.494101163506307,0.620539289527082,0.999991772058738,1,0.024060441252159,0.457001190329983,0.316580625453433,2,YES,0,"GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005248~voltage-gated sodium channel activity,GO:0005261~cation channel activity,GO:0005272~sodium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0031402~sodium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0001518~voltage-gated sodium channel complex,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034706~sodium channel complex,GO:0044459~plasma membrane part,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006814~sodium ion transport,GO:0007600~sensory perception,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0050877~neurological system process,GO:0050890~cognition,GO:0055085~transmembrane transport,",0,0,0
NCAPH2,"non-SMC condensin II complex, subunit H2",0.675823878784828,0.342096927505986,0.628457722964864,0.999999674583554,1,0.024066212966818,0.457001190329983,0.170145871358978,2,NO,0,"GO:0006323~DNA packaging,GO:0030261~chromosome condensation,GO:0051276~chromosome organization,",0,0,0
LPAR4,lysophosphatidic acid receptor 4,1,1,0.450810211687543,0.999999954692873,1,0.024117361538242,0.457348422510474,0.215871147957514,2,YES,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0001608~nucleotide receptor activity, G-protein coupled,GO:0001614~purinergic nucleotide receptor activity,GO:0008289~lipid binding,GO:0016502~nucleotide receptor activity,GO:0045028~purinergic nucleotide receptor activity, G-protein coupled,","hsa04080:Neuroactive ligand-receptor interaction,",0,0
TMEM117,Transmembrane protein 117,1,0.848879761867496,0.586563008794232,0.999954853271546,1,0.024310757739568,0.460182872160454,0.520231430977246,2,NO,0,"GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
CORO2B,"Coronin, actin binding protein, 2B",1,0.745415986888831,0.599319901491912,1,1,0.024352293899559,0.460182872160454,0.610361237174873,2,NO,0,"GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0007010~cytoskeleton organization,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,",0,0,0
RBM15B,RNA binding motif protein 15B,0.777171109936601,0.420265180899895,0.620539289527082,0.999929720896459,1,0.024396913110383,0.460182872160454,0.099242584409487,2,NO,0,"GO:0000381~regulation of alternative nuclear mRNA splicing, via spliceosome,GO:0006350~transcription,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006913~nucleocytoplasmic transport,GO:0008380~RNA splicing,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016071~mRNA metabolic process,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0043484~regulation of RNA splicing,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0046907~intracellular transport,GO:0048024~regulation of nuclear mRNA splicing, via spliceosome,GO:0050684~regulation of mRNA processing,GO:0051169~nuclear transport,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0003723~RNA binding,",0,0,0
BCL2L11,BCL2-like 11 (apoptosis facilitator),1,0.38222470049003,0.628457722964864,2.33E-07,9.91E-07,0.024433559520135,0.460182872160454,0.227004411671892,2,NO,0,"GO:0001655~urogenital system development,GO:0001701~in utero embryonic development,GO:0001776~leukocyte homeostasis,GO:0001782~B cell homeostasis,GO:0001783~B cell apoptosis,GO:0001822~kidney development,GO:0002260~lymphocyte homeostasis,GO:0002262~myeloid cell homeostasis,GO:0002520~immune system development,GO:0003006~reproductive developmental process,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0007423~sensory organ development,GO:0007548~sex differentiation,GO:0008219~cell death,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0008624~induction of apoptosis by extracellular signals,GO:0008633~activation of pro-apoptotic gene products,GO:0009791~post-embryonic development,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009886~post-embryonic morphogenesis,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0019953~sexual reproduction,GO:0022610~biological adhesion,GO:0030879~mammary gland development,GO:0031589~cell-substrate adhesion,GO:0032504~multicellular organism reproduction,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0040008~regulation of growth,GO:0042475~odontogenesis of dentine-containing tooth,GO:0042476~odontogenesis,GO:0042592~homeostatic process,GO:0042981~regulation of apoptosis,GO:0043009~chordate embryonic development,GO:0043029~T cell homeostasis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043583~ear development,GO:0045137~development of primary sexual characteristics,GO:0046546~development of primary male sexual characteristics,GO:0046620~regulation of organ growth,GO:0046661~male sex differentiation,GO:0048070~regulation of pigmentation during development,GO:0048232~male gamete generation,GO:0048534~hemopoietic or lymphoid organ development,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048563~post-embryonic organ morphogenesis,GO:0048569~post-embryonic organ development,GO:0048608~reproductive structure development,GO:0048609~reproductive process in a multicellular organism,GO:0048732~gland development,GO:0048872~homeostasis of number of cells,GO:0070227~lymphocyte apoptosis,GO:0000267~cell fraction,GO:0000300~peripheral to membrane of membrane fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0019867~outer membrane,GO:0019898~extrinsic to membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0008017~microtubule binding,GO:0008092~cytoskeletal protein binding,GO:0015631~tubulin binding,",0,0,0
CCNJ,cyclin J,1,1,0.332676355469261,0.999999999993029,1,0.024436535913464,0.460182872160454,0.470555849619175,2,NO,0,0,0,0,0
COL1A2,"collagen, type I, alpha 2",1,0.085263045669954,0.688986797626025,5.66E-08,2.49E-07,0.024453947777482,0.460182872160454,0.698214118892517,2,NO,0,"GO:0001501~skeletal system development,GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0003013~circulatory system process,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0007266~Rho protein signal transduction,GO:0007398~ectoderm development,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0008544~epidermis development,GO:0030198~extracellular matrix organization,GO:0030199~collagen fibril organization,GO:0042476~odontogenesis,GO:0043062~extracellular structure organization,GO:0043588~skin development,GO:0043589~skin morphogenesis,GO:0048729~tissue morphogenesis,GO:0048730~epidermis morphogenesis,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen,GO:0005583~fibrillar collagen,GO:0005584~collagen type I,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0019838~growth factor binding,GO:0030674~protein binding, bridging,GO:0042802~identical protein binding,GO:0046332~SMAD binding,GO:0048407~platelet-derived growth factor binding,","hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,",0,0
FRMD7,FERM domain containing 7,1,0.271476723733921,0.641447788305282,0.99999981649884,1,0.024488558002435,0.460182872160454,0.548164958075918,2,NO,0,"GO:0005856~cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,",0,0,0
CDH4,"cadherin 4, type 1, R-cadherin (retinal)",1,0.239978199885825,0.64908205921566,5.08E-20,3.54E-19,0.024555581360794,0.460515767307504,0.767861299569027,2,NO,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001558~regulation of cell growth,GO:0006928~cell motion,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion,GO:0007157~heterophilic cell adhesion,GO:0007409~axonogenesis,GO:0007411~axon guidance,GO:0008361~regulation of cell size,GO:0010720~positive regulation of cell development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010975~regulation of neuron projection development,GO:0016337~cell-cell adhesion,GO:0022604~regulation of cell morphogenesis,GO:0022610~biological adhesion,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030307~positive regulation of cell growth,GO:0030516~regulation of axon extension,GO:0031175~neuron projection development,GO:0031344~regulation of cell projection organization,GO:0031346~positive regulation of cell projection organization,GO:0032535~regulation of cellular component size,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0040008~regulation of growth,GO:0045597~positive regulation of cell differentiation,GO:0045664~regulation of neuron differentiation,GO:0045773~positive regulation of axon extension,GO:0045793~positive regulation of cell size,GO:0045927~positive regulation of growth,GO:0048638~regulation of developmental growth,GO:0048639~positive regulation of developmental growth,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0050767~regulation of neurogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050770~regulation of axonogenesis,GO:0050772~positive regulation of axonogenesis,GO:0051094~positive regulation of developmental process,GO:0051130~positive regulation of cellular component organization,GO:0051960~regulation of nervous system development,GO:0060284~regulation of cell development,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa04514:Cell adhesion molecules (CAMs),",0,0
IFT172,intraflagellar transport 172 homolog (Chlamydomonas),1,0.438023902931841,0.620539289527082,0.93965290894699,1,0.024658560894691,0.461983208577667,0.57464551191126,2,NO,0,"GO:0000902~cell morphogenesis,GO:0001838~embryonic epithelial tube formation,GO:0001841~neural tube formation,GO:0002009~morphogenesis of an epithelium,GO:0003002~regionalization,GO:0007166~cell surface receptor linked signal transduction,GO:0007224~smoothened signaling pathway,GO:0007368~determination of left/right symmetry,GO:0007389~pattern specification process,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009799~determination of symmetry,GO:0009855~determination of bilateral symmetry,GO:0009953~dorsal/ventral pattern formation,GO:0016331~morphogenesis of embryonic epithelium,GO:0016485~protein processing,GO:0021915~neural tube development,GO:0030030~cell projection organization,GO:0030031~cell projection assembly,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042384~cilium assembly,GO:0043009~chordate embryonic development,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0048858~cell projection morphogenesis,GO:0051604~protein maturation,GO:0060271~cilium morphogenesis,GO:0060429~epithelium development,GO:0060562~epithelial tube morphogenesis,GO:0005929~cilium,GO:0042995~cell projection,",0,0,0
POLM,"polymerase (DNA directed), mu",1,0.910322520092466,0.532650659483048,0.999999853599391,1,0.024831902902692,0.464299413733115,0.603473472333079,2,YES,0,"GO:0001775~cell activation,GO:0002200~somatic diversification of immune receptors,GO:0002252~immune effector process,GO:0002377~immunoglobulin production,GO:0002440~production of molecular mediator of immune response,GO:0002520~immune system development,GO:0002521~leukocyte differentiation,GO:0002566~somatic diversification of immune receptors via somatic mutation,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006955~immune response,GO:0016445~somatic diversification of immunoglobulins,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0030097~hemopoiesis,GO:0030098~lymphocyte differentiation,GO:0030183~B cell differentiation,GO:0042113~B cell activation,GO:0045321~leukocyte activation,GO:0046649~lymphocyte activation,GO:0048534~hemopoietic or lymphoid organ development,GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003912~DNA nucleotidylexotransferase activity,GO:0016779~nucleotidyltransferase activity,GO:0034061~DNA polymerase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,","hsa03450:Non-homologous end-joining,",0,0
SRP72,signal recognition particle 72kDa,1,1,0.361326479851158,2.75E-09,1.28E-08,0.024875720306575,0.464423645530041,0.534195552740029,2,YES,0,"GO:0006605~protein targeting,GO:0006612~protein targeting to membrane,GO:0006613~cotranslational protein targeting to membrane,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0033365~protein localization in organelle,GO:0034613~cellular protein localization,GO:0042493~response to drug,GO:0045047~protein targeting to ER,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070727~cellular macromolecule localization,GO:0005786~signal recognition particle, endoplasmic reticulum targeting,GO:0030529~ribonucleoprotein complex,GO:0048500~signal recognition particle,GO:0003723~RNA binding,GO:0005047~signal recognition particle binding,GO:0008312~7S RNA binding,GO:0043021~ribonucleoprotein binding,","hsa03060:Protein export,",0,0
KCMF1,Potassium channel modulatory factor 1,1,1,0.413900866678315,0.999970395621742,1,0.024903143017299,0.464423645530041,0.49727727330703,2,YES,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,",0,0,0
GAS8,growth arrest-specific 8,1,0.971784231743341,0.501831299149681,1,1,0.024913137363944,0.464423645530041,0.348812128614774,2,NO,0,"GO:0006928~cell motion,GO:0008285~negative regulation of cell proliferation,GO:0030317~sperm motility,GO:0042127~regulation of cell proliferation,GO:0048870~cell motility,GO:0051674~localization of cell,GO:0005794~Golgi apparatus,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005929~cilium,GO:0005932~microtubule basal body,GO:0009434~microtubule-based flagellum,GO:0015630~microtubule cytoskeleton,GO:0019861~flagellum,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044463~cell projection part,",0,0,0
MARK3,MAP/microtubule affinity-regulating kinase 3,1,1,0.140051375693358,0.999541621083415,1,0.024977896430124,0.464703314161632,0.700503644192824,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,",0,0,0
MLEC,malectin,1,0.621617423105817,0.616343584684641,0.999999999999978,1,0.025018612239119,0.464997669666172,0.577061275534496,2,NO,0,"GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0030246~carbohydrate binding,",0,0,0
HPCAL4,hippocalcin like 4,1,1,0.236520976817479,1.93E-16,1.22E-15,0.02511724611713,0.465354548101517,0.590830751621198,2,NO,0,"GO:0005246~calcium channel regulator activity,GO:0005509~calcium ion binding,GO:0008022~protein C-terminus binding,GO:0016247~channel regulator activity,GO:0019904~protein domain specific binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
RBM42,RNA binding motif protein 42,1,0.73524777513296,0.601943915278899,2.71E-17,1.75E-16,0.025174366644516,0.465354548101517,0.72922985413033,2,NO,0,"GO:0000166~nucleotide binding,GO:0003723~RNA binding,",0,0,0
CERS3,Ceramide Synthase 3,0.414150439101681,0.876560862545503,0.574103899756076,2.60E-10,1.29E-09,0.025186615148267,0.465354548101517,0.720721795711618,2,NO,0,"ceramide biosynthetic process, keratinocyte differentiation, small molecule metabolic process, sphingolipid biosynthetic process, endoplasmic reticulum membrane, integral to membrane, nuclear membrane, sequence-specific DNA binding transcription factor activity, sphingosine N-acyltransferase activity"," Sphingolipid metabolism, Metabolic pathways",0,0
TEK,"TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal)",1,0.342096927505986,0.631430927157748,0.999649173576059,1,0.025190963815748,0.465354548101517,0.477856921041001,2,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007267~cell-cell signaling,GO:0016310~phosphorylation,GO:0016337~cell-cell adhesion,GO:0022610~biological adhesion,GO:0030334~regulation of cell migration,GO:0031589~cell-substrate adhesion,GO:0040012~regulation of locomotion,GO:0042127~regulation of cell proliferation,GO:0045765~regulation of angiogenesis,GO:0051270~regulation of cell motion,",0,0,0
TNNI3K,TNNI3 interacting kinase; fucose-1-phosphate guanylyltransferase,1,0.623496195591604,0.616343584684641,0.064128231756219,0.189653458039014,0.025245661004968,0.465486562683723,0.541234968848796,2,YES,0,"GO:0005996~monosaccharide metabolic process,GO:0006004~fucose metabolic process,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0019318~hexose metabolic process,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0008022~protein C-terminus binding,GO:0008092~cytoskeletal protein binding,GO:0016779~nucleotidyltransferase activity,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0031013~troponin I binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0047341~fucose-1-phosphate guanylyltransferase activity,GO:0070568~guanylyltransferase activity,","hsa00051:Fructose and mannose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,",0,0
KLHL17,kelch-like 17 (Drosophila),1,0.025485718920263,0.755313294857079,0.999999999949404,1,0.025315022126546,0.465724426662599,0.554968003207753,2,YES,0,"GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0003779~actin binding,GO:0008092~cytoskeletal protein binding,",0,0,0
GFI1B,growth factor independent 1B transcription repressor,1,1,0.462781043665193,0.99837795536404,1,0.025356911072106,0.465724426662599,0.5788955494076,2,YES,0,"GO:0000080~G1 phase of mitotic cell cycle,GO:0000114~regulation of transcription during G1 phase of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051276~chromosome organization,GO:0051318~G1 phase,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,GO:0003677~DNA binding,GO:0003702~RNA polymerase II transcription factor activity,GO:0003704~specific RNA polymerase II transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
CHD9,chromodomain helicase DNA binding protein 9,0.55657847925564,0.01395172132005,0.790831000193366,1,1,0.025441159341354,0.465771369151433,0.397272754032241,2,YES,0,"GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006350~transcription,GO:0016568~chromatin modification,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0000785~chromatin,GO:0005694~chromosome,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",0,0,0
HTR3B,5-hydroxytryptamine (serotonin) receptor 3B,1,1,0.402080599844732,0.999900795943748,1,0.025485202464114,0.465771369151433,0.546430389581706,2,YES,0,"GO:0006811~ion transport,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007210~serotonin receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0019226~transmission of nerve impulse,GO:0050877~neurological system process,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0004993~serotonin receptor activity,GO:0005216~ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005261~cation channel activity,GO:0008227~amine receptor activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0030594~neurotransmitter receptor activity,GO:0042165~neurotransmitter binding,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
ANKDD1A,Ankyrin repeat and death domain containing 1A,1,0.780284580214678,0.594395772667206,0.999999996699822,1,0.025546469289539,0.465771369151433,0.404201671415941,2,NO,0,0,0,0,0
PPP2R3B,"protein phosphatase 2 (formerly 2A), regulatory subunit B'', beta",1,1,0.140051375693358,1,1,0.025558951409616,0.465771369151433,0.736939338266541,2,YES,0,"GO:0003682~chromatin binding,GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0005509~calcium ion binding,GO:0008601~protein phosphatase type 2A regulator activity,GO:0016791~phosphatase activity,GO:0019208~phosphatase regulator activity,GO:0019888~protein phosphatase regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0000159~protein phosphatase type 2A complex,GO:0008287~protein serine/threonine phosphatase complex,GO:0000080~G1 phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0016311~dephosphorylation,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0042127~regulation of cell proliferation,GO:0051318~G1 phase,GO:0051325~interphase,GO:0051329~interphase of mitotic cell cycle,",0,0,0
ZNF697,hypothetical LOC100130667; zinc finger protein 697,1,0.399243341661191,0.628457722964864,4.59E-05,0.000171190681223,0.025598413757183,0.466035838762587,0.44220394980957,2,NO,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
FN1,fibronectin 1,0.93497313539866,0.116981176010963,0.679130630618955,0.999987275057137,1,0.025729212851645,0.467505804334509,0.327991911162426,2,YES,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0002526~acute inflammatory response,GO:0006928~cell motion,GO:0006952~defense response,GO:0006953~acute-phase response,GO:0006954~inflammatory response,GO:0007044~cell-substrate junction assembly,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0008360~regulation of cell shape,GO:0009611~response to wounding,GO:0016477~cell migration,GO:0018149~peptide cross-linking,GO:0022604~regulation of cell morphogenesis,GO:0022610~biological adhesion,GO:0031589~cell-substrate adhesion,GO:0032989~cellular component morphogenesis,GO:0034329~cell junction assembly,GO:0034330~cell junction organization,GO:0034446~substrate adhesion-dependent cell spreading,GO:0042060~wound healing,GO:0048870~cell motility,GO:0051674~localization of cell,GO:0005576~extracellular region,GO:0005577~fibrinogen complex,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005793~ER-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0016324~apical plasma membrane,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0031091~platelet alpha granule,GO:0031093~platelet alpha granule lumen,GO:0031410~cytoplasmic vesicle,GO:0031974~membrane-enclosed lumen,GO:0031982~vesicle,GO:0031983~vesicle lumen,GO:0031988~membrane-bounded vesicle,GO:0043233~organelle lumen,GO:0044420~extracellular matrix part,GO:0044421~extracellular region part,GO:0044433~cytoplasmic vesicle part,GO:0044459~plasma membrane part,GO:0045177~apical part of cell,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0001871~pattern binding,GO:0005198~structural molecule activity,GO:0005201~extracellular matrix structural constituent,GO:0005518~collagen binding,GO:0005539~glycosaminoglycan binding,GO:0008047~enzyme activator activity,GO:0008201~heparin binding,GO:0016504~peptidase activator activity,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,","hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,",0,0
CDKL3,cyclin-dependent kinase-like 3,0.930929953899773,0.745415986888831,0.599319901491912,8.83E-31,8.20E-30,0.025825308094963,0.4687958502486,0.350650354398434,2,YES,0,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",0,0,0
ASB5,ankyrin repeat and SOCS box-containing 5,1,1,0.482145646983651,0.999786899359427,1,0.025910342211107,0.469882798214821,0.188668261226157,2,YES,0,"GO:0006508~proteolysis,GO:0006512~ubiquitin cycle,GO:0007242~intracellular signaling cascade,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,",0,0,0
RIC8B,resistance to inhibitors of cholinesterase 8 homolog B (C. elegans),0.8643690811695,0.337244195918755,0.641447788305282,0.987861923348368,1,0.025956641795791,0.470265870129555,0.244428140004975,2,NO,0,"GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0001965~G-protein alpha-subunit binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",0,0,0
SLC30A9,"Solute carrier family 30 (zinc transporter), member 9",1,0.848879761867496,0.594395772667206,0.999997947129766,1,0.026060901591765,0.470517563774185,0.710313824803237,2,YES,0,"GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005856~cytoskeleton,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0000041~transition metal ion transport,GO:0006350~transcription,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006829~zinc ion transport,GO:0030001~metal ion transport,GO:0045449~regulation of transcription,GO:0055085~transmembrane transport,",0,0,0
STXBP5,syntaxin binding protein 5 (tomosyn),1,0.321013121346181,0.641447788305282,0.999178628674679,1,0.026085076738381,0.470517563774185,0.418100955228567,2,NO,0,"GO:0006887~exocytosis,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032940~secretion by cell,GO:0045184~establishment of protein localization,GO:0046903~secretion,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0031224~intrinsic to membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0044456~synapse part,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0000149~SNARE binding,GO:0017075~syntaxin-1 binding,GO:0019905~syntaxin binding,",0,0,0
RBBP7,Retinoblastoma binding protein 7,1,0.420265180899895,0.628457722964864,0.999999999998765,1,0.026085288207584,0.470517563774185,0.652425960192389,2,YES,0,"GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0000118~histone deacetylase complex,GO:0005654~nucleoplasm,GO:0016581~NuRD complex,GO:0016585~chromatin remodeling complex,GO:0017053~transcriptional repressor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006325~chromatin organization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008283~cell proliferation,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0016568~chromatin modification,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051276~chromosome organization,",0,0,0
ZNF32,Zinc finger protein 32,1,1,0.114326682956047,5.93E-11,3.04E-10,0.026166348501405,0.470517563774185,0.553430339633701,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0045449~regulation of transcription,",0,0,0
ZNF600,Zinc finger protein 600,1,0.886481428527679,0.574103899756076,1,1,0.026171152361511,0.470517563774185,0.635016926945316,2,NO,0,"GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006350~transcription,GO:0045449~regulation of transcription,",0,0,0
FAM46C,"family with sequence similarity 46, member C",1,0.886481428527679,0.559248062668889,0.882862272151556,1,0.026190992995412,0.470517563774185,0.632001884092228,2,NO,0,0,0,0,0
MAP4K4,mitogen-activated protein kinase kinase kinase kinase 4,0.646696693936275,0.024938613744621,0.765782523299255,0.999973046892687,1,0.02619724109027,0.470517563774185,0.183774094968287,2,YES,0,"GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0016310~phosphorylation,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005083~small GTPase regulator activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030695~GTPase regulator activity,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04010:MAPK signaling pathway,",0,0
NEDD9,"Neural precursor cell expressed, developmentally down-regulated 9",1,1,0.338929778260947,1.54E-15,9.46E-15,0.026279685697438,0.471088078387015,0.797375865385233,2,NO,0,"GO:0005794~Golgi apparatus,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005924~cell-substrate adherens junction,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0015630~microtubule cytoskeleton,GO:0016323~basolateral plasma membrane,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030055~cell-substrate junction,GO:0031252~cell leading edge,GO:0042995~cell projection,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0044459~plasma membrane part,GO:0070161~anchoring junction,GO:0000087~M phase of mitotic cell cycle,GO:0000278~mitotic cell cycle,GO:0000279~M phase,GO:0000280~nuclear division,GO:0007010~cytoskeleton organization,GO:0007015~actin filament organization,GO:0007049~cell cycle,GO:0007067~mitosis,GO:0007155~cell adhesion,GO:0007166~cell surface receptor linked signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0022402~cell cycle process,GO:0022403~cell cycle phase,GO:0022610~biological adhesion,GO:0030029~actin filament-based process,GO:0030036~actin cytoskeleton organization,GO:0040008~regulation of growth,GO:0048285~organelle fission,GO:0051017~actin filament bundle formation,GO:0051301~cell division,",0,0,0
VAV1,vav 1 guanine nucleotide exchange factor,1,0.26518730604534,0.64908205921566,0.99999999527134,1,0.026328346995532,0.471088078387015,0.479380690875998,2,NO,0,"GO:0001775~cell activation,GO:0006897~endocytosis,GO:0006909~phagocytosis,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006955~immune response,GO:0007166~cell surface receptor linked signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0007242~intracellular signaling cascade,GO:0008219~cell death,GO:0008624~induction of apoptosis by extracellular signals,GO:0010324~membrane invagination,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016265~death,GO:0030155~regulation of cell adhesion,GO:0035023~regulation of Rho protein signal transduction,GO:0042110~T cell activation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043087~regulation of GTPase activity,GO:0045321~leukocyte activation,GO:0045785~positive regulation of cell adhesion,GO:0046578~regulation of Ras protein signal transduction,GO:0046649~lymphocyte activation,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0005083~small GTPase regulator activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0008270~zinc ion binding,GO:0008289~lipid binding,GO:0019992~diacylglycerol binding,GO:0030528~transcription regulator activity,GO:0030676~Rac guanyl-nucleotide exchange factor activity,GO:0030695~GTPase regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0060589~nucleoside-triphosphatase regulator activity,","hsa04062:Chemokine signaling pathway,hsa04510:Focal adhesion,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,",0,0
MYF6,myogenic factor 6 (herculin),1,0.897377981262048,0.559248062668889,0.999999999999978,1,0.02634905656565,0.471088078387015,0.587636863247448,2,NO,0,"GO:0001756~somitogenesis,GO:0003002~regionalization,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007389~pattern specification process,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0009611~response to wounding,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009952~anterior/posterior pattern formation,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0014706~striated muscle tissue development,GO:0016481~negative regulation of transcription,GO:0031099~regeneration,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0035282~segmentation,GO:0040007~growth,GO:0042060~wound healing,GO:0042246~tissue regeneration,GO:0043009~chordate embryonic development,GO:0043403~skeletal muscle regeneration,GO:0045449~regulation of transcription,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048589~developmental growth,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0060537~muscle tissue development,GO:0060538~skeletal muscle organ development,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,",0,0,0
CCDC171,coiled-coil domain containing 171,0.753093108138707,0.342096927505986,0.641447788305282,0.691945598910409,1,0.026371764159162,0.471088078387015,0.40549848042057,2,NO,0,0,0,0,0
OVOL2,ovo-like 2 (Drosophila),1,0.227591325759547,0.64908205921566,0.99999999997426,1,0.026380327104921,0.471088078387015,0.421130973730096,2,NO,0,"GO:0001667~ameboidal cell migration,GO:0001755~neural crest cell migration,GO:0001838~embryonic epithelial tube formation,GO:0001839~neural plate morphogenesis,GO:0001840~neural plate development,GO:0001841~neural tube formation,GO:0001842~neural fold formation,GO:0002009~morphogenesis of an epithelium,GO:0003002~regionalization,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006928~cell motion,GO:0007389~pattern specification process,GO:0007507~heart development,GO:0008285~negative regulation of cell proliferation,GO:0008593~regulation of Notch signaling pathway,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009890~negative regulation of biosynthetic process,GO:0009891~positive regulation of biosynthetic process,GO:0009953~dorsal/ventral pattern formation,GO:0009968~negative regulation of signal transduction,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010648~negative regulation of cell communication,GO:0010837~regulation of keratinocyte proliferation,GO:0010944~negative regulation of transcription by competitive promoter binding,GO:0014020~primary neural tube formation,GO:0014031~mesenchymal cell development,GO:0014032~neural crest cell development,GO:0014033~neural crest cell differentiation,GO:0016331~morphogenesis of embryonic epithelium,GO:0016477~cell migration,GO:0016481~negative regulation of transcription,GO:0021915~neural tube development,GO:0030856~regulation of epithelial cell differentiation,GO:0030857~negative regulation of epithelial cell differentiation,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0035148~tube lumen formation,GO:0035239~tube morphogenesis,GO:0035295~tube development,GO:0042127~regulation of cell proliferation,GO:0043009~chordate embryonic development,GO:0045449~regulation of transcription,GO:0045596~negative regulation of cell differentiation,GO:0045604~regulation of epidermal cell differentiation,GO:0045605~negative regulation of epidermal cell differentiation,GO:0045616~regulation of keratinocyte differentiation,GO:0045617~negative regulation of keratinocyte differentiation,GO:0045682~regulation of epidermis development,GO:0045683~negative regulation of epidermis development,GO:0045746~negative regulation of Notch signaling pathway,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0048546~digestive tract morphogenesis,GO:0048547~gut morphogenesis,GO:0048557~embryonic digestive tract morphogenesis,GO:0048558~embryonic gut morphogenesis,GO:0048562~embryonic organ morphogenesis,GO:0048565~gut development,GO:0048566~embryonic gut development,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048729~tissue morphogenesis,GO:0048762~mesenchymal cell differentiation,GO:0048870~cell motility,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0051674~localization of cell,GO:0051726~regulation of cell cycle,GO:0055123~digestive system development,GO:0060429~epithelium development,GO:0060485~mesenchyme development,GO:0060562~epithelial tube morphogenesis,GO:0060571~morphogenesis of an epithelial fold,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0010843~promoter binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
QTRTD1,queuine tRNA-ribosyltransferase domain containing 1,1,0.710053497962842,0.601943915278899,0.7257326758821,1,0.026487418260191,0.472097791681406,0.68574727725934,2,YES,0,"GO:0006396~RNA processing,GO:0006399~tRNA metabolic process,GO:0006400~tRNA modification,GO:0008033~tRNA processing,GO:0008616~queuosine biosynthetic process,GO:0008617~guanosine metabolic process,GO:0008618~7-methylguanosine metabolic process,GO:0009116~nucleoside metabolic process,GO:0009119~ribonucleoside metabolic process,GO:0009163~nucleoside biosynthetic process,GO:0009451~RNA modification,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034470~ncRNA processing,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0034660~ncRNA metabolic process,GO:0042278~purine nucleoside metabolic process,GO:0042451~purine nucleoside biosynthetic process,GO:0042455~ribonucleoside biosynthetic process,GO:0044271~nitrogen compound biosynthetic process,GO:0046114~guanosine biosynthetic process,GO:0046116~queuosine metabolic process,GO:0046118~7-methylguanosine biosynthetic process,GO:0046128~purine ribonucleoside metabolic process,GO:0046129~purine ribonucleoside biosynthetic process,GO:0005739~mitochondrion,GO:0008270~zinc ion binding,GO:0008479~queuine tRNA-ribosyltransferase activity,GO:0016763~transferase activity, transferring pentosyl groups,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
SPDYE5,speedy homolog E6 (Xenopus laevis); similar to speedy homolog A; speedy homolog E5 (Xenopus laevis); WBSCR19-like protein 8-like; speedy homolog E1 (Xenopus laevis),1,1,0.332676355469261,1,1,0.026576771440253,0.472899761213033,0.575675537528642,2,NO,0,0,0,0,0
CNOT1,"CCR4-NOT transcription complex, subunit 1",0.579299243471596,0.516028845538254,0.620539289527082,0.999999584815624,1,0.026583047768814,0.472899761213033,0.292467831507589,2,NO,0,"GO:0006350~transcription,GO:0045449~regulation of transcription,","hsa03018:RNA degradation,",0,0
RUNX1T1,"runt-related transcription factor 1; translocated to, 1 (cyclin D-related)",1,0.787282137643685,0.594395772667206,6.48E-25,5.22E-24,0.026623963451295,0.473176986971212,0.772885248949795,2,NO,0,"GO:0006091~generation of precursor metabolites and energy,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045444~fat cell differentiation,GO:0045449~regulation of transcription,GO:0051098~regulation of binding,GO:0051101~regulation of DNA binding,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0008270~zinc ion binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046983~protein dimerization activity,","hsa05200:Pathways in cancer,hsa05221:Acute myeloid leukemia,",0,0
NTNG1,netrin G1,1,0.279429256400848,0.641447788305282,0.995894312845563,1,0.026723957737911,0.47450266785783,0.513941544625017,2,NO,0,"GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0007409~axonogenesis,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0031175~neuron projection development,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048858~cell projection morphogenesis,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0046658~anchored to plasma membrane,","hsa04360:Axon guidance,",0,0
ARHGAP12,Rho GTPase activating protein 12,0.74735679281311,0.649072210399093,0.616343584684641,0.998008540078058,1,0.02681302491606,0.474593863588835,0.221408988213972,2,NO,0,"GO:0005096~GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",0,0,0
NRF1,nuclear respiratory factor 1,1,0.848879761867496,0.594395772667206,0.001109270967264,0.003744140295901,0.026946248283662,0.474593863588835,0.549230693488128,2,NO,0,"GO:0006091~generation of precursor metabolites and energy,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007005~mitochondrion organization,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,","hsa05016:Huntington's disease,",0,0
SLC26A3,"solute carrier family 26, member 3",1,0.858711823250435,0.594395772667206,0.241313999842274,0.666396245277031,0.0269470055392,0.474593863588835,0.636301820281036,2,NO,0,"GO:0006811~ion transport,GO:0006820~anion transport,GO:0007588~excretion,GO:0008272~sulfate transport,GO:0015698~inorganic anion transport,GO:0046903~secretion,GO:0055085~transmembrane transport,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0005903~brush border,GO:0016021~integral to membrane,GO:0016324~apical plasma membrane,GO:0031224~intrinsic to membrane,GO:0031253~cell projection membrane,GO:0031526~brush border membrane,GO:0042995~cell projection,GO:0044459~plasma membrane part,GO:0044463~cell projection part,GO:0045177~apical part of cell,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0008134~transcription factor binding,GO:0008271~secondary active sulfate transmembrane transporter activity,GO:0008509~anion transmembrane transporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0015116~sulfate transmembrane transporter activity,GO:0015297~antiporter activity,GO:0015300~solute:solute antiporter activity,GO:0015301~anion:anion antiporter activity,GO:0030528~transcription regulator activity,GO:0031404~chloride ion binding,GO:0043167~ion binding,GO:0043168~anion binding,",0,0,0
EPHA3,EPH receptor A3,1,0.271476723733921,0.64908205921566,0.999994444232814,1,0.026996373154095,0.474593863588835,0.455517469855574,2,YES,0,"GO:0001659~temperature homeostasis,GO:0001660~fever,GO:0002237~response to molecule of bacterial origin,GO:0002526~acute inflammatory response,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006952~defense response,GO:0006953~acute-phase response,GO:0006954~inflammatory response,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0009611~response to wounding,GO:0009617~response to bacterium,GO:0010033~response to organic substance,GO:0016310~phosphorylation,GO:0031649~heat generation,GO:0032496~response to lipopolysaccharide,GO:0034097~response to cytokine stimulus,GO:0042592~homeostatic process,GO:0048871~multicellular organismal homeostasis,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04360:Axon guidance,",0,0
ZPBP,zona pellucida binding protein,1,1,0.501831299149681,0.988000864296435,1,0.02702998561193,0.474593863588835,0.731337164400344,2,NO,0,"GO:0007338~single fertilization,GO:0007339~binding of sperm to zona pellucida,GO:0008037~cell recognition,GO:0009566~fertilization,GO:0009988~cell-cell recognition,GO:0019953~sexual reproduction,GO:0035036~sperm-egg recognition,GO:0048610~reproductive cellular process,GO:0005576~extracellular region,",0,0,0
ARVCF,armadillo repeat gene deletes in velocardiofacial syndrome,1,0.111721095746119,0.679130630618955,0.999999999999985,1,0.027054604488161,0.474593863588835,0.58762649067602,2,NO,0,"GO:0007155~cell adhesion,GO:0022610~biological adhesion,",0,0,0
DNAJB5,"DnaJ (Hsp40) homolog, subfamily B, member 5",1,1,0.317228921214738,0.000265097096955,0.000930604900212,0.027094747880059,0.474593863588835,0.638154007361914,2,NO,0,"GO:0006457~protein folding,GO:0006986~response to unfolded protein,GO:0010033~response to organic substance,GO:0051789~response to protein stimulus,GO:0031072~heat shock protein binding,GO:0051082~unfolded protein binding,",0,0,0
OLFM3,olfactomedin 3,1,0.495103207283815,0.620539289527082,0.999905650146357,1,0.027098770119936,0.474593863588835,0.433623708726107,2,NO,0,"GO:0001654~eye development,GO:0001754~eye photoreceptor cell differentiation,GO:0007423~sensory organ development,GO:0030182~neuron differentiation,GO:0042461~photoreceptor cell development,GO:0042462~eye photoreceptor cell development,GO:0046530~photoreceptor cell differentiation,GO:0048592~eye morphogenesis,GO:0048666~neuron development,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0044421~extracellular region part,",0,0,0
ZMPSTE24,"zinc metallopeptidase (STE24 homolog, S. cerevisiae)",1,0.76383376707594,0.599319901491912,5.11E-18,3.36E-17,0.027199216006497,0.474593863588835,0.549561689182606,2,YES,0,"GO:0006508~proteolysis,GO:0006997~nucleus organization,GO:0006998~nuclear envelope organization,GO:0009057~macromolecule catabolic process,GO:0010256~endomembrane organization,GO:0016044~membrane organization,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0030327~prenylated protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0008233~peptidase activity,GO:0008235~metalloexopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008238~exopeptidase activity,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,",0,0,0
TNFRSF19,"tumor necrosis factor receptor superfamily, member 19",1,0.910322520092466,0.559248062668889,0.999960263256245,1,0.027304634994081,0.474882008430574,0.628342989328213,2,YES,0,"GO:0000165~MAPKKK cascade,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007254~JNK cascade,GO:0008219~cell death,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0031098~stress-activated protein kinase signaling pathway,GO:0033554~cellular response to stress,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0005739~mitochondrion,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0005031~tumor necrosis factor receptor activity,GO:0019955~cytokine binding,GO:0043120~tumor necrosis factor binding,","hsa04060:Cytokine-cytokine receptor interaction,",0,0
SFMBT2,Scm-like with four mbt domains 2,1,0.179340642005228,0.669292822937893,0.070663615003072,0.207960558475245,0.027419957992488,0.476001296785948,0.726487663328705,2,YES,0,"GO:0045449~regulation of transcription,",0,0,0
PURB,Purine-rich element binding protein B,1,0.38222470049003,0.628457722964864,0.999999932091545,1,0.027505000705775,0.476591751561383,0.465416343852993,2,NO,0,"GO:0000900~translation repressor activity, nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0003700~transcription factor activity,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0016566~specific transcriptional repressor activity,GO:0030371~translation repressor activity,GO:0030528~transcription regulator activity,GO:0032422~purine-rich negative regulatory element binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0045182~translation regulator activity,GO:0046332~SMAD binding,GO:0000228~nuclear chromosome,GO:0005657~replication fork,GO:0005662~DNA replication factor A complex,GO:0005694~chromosome,GO:0030894~replisome,GO:0032993~protein-DNA complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043596~nuclear replication fork,GO:0043601~nuclear replisome,GO:0044427~chromosomal part,GO:0044454~nuclear chromosome part,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045637~regulation of myeloid cell differentiation,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,",0,0,0
ZBTB7C,Zinc finger and BTB domain containing 7C,1,1,0.49108803454918,0.999997033650091,1,0.027597455552938,0.477750576712998,0.55071269705081,2,YES,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
RSRC2,arginine/serine-rich coiled-coil 2,1,0.218555479368028,0.660850491134096,0.999980160936662,1,0.027725512247733,0.478240427850229,0.290080381168915,2,NO,0,0,0,0,0
CAPN2,"Calpain 2, (m/II) large subunit",1,0.58177193050653,0.620539289527082,1.01E-08,4.59E-08,0.027749168180649,0.478240427850229,0.790926018523433,2,YES,0,"GO:0004175~endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0008092~cytoskeletal protein binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0000768~syncytium formation by plasma membrane fusion,GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0001824~blastocyst development,GO:0006508~proteolysis,GO:0006949~syncytium formation,GO:0007520~myoblast fusion,GO:0009792~embryonic development ending in birth or egg hatching,GO:0014902~myotube differentiation,GO:0042692~muscle cell differentiation,GO:0043009~chordate embryonic development,GO:0051146~striated muscle cell differentiation,GO:0070482~response to oxygen levels,","hsa04210:Apoptosis,hsa04510:Focal adhesion,hsa05010:Alzheimer's disease,",0,0
SUPT16H,suppressor of Ty 16 homolog (S. cerevisiae); suppressor of Ty 16 homolog (S. cerevisiae) pseudogene,1,0.227591325759547,0.660850491134096,0.581281457865078,1,0.027753019482729,0.478240427850229,0.5199044328364,2,YES,0,"GO:0006259~DNA metabolic process,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006325~chromatin organization,GO:0006333~chromatin assembly or disassembly,GO:0006337~nucleosome disassembly,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0006974~response to DNA damage stimulus,GO:0022411~cellular component disassembly,GO:0031498~chromatin disassembly,GO:0032774~RNA biosynthetic process,GO:0032984~macromolecular complex disassembly,GO:0032986~protein-DNA complex disassembly,GO:0033554~cellular response to stress,GO:0034621~cellular macromolecular complex subunit organization,GO:0034623~cellular macromolecular complex disassembly,GO:0034728~nucleosome organization,GO:0043933~macromolecular complex subunit organization,GO:0045449~regulation of transcription,GO:0051276~chromosome organization,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0043233~organelle lumen,GO:0070013~intracellular organelle lumen,GO:0003711~transcription elongation regulator activity,GO:0008159~positive transcription elongation factor activity,GO:0030528~transcription regulator activity,",0,0,0
KCNA10,"potassium voltage-gated channel, shaker-related subfamily, member 10",1,0.876560862545503,0.593957751752409,0.001075209378083,0.003632453603401,0.027812768937246,0.478374503663734,0.54618519423141,2,YES,0,"GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0055085~transmembrane transport,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0044459~plasma membrane part,GO:0005216~ion channel activity,GO:0005217~intracellular ligand-gated ion channel activity,GO:0005221~intracellular cyclic nucleotide activated cation channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0015267~channel activity,GO:0015276~ligand-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022834~ligand-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0030955~potassium ion binding,GO:0031420~alkali metal ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0043855~cyclic nucleotide-gated ion channel activity,GO:0046872~metal ion binding,GO:0046873~metal ion transmembrane transporter activity,",0,0,0
ZNF76,zinc finger protein 76 (expressed in testis),1,1,0.296278406649975,0.043368133888523,0.13038361063958,0.027933803169311,0.480014268076872,0.53776215227851,2,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006359~regulation of transcription from RNA polymerase III promoter,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
GGA2,"Golgi associated, gamma adaptin ear containing, ARF binding protein 2",1,0.932145335372239,0.559248062668889,0.99999999760224,1,0.028288734011393,0.485666601653317,0.746960813787186,2,NO,0,"GO:0019899~enzyme binding,GO:0030306~ADP-ribosylation factor binding,GO:0031267~small GTPase binding,GO:0051020~GTPase binding,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0019898~extrinsic to membrane,GO:0030117~membrane coat,GO:0030118~clathrin coat,GO:0030119~AP-type membrane coat adaptor complex,GO:0030131~clathrin adaptor complex,GO:0044431~Golgi apparatus part,GO:0048475~coated membrane,GO:0006886~intracellular protein transport,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0034613~cellular protein localization,GO:0045184~establishment of protein localization,GO:0046907~intracellular transport,GO:0070727~cellular macromolecule localization,","hsa04142:Lysosome,",0,0
CAPSL,calcyphosine-like,1,0.780284580214678,0.599319901491912,3.10E-09,1.45E-08,0.028355906590764,0.486372800008151,0.687306722153096,2,NO,0,"GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
GPATCH2,G patch domain containing 2,1,0.556059539079281,0.620539289527082,0.000714208316427,0.002444694363667,0.028416594391514,0.486658849275222,0.663078987650742,2,NO,0,0,0,0,0
LRCH1,Leucine-rich repeats and calponin homology (CH) domain containing 1,1,0.142038435823367,0.679130630618955,0.993497208127096,1,0.028425539054324,0.486658849275222,0.472597203495999,2,NO,0,0,0,0,0
CLYBL,citrate lyase beta like,1,0.649072210399093,0.616343584684641,0.043970794029884,0.132110416870549,0.028482578738875,0.486658849275222,0.652311189346653,2,NO,0,"GO:0005739~mitochondrion,GO:0009346~citrate lyase complex,GO:0000287~magnesium ion binding,GO:0008815~citrate (pro-3S)-lyase activity,GO:0016833~oxo-acid-lyase activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,",0,0,0
RRAS2,Related RAS viral (r-ras) oncogene homolog 2,1,0.209374382696523,0.001052620449448,0.999980014103286,1,3.64E-07,0.000154608802017,0.613726754510099,1,YES,known,"GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0007265~Ras protein signal transduction,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,","hsa04010:MAPK signaling pathway,hsa04530:Tight junction,hsa04810:Regulation of actin cytoskeleton,","point mutation in ovarian carcinoma line is strongly transforming, characterized as oncogene (8052619); pverexpressed in many cancer types (21781067)",Ras related small GTPase that can drive oncogenesis through activation of PI3K and NFkB pathways (11850823); cells overexpressing this gene also lose sensitivity to antigrowth signals through the TGF-b pathway (17656362)
MBOAT2,Membrane bound O-acyltransferase domain containing 2,1,1,2.55E-05,0.964208446474986,1,3.47E-06,0.001178553805451,0.873530689000813,1,YES,novel,"GO:0003841~1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0008374~O-acyltransferase activity,GO:0016411~acylglycerol O-acyltransferase activity,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0006644~phospholipid metabolic process,GO:0008610~lipid biosynthetic process,GO:0008654~phospholipid biosynthetic process,GO:0019637~organophosphate metabolic process,",0,upregulated in PDAC and reversely correlated with patient survival (19260470),lysophospholipid acyltransferases with broad specificity (18154737)
ARF4,ADP-ribosylation factor 4,1,1,0.000276383233484,0.999701348766762,1,4.63E-05,0.011692834231994,0.557606330089436,1,YES,0,"GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0045184~establishment of protein localization,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005154~epidermal growth factor receptor binding,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,",0,0,0
MFGE8,Milk fat globule-EGF factor 8 protein,1,1,0.00050438743639,0.356789877317619,0.951524574302656,6.99E-05,0.016598827790823,0.836855606921132,1,NO,0,"GO:0001786~phosphatidylserine binding,GO:0005178~integrin binding,GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0008429~phosphatidylethanolamine binding,GO:0032403~protein complex binding,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0006897~endocytosis,GO:0006909~phagocytosis,GO:0006910~phagocytosis, recognition,GO:0006911~phagocytosis, engulfment,GO:0007155~cell adhesion,GO:0007338~single fertilization,GO:0007339~binding of sperm to zona pellucida,GO:0008037~cell recognition,GO:0008284~positive regulation of cell proliferation,GO:0009566~fertilization,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009988~cell-cell recognition,GO:0010033~response to organic substance,GO:0010324~membrane invagination,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0019953~sexual reproduction,GO:0022610~biological adhesion,GO:0030100~regulation of endocytosis,GO:0035036~sperm-egg recognition,GO:0042127~regulation of cell proliferation,GO:0043627~response to estrogen stimulus,GO:0045807~positive regulation of endocytosis,GO:0048545~response to steroid hormone stimulus,GO:0048610~reproductive cellular process,GO:0050764~regulation of phagocytosis,GO:0050766~positive regulation of phagocytosis,GO:0051050~positive regulation of transport,GO:0051130~positive regulation of cellular component organization,GO:0060627~regulation of vesicle-mediated transport,",0,0,0
NSMCE1,Non-SMC element 1 homolog (S. cerevisiae),1,1,0.00050438743639,0.999999999991445,1,0.000181090555249,0.034516229402943,0.831602204708779,1,NO,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~response to DNA damage stimulus,GO:0007242~intracellular signaling cascade,GO:0033554~cellular response to stress,",0,0,0
C16orf45,Chromosome 16 open reading frame 45,1,1,0.006047341309629,1,1,0.000909394542112,0.105241636604541,0.716894806128004,1,NO,0,0,0,0,0
STXBP6,Syntaxin binding protein 6 (amisyn),1,0.745415986888831,0.126985940527448,0.240265690304308,0.663795715011711,0.001009385853048,0.112171389784695,0.648097288103457,1,NO,0,"GO:0016021~integral to membrane,GO:0019898~extrinsic to membrane,GO:0031224~intrinsic to membrane,GO:0016192~vesicle-mediated transport,",0,0,0
MLLT11,"Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11",0.865384930113013,1,0.018809954722435,2.97E-87,1.14E-85,0.001076512311244,0.115033552412092,0.856833604241893,1,NO,0,0,0,0,0
ARHGEF33,Rho guanine nucleotide exchange factor (GEF) 33,1,0.73524777513296,0.140051375693358,0.979214628239618,1,0.001088741613014,0.115033552412092,0.701844489828345,1,NO,0,"regulation of Rho protein signal transduction, Rho guanyl-nucleotide exchange factor activity",0,0,0
TMEM11,Transmembrane protein 11,1,1,0.006047341309629,0.999874317346814,1,0.001238035102725,0.121552332607925,0.731079457875672,1,YES,0,"GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,",0,0,0
NENF,Neuron derived neurotrophic factor,1,0.886481428527679,0.108469860173985,0.001119490055687,0.003776585651107,0.001418446875183,0.133141553676105,0.7947874464197,1,NO,0,"GO:0005506~iron ion binding,GO:0008083~growth factor activity,GO:0020037~heme binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046914~transition metal ion binding,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0009967~positive regulation of signal transduction,GO:0010627~regulation of protein kinase cascade,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0043408~regulation of MAPKKK cascade,GO:0043410~positive regulation of MAPKKK cascade,",0,0,0
UBE2QL1,probable ubiquitin-conjugating enzyme E2 FLJ25076,1,1,0.071350057792824,3.35E-18,2.22E-17,0.001634929172623,0.146821355843381,0.783195668511136,1,YES,0,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004842~ubiquitin-protein ligase activity,GO:0005524~ATP binding,GO:0016879~ligase activity, forming carbon-nitrogen bonds,GO:0016881~acid-amino acid ligase activity,GO:0017076~purine nucleotide binding,GO:0019787~small conjugating protein ligase activity,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,","hsa04120:Ubiquitin mediated proteolysis,",0,0
ITM2C,Integral membrane protein 2C,1,0.621617423105817,0.236520976817479,0.998779359125597,1,0.001847074921385,0.156825056620689,0.602754043727757,1,NO,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
REXO2,"REX2, RNA exonuclease 2 homolog (S. cerevisiae)",1,1,0.078426138322827,0.999999993224824,1,0.001945104259124,0.161478233138557,0.454126464601346,1,YES,0,"GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0008408~3'-5' exonuclease activity,GO:0030145~manganese ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005739~mitochondrion,",0,0,0
C16orf80,Ribosomal protein S24,1,1,0.108469860173985,1,1,0.002299164250279,0.178236140672354,0.709180288289875,1,NO,0,0,0,0,0
SAP30,Suppressor of cytokine signaling 5,1,1,0.003358140319185,0.99978427624419,1,0.00237012065356,0.180440880808866,0.708053187568003,1,NO,0,"GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0000118~histone deacetylase complex,GO:0005654~nucleoplasm,GO:0016585~chromatin remodeling complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010629~negative regulation of gene expression,GO:0016481~negative regulation of transcription,GO:0031327~negative regulation of cellular biosynthetic process,GO:0045449~regulation of transcription,GO:0045892~negative regulation of transcription, DNA-dependent,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,",0,0,0
MRPL49,mitochondrial ribosomal protein L49,1,1,0.071350057792824,0.99998602337914,1,0.002386043019422,0.180440880808866,0.656555078798515,1,YES,0,"GO:0006412~translation,GO:0005739~mitochondrion,GO:0005840~ribosome,GO:0030529~ribonucleoprotein complex,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0003735~structural constituent of ribosome,GO:0005198~structural molecule activity,",0,0,0
C3orf27,Chromosome 3 open reading frame 27,1,1,0.078426138322827,0.999756694519721,1,0.002821810995613,0.198900405988871,0.762432489264297,1,NO,0,0,0,0,0
C16orf87,chromosome 16 open reading frame 87,1,0.886481428527679,0.188473503474035,0.999996494145507,1,0.003137553074169,0.210058616030087,0.634789110654367,1,NO,0,0,0,0,0
NDUFS5,"similar to NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)",1,1,0.140051375693358,1.57E-14,9.33E-14,0.003157084018601,0.210611329940864,0.474299085050373,1,NO,0,"GO:0006091~generation of precursor metabolites and energy,GO:0006119~oxidative phosphorylation,GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006461~protein complex assembly,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007005~mitochondrion organization,GO:0010257~NADH dehydrogenase complex assembly,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016310~phosphorylation,GO:0022900~electron transport chain,GO:0022904~respiratory electron transport chain,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0033108~mitochondrial respiratory chain complex assembly,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0042773~ATP synthesis coupled electron transport,GO:0042775~mitochondrial ATP synthesis coupled electron transport,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0045333~cellular respiration,GO:0055114~oxidation reduction,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0005747~mitochondrial respiratory chain complex I,GO:0019866~organelle inner membrane,GO:0030964~NADH dehydrogenase complex,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0044455~mitochondrial membrane part,GO:0045271~respiratory chain complex I,GO:0070469~respiratory chain,GO:0003954~NADH dehydrogenase activity,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0016651~oxidoreductase activity, acting on NADH or NADPH,GO:0016655~oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor,GO:0050136~NADH dehydrogenase (quinone) activity,","hsa00190:Oxidative phosphorylation,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,",0,0
PNOC,Prepronociceptin,1,1,0.071350057792824,0.999999561197199,1,0.003624831525072,0.221994190350229,0.596448056728571,1,NO,0,"GO:0001515~opioid peptide activity,GO:0005179~hormone activity,GO:0005184~neuropeptide hormone activity,GO:0005576~extracellular region,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007600~sensory perception,GO:0019226~transmission of nerve impulse,GO:0050877~neurological system process,GO:0050890~cognition,",0,0,0
STK16,Serine/threonine kinase 16,1,0.475808461183278,0.413900866678315,7.97E-06,3.12E-05,0.003762689185485,0.224379370119716,0.663593063635187,1,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0006461~protein complex assembly,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016310~phosphorylation,GO:0043933~macromolecular complex subunit organization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,",0,0,0
KRTAP19-1,Keratin associated protein 19-1,1,1,0.016901928635041,0.999992573633313,1,0.003771889406156,0.224379370119716,0.731413456117894,1,NO,0,"GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045111~intermediate filament cytoskeleton,",0,0,0
CNPY1,Canopy 1 homolog (zebrafish),1,0.600158415358331,0.372574147431736,3.07E-07,1.30E-06,0.004074928437077,0.233036105475516,0.822881551324022,1,NO,0,0,0,0,0
HBEGF,Heparin-binding EGF-like growth factor,1,0.175460844584417,0.594395772667206,5.97E-37,6.80E-36,0.004198066997189,0.237625188884391,0.676882335061174,1,NO,0,"GO:0001871~pattern binding,GO:0005154~epidermal growth factor receptor binding,GO:0005539~glycosaminoglycan binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0030246~carbohydrate binding,GO:0030247~polysaccharide binding,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0001558~regulation of cell growth,GO:0006928~cell motion,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007517~muscle organ development,GO:0008016~regulation of heart contraction,GO:0008284~positive regulation of cell proliferation,GO:0008361~regulation of cell size,GO:0009611~response to wounding,GO:0009890~negative regulation of biosynthetic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0010561~negative regulation of glycoprotein biosynthetic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0016477~cell migration,GO:0030307~positive regulation of cell growth,GO:0030334~regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0031327~negative regulation of cellular biosynthetic process,GO:0032535~regulation of cellular component size,GO:0035313~wound healing, spreading of epidermal cells,GO:0040008~regulation of growth,GO:0040012~regulation of locomotion,GO:0040017~positive regulation of locomotion,GO:0042060~wound healing,GO:0042127~regulation of cell proliferation,GO:0044057~regulation of system process,GO:0045793~positive regulation of cell size,GO:0045927~positive regulation of growth,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048870~cell motility,GO:0051270~regulation of cell motion,GO:0051272~positive regulation of cell motion,GO:0051543~regulation of elastin biosynthetic process,GO:0051545~negative regulation of elastin biosynthetic process,GO:0051547~regulation of keratinocyte migration,GO:0051549~positive regulation of keratinocyte migration,GO:0051674~localization of cell,","hsa04012:ErbB signaling pathway,hsa04912:GnRH signaling pathway,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,",0,0
GNG3,"Guanine nucleotide binding protein (G protein), gamma 3",0.930929953899773,1,0.078426138322827,0.998197530642943,1,0.00425738413149,0.238809844420706,0.700533496768456,1,YES,0,"GO:0003924~GTPase activity,GO:0031701~angiotensin receptor binding,GO:0031702~type 1 angiotensin receptor binding,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0044459~plasma membrane part,GO:0000165~MAPKKK cascade,GO:0000187~activation of MAPK activity,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007204~elevation of cytosolic calcium ion concentration,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009755~hormone-mediated signaling,GO:0010033~response to organic substance,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0019725~cellular homeostasis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0032870~cellular response to hormone stimulus,GO:0033674~positive regulation of kinase activity,GO:0042325~regulation of phosphorylation,GO:0042592~homeostatic process,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0051174~regulation of phosphorus metabolic process,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051480~cytosolic calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,","hsa04062:Chemokine signaling pathway,hsa04742:Taste transduction,",0,0
NICN1,nicolin 1,1,1,0.140051375693358,0.999996095567713,1,0.004590211389319,0.249972473880711,0.187413910890407,1,NO,0,"GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,",0,0,0
TXNL1,Thioredoxin-like 1,0.943747496116349,1,0.088933945143094,0.999963299398056,1,0.004717461577153,0.251577990175547,0.735071001782456,1,YES,0,"GO:0015036~disulfide oxidoreductase activity,GO:0016667~oxidoreductase activity, acting on sulfur group of donors,GO:0006091~generation of precursor metabolites and energy,GO:0019725~cellular homeostasis,GO:0022900~electron transport chain,GO:0042592~homeostatic process,GO:0045454~cell redox homeostasis,GO:0055114~oxidation reduction,",0,0,0
SLBP,stem-loop binding protein,1,1,0.108469860173985,2.02E-44,3.03E-43,0.004758684630354,0.252182298860806,0.485765027398848,1,NO,0,"GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0006398~histone mRNA 3'-end processing,GO:0008334~histone mRNA metabolic process,GO:0016071~mRNA metabolic process,GO:0031123~RNA 3'-end processing,GO:0031124~mRNA 3'-end processing,GO:0030529~ribonucleoprotein complex,GO:0003723~RNA binding,GO:0003729~mRNA binding,",0,0,0
LY6D,"lymphocyte antigen 6 complex, locus D",1,1,0.108469860173985,1.90E-132,1.09E-130,0.005069465277821,0.258439940675551,0.849942288499726,1,NO,0,"GO:0007155~cell adhesion,GO:0022610~biological adhesion,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005886~plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,",0,0,0
HS3ST6,Heparan sulfate (glucosamine) 3-O-sulfotransferase 6,1,1,0.188473503474035,0.999945944993984,1,0.005077758885804,0.258439940675551,0.80766008143962,1,NO,0,"GO:0008146~sulfotransferase activity,GO:0008467~[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,GO:0016782~transferase activity, transferring sulfur-containing groups,GO:0034483~heparan sulfate sulfotransferase activity,GO:0005794~Golgi apparatus,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0006948~induction by virus of host cell-cell fusion,GO:0016032~viral reproduction,GO:0019048~virus-host interaction,GO:0019058~viral infectious cycle,GO:0019059~initiation of viral infection,GO:0022415~viral reproductive process,GO:0030260~entry into host cell,GO:0044409~entry into host,GO:0046718~entry of virus into host cell,GO:0051806~entry into cell of other organism during symbiotic interaction,GO:0051828~entry into other organism during symbiotic interaction,GO:0052126~movement in host environment,GO:0052192~movement in environment of other organism during symbiotic interaction,",0,0,0
ZNRF2,zinc and ring finger 2,1,1,0.140051375693358,0.991643716576156,1,0.005138093999015,0.25869126093692,0.668811661370943,1,YES,0,"GO:0006508~proteolysis,GO:0009057~macromolecule catabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000323~lytic vacuole,GO:0005764~lysosome,GO:0005768~endosome,GO:0005773~vacuole,GO:0005886~plasma membrane,GO:0019898~extrinsic to membrane,GO:0030054~cell junction,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
PLN,phospholamban,1,1,0.078426138322827,0.999999990463206,1,0.005263942183027,0.26150312775733,0.350139814233279,1,NO,0,"GO:0002026~regulation of the force of heart contraction,GO:0003013~circulatory system process,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006816~calcium ion transport,GO:0006873~cellular ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0008015~blood circulation,GO:0008016~regulation of heart contraction,GO:0010959~regulation of metal ion transport,GO:0014706~striated muscle tissue development,GO:0015674~di-, tri-valent inorganic cation transport,GO:0019725~cellular homeostasis,GO:0030001~metal ion transport,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0042592~homeostatic process,GO:0043269~regulation of ion transport,GO:0044057~regulation of system process,GO:0045822~negative regulation of heart contraction,GO:0048738~cardiac muscle tissue development,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0051241~negative regulation of multicellular organismal process,GO:0051924~regulation of calcium ion transport,GO:0055065~metal ion homeostasis,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060537~muscle tissue development,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0016528~sarcoplasm,GO:0016529~sarcoplasmic reticulum,GO:0031224~intrinsic to membrane,GO:0031982~vesicle,GO:0004857~enzyme inhibitor activity,GO:0005246~calcium channel regulator activity,GO:0016247~channel regulator activity,GO:0042030~ATPase inhibitor activity,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0060590~ATPase regulator activity,","hsa04020:Calcium signaling pathway,hsa05414:Dilated cardiomyopathy,",0,0
RAB7L1,"RAB7, member RAS oncogene family-like 1",1,0.886481428527679,0.270573056590474,0.000156357172574,0.000557897922924,0.005327232582263,0.261775195189312,0.784688361992882,1,YES,0,"GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0044459~plasma membrane part,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0008104~protein localization,GO:0015031~protein transport,GO:0045184~establishment of protein localization,",0,0,0
RPL39,Ribosomal protein L39,1,1,0.071350057792824,1,1,0.006021026411655,0.268192674653786,0.794558951345462,1,NO,0,"GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005198~structural molecule activity,GO:0005829~cytosol,GO:0005840~ribosome,GO:0015934~large ribosomal subunit,GO:0022625~cytosolic large ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0030529~ribonucleoprotein complex,GO:0033279~ribosomal subunit,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044445~cytosolic part,GO:0006412~translation,GO:0006414~translational elongation,","hsa03010:Ribosome,",0,0
SOCS2,Suppressor of cytokine signaling 2,1,0.745415986888831,0.352752213519394,0.996994388933372,1,0.006067848650195,0.268192674653786,0.683002961269312,1,YES,0,"GO:0005070~SH3/SH2 adaptor activity,GO:0005131~growth hormone receptor binding,GO:0005148~prolactin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0008269~JAK pathway signal transduction adaptor activity,GO:0030674~protein binding, bridging,GO:0051427~hormone receptor binding,GO:0060090~molecular adaptor activity,GO:0001558~regulation of cell growth,GO:0006508~proteolysis,GO:0006916~anti-apoptosis,GO:0007166~cell surface receptor linked signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007259~JAK-STAT cascade,GO:0007568~aging,GO:0009057~macromolecule catabolic process,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009968~negative regulation of signal transduction,GO:0010033~response to organic substance,GO:0010648~negative regulation of cell communication,GO:0010941~regulation of cell death,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0032355~response to estradiol stimulus,GO:0032870~cellular response to hormone stimulus,GO:0040008~regulation of growth,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043434~response to peptide hormone stimulus,GO:0043627~response to estrogen stimulus,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0048545~response to steroid hormone stimulus,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060396~growth hormone receptor signaling pathway,GO:0060416~response to growth hormone stimulus,GO:0060548~negative regulation of cell death,","hsa04630:Jak-STAT signaling pathway,hsa04910:Insulin signaling pathway,hsa04930:Type II diabetes mellitus,",0,0
GJC3,"Gap junction protein, gamma 3, 30.2kDa",1,1,0.078426138322827,3.83E-11,1.99E-10,0.006095815014078,0.268192674653786,0.794534753791619,1,NO,0,"GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005921~gap junction,GO:0005922~connexon complex,GO:0016021~integral to membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0043209~myelin sheath,GO:0044459~plasma membrane part,GO:0001508~regulation of action potential,GO:0006873~cellular ion homeostasis,GO:0007272~ensheathment of neurons,GO:0007600~sensory perception,GO:0007605~sensory perception of sound,GO:0008366~axon ensheathment,GO:0019226~transmission of nerve impulse,GO:0019228~regulation of action potential in neuron,GO:0019725~cellular homeostasis,GO:0042391~regulation of membrane potential,GO:0042552~myelination,GO:0042592~homeostatic process,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050954~sensory perception of mechanical stimulus,GO:0055082~cellular chemical homeostasis,",0,0,0
KRTAP12-4,keratin associated protein 12-4,1,1,0.140051375693358,0.965271481511782,1,0.006404093235185,0.271868312590957,0.508437766534803,1,NO,0,"GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044430~cytoskeletal part,GO:0045095~keratin filament,GO:0045111~intermediate filament cytoskeleton,",0,0,0
PSMA3,"Proteasome (prosome, macropain) subunit, alpha type, 3",1,1,0.140051375693358,0.999999999999999,1,0.006404093235185,0.271868312590957,0.66647237867143,1,YES,0,"GO:0004175~endopeptidase activity,GO:0004298~threonine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0070003~threonine-type peptidase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0000502~proteasome complex,GO:0005829~cytosol,GO:0005839~proteasome core complex,GO:0005856~cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0000278~mitotic cell cycle,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0009057~macromolecule catabolic process,GO:0010498~proteasomal protein catabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0030163~protein catabolic process,GO:0031145~anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031396~regulation of protein ubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051340~regulation of ligase activity,GO:0051351~positive regulation of ligase activity,GO:0051352~negative regulation of ligase activity,GO:0051436~negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051439~regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051443~positive regulation of ubiquitin-protein ligase activity,GO:0051444~negative regulation of ubiquitin-protein ligase activity,GO:0051603~proteolysis involved in cellular protein catabolic process,","hsa03050:Proteasome,",0,0
BATF3,"basic leucine zipper transcription factor, ATF-like 3",1,1,0.119580038737757,8.73E-10,4.18E-09,0.006787737852592,0.281751456330134,0.623309055913052,1,NO,0,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0008134~transcription factor binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0046983~protein dimerization activity,",0,0,0
MCUR1,mitochondrial calcium uniporter regulator 1,1,0.227591325759547,0.601943915278899,8.78E-10,4.21E-09,0.00697069174526,0.286796368083052,0.486943467354681,1,NO,0,"elevation of mitochondrial calcium ion concentration, mitochondrial calcium ion transport, integral to mitochondrial inner membrane, protein binding",0,0,0
PPP2CB,"protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform",1,0.621617423105817,0.450365116245565,0.999999998705628,1,0.007060102717861,0.286875755392808,0.334580868631876,1,YES,0,"GO:0000302~response to reactive oxygen species,GO:0006470~protein amino acid dephosphorylation,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0006979~response to oxidative stress,GO:0009057~macromolecule catabolic process,GO:0009968~negative regulation of signal transduction,GO:0010035~response to inorganic substance,GO:0010498~proteasomal protein catabolic process,GO:0010648~negative regulation of cell communication,GO:0010941~regulation of cell death,GO:0016311~dephosphorylation,GO:0019941~modification-dependent protein catabolic process,GO:0030163~protein catabolic process,GO:0042542~response to hydrogen peroxide,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0046578~regulation of Ras protein signal transduction,GO:0046580~negative regulation of Ras protein signal transduction,GO:0046677~response to antibiotic,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051058~negative regulation of small GTPase mediated signal transduction,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0060548~negative regulation of cell death,GO:0000159~protein phosphatase type 2A complex,GO:0000775~chromosome, centromeric region,GO:0005694~chromosome,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0008287~protein serine/threonine phosphatase complex,GO:0015630~microtubule cytoskeleton,GO:0043228~non-membrane-bounded organelle,GO:0043232~intracellular non-membrane-bounded organelle,GO:0044427~chromosomal part,GO:0044430~cytoskeletal part,GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0005506~iron ion binding,GO:0008022~protein C-terminus binding,GO:0016791~phosphatase activity,GO:0019904~protein domain specific binding,GO:0030145~manganese ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,","hsa04114:Oocyte meiosis,hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04530:Tight junction,hsa04730:Long-term depression,",0,0
FOXE3,forkhead box E3,0.870073081188473,0.344697204816764,0.594395772667206,0.988855086742032,1,0.008481612877428,0.316223646581789,0.320985144961816,1,NO,0,"GO:0001654~eye development,GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006355~regulation of transcription, DNA-dependent,GO:0006366~transcription from RNA polymerase II promoter,GO:0007423~sensory organ development,GO:0008284~positive regulation of cell proliferation,GO:0032774~RNA biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0045449~regulation of transcription,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051252~regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003700~transcription factor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,",0,0,0
MLANA,GTP cyclohydrolase I feedback regulator,1,1,0.071350057792824,0.053533991688428,0.159534369934293,0.009100677826499,0.323329346821258,0.819849861777318,1,NO,0,"GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0012505~endomembrane system,GO:0016021~integral to membrane,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0031090~organelle membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042175~nuclear envelope-endoplasmic reticulum network,GO:0042470~melanosome,GO:0044431~Golgi apparatus part,GO:0044432~endoplasmic reticulum part,GO:0044459~plasma membrane part,GO:0048770~pigment granule,",0,0,0
FAM115C,"family with sequence similarity 115, member C; family with sequence similarity 115, member D (pseudogene)",1,1,0.025719815361466,0.999843504410179,1,0.009304562621366,0.323329346821258,0.559520592271811,1,NO,0,0,0,0,0
CPLX3,complexin 3,1,1,0.108469860173985,2.08E-31,1.98E-30,0.00966132408207,0.329317029963092,0.390657661959957,1,NO,0,"GO:0001505~regulation of neurotransmitter levels,GO:0002790~peptide secretion,GO:0003001~generation of a signal involved in cell-cell signaling,GO:0006836~neurotransmitter transport,GO:0006887~exocytosis,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0009914~hormone transport,GO:0010817~regulation of hormone levels,GO:0015833~peptide transport,GO:0016079~synaptic vesicle exocytosis,GO:0016192~vesicle-mediated transport,GO:0019226~transmission of nerve impulse,GO:0030072~peptide hormone secretion,GO:0030073~insulin secretion,GO:0031644~regulation of neurological system process,GO:0032940~secretion by cell,GO:0044057~regulation of system process,GO:0046879~hormone secretion,GO:0046903~secretion,GO:0046928~regulation of neurotransmitter secretion,GO:0048489~synaptic vesicle transport,GO:0050804~regulation of synaptic transmission,GO:0050877~neurological system process,GO:0051046~regulation of secretion,GO:0051588~regulation of neurotransmitter transport,GO:0051969~regulation of transmission of nerve impulse,GO:0060341~regulation of cellular localization,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0044459~plasma membrane part,GO:0045202~synapse,GO:0000149~SNARE binding,GO:0005326~neurotransmitter transporter activity,GO:0019905~syntaxin binding,",0,0,0
ATAD1,"ATPase family, AAA domain containing 1",1,0.344697204816764,0.601943915278899,0.999956076872124,1,0.010028477105766,0.333907172653477,0.14364276960145,1,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0005524~ATP binding,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,",0,0,0
CKMT1A,"Creatine kinase, mitochondrial 1A",1,1,0.140051375693358,0.996419029035007,1,0.010427252108224,0.340873872752955,0.654990953363197,1,YES,0,"GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0001883~purine nucleoside binding,GO:0004111~creatine kinase activity,GO:0005524~ATP binding,GO:0016775~phosphotransferase activity, nitrogenous group as acceptor,GO:0017076~purine nucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032559~adenyl ribonucleotide binding,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0019866~organelle inner membrane,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0006575~cellular amino acid derivative metabolic process,GO:0006599~phosphagen metabolic process,GO:0006600~creatine metabolic process,","hsa00330:Arginine and proline metabolism,",0,0
WBP4,WW domain binding protein 4 (formin binding protein 21),0.660630962226537,1,0.236520976817479,0.784625818957347,1,0.010866603933019,0.343922656430546,0.664204574325361,1,NO,0,"GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0005654~nucleoplasm,GO:0005681~spliceosome,GO:0016604~nuclear body,GO:0016607~nuclear speck,GO:0030529~ribonucleoprotein complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0016071~mRNA metabolic process,",0,0,0
PSMA7,"proteasome (prosome, macropain) subunit, alpha type, 7",1,1,0.236520976817479,1.34E-18,8.97E-18,0.010866603933019,0.343922656430546,0.806892355785153,1,YES,0,"GO:0000278~mitotic cell cycle,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007049~cell cycle,GO:0009057~macromolecule catabolic process,GO:0010498~proteasomal protein catabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0019941~modification-dependent protein catabolic process,GO:0022402~cell cycle process,GO:0030163~protein catabolic process,GO:0031145~anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,GO:0031396~regulation of protein ubiquitination,GO:0031397~negative regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032268~regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0043085~positive regulation of catalytic activity,GO:0043086~negative regulation of catalytic activity,GO:0043161~proteasomal ubiquitin-dependent protein catabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0044092~negative regulation of molecular function,GO:0044093~positive regulation of molecular function,GO:0044257~cellular protein catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051340~regulation of ligase activity,GO:0051351~positive regulation of ligase activity,GO:0051352~negative regulation of ligase activity,GO:0051436~negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051437~positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051438~regulation of ubiquitin-protein ligase activity,GO:0051439~regulation of ubiquitin-protein ligase activity during mitotic cell cycle,GO:0051443~positive regulation of ubiquitin-protein ligase activity,GO:0051444~negative regulation of ubiquitin-protein ligase activity,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0000502~proteasome complex,GO:0005829~cytosol,GO:0005839~proteasome core complex,GO:0004175~endopeptidase activity,GO:0004298~threonine-type endopeptidase activity,GO:0008233~peptidase activity,GO:0042802~identical protein binding,GO:0070003~threonine-type peptidase activity,GO:0070011~peptidase activity, acting on L-amino acid peptides,","hsa03050:Proteasome,",0,0
HPRT1,Hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome),1,0.428948972702908,0.594395772667206,0.816395538006828,1,0.010900059564585,0.343922656430546,0.664299998613291,1,NO,0,"GO:0000287~magnesium ion binding,GO:0002054~nucleobase binding,GO:0002060~purine binding,GO:0004422~hypoxanthine phosphoribosyltransferase activity,GO:0016763~transferase activity, transferring pentosyl groups,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046983~protein dimerization activity,GO:0000267~cell fraction,GO:0005625~soluble fraction,GO:0005829~cytosol,GO:0000902~cell morphogenesis,GO:0000904~cell morphogenesis involved in differentiation,GO:0001775~cell activation,GO:0001975~response to amphetamine,GO:0006144~purine base metabolic process,GO:0006163~purine nucleotide metabolic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006166~purine ribonucleoside salvage,GO:0006168~adenine salvage,GO:0006178~guanine salvage,GO:0006461~protein complex assembly,GO:0006575~cellular amino acid derivative metabolic process,GO:0006576~biogenic amine metabolic process,GO:0006584~catecholamine metabolic process,GO:0007610~behavior,GO:0007625~grooming behavior,GO:0008219~cell death,GO:0008283~cell proliferation,GO:0009112~nucleobase metabolic process,GO:0009113~purine base biosynthetic process,GO:0009116~nucleoside metabolic process,GO:0009119~ribonucleoside metabolic process,GO:0009163~nucleoside biosynthetic process,GO:0009165~nucleotide biosynthetic process,GO:0009712~catechol metabolic process,GO:0009719~response to endogenous stimulus,GO:0010033~response to organic substance,GO:0010243~response to organic nitrogen,GO:0014075~response to amine stimulus,GO:0016265~death,GO:0016358~dendrite development,GO:0018130~heterocycle biosynthetic process,GO:0018958~phenol metabolic process,GO:0019835~cytolysis,GO:0021537~telencephalon development,GO:0021544~subpallium development,GO:0021756~striatum development,GO:0021895~cerebral cortex neuron differentiation,GO:0021953~central nervous system neuron differentiation,GO:0021954~central nervous system neuron development,GO:0030030~cell projection organization,GO:0030182~neuron differentiation,GO:0030900~forebrain development,GO:0031175~neuron projection development,GO:0032943~mononuclear cell proliferation,GO:0032989~cellular component morphogenesis,GO:0032990~cell part morphogenesis,GO:0033238~regulation of cellular amine metabolic process,GO:0033240~positive regulation of cellular amine metabolic process,GO:0034311~diol metabolic process,GO:0034404~nucleobase, nucleoside and nucleotide biosynthetic process,GO:0034654~nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process,GO:0042053~regulation of dopamine metabolic process,GO:0042069~regulation of catecholamine metabolic process,GO:0042278~purine nucleoside metabolic process,GO:0042417~dopamine metabolic process,GO:0042440~pigment metabolic process,GO:0042451~purine nucleoside biosynthetic process,GO:0042455~ribonucleoside biosynthetic process,GO:0043094~cellular metabolic compound salvage,GO:0043096~purine base salvage,GO:0043101~purine salvage,GO:0043174~nucleoside salvage,GO:0043933~macromolecular complex subunit organization,GO:0044271~nitrogen compound biosynthetic process,GO:0045321~leukocyte activation,GO:0045915~positive regulation of catecholamine metabolic process,GO:0045964~positive regulation of dopamine metabolic process,GO:0046083~adenine metabolic process,GO:0046084~adenine biosynthetic process,GO:0046098~guanine metabolic process,GO:0046099~guanine biosynthetic process,GO:0046100~hypoxanthine metabolic process,GO:0046112~nucleobase biosynthetic process,GO:0046128~purine ribonucleoside metabolic process,GO:0046129~purine ribonucleoside biosynthetic process,GO:0046148~pigment biosynthetic process,GO:0046649~lymphocyte activation,GO:0046651~lymphocyte proliferation,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048812~neuron projection morphogenesis,GO:0048813~dendrite morphogenesis,GO:0048858~cell projection morphogenesis,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051262~protein tetramerization,GO:0051289~protein homotetramerization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0070661~leukocyte proliferation,","hsa00230:Purine metabolism,hsa00983:Drug metabolism,",0,0
TCEA2,"transcription elongation factor A (SII), 2",1,1,0.296278406649975,0.999999972049038,1,0.011227640235757,0.348851864114871,0.508538021683618,1,NO,0,"GO:0006350~transcription,GO:0006351~transcription, DNA-dependent,GO:0006354~RNA elongation,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032774~RNA biosynthetic process,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0005654~nucleoplasm,GO:0008023~transcription elongation factor complex,GO:0031974~membrane-enclosed lumen,GO:0031981~nuclear lumen,GO:0043233~organelle lumen,GO:0044451~nucleoplasm part,GO:0070013~intracellular organelle lumen,GO:0003677~DNA binding,GO:0003702~RNA polymerase II transcription factor activity,GO:0003711~transcription elongation regulator activity,GO:0003746~translation elongation factor activity,GO:0008135~translation factor activity, nucleic acid binding,GO:0008270~zinc ion binding,GO:0030528~transcription regulator activity,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
C15orf53,chromosome 15 open reading frame 53,1,1,0.071350057792824,0.999999992448773,1,0.01209631862773,0.360160260901157,0.185857185939201,1,NO,0,0,0,0,0
HESX1,HESX homeobox 1,1,1,0.296278406649975,0.999992873081546,1,0.012209868062736,0.360511701736542,0.502717808397823,1,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0007423~sensory organ development,GO:0030900~forebrain development,GO:0030916~otic vesicle formation,GO:0042471~ear morphogenesis,GO:0042472~inner ear morphogenesis,GO:0043583~ear development,GO:0043584~nose development,GO:0045449~regulation of transcription,GO:0048562~embryonic organ morphogenesis,GO:0048568~embryonic organ development,GO:0048598~embryonic morphogenesis,GO:0048839~inner ear development,GO:0048853~forebrain morphogenesis,GO:0048854~brain morphogenesis,GO:0051252~regulation of RNA metabolic process,GO:0060541~respiratory system development,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity,GO:0008022~protein C-terminus binding,GO:0016564~transcription repressor activity,GO:0030528~transcription regulator activity,GO:0043565~sequence-specific DNA binding,GO:0047485~protein N-terminus binding,",0,0,0
C5orf28,Chromosome 5 open reading frame 28,1,1,0.188473503474035,4.64E-07,1.94E-06,0.014015406913827,0.374540620790049,0.858948106288967,1,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
CHCHD4,Coiled-coil-helix-coiled-coil-helix domain containing 4,1,0.428948972702908,0.601943915278899,0.039137687129898,0.118255072452178,0.014136256633491,0.374540620790049,0.615161725065536,1,NO,0,"GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005758~mitochondrial intermembrane space,GO:0031967~organelle envelope,GO:0031970~organelle envelope lumen,GO:0031974~membrane-enclosed lumen,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0008104~protein localization,GO:0015031~protein transport,GO:0045184~establishment of protein localization,GO:0055085~transmembrane transport,",0,0,0
DNAJC24,"DnaJ (Hsp40) homolog, subfamily C, member 24",1,0.428948972702908,0.601943915278899,6.41E-05,0.000235867051456,0.014136256633491,0.374540620790049,0.726091432034797,1,NO,0,"GO:0008270~zinc ion binding,GO:0031072~heat shock protein binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
S100A8,S100 calcium binding protein A8,1,1,0.078426138322827,1.71E-30,1.57E-29,0.014366827974655,0.376378653209795,0.88893640540534,1,NO,0,"GO:0005509~calcium ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0009611~response to wounding,",0,0,0
TNFSF12,"TNFSF12-TNFSF13 readthrough transcript; tumor necrosis factor (ligand) superfamily, member 12; tumor necrosis factor (ligand) superfamily, member 13",1,1,0.108469860173985,8.52E-45,1.29E-43,0.014536616865035,0.37796408661028,0.424751213573294,1,NO,0,"GO:0000018~regulation of DNA recombination,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001936~regulation of endothelial cell proliferation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001944~vasculature development,GO:0002637~regulation of immunoglobulin production,GO:0002684~positive regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002696~positive regulation of leukocyte activation,GO:0002697~regulation of immune effector process,GO:0002700~regulation of production of molecular mediator of immune response,GO:0002703~regulation of leukocyte mediated immunity,GO:0002706~regulation of lymphocyte mediated immunity,GO:0002712~regulation of B cell mediated immunity,GO:0002819~regulation of adaptive immune response,GO:0002822~regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002889~regulation of immunoglobulin mediated immune response,GO:0006915~apoptosis,GO:0006917~induction of apoptosis,GO:0006928~cell motion,GO:0006955~immune response,GO:0008219~cell death,GO:0008284~positive regulation of cell proliferation,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010941~regulation of cell death,GO:0010942~positive regulation of cell death,GO:0012501~programmed cell death,GO:0012502~induction of programmed cell death,GO:0016265~death,GO:0016477~cell migration,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptosis,GO:0043065~positive regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043542~endothelial cell migration,GO:0045191~regulation of isotype switching,GO:0045765~regulation of angiogenesis,GO:0045766~positive regulation of angiogenesis,GO:0045830~positive regulation of isotype switching,GO:0045911~positive regulation of DNA recombination,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048296~regulation of isotype switching to IgA isotypes,GO:0048298~positive regulation of isotype switching to IgA isotypes,GO:0048514~blood vessel morphogenesis,GO:0048870~cell motility,GO:0050864~regulation of B cell activation,GO:0050865~regulation of cell activation,GO:0050867~positive regulation of cell activation,GO:0050871~positive regulation of B cell activation,GO:0051052~regulation of DNA metabolic process,GO:0051054~positive regulation of DNA metabolic process,GO:0051094~positive regulation of developmental process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051251~positive regulation of lymphocyte activation,GO:0051674~localization of cell,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044421~extracellular region part,GO:0044459~plasma membrane part,GO:0048471~perinuclear region of cytoplasm,GO:0005125~cytokine activity,GO:0005164~tumor necrosis factor receptor binding,GO:0032813~tumor necrosis factor receptor superfamily binding,","hsa04060:Cytokine-cytokine receptor interaction,hsa04672:Intestinal immune network for IgA production,",0,0
PPT1,palmitoyl-protein thioesterase 1,1,1,0.332676355469261,2.04E-18,1.36E-17,0.014595097293867,0.378116258463431,0.47589616071774,1,YES,0,"GO:0000737~DNA catabolic process, endonucleolytic,GO:0001558~regulation of cell growth,GO:0002084~protein depalmitoylation,GO:0006259~DNA metabolic process,GO:0006308~DNA catabolic process,GO:0006309~DNA fragmentation involved in apoptosis,GO:0006643~membrane lipid metabolic process,GO:0006665~sphingolipid metabolic process,GO:0006873~cellular ion homeostasis,GO:0006885~regulation of pH,GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0006907~pinocytosis,GO:0006915~apoptosis,GO:0006921~cell structure disassembly during apoptosis,GO:0006997~nucleus organization,GO:0007033~vacuole organization,GO:0007040~lysosome organization,GO:0007042~lysosomal lumen acidification,GO:0007267~cell-cell signaling,GO:0007268~synaptic transmission,GO:0007600~sensory perception,GO:0007601~visual perception,GO:0008104~protein localization,GO:0008219~cell death,GO:0008361~regulation of cell size,GO:0009057~macromolecule catabolic process,GO:0010324~membrane invagination,GO:0010941~regulation of cell death,GO:0012501~programmed cell death,GO:0015031~protein transport,GO:0016042~lipid catabolic process,GO:0016044~membrane organization,GO:0016192~vesicle-mediated transport,GO:0016265~death,GO:0019226~transmission of nerve impulse,GO:0019725~cellular homeostasis,GO:0022411~cellular component disassembly,GO:0030003~cellular cation homeostasis,GO:0030004~cellular monovalent inorganic cation homeostasis,GO:0030100~regulation of endocytosis,GO:0030149~sphingolipid catabolic process,GO:0030163~protein catabolic process,GO:0030182~neuron differentiation,GO:0030262~apoptotic nuclear changes,GO:0030308~negative regulation of cell growth,GO:0030641~regulation of cellular pH,GO:0031579~membrane raft organization,GO:0032535~regulation of cellular component size,GO:0040008~regulation of growth,GO:0042157~lipoprotein metabolic process,GO:0042159~lipoprotein catabolic process,GO:0042592~homeostatic process,GO:0042981~regulation of apoptosis,GO:0043066~negative regulation of apoptosis,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0043523~regulation of neuron apoptosis,GO:0043524~negative regulation of neuron apoptosis,GO:0044242~cellular lipid catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0045184~establishment of protein localization,GO:0045792~negative regulation of cell size,GO:0045807~positive regulation of endocytosis,GO:0045851~pH reduction,GO:0045926~negative regulation of growth,GO:0046466~membrane lipid catabolic process,GO:0048259~regulation of receptor-mediated endocytosis,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0048548~regulation of pinocytosis,GO:0048549~positive regulation of pinocytosis,GO:0048666~neuron development,GO:0048878~chemical homeostasis,GO:0050801~ion homeostasis,GO:0050803~regulation of synapse structure and activity,GO:0050877~neurological system process,GO:0050890~cognition,GO:0050953~sensory perception of light stimulus,GO:0051050~positive regulation of transport,GO:0051130~positive regulation of cellular component organization,GO:0051181~cofactor transport,GO:0051186~cofactor metabolic process,GO:0051452~intracellular pH reduction,GO:0051453~regulation of intracellular pH,GO:0055067~monovalent inorganic cation homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0060548~negative regulation of cell death,GO:0060627~regulation of vesicle-mediated transport,GO:0000267~cell fraction,GO:0000323~lytic vacuole,GO:0005576~extracellular region,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005764~lysosome,GO:0005773~vacuole,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0008021~synaptic vesicle,GO:0016023~cytoplasmic membrane-bounded vesicle,GO:0030135~coated vesicle,GO:0030136~clathrin-coated vesicle,GO:0030424~axon,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0031988~membrane-bounded vesicle,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0044456~synapse part,GO:0045121~membrane raft,GO:0045202~synapse,GO:0008474~palmitoyl-(protein) hydrolase activity,GO:0016289~CoA hydrolase activity,GO:0016290~palmitoyl-CoA hydrolase activity,GO:0016291~acyl-CoA thioesterase activity,GO:0016790~thiolester hydrolase activity,","hsa00062:Fatty acid elongation in mitochondria,hsa04142:Lysosome,",0,0
HRSP12,Heat-responsive protein 12,1,1,0.140051375693358,1.59E-58,3.33E-57,0.014806010263608,0.38034222428878,0.871294448788267,1,NO,0,"GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0006417~regulation of translation,GO:0006449~regulation of translational termination,GO:0010608~posttranscriptional regulation of gene expression,GO:0032268~regulation of cellular protein metabolic process,GO:0043244~regulation of protein complex disassembly,",0,0,0
OXCT2,3-oxoacid CoA transferase 2,1,0.259421173804159,0.620539289527082,1.00E-18,6.77E-18,0.014850773440525,0.38051796583755,0.589053586240041,1,NO,0,"GO:0046950~cellular ketone body metabolic process,GO:0046952~ketone body catabolic process,GO:0005739~mitochondrion,GO:0009434~microtubule-based flagellum,GO:0019861~flagellum,GO:0042995~cell projection,GO:0008260~3-oxoacid CoA-transferase activity,GO:0008410~CoA-transferase activity,GO:0016782~transferase activity, transferring sulfur-containing groups,","hsa00072:Synthesis and degradation of ketone bodies,hsa00280:Valine, leucine and isoleucine degradation,hsa00650:Butanoate metabolism,",0,0
NUDT15,nudix (nucleoside diphosphate linked moiety X)-type motif 15,1,1,0.108469860173985,0.654246208155478,1,0.01506054206958,0.383645334188889,0.587186369680258,1,NO,0,"GO:0000287~magnesium ion binding,GO:0030145~manganese ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
C8orf33,chromosome 8 open reading frame 33,1,0.475808461183278,0.601943915278899,1,1,0.015471047815663,0.388063923249691,0.670305257799383,1,NO,0,0,0,0,0
SORD,sorbitol dehydrogenase,1,0.475808461183278,0.601943915278899,0.999999993305407,1,0.015471047815663,0.388063923249691,0.40613327393398,1,NO,0,"GO:0005996~monosaccharide metabolic process,GO:0006000~fructose metabolic process,GO:0006006~glucose metabolic process,GO:0006059~hexitol metabolic process,GO:0006060~sorbitol metabolic process,GO:0006062~sorbitol catabolic process,GO:0006928~cell motion,GO:0016051~carbohydrate biosynthetic process,GO:0016052~carbohydrate catabolic process,GO:0019318~hexose metabolic process,GO:0019319~hexose biosynthetic process,GO:0019400~alditol metabolic process,GO:0019405~alditol catabolic process,GO:0019407~hexitol catabolic process,GO:0019519~pentitol metabolic process,GO:0019527~pentitol catabolic process,GO:0019751~polyol metabolic process,GO:0030317~sperm motility,GO:0034637~cellular carbohydrate biosynthetic process,GO:0044275~cellular carbohydrate catabolic process,GO:0046164~alcohol catabolic process,GO:0046165~alcohol biosynthetic process,GO:0046174~polyol catabolic process,GO:0046364~monosaccharide biosynthetic process,GO:0046370~fructose biosynthetic process,GO:0048870~cell motility,GO:0051160~L-xylitol catabolic process,GO:0051164~L-xylitol metabolic process,GO:0051674~localization of cell,GO:0055114~oxidation reduction,GO:0000267~cell fraction,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005624~membrane fraction,GO:0005625~soluble fraction,GO:0005626~insoluble fraction,GO:0044421~extracellular region part,GO:0000166~nucleotide binding,GO:0003939~L-iditol 2-dehydrogenase activity,GO:0005529~sugar binding,GO:0008270~zinc ion binding,GO:0030246~carbohydrate binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,GO:0048037~cofactor binding,GO:0050662~coenzyme binding,GO:0051287~NAD or NADH binding,","hsa00051:Fructose and mannose metabolism,",0,0
GFER,"growth factor, augmenter of liver regeneration",1,0.524342468927875,0.601943915278899,0.999997593330469,1,0.018179968498227,0.413343985137457,0.482185691737829,1,NO,0,"GO:0007276~gamete generation,GO:0007283~spermatogenesis,GO:0008283~cell proliferation,GO:0019953~sexual reproduction,GO:0032504~multicellular organism reproduction,GO:0048232~male gamete generation,GO:0048609~reproductive process in a multicellular organism,GO:0055114~oxidation reduction,GO:0005739~mitochondrion,GO:0016667~oxidoreductase activity, acting on sulfur group of donors,GO:0016670~oxidoreductase activity, acting on sulfur group of donors, oxygen as acceptor,GO:0016972~thiol oxidase activity,",0,0,0
LCN2,lipocalin 2,1,1,0.188473503474035,0.999999938820577,1,0.018272941040353,0.413343985137457,0.312185643236581,1,NO,0,"GO:0009615~response to virus,GO:0005576~extracellular region,",0,0,0
TMEM106A,hypothetical LOC728772; transmembrane protein 106A,1,1,0.188473503474035,0.999998628694671,1,0.018272941040353,0.413343985137457,0.486836007276002,1,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
TGFA,"Transforming growth factor, alpha",1,1,0.188473503474035,1.56E-14,9.30E-14,0.018272941040353,0.413343985137457,0.628384281752115,1,NO,0,"GO:0001948~glycoprotein binding,GO:0004672~protein kinase activity,GO:0004708~MAP kinase kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0005154~epidermal growth factor receptor binding,GO:0008083~growth factor activity,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0044421~extracellular region part,GO:0000165~MAPKKK cascade,GO:0000187~activation of MAPK activity,GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001944~vasculature development,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007088~regulation of mitosis,GO:0007176~regulation of epidermal growth factor receptor activity,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007346~regulation of mitotic cell cycle,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0009967~positive regulation of signal transduction,GO:0010469~regulation of receptor activity,GO:0010564~regulation of cell cycle process,GO:0010638~positive regulation of organelle organization,GO:0010647~positive regulation of cell communication,GO:0016310~phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0033043~regulation of organelle organization,GO:0033674~positive regulation of kinase activity,GO:0042058~regulation of epidermal growth factor receptor signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042325~regulation of phosphorylation,GO:0043085~positive regulation of catalytic activity,GO:0043405~regulation of MAP kinase activity,GO:0043406~positive regulation of MAP kinase activity,GO:0043549~regulation of kinase activity,GO:0044093~positive regulation of molecular function,GO:0045741~positive regulation of epidermal growth factor receptor activity,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0045787~positive regulation of cell cycle,GO:0045840~positive regulation of mitosis,GO:0045859~regulation of protein kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0048514~blood vessel morphogenesis,GO:0050678~regulation of epithelial cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051130~positive regulation of cellular component organization,GO:0051174~regulation of phosphorus metabolic process,GO:0051302~regulation of cell division,GO:0051338~regulation of transferase activity,GO:0051347~positive regulation of transferase activity,GO:0051726~regulation of cell cycle,GO:0051781~positive regulation of cell division,GO:0051783~regulation of nuclear division,GO:0051785~positive regulation of nuclear division,","hsa04012:ErbB signaling pathway,hsa05200:Pathways in cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05223:Non-small cell lung cancer,",0,0
KRTAP20-2,Keratin associated protein 20-2,1,1,0.108469860173985,0.999992579204969,1,0.018653264789529,0.415780826973287,0.581487424680345,1,NO,0,GO:0005882,0,0,0
KRTAP4-7,Keratin associated protein 4-7,1,1,0.108469860173985,0.999999910586905,1,0.018653264789529,0.415780826973287,0.875148923094927,1,NO,novel,GO:0045095,0,freqeunt target of high copy amplification in pancreatic adenocarcinoma (16080956); expression induced in mammary tumors of transgenic mice expressing mutant activated Neu (17699761),0
MGST1,microsomal glutathione S-transferase 1,1,1,0.332676355469261,0.999997501663887,1,0.0196014748403,0.424125861294527,0.683417900146342,1,YES,0,"GO:0002237~response to molecule of bacterial origin,GO:0003006~reproductive developmental process,GO:0006518~peptide metabolic process,GO:0006575~cellular amino acid derivative metabolic process,GO:0006732~coenzyme metabolic process,GO:0006749~glutathione metabolic process,GO:0006790~sulfur metabolic process,GO:0007548~sex differentiation,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0009617~response to bacterium,GO:0009719~response to endogenous stimulus,GO:0010033~response to organic substance,GO:0010243~response to organic nitrogen,GO:0032496~response to lipopolysaccharide,GO:0033327~Leydig cell differentiation,GO:0042493~response to drug,GO:0045137~development of primary sexual characteristics,GO:0046546~development of primary male sexual characteristics,GO:0046661~male sex differentiation,GO:0048608~reproductive structure development,GO:0048610~reproductive cellular process,GO:0051186~cofactor metabolic process,GO:0000267~cell fraction,GO:0005624~membrane fraction,GO:0005626~insoluble fraction,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005741~mitochondrial outer membrane,GO:0005743~mitochondrial inner membrane,GO:0005777~peroxisome,GO:0005778~peroxisomal membrane,GO:0005783~endoplasmic reticulum,GO:0005792~microsome,GO:0019866~organelle inner membrane,GO:0019867~outer membrane,GO:0019898~extrinsic to membrane,GO:0031090~organelle membrane,GO:0031903~microbody membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031968~organelle outer membrane,GO:0031975~envelope,GO:0042579~microbody,GO:0042598~vesicular fraction,GO:0044429~mitochondrial part,GO:0044438~microbody part,GO:0044439~peroxisomal part,GO:0045177~apical part of cell,GO:0004364~glutathione transferase activity,GO:0016765~transferase activity, transferring alkyl or aryl (other than methyl) groups,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046983~protein dimerization activity,","hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism,",0,0
CLEC18C,"C-type lectin domain family 18, member C",1,1,0.078426138322827,1,1,0.019923359547127,0.425108868211173,0.588896664782234,1,NO,0,"GO:0005576~extracellular region,GO:0005529~sugar binding,GO:0030246~carbohydrate binding,",0,0,0
RNF141,ring finger protein 141,1,1,0.140051375693358,4.65E-37,5.33E-36,0.02005850500602,0.425108868211173,0.567582826932733,1,YES,0,"GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
RAB13,"RAB13, member RAS oncogene family; similar to hCG24991",1,1,0.140051375693358,1.09E-61,2.60E-60,0.02005850500602,0.425108868211173,0.760081549857444,1,YES,0,"GO:0007155~cell adhesion,GO:0007242~intracellular signaling cascade,GO:0007264~small GTPase mediated signal transduction,GO:0008104~protein localization,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0022610~biological adhesion,GO:0045184~establishment of protein localization,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~tight junction,GO:0009898~internal side of plasma membrane,GO:0016327~apicolateral plasma membrane,GO:0030054~cell junction,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0043296~apical junction complex,GO:0044459~plasma membrane part,GO:0070160~occluding junction,GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,","hsa04530:Tight junction,",0,0
CXCL5,Chemokine (C-X-C motif) ligand 5,1,0.600158415358331,0.601943915278899,0.758841951696659,1,0.020446605382969,0.429126002189307,0.532730668281287,1,NO,0,"GO:0005125~cytokine activity,GO:0008009~chemokine activity,GO:0042379~chemokine receptor binding,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0044421~extracellular region part,GO:0006935~chemotaxis,GO:0006955~immune response,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007267~cell-cell signaling,GO:0007610~behavior,GO:0007626~locomotory behavior,GO:0008284~positive regulation of cell proliferation,GO:0042127~regulation of cell proliferation,GO:0042330~taxis,","hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,",0,0
KCTD11,Potassium channel tetramerisation domain containing 11,1,0.475808461183278,0.616343584684641,0.999999763243761,1,0.020778324302823,0.431242577391589,0.532726013034541,1,YES,0,"GO:0005216~ion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005249~voltage-gated potassium channel activity,GO:0005261~cation channel activity,GO:0005267~potassium channel activity,GO:0015267~channel activity,GO:0022803~passive transmembrane transporter activity,GO:0022832~voltage-gated channel activity,GO:0022836~gated channel activity,GO:0022838~substrate specific channel activity,GO:0022843~voltage-gated cation channel activity,GO:0046873~metal ion transmembrane transporter activity,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031226~intrinsic to plasma membrane,GO:0034702~ion channel complex,GO:0034703~cation channel complex,GO:0034705~potassium channel complex,GO:0044459~plasma membrane part,GO:0006811~ion transport,GO:0006812~cation transport,GO:0006813~potassium ion transport,GO:0007049~cell cycle,GO:0015672~monovalent inorganic cation transport,GO:0030001~metal ion transport,GO:0040008~regulation of growth,GO:0042127~regulation of cell proliferation,",0,0,0
NDUFA8,"NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa",0.617460903123271,0.475808461183278,0.616343584684641,0.99999999989628,1,0.020778324302823,0.431242577391589,0.164693181433317,1,NO,0,"GO:0006091~generation of precursor metabolites and energy,GO:0006119~oxidative phosphorylation,GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0016310~phosphorylation,GO:0022900~electron transport chain,GO:0022904~respiratory electron transport chain,GO:0042773~ATP synthesis coupled electron transport,GO:0042775~mitochondrial ATP synthesis coupled electron transport,GO:0045333~cellular respiration,GO:0055114~oxidation reduction,GO:0005739~mitochondrion,GO:0005740~mitochondrial envelope,GO:0005743~mitochondrial inner membrane,GO:0005746~mitochondrial respiratory chain,GO:0005747~mitochondrial respiratory chain complex I,GO:0019866~organelle inner membrane,GO:0030964~NADH dehydrogenase complex,GO:0031090~organelle membrane,GO:0031966~mitochondrial membrane,GO:0031967~organelle envelope,GO:0031975~envelope,GO:0044429~mitochondrial part,GO:0044455~mitochondrial membrane part,GO:0045271~respiratory chain complex I,GO:0070469~respiratory chain,GO:0003954~NADH dehydrogenase activity,GO:0008137~NADH dehydrogenase (ubiquinone) activity,GO:0016651~oxidoreductase activity, acting on NADH or NADPH,GO:0016655~oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor,GO:0050136~NADH dehydrogenase (quinone) activity,","hsa00190:Oxidative phosphorylation,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,",0,0
GNG2,"Guanine nucleotide binding protein (G protein), gamma 2",0.782595818014484,0.475808461183278,0.616343584684641,0.999997953372868,1,0.020778324302823,0.431242577391589,0.677203052559316,1,YES,0,"GO:0005794~Golgi apparatus,GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0009898~internal side of plasma membrane,GO:0019897~extrinsic to plasma membrane,GO:0019898~extrinsic to membrane,GO:0044459~plasma membrane part,GO:0007166~cell surface receptor linked signal transduction,GO:0007186~G-protein coupled receptor protein signaling pathway,GO:0007242~intracellular signaling cascade,GO:0008283~cell proliferation,GO:0009719~response to endogenous stimulus,GO:0009725~response to hormone stimulus,GO:0009755~hormone-mediated signaling,GO:0010033~response to organic substance,GO:0032870~cellular response to hormone stimulus,","hsa04062:Chemokine signaling pathway,",0,0
UBL3,ubiquitin-like 3,1,0.524342468927875,0.616343584684641,0.052578601559959,0.156837383988896,0.021024058932192,0.432975079155907,0.471802284203411,1,NO,0,"GO:0005886~plasma membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,",0,0,0
OARD1,O-acyl-ADP-ribose deacylase 1,1,0.73524777513296,0.594395772667206,0.005274187065395,0.017100597152318,0.022106535079535,0.445445489482877,0.54157130755813,1,NO,0,"purine nucleoside metabolic process, deacetylase activity, protein binding, purine nucleoside binding",0,0,0
ZNF763,zinc finger protein 763,0.46255728259106,1,0.444921389161528,6.06E-10,2.94E-09,0.022414669038123,0.446025619336914,0.355256932224317,1,NO,0,"GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0045449~regulation of transcription,GO:0051252~regulation of RNA metabolic process,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
YIPF4,"Yip1 domain family, member 4",1,0.621617423105817,0.601943915278899,0.786834608184931,1,0.022819527395528,0.448713055333932,0.739968348387254,1,NO,0,"GO:0005783~endoplasmic reticulum,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
SH3BGRL2,SH3 domain binding glutamic acid-rich protein like 2,NA,0.621617423105817,0.601943915278899,0.999999968336474,1,0.023037743810186,0.450416850025752,0.249664706559136,1,NO,0,"GO:0017124~SH3 domain binding,GO:0019904~protein domain specific binding,",0,0,0
OOEP,oocyte expressed protein homolog (dog),1,1,0.188473503474035,0.999999965840174,1,0.023311209521351,0.45264188454474,0.194777783462583,1,NO,0,"GO:0000902~cell morphogenesis,GO:0001701~in utero embryonic development,GO:0006461~protein complex assembly,GO:0006468~protein amino acid phosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0007163~establishment or maintenance of cell polarity,GO:0007389~pattern specification process,GO:0007565~female pregnancy,GO:0007566~embryo implantation,GO:0009566~fertilization,GO:0009792~embryonic development ending in birth or egg hatching,GO:0009880~embryonic pattern specification,GO:0016310~phosphorylation,GO:0019953~sexual reproduction,GO:0032989~cellular component morphogenesis,GO:0034621~cellular macromolecular complex subunit organization,GO:0034622~cellular macromolecular complex assembly,GO:0035088~establishment or maintenance of apical/basal cell polarity,GO:0043009~chordate embryonic development,GO:0043623~cellular protein complex assembly,GO:0043933~macromolecular complex subunit organization,GO:0065003~macromolecular complex assembly,GO:0070271~protein complex biogenesis,GO:0005938~cell cortex,GO:0045177~apical part of cell,GO:0003723~RNA binding,",0,0,0
CCDC92,coiled-coil domain containing 92,1,0.475808461183278,0.620539289527082,0.999999969758604,1,0.023886800187982,0.456034825537431,0.581078434570206,1,YES,0,0,0,0,0
ARL15,ADP-ribosylation factor-like 15,1,0.475808461183278,0.620539289527082,0.999954522833869,1,0.023886800187982,0.456034825537431,0.595890543818629,1,NO,0,"GO:0000166~nucleotide binding,GO:0005525~GTP binding,GO:0017076~purine nucleotide binding,GO:0019001~guanyl nucleotide binding,GO:0032553~ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032561~guanyl ribonucleotide binding,",0,0,0
DEFB114,"defensin, beta 114",1,1,0.296278406649975,0.983929309510182,1,0.024487056096751,0.460182872160454,0.690231261644274,1,NO,0,"GO:0006952~defense response,GO:0009617~response to bacterium,GO:0042742~defense response to bacterium,GO:0005576~extracellular region,",0,0,0
BHLHE23,"basic helix-loop-helix family, member e23",1,0.73524777513296,0.599319901491912,1.10E-09,5.26E-09,0.024692453118098,0.462154641075099,0.636558002885584,1,NO,0,"GO:0001654~eye development,GO:0006350~transcription,GO:0006355~regulation of transcription, DNA-dependent,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007423~sensory organ development,GO:0009791~post-embryonic development,GO:0009886~post-embryonic morphogenesis,GO:0009891~positive regulation of biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010628~positive regulation of gene expression,GO:0010941~regulation of cell death,GO:0031328~positive regulation of cellular biosynthetic process,GO:0043067~regulation of programmed cell death,GO:0043069~negative regulation of programmed cell death,GO:0045449~regulation of transcription,GO:0045893~positive regulation of transcription, DNA-dependent,GO:0045935~positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0045941~positive regulation of transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046668~regulation of retinal cell programmed cell death,GO:0046671~negative regulation of retinal cell programmed cell death,GO:0048050~post-embryonic eye morphogenesis,GO:0048563~post-embryonic organ morphogenesis,GO:0048569~post-embryonic organ development,GO:0048592~eye morphogenesis,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051254~positive regulation of RNA metabolic process,GO:0060284~regulation of cell development,GO:0060548~negative regulation of cell death,GO:0003677~DNA binding,GO:0016563~transcription activator activity,GO:0030528~transcription regulator activity,",0,0,0
OR52W1,"Olfactory receptor, family 52, subfamily W, member 1",1,1,0.140051375693358,0.999999999992588,1,0.025442779723777,0.465771369151433,0.565037027357523,1,NO,0,"GO:0001584,GO:0004872,GO:0004984,GO:0007165,GO:0007186,GO:0007608,GO:0016020,GO:0016021,GO:0050896",0,0,0
MT1G,metallothionein 1G,1,1,0.140051375693358,0.999999706778373,1,0.025442779723777,0.465771369151433,0.684162554139349,1,NO,0,"GO:0005507~copper ion binding,GO:0008270~zinc ion binding,GO:0043167~ion binding,GO:0043169~cation binding,GO:0046870~cadmium ion binding,GO:0046872~metal ion binding,GO:0046914~transition metal ion binding,",0,0,0
PI3,"peptidase inhibitor 3, skin-derived",1,1,0.207292071105334,9.80E-05,0.000355959800147,0.026006925202373,0.470517563774185,0.756274893883819,1,NO,0,"GO:0007618~mating,GO:0007620~copulation,GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0044421~extracellular region part,GO:0004857~enzyme inhibitor activity,GO:0004866~endopeptidase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0030414~peptidase inhibitor activity,",0,0,0
DUSP14,dual specificity phosphatase 14,1,1,0.188473503474035,4.10E-05,0.000153137316081,0.026762523965537,0.474593863588835,0.620592163228948,1,YES,0,"GO:0006470~protein amino acid dephosphorylation,GO:0006793~phosphorus metabolic process,GO:0006796~phosphate metabolic process,GO:0016311~dephosphorylation,GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0033549~MAP kinase phosphatase activity,","hsa04010:MAPK signaling pathway,",0,0
NUDT1,Nudix (nucleoside diphosphate linked moiety X)-type motif 1,1,1,0.236520976817479,0.992483557886955,1,0.02687012539844,0.474593863588835,0.81574720934808,1,NO,0,"GO:0003924~GTPase activity,GO:0008413~8-oxo-7,8-dihydroguanine triphosphatase activity,GO:0006163~purine nucleotide metabolic process,GO:0006195~purine nucleotide catabolic process,GO:0006203~dGTP catabolic process,GO:0006259~DNA metabolic process,GO:0006281~DNA repair,GO:0006974~response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0009141~nucleoside triphosphate metabolic process,GO:0009143~nucleoside triphosphate catabolic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009146~purine nucleoside triphosphate catabolic process,GO:0009151~purine deoxyribonucleotide metabolic process,GO:0009155~purine deoxyribonucleotide catabolic process,GO:0009166~nucleotide catabolic process,GO:0009200~deoxyribonucleoside triphosphate metabolic process,GO:0009204~deoxyribonucleoside triphosphate catabolic process,GO:0009215~purine deoxyribonucleoside triphosphate metabolic process,GO:0009217~purine deoxyribonucleoside triphosphate catabolic process,GO:0009262~deoxyribonucleotide metabolic process,GO:0009264~deoxyribonucleotide catabolic process,GO:0009394~2'-deoxyribonucleotide metabolic process,GO:0033554~cellular response to stress,GO:0034655~nucleobase, nucleoside, nucleotide and nucleic acid catabolic process,GO:0034656~nucleobase, nucleoside and nucleotide catabolic process,GO:0044270~nitrogen compound catabolic process,GO:0046070~dGTP metabolic process,GO:0046700~heterocycle catabolic process,",0,0,0
LY96,Lymphocyte antigen 96,1,0.745415986888831,0.599319901491912,1.17E-18,7.86E-18,0.027167150186949,0.474593863588835,0.85646628123208,1,NO,0,"GO:0001530~lipopolysaccharide binding,GO:0001875~lipopolysaccharide receptor activity,GO:0008329~pattern recognition receptor activity,GO:0015026~coreceptor activity,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0043235~receptor complex,GO:0044421~extracellular region part,GO:0046696~lipopolysaccharide receptor complex,GO:0002237~response to molecule of bacterial origin,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006968~cellular defense response,GO:0007166~cell surface receptor linked signal transduction,GO:0007242~intracellular signaling cascade,GO:0007243~protein kinase cascade,GO:0007249~I-kappaB kinase/NF-kappaB cascade,GO:0009593~detection of chemical stimulus,GO:0009595~detection of biotic stimulus,GO:0009611~response to wounding,GO:0009617~response to bacterium,GO:0010033~response to organic substance,GO:0032490~detection of molecule of bacterial origin,GO:0032496~response to lipopolysaccharide,GO:0032497~detection of lipopolysaccharide,GO:0051606~detection of stimulus,","hsa04620:Toll-like receptor signaling pathway,hsa05130:Pathogenic Escherichia coli infection,",0,0
NDFIP1,Nedd4 family interacting protein 1,1,0.475808461183278,0.620539289527082,1.65E-36,1.82E-35,0.027232543052513,0.474593863588835,0.724393766312792,1,NO,0,"GO:0019904~protein domain specific binding,GO:0050699~WW domain binding,GO:0005794~Golgi apparatus,GO:0005938~cell cortex,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0048471~perinuclear region of cytoplasm,GO:0000018~regulation of DNA recombination,GO:0001817~regulation of cytokine production,GO:0001818~negative regulation of cytokine production,GO:0002637~regulation of immunoglobulin production,GO:0002683~negative regulation of immune system process,GO:0002694~regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0002697~regulation of immune effector process,GO:0002700~regulation of production of molecular mediator of immune response,GO:0002703~regulation of leukocyte mediated immunity,GO:0002706~regulation of lymphocyte mediated immunity,GO:0002712~regulation of B cell mediated immunity,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002819~regulation of adaptive immune response,GO:0002820~negative regulation of adaptive immune response,GO:0002822~regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002823~negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002828~regulation of T-helper 2 type immune response,GO:0002829~negative regulation of T-helper 2 type immune response,GO:0002889~regulation of immunoglobulin mediated immune response,GO:0006873~cellular ion homeostasis,GO:0006879~cellular iron ion homeostasis,GO:0008285~negative regulation of cell proliferation,GO:0009894~regulation of catabolic process,GO:0009896~positive regulation of catabolic process,GO:0009967~positive regulation of signal transduction,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010627~regulation of protein kinase cascade,GO:0010629~negative regulation of gene expression,GO:0010647~positive regulation of cell communication,GO:0010740~positive regulation of protein kinase cascade,GO:0019725~cellular homeostasis,GO:0030003~cellular cation homeostasis,GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,GO:0031348~negative regulation of defense response,GO:0031396~regulation of protein ubiquitination,GO:0031398~positive regulation of protein ubiquitination,GO:0031399~regulation of protein modification process,GO:0031401~positive regulation of protein modification process,GO:0032101~regulation of response to external stimulus,GO:0032102~negative regulation of response to external stimulus,GO:0032268~regulation of cellular protein metabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032409~regulation of transporter activity,GO:0032410~negative regulation of transporter activity,GO:0032673~regulation of interleukin-4 production,GO:0032713~negative regulation of interleukin-4 production,GO:0032880~regulation of protein localization,GO:0032944~regulation of mononuclear cell proliferation,GO:0032945~negative regulation of mononuclear cell proliferation,GO:0042127~regulation of cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042130~negative regulation of T cell proliferation,GO:0042176~regulation of protein catabolic process,GO:0042592~homeostatic process,GO:0043122~regulation of I-kappaB kinase/NF-kappaB cascade,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB cascade,GO:0044092~negative regulation of molecular function,GO:0045191~regulation of isotype switching,GO:0045619~regulation of lymphocyte differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045732~positive regulation of protein catabolic process,GO:0045829~negative regulation of isotype switching,GO:0045910~negative regulation of DNA recombination,GO:0045934~negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process,GO:0048293~regulation of isotype switching to IgE isotypes,GO:0048294~negative regulation of isotype switching to IgE isotypes,GO:0048302~regulation of isotype switching to IgG isotypes,GO:0048585~negative regulation of response to stimulus,GO:0048878~chemical homeostasis,GO:0050670~regulation of lymphocyte proliferation,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050727~regulation of inflammatory response,GO:0050728~negative regulation of inflammatory response,GO:0050777~negative regulation of immune response,GO:0050801~ion homeostasis,GO:0050863~regulation of T cell activation,GO:0050864~regulation of B cell activation,GO:0050865~regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050868~negative regulation of T cell activation,GO:0050869~negative regulation of B cell activation,GO:0051051~negative regulation of transport,GO:0051052~regulation of DNA metabolic process,GO:0051053~negative regulation of DNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051223~regulation of protein transport,GO:0051224~negative regulation of protein transport,GO:0051241~negative regulation of multicellular organismal process,GO:0051247~positive regulation of protein metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0055066~di-, tri-valent inorganic cation homeostasis,GO:0055072~iron ion homeostasis,GO:0055080~cation homeostasis,GO:0055082~cellular chemical homeostasis,GO:0070201~regulation of establishment of protein localization,GO:0070663~regulation of leukocyte proliferation,GO:0070664~negative regulation of leukocyte proliferation,",0,0,0
EFNA4,Ephrin-A4,1,1,0.366923577158073,7.89E-43,1.12E-41,0.027245817353351,0.474593863588835,0.803729813829701,1,YES,0,"GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005003~ephrin receptor activity,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral to plasma membrane,GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,GO:0031225~anchored to membrane,GO:0031226~intrinsic to plasma membrane,GO:0044459~plasma membrane part,GO:0007267~cell-cell signaling,","hsa04360:Axon guidance,",0,0
TBC1D3,"TBC1 domain family, member 3E; TBC1 domain family, member 3F; TBC1 domain family, member 3G; TBC1 domain family member 3C-like protein ENSP00000341742; TBC1 domain family, member 3H; TBC1 domain family, member 3; TBC1 domain family, member 3I; TBC1 domain family, member 3B; TBC1 domain family, member 3C",1,0.745415986888831,0.599319901491912,0.999991343782627,1,0.02726265943738,0.474593863588835,0.573991274559522,1,NO,0,"GO:0032313~regulation of Rab GTPase activity,GO:0032318~regulation of Ras GTPase activity,GO:0032483~regulation of Rab protein signal transduction,GO:0043087~regulation of GTPase activity,GO:0046578~regulation of Ras protein signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051336~regulation of hydrolase activity,GO:0005083~small GTPase regulator activity,GO:0005096~GTPase activator activity,GO:0005097~Rab GTPase activator activity,GO:0005099~Ras GTPase activator activity,GO:0008047~enzyme activator activity,GO:0030695~GTPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,",0,0,0
TMEM151B,transmembrane protein 151B,1,0.745415986888831,0.599319901491912,1.47E-06,5.98E-06,0.027447295332852,0.476033453595485,0.674887532687962,1,NO,0,"GO:0016021~integral to membrane,GO:0031224~intrinsic to membrane,",0,0,0
